A0_Samples	A17_Age	A18_Sex	A1_OS	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A7_Grade	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	age_at_initial_pathologic_diagnosis	animal_insect_allergy_history	animal_insect_allergy_types	asthma_history	bcr_patient_barcode	bcr_patient_uuid	day_of_form_completion	days_to_birth	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_performance_status_assessment	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	eastern_cancer_oncology_group	eczema_history	ethnicity	family_history_of_cancer	family_history_of_primary_brain_tumor	first_diagnosis_age_asth_ecz_hay_fev_mold_dust	first_diagnosis_age_of_animal_insect_allergy	first_diagnosis_age_of_food_allergy	first_presenting_symptom	first_presenting_symptom_longest_duration	follow_ups.follow_up.additional_pharmaceutical_therapy	follow_ups.follow_up.additional_radiation_therapy	follow_ups.follow_up.additional_surgery_locoregional_procedure	follow_ups.follow_up.additional_surgery_metastatic_procedure	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_additional_surgery_locoregional_procedure	follow_ups.follow_up.days_to_additional_surgery_metastatic_procedure	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.days_to_performance_status_assessment	follow_ups.follow_up.eastern_cancer_oncology_group	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.followup_treatment_success	follow_ups.follow_up.karnofsky_performance_score	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_event_after_initial_treatment	follow_ups.follow_up.patient_death_reason	follow_ups.follow_up.performance_status_scale_timing	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.primary_therapy_outcome_success	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	food_allergy_history	food_allergy_types	gender	hay_fever_history	headache_history	histological_type	history_ionizing_rt_to_head	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	inherited_genetic_syndrome_found	inherited_genetic_syndrome_result	karnofsky_performance_score	laterality	ldh1_mutation_found	ldh1_mutation_test_method	ldh1_mutation_tested	mental_status_changes	mold_or_dust_allergy_history	month_of_form_completion	motor_movement_changes	neoplasm_histologic_grade	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.locoregional_procedure.additional_surgery_locoregional_procedure	new_tumor_events.new_tumor_event.locoregional_procedure.days_to_additional_surgery_locoregional_procedure	new_tumor_events.new_tumor_event.metastatic_procedure.additional_surgery_metastatic_procedure	new_tumor_events.new_tumor_event.metastatic_procedure.days_to_additional_surgery_metastatic_procedure	new_tumor_events.new_tumor_event_after_initial_treatment	other_dx	patient_id	performance_status_scale_timing	person_neoplasm_cancer_status	postoperative_rx_tx	preoperative_antiseizure_meds	preoperative_corticosteroids	primary_therapy_outcome_success	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	seizure_history	sensory_changes	supratentorial_localization	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_location	tumor_tissue_site	visual_changes	vital_status	year_of_form_completion	year_of_initial_pathologic_diagnosis
TCGA-DU-A7TI	32	MALE	1183	Astrocytoma	Central nervous system	Dead	G3	1	822.0			WITH TUMOR		32	Unknown	Not Available	Unknown	TCGA-DU-A7TI	0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1	5	-11906	1183	0	Not Available	Not Available	Not Available	TCGA-DU-A7TI-D56400;TCGA-DU-A7TI-D56401;TCGA-DU-A7TI-D56402;TCGA-DU-A7TI-D56403;TCGA-DU-A7TI-D56404	3DBCD02E-18B5-4232-83A3-CBC38B81A66A;FBC93972-332A-4D0B-B1F9-36513FE8138C;0B8FDF31-EB56-4FB1-8911-0881FCD1E914;8D714D3D-DD1F-44B6-B734-026BF73E8416;F92A10E6-179B-4166-8B5F-6D6EA935DA87	Targeted Molecular Therapy;Targeted Molecular Therapy;Not Available;Not Available;Not Available	5;5;5;5;5	567;840;1085;1154;1154	232;840;932;1115;1115	SU101;ONYX-015;Temozolomide;cis-retinoic acid;Carmustine (BCNU)	Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	2;2;2;2;2	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Not Available;Not Available;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;NO;NO;NO	2014;2014;2014;2014;2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	91 - 180 Days																														Unknown	Not Available	MALE	Unknown	NO	Astrocytoma	Not Available	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	YES	Unknown	2	NO	G3	YES	NO	822	YES	840	NO	Not Available	YES	No	A7TI	Not Evaluated	WITH TUMOR	YES	YES	Unknown	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-DU-A7TI-R56399	F0B2F0E0-52FD-4325-82B1-72BF7AFBE618	Not Available	5	Discrepancy	Discrepancy	Radiographic Progressive Disease	2	Not Available	59	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Cerebral Cortex	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	1998
TCGA-S9-A7J2	25	MALE	62	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		25	NO	Not Available	NO	TCGA-S9-A7J2	194E8231-E8D4-477F-8C62-E11F2484ECCE	12	-9345	Not Applicable	0	62	Not Available	-4	TCGA-S9-A7J2-D54313;TCGA-S9-A7J2-D55870;TCGA-S9-A7J2-D55871	6C6D2716-FE6F-46D4-9E96-4D71B6C39880;37EB9F05-E168-4FD1-9867-222ABCFCA522;F5C63655-7238-45FE-9889-E99852633505	Not Available;Not Available;Not Available	18;17;17	Not Available;Not Available;Not Available	62;62;62	Lomustine;Procarbazine;VINCRISTINE	Not Available;Not Available;Not Available	12;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2014;2014	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-S9-A7J2-F67229;TCGA-S9-A7J2-F70007;TCGA-S9-A7J2-F71266	CAFF3CB5-9818-44B4-813B-88A828B54001;F8352C7D-BB52-4B61-94DE-F8D34F56CEAE;2A1E837B-0A03-4DBA-B82C-D740B12C1218	3;26;24	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	62;62;62	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown;Unknown	Not Available;Not Available;Not Available	YES;YES;YES	11;1;3	Not Available;Not Available;Not Available	Unknown;Unknown;Unknown	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Partial Remission/Response;Partial Remission/Response;Partial Remission/Response	NO;NO;NO	Alive;Alive;Alive	2014;2015;2015	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	80	Left	YES	IHC	YES	YES	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7J2	Preoperative	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-P5-A730	22	MALE	333	Oligoastrocytoma	Central nervous system	Alive	G3	0	333			TUMOR FREE		22	Not Available	Not Available	Not Available	TCGA-P5-A730	446D76DF-3E78-4272-A942-CED0DE27C794	13	-8043	Not Applicable	0	6	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A730-F69023	90E089B7-AB1C-4884-9506-E7D1081B8640	24	Not Available	Not Available	Not Applicable	333	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	NO	12	Not Available	NO	Not Available	Not Available	Not Available	NO	Complete Remission/Response	NO	Alive	2014	Not Available	Not Available	MALE	Not Available	Not Available	Oligoastrocytoma	Not Available	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A730	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown																			Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Occipital Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-HT-7474	52	MALE	114	Oligoastrocytoma	Central nervous system	Alive	G2	0	114			Not Available		52	NO	Not Available	NO	TCGA-HT-7474	72aa812d-5daa-4bd7-9028-ec541b1f25bd	7	-19149	Not Applicable	0	114	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7474-F28779	0c1eeecc-366a-4982-923e-0025d0ddc9c5	1	Not Available	Not Available	Not Applicable	114	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7474	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-TM-A84C	32	MALE	492	Astrocytoma	Central nervous system	Dead	G2	1				WITH TUMOR		32	NO	Not Available	YES	TCGA-TM-A84C	8643437F-CD1B-47C8-86BD-87B6C2F80747	16	-11849	Not Applicable	0	459	Not Available	0	TCGA-TM-A84C-D56641	315CD50A-7BFA-4B52-8B0F-126DDC841902	Not Available	16	459	297	Temozolomide	Clinical Progressive Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	< 12 Years	Not Available	Not Available	Visual Changes	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84C-F64988	2FA0705B-BA34-4CD6-B6AB-052EA1B76EA9	17	Not Available	Not Available	492	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	80	Midline	NO	IHC	YES	YES	NO	2	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84C	Preoperative	WITH TUMOR	YES	Unknown	Unknown	Progressive Disease	WHITE	NO																			NO	YES	Not listed in Medical Record	NO	YES	TM	Posterior Fossa, Brain Stem	Central nervous system	YES	Alive	2014	2012
TCGA-TQ-A7RG	36	MALE	599	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		36	NO	Not Available	NO	TCGA-TQ-A7RG	619E18C1-09B9-468C-816D-6789C0BEF0A8	25	-13227	Not Applicable	0	599	Not Available	-32																								Unknown	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RG-F65500	A81604C3-CCBB-45BE-8DCE-6C26ED7466BA	19	Not Available	Not Available	Not Applicable	599	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	NO	2	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2015	NO	Not Available	MALE	NO	Unknown	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	Unknown	NO	NO	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A7RG	Preoperative	WITH TUMOR	YES	YES	YES	Partial Remission/Response	WHITE	NO																			YES	NO	White Matter	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2014	2012
TCGA-HT-A74O	34	MALE	3	Astrocytoma	Central nervous system	Alive	G3	0	3			Unknown		34	NO	Not Available	NO	TCGA-HT-A74O	723CAD09-AA2D-4492-B19D-661B310E1C58	18	-12460	Not Applicable	0	3	Not Available	Not Available																								Unknown	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A74O-F63075	C0524DA4-BB43-462B-A48C-783387D53A16	30	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	7	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Unknown	Left	Not Available	Not Available	NO	NO	NO	11	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A74O	Not Available	Unknown	Unknown	YES	NO	Unknown	WHITE	Unknown																			NO	YES	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2013	2013
TCGA-S9-A7J3	52	FEMALE	629	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		52	NO	Not Available	NO	TCGA-S9-A7J3	032096A6-1923-44B9-A1CB-181BED041C8E	12	-19056	Not Applicable	0	247	Not Available	-14	TCGA-S9-A7J3-D54317;TCGA-S9-A7J3-D55872;TCGA-S9-A7J3-D55873	340DB40F-BC8C-4491-97EB-77052E2774E2;AA5936A5-5DA4-4CD8-8BB0-B78072DC246F;66B33756-4A29-4BFE-953E-AAB81C2A11F5	Not Available;Not Available;Not Available	18;17;17	177;177;177	2;2;2	Lomustine;Procarbazine;Vincristine	Stable Disease;Stable Disease;Stable Disease	12;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2014;2014	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A7J3-F67230;TCGA-S9-A7J3-F70008	74F5BFF2-9C9C-4951-AB24-CA825A819786;0089861F-AB99-4D41-AC07-534421090472	3;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	518;629	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	11;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Partial Remission/Response;Partial Remission/Response	YES;YES	Alive;Alive	2014;2015	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7J3	Preoperative	WITH TUMOR	YES	YES	YES	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A7J3-R54314	CC0365A5-9566-44AF-8791-C6A985CA0A8F	Not Available	18	247	177	Stable Disease	12	33	59.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	NO	YES	S9	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-CS-6666	22	MALE	1428	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		22	NO	Not Available	NO	TCGA-CS-6666	8cba230b-46db-4d35-8123-3879eba32402	24	-8340	Not Applicable	0	258	Not Available	-1	TCGA-CS-6666-D17578	e4bada7d-4627-43bb-9c13-8188395833ad	Not Available	24	Not Available	32	Temodar	Not Available	9	Not Available	Not Available	mg	ADJUVANT	Not Applicable	1	PO	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-6666-F17577;TCGA-CS-6666-F71562	19fe5289-f597-4775-bdb3-bbfd696290cf;02F1355A-8BB3-411F-9A9B-3DD296E3ED2F	24;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	258;1428	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	9;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;TUMOR FREE	YES;Not Available	Stable Disease;Complete Remission/Response	YES;Not Available	Alive;Alive	2011;2015	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6666	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-6666-R17579	3d9002a8-63ef-4d97-beb6-0941ed9f586c	1	13	78	Not Available	Not Available	10	Not Available	59.4	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-FG-7637	49	MALE	1219	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		49	NO	Not Available	NO	TCGA-FG-7637	c40ab957-fe46-43b1-992d-b4e2040a3f57	6	-18084	Not Applicable	0	802	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	Not Available	Not Available	Seizures	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-7637-F32987;TCGA-FG-7637-F41579	54453E51-BFD0-4138-BFC1-8B6F90F7CB32;07AB414A-C552-4199-898A-2279B5E9E8DF	18;21	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1020;1219	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	Not Available;NO	6;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Stable Disease;Stable Disease	NO;NO	Alive;Alive	2012;2013	NO	Not Available	MALE	YES	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7637	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-FG-A6IZ	60	MALE	457	Oligodendroglioma	Central nervous system	Alive	G2	0	457			TUMOR FREE		60	NO	Not Available	NO	TCGA-FG-A6IZ	DA13446A-C4DC-4D02-80C8-410273925AC4	4	-22275	Not Applicable	0	128	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	> 20 Years	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A6IZ-F63721	D2D7B214-DC45-4A3C-A45B-D5A79E9F6C6F	15	Not Available	Not Available	Not Applicable	457	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	8	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	YES	NO	NO	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6IZ	Not Evaluated	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-FG-A6IZ-R48033	8006C123-BCEE-4F88-9213-CC784494C625	Not Available	4	93	54	Complete Response	9	30	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Cerebral Cortex	YES	NO	FG	Supratentorial, Not Otherwise Specified	Central nervous system	NO	Alive	2013	2013
TCGA-S9-A6UB	52	MALE	3761	Oligodendroglioma	Central nervous system	Alive	G2	0	3761			TUMOR FREE		52	NO	Not Available	YES	TCGA-S9-A6UB	DD85DBB2-31C3-4BC2-9DFF-3BD27C79A9AD	4	-19223	Not Applicable	0	3156	Not Available	-1																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-S9-A6UB-F63761;TCGA-S9-A6UB-F69985;TCGA-S9-A6UB-F71262;TCGA-S9-A6UB-F72418	CFA58D11-9D10-4D94-A2D6-01BCE7952DF8;CEFE444E-F00B-46CA-8FE1-E6ACD5D007D1;5A8501B0-1662-40EF-9E8E-664B05E4592E;358540A0-96C2-4774-AE5D-C82FB555FE22	18;26;24;15	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3236;3236;3236;3761	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease;Stable Disease;Unknown	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;NO	8;1;3;6	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;Unknown	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE;Unknown	NO;NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2014;2015;2015;2015	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	11	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6UB	Preoperative	TUMOR FREE	NO	NO	NO	Complete Remission/Response	WHITE	NO																			NO	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2005
TCGA-TQ-A7RP	66	MALE	914	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		66	NO	Not Available	NO	TCGA-TQ-A7RP	7116CE06-D730-40E4-92D7-AEF1F869B1D5	17	-24109	Not Applicable	0	914	Not Available	152																								0	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RP-F65564	6DAD6A02-3546-4A38-A3E8-6A717F6A7E3C	17	Not Available	Not Available	Not Applicable	914	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	YES	2	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2015	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RP	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Partial Remission/Response	BLACK OR AFRICAN AMERICAN	YES																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-DU-7015	41	FEMALE	2761	Oligodendroglioma	Central nervous system	Alive	G2	1	591.0			WITH TUMOR		41	Not Available	Not Available	Not Available	TCGA-DU-7015	ec82a00f-3909-4781-8ae2-e54cbc1ac7ac	8	-15041	Not Applicable	0	2761	Not Available	14	TCGA-DU-7015-D18637;TCGA-DU-7015-D18634;TCGA-DU-7015-D18635	6c6ae3a3-1841-4e11-abd9-db485469e117;6d0329fe-9b8c-4443-b156-60a52d35590c;8163fd2e-6bd9-4728-89fb-b7b1aaf8868d	Not Available;Not Available;Not Available	8;8;8	Not Available;884;1460	930;616;930	Bevacizumab;Temozolomide;Irinotecan	Not Available;Not Available;Not Available	11;11;11	Not Available;6;17	Not Available;200;Not Available	mg/kg;mg/m2;mg/kg	PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	2;1;2	IV;PO;IV	YES;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;440;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	YES	NO	TCGA-DU-7015-F18631	5fb1e5fc-065b-46b0-9c59-f925f4349753	8	591	Not Available	Not Applicable	2761	591	613	Not Available	Not Available	Progressive Disease	90	Not Available	11	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	NO	Progressive Disease	NO	Alive	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	11	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7015	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7015-R18633	5f3e4416-9b58-4f4f-b7b3-a40bfdb420c8	1	8	810	756	Not Available	11	Not Available	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2004
TCGA-HT-7857	24	FEMALE	7	Astrocytoma	Central nervous system	Alive	G3	0	7			TUMOR FREE		24	NO	Not Available	NO	TCGA-HT-7857	4e1606e5-f4c1-41a2-9f2c-ad0d02650070	27	-8912	Not Applicable	0	7	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7857-F29669	baad7653-c89d-474a-95fe-3de3bd1cdaf3	15	Not Available	Not Available	Not Applicable	7	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Not Available	NO	Alive	2012	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	3	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7857	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available																			NO	NO	Not listed in Medical Record	Not Available	Not Available	HT	Supratentorial, Not Otherwise Specified	Central nervous system	YES	Alive	2012	2006
TCGA-CS-4943	37	MALE	1106	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		37	Not Available	Not Available	Not Available	TCGA-CS-4943	952dfd5d-e65a-4307-b6a9-2ed2b0d2d9ce	16	-13565	Not Applicable	0	481	Not Available	9	TCGA-CS-4943-D10215	442c5dd3-d3e9-4c63-8979-b2db1ad4b768	Not Available	12	Not Available	408	Temodar	Not Available	4	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	PO	YES	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-4943-F10324;TCGA-CS-4943-F71549	0d866ea1-a604-4de4-996b-40d88d3705e1;2D40131D-7718-4D0A-AACA-F72DAADCACDE	12;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;1106	552;Not Available	Not Available;Not Available	9;Not Available	4;Not Available	Not Available;Not Available	Not Available;Not Applicable	50;Not Available	Not Available;NO	4;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Preoperative;Not Available	WITH TUMOR;Unknown	YES;Not Available	Not Available;Not Available	NO;Not Available	Alive;Dead	2011;2015	Not Available	Not Available	MALE	Not Available	YES	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	50	Left	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4943	Preoperative	WITH TUMOR	Not Available	YES	Not Available	Not Available	WHITE	Not Available																			YES	Not Available	Cerebral Cortex	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2011	2009
TCGA-P5-A77W	37	FEMALE	584	Oligoastrocytoma	Central nervous system	Alive	G3	0	584			TUMOR FREE		37	Not Available	Not Available	Not Available	TCGA-P5-A77W	EEF15B5C-5FBE-482A-B3B0-DD091888A6A2	13	-13545	Not Applicable	0	5	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A77W-F69028	2C6950F9-8C92-4DC0-8DF0-F8984EDD6958	24	Not Available	Not Available	Not Applicable	584	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Unknown	NO	Not Applicable	NO	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Oligoastrocytoma	Not Available	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A77W	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown																			Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-HT-7884	44	FEMALE	343	Astrocytoma	Central nervous system	Alive	G2	0	343			Discrepancy		44	NO	Not Available	YES	TCGA-HT-7884	86aa5790-9afd-4653-926a-625516df1f56	12	-16280	Not Applicable	0	343	Not Available	112	TCGA-HT-7884-D35007;TCGA-HT-7884-D35008	B10095BE-6E20-46D6-92AD-0C978F3ED062;9460EED9-0696-49E1-846F-0C0B13665B01	Not Available;Not Available	12;12	84;Not Available	44;112	Temodar;Temodar	Stable Disease;Not Applicable	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2012;2012	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	< 12 Years	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7884-F35005	AB65BCB6-8C94-4A94-A114-43967C477ACE	12	Not Available	Not Available	Not Applicable	343	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	Discrepancy	YES	Stable Disease	YES	Alive	2012	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	80	Left	Not Available	Not Available	NO	YES	NO	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	7884	Post-Adjuvant Therapy	Discrepancy	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-HT-7884-R35006	7D183F05-47EA-4BD2-ADDF-1967C989AB0C	Not Available	12	84	44	Stable Disease	9	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-DU-7007	33	MALE	1915	Astrocytoma	Central nervous system	Dead	G2	0	1915			Not Available		33	Not Available	Not Available	YES	TCGA-DU-7007	8e2dcc00-9f7e-4dee-b24d-43c8b30294c5	28	-12245	1915	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-7007-F17216	bfa51466-5aea-4999-94b1-107a64bd5d84	28	Not Available	Not Available	1915	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Dead	2011	Not Available	Not Available	MALE	Not Available	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	NO	Not Available	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7007	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			NO	YES	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1997
TCGA-FG-A6J1	44	FEMALE	500	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		44	NO	Not Available	NO	TCGA-FG-A6J1	EA31C705-4CF8-48F5-8D13-E43563213C91	21	-16106	Not Applicable	0	124	Not Available	27																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A6J1-F63724	F39DBC46-888E-4D01-8286-4B18DC934090	15	Not Available	Not Available	Not Applicable	500	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	8	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	70	Left	YES	IHC	YES	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6J1	Pre-Adjuvant Therapy	WITH TUMOR	NO	NO	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-FG-A6J1-R47034	4D29F4AB-3B72-4D30-AEC1-489367A6C7CF	Not Available	21	95	55	Stable Disease	8	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Not Otherwise Specified	Central nervous system	NO	Alive	2013	2013
TCGA-E1-5304	42	MALE	1251	Astrocytoma	Central nervous system	Dead	G3	1	903.0			WITH TUMOR		42	NO	Not Available	NO	TCGA-E1-5304	691d5202-90cc-4e08-83a3-0620a89d3a4b	20	-15481	1251	0	Not Available	Not Available	160	TCGA-E1-5304-D7549;TCGA-E1-5304-D7554;TCGA-E1-5304-D7556;TCGA-E1-5304-D7560;TCGA-E1-5304-D7563;TCGA-E1-5304-D7553;TCGA-E1-5304-D7566;TCGA-E1-5304-D7551	be795a9f-dcdf-4a7d-aa4f-94b92b08bd4b;95c00cf2-46a2-4357-9580-f19c65b86363;4266f715-faf8-4d2a-b45d-e1437dfe2d72;6d9b29fb-5777-4b46-aaaf-703389881871;21d4ba99-933d-45ca-b175-dde2cbeb3208;b6b37b85-64d1-4954-bc27-52ef5a91f85f;6b8d7114-8189-4922-a268-49d24d41d79e;a306ab5e-3ea9-444f-b6e0-4bbff0380335	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20;20;20;20	125;312;398;1113;1166;249;1198;160	95;249;312;995;1128;160;1167;125	Temozolomide;Temozolomide;CCNU;Temozolomide;CPT-11;CCNU;VP-16;Temozolomide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1;1	1;2;2;4;1;2;1;1	150;200;110;200;125;110;50;200	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;6;7;8;9;5;10;4	PO;PO;PO;PO;IV;PO;PO;PO	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1500;3950;440;7700;723;420;2100;2000	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	YES	YES	NO	TCGA-E1-5304-F7470	5ef4a4c6-50e3-437b-b7f2-f2ea4366ad0e	20	980	Not Available	1251	Not Available	903	160	Not Available	Not Available	Stable Disease	90	Not Available	1	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	YES	Dead	2011	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	Not Available	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5304	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5304-R7547	c04cff22-389e-4190-87f5-2f6238b37750	2	19	69	21	Not Available	1	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	YES	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1999
TCGA-E1-5322	38	FEMALE	3978	Oligoastrocytoma	Central nervous system	Dead	G2	1	1085.0			Not Available		38	Not Available	Not Available	Not Available	TCGA-E1-5322	5ea230a6-77aa-4aa5-867c-09651d481d8b	27	-13903	3978	0	Not Available	Not Available	3305	TCGA-E1-5322-D7467	5f1f8156-edae-4626-873b-b85e38a002d4	Not Available	27	1109	1085	Gliadel Wafer	Not Available	1	7	8	{Wafer}	ADJUVANT	Not Applicable	1	INTUM	NO	Chemotherapy	Not Available	8	{Wafer}	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	Not Available	YES	YES	YES	NO	TCGA-E1-5322-F7464	8f4b12a5-81a3-43a1-8f09-c09988dd0bb2	27	1085	Not Available	3978	Not Available	1085	3305	Not Available	Not Available	Stable Disease	90	Not Available	1	Not Available	YES	Not Available	Post-Adjuvant Therapy	Not Available	Discrepancy	Stable Disease	Discrepancy	Dead	2011	Not Available	Not Available	FEMALE	Not Available	Not Available	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5322	Post-Adjuvant Therapy	Not Available	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5322-R7465	f25a2818-3389-4735-bd85-78dfa9fde813	2	27	1150	1109	Not Available	1	32	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	Not Available	Not listed in Medical Record	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Dead	2011	1999
TCGA-HT-8558	29	FEMALE	418	Oligodendroglioma	Central nervous system	Alive	G2	0	418			TUMOR FREE		29	NO	Not Available	NO	TCGA-HT-8558	9b288f0e-5155-4736-bc22-e0e801d8b738	16	-10950	Not Applicable	0	52	Not Available	Not Available																								Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8558-F48474	266B3477-20CD-4D75-AE57-3C88CBF676B6	13	Not Available	Not Available	Not Applicable	418	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	YES	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	Not Available	Complete Remission/Response	Not Available	Alive	2013	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	Unknown	Left	Not Available	Not Available	Unknown	NO	NO	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	8558	Not Available	TUMOR FREE	NO	YES	YES	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-CS-5394	40	MALE	8	Astrocytoma	Central nervous system	Alive	G3	1				Not Available		40	NO	Not Available	NO	TCGA-CS-5394	97bf8065-3e7d-4702-a426-24908f4d66a4	13	-14920	Not Applicable	0	3	Not Available	-1																								Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-5394-F10340;TCGA-CS-5394-F71692	634883b5-62ce-4373-b103-2113e36fb8f5;8EF7CB92-498C-4E6B-894D-8601FB82C667	14;31	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	3;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;YES	4;3	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	NO;Not Available	Not Available;Unknown	NO;Not Available	Alive;Alive	2011;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	4	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5394	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2005
TCGA-QH-A6X9	73	FEMALE	58	Oligodendroglioma	Central nervous system	Alive	G2	0	58			Unknown		73	NO	Not Available	NO	TCGA-QH-A6X9	1CA2E1B3-E3EB-4740-A69A-800E3EB60787	9	-26992	Not Applicable	0	58	Not Available	58																								3	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A6X9-F67996	D32F81E0-E807-4561-B725-7B5D276A9CB5	13	Not Available	Not Available	Not Applicable	58	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	11	Not Available	NO	Not Available	Not Available	Unknown	NO	Unknown	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	40	Right	YES	Sequence Analysis	YES	YES	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A6X9	Pre-Adjuvant Therapy	Unknown	Unknown	YES	NO	Unknown	WHITE	Unknown																			YES	NO	White Matter	YES	NO	QH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-TM-A84F	48	MALE	1796	Astrocytoma	Central nervous system	Alive	G3	0	1796			TUMOR FREE		48	NO	Not Available	NO	TCGA-TM-A84F	3B68B6FF-7EFB-4D53-8BD8-C76CD68AB7C0	17	-17744	Not Applicable	0	1544	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Visual Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84F-F65393	7A2F0583-AFE6-4B50-B39F-539DE8BEA9F1	8	Not Available	Not Available	Not Applicable	1796	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84F	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A84F-R56468	9FE06891-AD78-4C5B-9645-7EFAB6553F52	Not Available	17	84	41	Complete Response	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2009
TCGA-S9-A6TZ	39	FEMALE	1120	Astrocytoma	Central nervous system	Alive	G2	1	552.0			WITH TUMOR		39	NO	Not Available	NO	TCGA-S9-A6TZ	B297C4DC-EC58-4392-908A-586E81D57EF0	31	-14592	Not Applicable	0	658	Not Available	-15																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6TZ-F63759;TCGA-S9-A6TZ-F69980	1210ED73-346A-4862-96D4-FAD472D23511;22F17F80-0D24-4889-90F7-1F2867C444FB	18;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	873;1120	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	8;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Partial Remission/Response;Partial Remission/Response	NO;NO	Alive;Alive	2014;2015	Not Available	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	YES	NO	10	NO	G2	NO	YES	552	NO	Not Available	Not Available	Not Available	YES	No	A6TZ	Preoperative	WITH TUMOR	NO	NO	YES	Partial Remission/Response	WHITE	NO	Primary Tumor Field	TCGA-S9-A6TZ-R54133	473045FD-11FC-4C17-B5AD-963A42995EB0	Not Available	17	658	627	Stable Disease	12	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-DU-7294	53	FEMALE	2869	Oligodendroglioma	Central nervous system	Alive	G2	0	2869			TUMOR FREE		53	Not Available	Not Available	Not Available	TCGA-DU-7294	3f6ffb08-32a9-4555-bfd1-243b7f526105	5	-19616	Not Applicable	0	2869	Not Available	793																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-DU-7294-F17513	e1cd788f-e2eb-41b5-859f-6b3c6fbd2fb6	5	Not Available	Not Available	Not Applicable	2869	Not Available	Not Available	Not Available	Not Available	Stable Disease	Not Available	Not Available	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	Not Available	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7294	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2003
TCGA-TQ-A7RN	32	MALE	1026	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		32	NO	Not Available	NO	TCGA-TQ-A7RN	C05F9E21-B8FA-4537-9AE7-39D6FC9D7933	17	-11823	Not Applicable	0	1026	Not Available	11																								0	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RN-F65559	7A00CED6-5D8F-4C42-9152-C23E89659C38	17	Not Available	Not Available	Not Applicable	1026	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	2	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2015	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RN	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	YES																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2015	2011
TCGA-TM-A7C3	43	FEMALE	1666	Astrocytoma	Central nervous system	Dead	G3	1	713.0			WITH TUMOR		43	NO	Not Available	YES	TCGA-TM-A7C3	D13AC936-87A9-4164-BDAB-02CCF3908CFE	9	-16021	Not Applicable	0	1504	Not Available	0	TCGA-TM-A7C3-D52932	8BF19BF0-DF98-4865-9F48-EFFCAB78B2A5	Not Available	9	Not Available	748	Temozolomide	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	YES	NOT HISPANIC OR LATINO	YES	NO	< 12 Years	Not Available	Not Available	Seizures	0 - 30 Days	YES;Not Available	NO;Not Available	YES;Not Available	Not Available;Not Available	TCGA-TM-A7C3-F52933;TCGA-TM-A7C3-F63557	3A6F60F1-0AD1-4F3A-9811-B68430E4553C;59E3E503-1E3B-4676-99A4-89038E61C060	9;12	1323;Not Available	Not Available;Not Available	Not Applicable;1666	1504;Not Available	1323;Not Available	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Partial Remission/Response;Progressive Disease	Not Available;Not Available	NO;NO	12;8	Not Available;Not Available	YES;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Dead	2013;2014	NO	Not Available	FEMALE	YES	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Left	NO	Not Available	Not Available	NO	NO	12	NO	G3	YES	YES	713	YES	713	Not Available	Not Available	YES	No	A7C3	Preoperative	WITH TUMOR	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO	Primary Tumor Field	TCGA-TM-A7C3-R52931	B44025D6-86A2-4A39-8656-2BEDFC844A42	Not Available	9	789	748	Complete Response	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2009
TCGA-DB-A75M	47	MALE	544	Astrocytoma	Central nervous system	Alive	G2	0	544			TUMOR FREE		47	NO	Not Available	NO	TCGA-DB-A75M	0709DBCC-0828-4066-AA01-96F059E5FA97	30	-17289	Not Applicable	0	313	Not Available	Not Available	TCGA-DB-A75M-D56231	18A2D014-E215-4CAC-BA38-A9A84289DF04	E3FO5	30	Not Available	47	CDR0000654697	Not Applicable	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	YES	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A75M-F67637	D5662A52-3931-4845-AA8A-62BE5AD362CE	7	Not Available	Not Available	Not Applicable	544	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	YES	Sequence Analysis	YES	NO	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A75M	Not Available	TUMOR FREE	YES	YES	NO	Not Applicable	WHITE	YES	Primary Tumor Field	TCGA-DB-A75M-R56230	8CBB7949-502D-4EF8-8857-71E121E115CC	Not Available	30	84	47	Complete Response	1	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-A5TS	42	MALE	964	Oligodendroglioma	Central nervous system	Alive	G2	1	551.0			TUMOR FREE		42	Unknown	Not Available	Unknown	TCGA-DU-A5TS	DD163547-43AD-4FE4-873E-83C4C6BE4465	10	-15650	Not Applicable	0	460	Not Available	13	TCGA-DU-A5TS-D48194	1CDA5AF0-27B3-4B75-AB14-AF4DECFDF770	Not Available	10	415	25	Temodar	Stable Disease	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	YES	NO	NO	NO	TCGA-DU-A5TS-F71496	C2CAA0D1-7B61-424E-B086-3AA4B95B92C3	26	Not Available	Not Available	Not Applicable	964	551	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2015	Unknown	Not Available	MALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	Unknown	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5TS	Pre-Adjuvant Therapy	TUMOR FREE	YES	NO	YES	Stable Disease	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-DU-A5TS-R48193	47A2C01C-E084-45E9-BCC0-801AA6B81A4A	Not Available	10	49	25	Stable Disease	9	30	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DB-A4XD	32	MALE	1210	Astrocytoma	Central nervous system	Alive	G3	0	1210			TUMOR FREE		32	Unknown	Not Available	NO	TCGA-DB-A4XD	1BFF1E07-4923-43D5-B2D3-CB46B6568EED	21	-11741	Not Applicable	0	822	Not Available	Not Available	TCGA-DB-A4XD-D40472	031BBEB5-469C-4856-AB64-13746690D8E2	Not Available	21	291	24	Temodar	Complete Response	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	YES	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XD-F60950	D94A5C65-553F-4D10-BACF-88FBB58FD04A	19	Not Available	Not Available	Not Applicable	1210	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	Unknown	Not Available	MALE	Unknown	NO	Astrocytoma	NO	No	C71.2	9401/3	C71.2	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	NO	Unknown	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4XD	Not Available	TUMOR FREE	YES	NO	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-DB-A4XD-R40473	53B6D106-00D6-420C-8694-BB3C2D1749DD	Not Available	21	69	24	Stable Disease	2	31	5890	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-DH-5142	29	MALE	1943	Astrocytoma	Central nervous system	Alive	G3	1	1627.0			TUMOR FREE		29	NO	Not Available	YES	TCGA-DH-5142	5b744051-7355-4e15-b035-0621e709a5d7	8	-10678	Not Applicable	0	922	Not Available	10	TCGA-DH-5142-D6544;TCGA-DH-5142-D6543;TCGA-DH-5142-D6545	91998a7d-11c1-427d-b99b-db9ef95ed478;b983b0e5-76b1-4c94-90ec-c9f65f430202;9111add0-24dc-4c01-9713-7daf44bd49a3	Not Available;Not Available;Not Available	20;20;20	93;52;400	89;21;117	Temozolomide;Temozolomide;Temozolomide	Not Available;Not Available;Not Available	12;12;12	1;1;11	360;75;480	mg/day;mg/m2/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;3	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1800;2400;5280	mg;mg/m2;mg	Not Available;Not Available;Not Available	2010;2010;2010	0	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;YES	Not Available;NO	Not Available;NO	Not Available;Not Available	TCGA-DH-5142-F6539;TCGA-DH-5142-F66689	80691eab-fcc9-4041-95b5-85b111b17bd1;69870580-2062-412B-9F1E-5369310C1A7E	8;22	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	922;1943	Not Available;1627	Not Available;Not Available	0;Not Available	Not Available;Scheduled Follow-up Submission	Stable Disease;Unknown	90;Not Available	Not Available;YES	12;10	Not Available;Not Available	NO;YES	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2010;2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5142	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DH-5142-R6541	f6f74ced-0454-4887-b0eb-f5e2288b46b3	1	17	52	21	Not Available	12	41	4920	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	YES	NO	Cerebral Cortex	NO	YES	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2010	2008
TCGA-WY-A85D	60	MALE	1147	Oligoastrocytoma	Central nervous system	Alive	G2	1	887.0			WITH TUMOR		60	NO	Not Available	NO	TCGA-WY-A85D	0D5A4C63-C3FB-4295-A433-D90CDBFC4ED6	26	-21979	Not Applicable	0	1147	Not Available	Not Available																								1	NO	Unknown	YES	NO	Not Available	Not Available	Not Available	Sensory Changes	> 181 Days																														NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	NO	G2	YES	YES	887	Not Available	922	Not Available	Not Available	YES	No	A85D	Not Available	WITH TUMOR	NO	NO	YES	Partial Remission/Response	WHITE	NO																			NO	YES	Not listed in Medical Record	NO	YES	WY	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2010
TCGA-P5-A5F0	33	MALE	287	Oligodendroglioma	Central nervous system	Alive	G2	0	287			WITH TUMOR		33	Unknown	Not Available	NO	TCGA-P5-A5F0	7EB5D055-E1C8-4B93-9205-A49A6E79DFD4	12	-12157	Not Applicable	0	125	Not Available	Not Available	TCGA-P5-A5F0-D56613;TCGA-P5-A5F0-D59339;TCGA-P5-A5F0-D59340	23BCC949-2852-41F4-BDAF-D4952D034C99;805459C3-71F0-4B2F-A213-299DB0870A26;BBF4D2E7-E9D8-4C79-ABF5-15A7A8699D7C	Not Available;Not Available;Not Available	8;8;8	287;287;287	89;89;89	Lomustine;Vincristine;Procarbazine	Partial Response;Partial Response;Partial Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Unknown	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5F0-F69045	5FF200EA-CC7D-41B7-82F0-6814B7181D40	24	Not Available	Not Available	Not Applicable	287	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Discrepancy	YES	Partial Remission/Response	YES	Alive	2014	Unknown	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	NO	Not Available	80	Right	Not Available	Not Available	NO	NO	NO	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5F0	Unknown	WITH TUMOR	YES	NO	NO	Unknown	WHITE	YES	Primary Tumor Field	TCGA-P5-A5F0-R56612	2C6D0A9F-D4A0-4CE8-AE17-78A61256F79C	Not Available	8	70	23	Partial Response	5	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	YES	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2013	2012
TCGA-HT-7476	26	MALE	199	Astrocytoma	Central nervous system	Alive	G2	0	199			TUMOR FREE		26	NO	Not Available	NO	TCGA-HT-7476	27d0d3cb-16c0-4ba8-9662-95917f665004	7	-9614	Not Applicable	0	199	Not Available	Not Available	TCGA-HT-7476-D21244;TCGA-HT-7476-D21243	7b368f14-efc6-449e-a680-2b1dacafae06;1087cef3-36cb-4992-ad47-390efd05380e	Not Available;Not Available	7;7	Not Available;80	118;41	temodar;temodar	Not Available;Not Available	2;2	3;1	280;140	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	YES;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1400;4200	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7476-F21240	b458719d-93c2-4787-8cc4-d347621d3f46	7	Not Available	Not Available	Not Applicable	199	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	2	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7476	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7476-R21241	f5197e34-b55f-4791-8416-7861a4b4786c	1	7	80	41	Not Available	2	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	YES	Cerebral Cortex	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-TM-A84G	54	FEMALE	1236	Oligodendroglioma	Central nervous system	Alive	G3	0	1236			TUMOR FREE		54	NO	Not Available	NO	TCGA-TM-A84G	63F4AA26-DEC0-4309-8B75-6446A7241527	17	-20014	Not Applicable	0	1045	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84G-F65394	7B7538D1-BA60-4CF3-8792-7F94039ED93A	23	Not Available	Not Available	Not Applicable	1236	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84G	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A84G-R56470	6CD89CD7-37A1-4F68-AB8F-835A5AEEDF86	Not Available	17	105	63	Complete Response	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2010
TCGA-VM-A8CF	44	FEMALE	609	Astrocytoma	Central nervous system	Alive	G3	0	609			WITH TUMOR		44	Unknown	Not Available	Unknown	TCGA-VM-A8CF	0073A136-D5F4-4FD6-88F9-711768F2ABC6	14	-16334	Not Applicable	0	294	Not Available	26	TCGA-VM-A8CF-D56941	6AF8B596-1900-4064-83A0-438EF1CC6731	Not Available	30	88	41	Temodar	Stable Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	Unknown	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-VM-A8CF-F66857	F2EEC069-0622-4000-AA45-164C54A37387	24	Not Available	Not Available	Not Applicable	609	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Unknown	YES	Alive	2014	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	60	Left	YES	IHC	YES	NO	Unknown	1	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8CF	Pre-Adjuvant Therapy	WITH TUMOR	NO	NO	NO	Unknown	WHITE	YES	Primary Tumor Field;Primary Tumor Field	TCGA-VM-A8CF-R56936;TCGA-VM-A8CF-R56940	7BBA7F69-915E-45DA-9B0F-440EC5EC7A61;0B9D92BC-0B07-48B5-B85D-645F3CB467B1	Not Available;Not Available	26;26	81;88	42;82	Stable Disease;Stable Disease	2;2	28;5	5040;900	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	NO	NO	Not listed in Medical Record	NO	YES	VM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DB-A64W	65	FEMALE	438	Oligoastrocytoma	Central nervous system	Dead	G3	0	438			WITH TUMOR		65	Unknown	Not Available	NO	TCGA-DB-A64W	DF22BC30-96E2-42DE-9A39-2954DB49841D	7	-23936	Not Applicable	0	415	Not Available	-20	TCGA-DB-A64W-D46509	07E285BC-D322-4AB9-8083-F1F3F64A2814	Not Available	7	274	34	Temodar	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64W-F62623	D3CB1ABF-C616-4FFA-905C-9AAD4DF98857	22	Not Available	Not Available	438	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Dead	2014	Unknown	Not Available	FEMALE	Unknown	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	Unknown	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64W	Preoperative	WITH TUMOR	YES	YES	YES	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DB-A64W-R46508	649811CF-0CB8-40D3-91D6-E2B58EADD1AA	Not Available	7	79	34	Stable Disease	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-HT-7482	18	FEMALE	3253	Oligoastrocytoma	Central nervous system	Alive	G2	1	374.0			WITH TUMOR		18	NO	Not Available	NO	TCGA-HT-7482	448d3e3b-622c-4e79-bb1d-b5f2e92970e8	6	-6857	Not Applicable	0	1644	Not Available	Not Available	TCGA-HT-7482-D29533	5e15e3a1-af84-4651-a196-a1b6efb3969a	Not Available	9	853	577	Temodar	Not Available	3	10	370	mg/day	PROGRESSION	Not Applicable	1	PO	NO	Chemotherapy	Not Available	18500	mg	Not Available	2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES;NO	YES;NO	YES;YES	Not Available;Not Available	TCGA-HT-7482-F29532;TCGA-HT-7482-F66423	94431290-31f7-4884-adda-8c93aa2cef26;A88A864D-8460-42DD-BF38-2303157EB899	9;14	377;377	Not Available;Not Available	Not Applicable;Not Applicable	1826;3253	374;374	388;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Partial Remission/Response;Complete Remission/Response	90;Not Available	Not Available;NO	3;10	Not Available;Not Available	YES;YES	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	WITH TUMOR;TUMOR FREE	NO;YES	Partial Remission/Response;Partial Remission/Response	YES;YES	Alive;Alive	2012;2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7482	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7482-R29534	e4485cf5-4dbc-4374-8030-989d981cab37	1	9	447	405	Not Available	3	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2005
TCGA-QH-A65R	38	FEMALE	461	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		38	YES	CAT	NO	TCGA-QH-A65R	505E9812-D13E-42D3-AEE2-55A85D6F4551	2	-14073	Not Applicable	0	175	Not Available	-10	TCGA-QH-A65R-D46271	2B190C17-1558-498E-B160-A6E7434F0D02	Not Available	5	430	32	TEMOZOLOMIDE	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	YES	NO	< 12 Years	> 20 Years	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A65R-F59571	0FE6ACFC-9A2B-49F6-9EAF-DB1F644290C7	10	Not Available	Not Available	Not Applicable	461	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	YES	NO	Oligodendroglioma	NO	No	C71.9	9451/3	C71.9	YES	NO	Not Available	100	Left	YES	IHC	YES	NO	YES	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A65R	Preoperative	WITH TUMOR	YES	NO	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-QH-A65R-R46275	53AD1607-2E46-4B95-B036-503A24ADCA4D	Not Available	5	69	32	Stable Disease	8	26	52	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	White Matter	NO	YES	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-QH-A6CZ	38	MALE	279	Oligoastrocytoma	Central nervous system	Alive	G2	0	279			TUMOR FREE		38	NO	Not Available	NO	TCGA-QH-A6CZ	B4F4C9B5-BC50-4F35-A7DA-FD011C3B2C02	2	-14007	Not Applicable	0	96	Not Available	-51																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	Not Available	TCGA-QH-A6CZ-F60216	6C5CF2CB-E23F-4BB2-AF28-E07457CC2F43	3	Not Available	Not Available	Not Applicable	279	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	YES	IHC	YES	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6CZ	Preoperative	TUMOR FREE	NO	YES	YES	Partial Remission/Response	WHITE	NO																			YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-S9-A6U0	46	MALE	742	Astrocytoma	Central nervous system	Dead	G3	1	692.0			WITH TUMOR		46	NO	Not Available	NO	TCGA-S9-A6U0	A343FBE3-147A-4656-9E90-5408298CA12C	31	-16890	Not Applicable	0	498	Not Available	-18	TCGA-S9-A6U0-D54135;TCGA-S9-A6U0-D54136;TCGA-S9-A6U0-D65506;TCGA-S9-A6U0-D70003;TCGA-S9-A6U0-D70005	E8308CBE-67F1-4074-B091-5B632DC7B1E5;DB7B276C-FD50-475A-B68F-9974D22DFA38;61FB2564-39E2-4F0F-B0B7-BE0E4D4F4ACD;75759921-173C-42B8-9F23-1ED2D3FA32FC;DE7BF179-1B4B-4870-AFA3-F954B842FD71	Not Available;Not Available;Not Available;Not Available;Not Available	17;17;24;26;26	64;264;Not Available;Not Available;Not Available	30;96;698;603;603	Temozolomide;Temozolomide;Bevacizumab;Carmustine;Teniposide	Stable Disease;Stable Disease;Not Applicable;Clinical Progressive Disease;Clinical Progressive Disease	12;12;9;1;1	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2013;2013;2014;2015;2015	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES;Not Available	NO;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6U0-F65505;TCGA-S9-A6U0-F72340	E6AAFF5B-8B77-45E0-B9DA-B6AE02E6C64E;311F9CE3-EB25-4E54-A3B3-081A1852C1EE	24;27	Not Available;Not Available	Not Available;Not Available	Not Applicable;742	698;Not Available	692;Not Available	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	9;5	Not Available;Not Available	YES;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Partial Remission/Response;Partial Remission/Response	YES;YES	Alive;Dead	2014;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	NO	IHC	YES	NO	NO	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6U0	Preoperative	WITH TUMOR	YES	NO	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6U0-R54134	C2C4D8EA-77C5-4AC0-974D-EF7ACDD5BD1F	Not Available	17	64	30	Stable Disease	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-QH-A6CV	51	MALE	442	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		51	NO	Not Available	NO	TCGA-QH-A6CV	29E95C77-F55B-42E1-B81E-EAB4BB3CF803	2	-18955	Not Applicable	0	90	Not Available	-42																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	NO	NO	NO	Not Available	TCGA-QH-A6CV-F60218	70A70972-137D-40D1-89E8-AACCCB9AD568	6	Not Available	Not Available	Not Applicable	442	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	YES	Alive	2014	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	YES	Sequence Analysis	YES	NO	NO	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6CV	Preoperative	WITH TUMOR	NO	YES	NO	Unknown	ASIAN	YES	Primary Tumor Field;Primary Tumor Field	TCGA-QH-A6CV-R46346;TCGA-QH-A6CV-R60217	CEE9F6B3-471E-4853-B540-D2AD08C29729;E3F26EC2-720C-42DB-8776-E0B8D5888C04	Not Available;Not Available	9;6	90;351	50;348	Unknown;Stable Disease	12;6	27;3	54;24	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2014	YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-S9-A6TS	48	FEMALE	1891	Astrocytoma	Central nervous system	Dead	G3	1	1324.0			WITH TUMOR		48	NO	Not Available	NO	TCGA-S9-A6TS	41E4DC71-7767-44C2-9D38-110DCD37B451	30	-17857	1891	0	Not Available	Not Available	-10	TCGA-S9-A6TS-D51943;TCGA-S9-A6TS-D51942;TCGA-S9-A6TS-D51944	7263A8F3-DF15-43AC-AFFB-AFC300FD85C3;58259028-B8FE-40C9-81C8-A5710FB35B17;2130E3E9-86B7-4792-ABF1-36699EE70C58	Not Available;Not Available;Not Available	26;26;26	1697;1603;1859	1614;1352;1704	Carmustine;Temozolamide;Bevacizumab	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	NO	YES	Not Available	TCGA-S9-A6TS-F51945	74B6FEC2-31FE-4373-93A8-2FA1CD37B9BE	26	1324	Not Available	1891	Not Available	1324	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2013	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	10	NO	G3	YES	NO	1324	YES	1324	Not Available	Not Available	YES	No	A6TS	Preoperative	WITH TUMOR	NO	NO	NO	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-S9-A6TS-R51941	C2573AC2-6094-484C-8447-D7001862CBFC	Not Available	26	78	0	Stable Disease	11	33	59.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2013	2006
TCGA-HT-8106	53	MALE	3	Astrocytoma	Central nervous system	Alive	G3	0	3			Not Available		53	NO	Not Available	NO	TCGA-HT-8106	bae316e3-1fa4-4fa7-8ad6-a458857a85d4	3	-19555	Not Applicable	0	3	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8106-F32632	cfde7285-8d0e-4079-9649-78ae297d9ef3	4	Not Available	Not Available	Not Applicable	3	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Midline	Not Available	Not Available	NO	NO	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8106	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-DU-A76L	54	MALE	814	Oligodendroglioma	Central nervous system	Dead	G3	1	410.0			WITH TUMOR		54	Unknown	Not Available	Unknown	TCGA-DU-A76L	395798C5-3136-4A30-8557-A67A3ABDECAF	22	-19823	814	0	Not Available	Not Available	Not Available	TCGA-DU-A76L-D50323;TCGA-DU-A76L-D50324;TCGA-DU-A76L-D50331;TCGA-DU-A76L-D50332	17E31019-21A1-48CA-8472-48CD1CEAD9B5;D3A914AA-DC46-4157-98C9-D4F975FFD86B;225CBF1C-33B0-428A-9718-F9F4236532BA;6ACA75BD-AD14-4501-9992-FF1E76A48199	Not Available;Not Available;Not Available;Not Available	22;22;22;22	57;406;617;732	16;54;588;651	Temozolomide;Temozolomide;Procarbazine;Cilengtide	Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	10;10;10;10	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;YES	2013;2013;2013;2013	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	YES	Unknown	Not Available	Not Available	Not Available	Headaches	0 - 30 Days																														Unknown	Not Available	MALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	NO	Unknown	10	NO	G3	YES	NO	410	YES	441	NO	Not Available	YES	No	A76L	Not Available	WITH TUMOR	YES	Unknown	Unknown	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-DU-A76L-R50322	535FF4EB-212C-4AD2-8AE7-37C121D9891E	Not Available	22	57	16	Stable Disease	10	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2013	2000
TCGA-HT-7611	36	MALE	1752	Oligoastrocytoma	Central nervous system	Alive	G2	0	1752			TUMOR FREE		36	NO	Not Available	NO	TCGA-HT-7611	0ce8d92b-54e2-45d4-a551-0faf94a27d46	16	-13314	Not Applicable	0	1752	Not Available	Not Available																								Unknown	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7611-F51026	8818A585-8B73-4738-878E-8133AE74B098	5	Not Available	Not Available	Not Applicable	1752	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	11	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Alive	2013	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	Not Available	Not Available	Unknown	NO	NO	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	7611	Other	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO																			NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2007
TCGA-FG-A60J	47	FEMALE	449	Oligoastrocytoma	Central nervous system	Alive	G2	0	449			TUMOR FREE		47	NO	Not Available	NO	TCGA-FG-A60J	C031F2A5-A563-4D5B-BD62-49D4FA5ECA78	26	-17339	Not Applicable	0	214	Not Available	-18																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-A60J-F61188;TCGA-FG-A60J-F65604	C8654DD0-C082-469D-9D72-B69021F6242D;DA1C5F97-85AE-4FE3-BC40-B85D8BD73B7D	25;25	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	449;449	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown	Not Available;Not Available	NO;YES	6;9	Not Available;Not Available	Unknown;Unknown	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	NO	NO	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A60J	Preoperative	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-A60L	34	FEMALE	655	Astrocytoma	Central nervous system	Alive	G2	0	655			TUMOR FREE		34	Unknown	Not Available	NO	TCGA-FG-A60L	738F5C96-EE44-4FD7-BB8C-E2B86F8053C8	26	-12580	Not Applicable	0	214	Not Available	8																								0	NO	NOT HISPANIC OR LATINO	Unknown	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-A60L-F63166;TCGA-FG-A60L-F65511	F0264CBD-1035-46E1-86AF-C1678AF54ACF;B1194B59-2D87-422A-83A7-D2BDB36EFFC5	1;24	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	499;655	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	8;9	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2014	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	NO	Unknown	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A60L	Other	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-A6S2	37	FEMALE	777	Oligodendroglioma	Central nervous system	Alive	G2	0	777			TUMOR FREE		37	YES	long hair cats	NO	TCGA-DU-A6S2	BAADDD76-277F-4C90-9CC2-0FECE30C9735	23	-13597	Not Applicable	0	263	Not Available	11																								Not Evaluated	YES	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	< 12 Years	Not Available	Headaches	31 - 90 Days	NO	NO	Not Available	Not Available	TCGA-DU-A6S2-F71620	3A968595-C0A1-42BE-A3EC-D2FEF91A6A27	27	Not Available	Not Available	Not Applicable	777	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2015	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	70	Right	YES	IHC	YES	NO	YES	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6S2	Pre-Adjuvant Therapy	TUMOR FREE	NO	NO	YES	Stable Disease	BLACK OR AFRICAN AMERICAN	NO																			NO	NO	Cerebral Cortex	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-DB-A4XH	53	FEMALE	962	Oligoastrocytoma	Central nervous system	Alive	G2	0	962			TUMOR FREE		53	Unknown	Not Available	NO	TCGA-DB-A4XH	5CCD86AB-2587-4F35-B96A-4F4320B10FB9	21	-19710	Not Applicable	0	383	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XH-F60959	1997DE55-A0CA-450E-B3F7-C0F18130DCF7	22	Not Available	Not Available	Not Applicable	962	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2014	Unknown	Not Available	FEMALE	Unknown	NO	Oligoastrocytoma	NO	No	C71.1	9382/3	C71.1	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4XH	Not Available	TUMOR FREE	NO	YES	YES	Stable Disease	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-S9-A6WI	56	FEMALE	2585	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		56	NO	Not Available	NO	TCGA-S9-A6WI	0B283F95-DBD4-4C36-9201-2198A90EE0D6	5	-20609	Not Applicable	0	2149	Not Available	-1																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	Not Available	NO	NO	Not Available	Not Available	TCGA-S9-A6WI-F63762	B3F7FE1D-25BE-4DC5-ADCB-C6923364F0A1	18	Not Available	Not Available	Not Applicable	2585	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	8	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	YES	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	YES	NO	11	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WI	Preoperative	WITH TUMOR	NO	NO	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6WI-R54281	75D2B520-529E-4068-A875-DD65F597BC2A	Not Available	18	120	57	Stable Disease	12	30	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	White Matter	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2006
TCGA-FG-A6J3	52	FEMALE	677	Astrocytoma	Central nervous system	Alive	G3	1	285.0			WITH TUMOR		52	NO	Not Available	Unknown	TCGA-FG-A6J3	AE4F0714-3B74-46C0-9C1B-F028C7CF2E62	3	-19138	Not Applicable	0	322	Not Available	106	TCGA-FG-A6J3-D48232;TCGA-FG-A6J3-D48501	1EB2DA09-3CFC-44F9-B194-06BBE1D6AE9C;9889AC41-FA07-43AF-8AE0-D489D0085685	Not Available;Not Available	10;16	74;Not Available	27;116	Temodar;Temodar	Stable Disease;Not Applicable	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Sensory Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A6J3-F64032	53B1E960-0D9E-499F-A118-9E3B068B6EE2	25	Not Available	Not Available	Not Applicable	677	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	8	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Right	YES	IHC	YES	NO	NO	9	NO	G3	YES	NO	285	YES	340	Not Available	Not Available	YES	No	A6J3	Post-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-FG-A6J3-R48233	92FEAF12-7BCE-4750-8F76-E98F04B2086C	Not Available	10	74	27	Stable Disease	9	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	YES	Cerebral Cortex	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-8189	33	FEMALE	685	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		33	NO	Not Available	YES	TCGA-FG-8189	5469c0e8-0c58-4870-b897-8fa0704599a7	9	-12384	Not Applicable	0	361	Not Available	83	TCGA-FG-8189-D42251;TCGA-FG-8189-D42255	9A6538E8-AB2B-44EF-A0F5-1AA3B71111EF;6AD8B764-E9BA-499F-9D06-724575C8DBA0	Chemotherapy;Chemotherapy	15;15	159;221	105;190	Temodar;Temodar	Stable Disease;Stable Disease	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2013;2013	Not Available	YES	NOT HISPANIC OR LATINO	NO	NO	> 20 Years	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-8189-F58503	9F37B92F-EFA9-424C-9FB8-FFDE8BE5A452	11	Not Available	Not Available	Not Applicable	685	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	4	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	NO	Not Available	FEMALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	70	Right	Not Available	Not Available	NO	NO	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	8189	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-FG-8189-R42249	59127A65-B6ED-4457-9346-017C275407A9	Not Available	15	159	105	Stable Disease	4	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DB-A4XB	38	MALE	919	Astrocytoma	Central nervous system	Alive	G3	0	919			TUMOR FREE		38	Unknown	Not Available	NO	TCGA-DB-A4XB	FB6437F9-ADE8-4C33-A0D0-CEACB2BF784D	21	-13990	Not Applicable	0	387	Not Available	Not Available	TCGA-DB-A4XB-D40508	49B0E615-ABFF-4D27-B8E9-50F9544D9EAA	Not Available	21	57	28	Temodar	Stable Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XB-F60944	753DEB70-9A2F-4548-B069-6F2A4F484891	19	Not Available	Not Available	Not Applicable	919	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2014	Unknown	Not Available	MALE	Unknown	NO	Astrocytoma	NO	No	C71.4	9401/3	C71.4	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	YES	NO	Unknown	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4XB	Not Available	TUMOR FREE	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DB-A4XB-R40509	210D7B03-4774-49B9-862C-35FB7CB5AD72	Not Available	22	79	28	Stable Disease	2	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-DU-8166	29	FEMALE	516	Oligoastrocytoma	Central nervous system	Alive	G2	1	193.0			WITH TUMOR		29	Not Available	Not Available	Not Available	TCGA-DU-8166	e488f613-f155-4e11-87d4-8c789ea81691	15	-10641	Not Applicable	0	68	Not Available	Not Available	TCGA-DU-8166-D44354;TCGA-DU-8166-D44355;TCGA-DU-8166-D44356	03D4FB11-E295-4227-B12E-3021FB09BC50;2F9D24F7-6365-4143-90DF-EE052C74E6F0;A971AAD3-1AD3-494D-8945-35B91A1AF170	Not Available;Not Available;Not Available	19;19;19	143;433;433	62;237;237	Temozolomide;Lomustine;Procarbazine	Clinical Progressive Disease;Stable Disease;Stable Disease	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	NO	Not Available	TCGA-DU-8166-F46665	333C66B0-13E2-4F27-9C7E-1B5959F82CB8	13	Not Available	Not Available	Not Applicable	516	193	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2013	Not Available	Not Available	FEMALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8166	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-8166-R44353	B95D4DF6-ADC2-4A97-93FC-6854F954FB1D	Not Available	19	106	53	Radiographic Progressive Disease	6	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Cerebral Cortex	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2012
TCGA-FG-A60K	34	FEMALE	542	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		34	YES	Dogs	NO	TCGA-FG-A60K	A85AEBDA-B182-41BA-815A-3FF055E22829	8	-12445	Not Applicable	0	202	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	> 20 Years	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A60K-F61189	20A6E795-01E4-4DFB-95FB-E30C2CA31502	25	Not Available	Not Available	Not Applicable	542	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2014	NO	Not Available	FEMALE	YES	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	YES	NO	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Prior Malignancy	A60K	Not Evaluated	WITH TUMOR	NO	NO	NO	Stable Disease	WHITE	NO																			NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-8185	37	MALE	433	Astrocytoma	Central nervous system	Alive	G3	0	433			TUMOR FREE		37	NO	Not Available	NO	TCGA-FG-8185	fb3884df-3680-4c5b-8092-981007aeba03	31	-13621	Not Applicable	0	70	Not Available	21	TCGA-FG-8185-D32545;TCGA-FG-8185-D43369	CE3F4131-147E-44A0-A306-3F54F2F9BDFE;CDCD9C6D-0CD2-4E48-B07E-DBC61F09EE3A	Not Available;Not Available	31;20	70;412	21;97	Temodar;Temodar	Stable Disease;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2013	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	> 20 Years	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-8185-F43366	32BB4429-3BDE-4A73-AA05-F3C427B314E6	20	Not Available	Not Available	Not Applicable	433	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	YES	Unknown	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	Not Available	NO	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8185	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-8185-R32542	55D1CA41-996F-49CA-A286-0C458F58BC54	Not Available	31	70	26	Stable Disease	5	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	NO	NO	White Matter	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2012
TCGA-S9-A7QY	35	FEMALE	863	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		35	NO	Not Available	NO	TCGA-S9-A7QY	94A2FF09-F7AC-4AEA-A2B2-0DC1B82AE635	5	-12853	Not Applicable	0	554	Not Available	-2	TCGA-S9-A7QY-D52662	18543B64-497C-49FA-A339-DE4E5F196698	Not Available	5	372	20	Temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	NO	Not Available	Not Available	TCGA-S9-A7QY-F62949	0C9747C7-5BEE-4C5D-B274-5CC1ADDCDE9A	29	Not Available	Not Available	Not Applicable	863	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	7	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	100	Left	NO	IHC	YES	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7QY	Preoperative	WITH TUMOR	YES	YES	YES	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DB-A64L	67	FEMALE	736	Oligodendroglioma	Central nervous system	Alive	G2	1	724.0			TUMOR FREE		67	NO	Not Available	NO	TCGA-DB-A64L	DA735A88-D811-49F1-9091-A097C59ED68E	7	-24690	Not Applicable	0	335	Not Available	8																								Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	NO	TCGA-DB-A64L-F62609	08BAF95A-E982-4C89-893E-4F554939BEEE	7	Not Available	Not Available	Not Applicable	736	724	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response	NO	Alive	2014	Unknown	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	YES	Not Available	70	Right	YES	IHC	YES	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64L	Preoperative	TUMOR FREE	NO	YES	Not Available	Complete Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-8164	51	MALE	651	Oligodendroglioma	Central nervous system	Alive	G2	0	651			WITH TUMOR		51	Not Available	Not Available	Not Available	TCGA-DU-8164	f97a9afe-e54a-4ef0-b458-0c77f938552e	15	-18735	Not Applicable	0	202	Not Available	Not Available	TCGA-DU-8164-D33147	D44F7932-9A40-4D47-BBBB-AA99E873F87A	Not Available	21	Not Available	35	Temozolomide	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-8164-F44373	555B381F-9838-4DD0-85B9-4B67E76861A4	19	Not Available	Not Available	Not Applicable	651	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2013	Not Available	Not Available	MALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Right	YES	IHC	YES	NO	Not Available	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8164	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-VM-A8CA	54	MALE	411	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		54	Unknown	Not Available	NO	TCGA-VM-A8CA	CDD1FD4C-3427-496C-8391-4AEB6730D3CC	13	-19991	Not Applicable	0	411	Not Available	19	TCGA-VM-A8CA-D56923	D67720C8-8514-4D9F-9DF3-1F6C30C595DC	Not Available	26	Not Available	373	temodar	Not Applicable	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	Unknown	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-VM-A8CA-F63647	C4D981CB-2394-491F-B2A5-3BCD1D1A07A1	24	Not Available	Not Available	Not Applicable	411	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	10	Not Available	Unknown	Not Available	Not Available	WITH TUMOR	Unknown	Unknown	Unknown	Alive	2014	Unknown	Not Available	MALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	70	Left	Not Available	Not Available	NO	YES	Unknown	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A8CA	Pre-Adjuvant Therapy	WITH TUMOR	YES	Unknown	Unknown	Unknown	Unknown	NO																			NO	NO	Not listed in Medical Record	NO	YES	VM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-HT-7609	34	MALE	1399	Oligoastrocytoma	Central nervous system	Alive	G3	0	1399			TUMOR FREE		34	NO	Not Available	YES	TCGA-HT-7609	bfbc0d1e-2a0b-4c60-8a37-91e3ce4b79ee	27	-12607	Not Applicable	0	1399	Not Available	1	TCGA-HT-7609-D28836;TCGA-HT-7609-D28832	3eecb529-e763-469f-967e-ccf4df7f927e;5f8b5235-08c0-4073-b842-31c4320b6809	Not Available;Not Available	1;1	484;75	111;28	temodar;Temodar	Not Available;Not Available	3;3	12;1	280;140	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	16800;6860	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7609-F28823	b2709844-e682-4a18-ba98-90a7901fcaa1	1	Not Available	Not Available	Not Applicable	1399	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	YES	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7609	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7609-R28828	bfc4a9a9-fdc0-482d-b1b2-5379e3791a34	1	1	75	28	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2007
TCGA-DU-8158	57	FEMALE	155	Astrocytoma	Central nervous system	Dead	G3	0	155			WITH TUMOR		57	Not Available	Not Available	Not Available	TCGA-DU-8158	b8df1577-2a75-4eb7-ab27-f2dd76160730	15	-21129	155	0	Not Available	Not Available	8	TCGA-DU-8158-D33125	6009C075-F6A2-495D-929C-4154C2C079EA	Not Available	21	66	21	Temozolomide	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days																														Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	80	Left	Not Available	Not Available	NO	YES	Not Available	6	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8158	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-8158-R33124	64C652D7-7D1D-4C3B-85A0-767206AC2316	Not Available	21	66	21	Stable Disease	6	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Available	Not Available	Not Available	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Dead	2012	2001
TCGA-HT-7881	38	MALE	1079	Oligodendroglioma	Central nervous system	Alive	G2	0	1079			TUMOR FREE		38	NO	Not Available	NO	TCGA-HT-7881	275cb949-2f61-48c9-84f0-ba8ae4fa35c4	1	-14171	Not Applicable	0	89	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HT-7881-F29663;TCGA-HT-7881-F66426	b6ac4bd8-6b05-4761-9d82-82c6716cca2a;16C8114E-7798-4D8D-A4D3-83C0D4B99A57	19;14	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	89;1079	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	3;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;YES	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Alive	2012;2014	Not Available	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	3	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7881	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-HT-7881-R29665	cec4b1bd-cb35-4ce3-8640-fd95aa9d2fb6	1	15	83	46	Not Available	3	31	5580	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-VW-A8FI	66	MALE	245	Astrocytoma	Central nervous system	Dead	G3	0	245			WITH TUMOR		66	NO	Not Available	NO	TCGA-VW-A8FI	4FB16AEE-DF08-441A-846B-558E0EFE8342	10	-24411	245	0	Not Available	Not Available	Not Available	TCGA-VW-A8FI-D57346	C5A6EC5D-6923-4747-B936-BDD1F1B6EEA3	Not Available	10	78	19	Temozolomide	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	31 - 90 Days																														NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	YES	NO	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8FI	Not Available	WITH TUMOR	YES	NO	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-VW-A8FI-R57345	48ABCB71-7AD4-413B-94A6-BD091947F5FA	Not Available	10	78	33	Unknown	3	180	900	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	White Matter	YES	NO	VW	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2013
TCGA-VM-A8C8	50	FEMALE	1397	Oligodendroglioma	Central nervous system	Alive	G2	1	456.0			Unknown		50	Unknown	Not Available	Unknown	TCGA-VM-A8C8	A66A3847-7570-4486-8845-86B6125104A2	13	-18494	Not Applicable	0	1006	Not Available	19	TCGA-VM-A8C8-D66844	AD48C107-E4BE-4D61-947F-A3A66DFAD1AB	Not Available	24	1431	1282	Temozolomide	Stable Disease	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	Unknown	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	> 181 Days	NO;NO	NO;NO	Not Available;Not Available	Not Available;Not Available	TCGA-VM-A8C8-F66843;TCGA-VM-A8C8-F69643	1A624A25-8814-43CE-BA84-B57AE1250927;7BAAA8C8-C7CA-4DF0-8820-F8FFF6C964F3	24;15	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1309;1397	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	NO;NO	10;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	YES;YES	Unknown;Unknown	YES;YES	Alive;Alive	2014;2015	Unknown	Not Available	FEMALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	90	Right	YES	IHC	YES	NO	Unknown	1	YES	G2	NO	NO	456	NO	Not Available	NO	Not Available	YES	No	A8C8	Pre-Adjuvant Therapy	Unknown	NO	Unknown	Unknown	Unknown	WHITE	YES	Primary Tumor Field	TCGA-VM-A8C8-R56920	AA7777DE-6C72-473D-A10F-C45118487550	Not Available	26	783	749	Unknown	2	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	Not listed in Medical Record	NO	YES	VM	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-RY-A847	45	MALE	933	Oligodendroglioma	Central nervous system	Alive	G2	0	933			TUMOR FREE		45	Not Available	Not Available	Not Available	TCGA-RY-A847	FFF304A2-113F-499D-A88C-9D3660C348D9	16	-16732	Not Applicable	0	933	Not Available	62																								Not Evaluated	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-RY-A847-F69806	C6397C70-0482-41A4-987F-5E5A473DB207	20	Not Available	Not Available	Not Applicable	933	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Applicable	NO	Alive	2015	Not Available	Not Available	MALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	Not Available	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A847	Other	TUMOR FREE	NO	Not Available	Not Available	Not Applicable	WHITE	NO																			NO	NO	Cerebral Cortex	YES	NO	RY	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-QH-A86X	33	MALE	337	Oligodendroglioma	Central nervous system	Alive	G2	0	337			TUMOR FREE		33	NO	Not Available	NO	TCGA-QH-A86X	A96BCA45-ECC7-44F6-ACB6-48B0CEC3DE4D	12	-12385	Not Applicable	0	106	Not Available	106																								0	NO	NOT HISPANIC OR LATINO	YES	Unknown	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A86X-F67829	141FF06B-0B90-43FA-BACB-DC729D4C533C	12	Not Available	Not Available	Not Applicable	337	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	100	Left	YES	IHC	YES	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A86X	Other	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-TM-A84M	40	MALE	754	Oligodendroglioma	Central nervous system	Alive	G3	0	754			TUMOR FREE		40	NO	Not Available	NO	TCGA-TM-A84M	61FF31A4-4FDC-476C-B456-2A2FED4BAE6B	17	-14660	Not Applicable	0	502	Not Available	0	TCGA-TM-A84M-D56522;TCGA-TM-A84M-D58912;TCGA-TM-A84M-D58913	796B3758-7F92-49E4-8FAB-5AF004C37379;B8E667B8-9536-4B24-9BD6-5E4A8C662574;12389314-83EC-4478-B017-CBE512918876	Not Available;Not Available;Not Available	17;28;28	264;264;264	138;138;138	Procarbazine;LOMUSTINE (CCNU);VINCRISTINE	Complete Response;Complete Response;Complete Response	2;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84M-F65392	BEEB7ACA-80A5-49B5-9B1D-930C4589576F	23	Not Available	Not Available	Not Applicable	754	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84M	Preoperative	TUMOR FREE	YES	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A84M-R56521	4016ED49-558D-464F-817C-7D432BF16C4A	Not Available	17	122	73	Complete Response	2	33	59.06	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-DU-7010	58	FEMALE	456	Astrocytoma	Central nervous system	Dead	G3	1	193.0			WITH TUMOR		58	Not Available	Not Available	Not Available	TCGA-DU-7010	834e560a-a506-456d-baf2-a206ca058153	28	-21199	456	0	Not Available	Not Available	Not Available	TCGA-DU-7010-D17063;TCGA-DU-7010-D17061	caa0c4b5-9983-49d8-95a8-efe28a285e84;fd9d915c-a824-445d-999e-3173cc38d953	Not Available;Not Available	28;28	162;70	70;11	Temozolomide;Temozolomide	Not Available;Not Available	9;9	Not Available;1	Not Available;Not Available	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	YES	NO	TCGA-DU-7010-F17059	1927a2bd-f87a-43d3-9f98-d941d635d514	28	193	Not Available	456	Not Available	193	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	9	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7010	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7010-R17060	abac35da-6de2-43cc-9b65-056ed2b1e8e9	1	28	70	11	Not Available	9	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2001
TCGA-DU-5849	48	MALE	443	Oligodendroglioma	Central nervous system	Alive	G2	0	443			TUMOR FREE		48	Not Available	Not Available	Not Available	TCGA-DU-5849	5af8ada5-86b5-4832-8a8e-e975ecca5515	21	-17663	Not Applicable	0	443	Not Available	Not Available	TCGA-DU-5849-D14890	265ff908-1f73-4a94-9166-64c735e61e58	Not Available	25	226	42	Temozolomide	Not Available	5	06	Not Available	mg/m2	ADJUVANT	Not Applicable	01	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-5849-F14889	5c102075-8b52-424e-85b6-3b30d6984c57	25	Not Available	Not Available	Not Applicable	443	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2011	Not Available	Not Available	MALE	Not Available	NO	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5849	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available																			YES	NO	White Matter	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-VM-A8CB	33	MALE	3	Oligodendroglioma	Central nervous system	Alive	G3	0	3			TUMOR FREE		33	Unknown	Not Available	Unknown	TCGA-VM-A8CB	33600812-1894-4471-A365-75AE4D990B72	13	-12340	Not Applicable	0	3	Not Available	Not Available																								Not Evaluated	Unknown	Unknown	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-VM-A8CB-F66847	1B51F626-4FDD-4893-A8F3-14328116C2E0	24	Not Available	Not Available	Not Applicable	3	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	10	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	Unknown	Unknown	Unknown	Alive	2014	Unknown	Not Available	MALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A8CB	Not Evaluated	TUMOR FREE	Unknown	YES	YES	Unknown	Unknown	Unknown																			YES	NO	Not listed in Medical Record	NO	YES	VM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-DU-5853	29	MALE	407	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		29	Not Available	Not Available	Not Available	TCGA-DU-5853	2d42dd0e-be3a-46ae-a635-c6f9c52f9fa2	20	-10624	Not Applicable	0	407	Not Available	18	TCGA-DU-5853-D16883	dda7fbcd-163a-4afe-b64b-e6d76c7c3552	Not Available	20	65	28	Temozolomide	Not Available	9	1	75	mg/m2	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	165	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-5853-F16881	0f5dbcc1-13b5-41f3-ab79-a2d171a8a790	20	Not Available	Not Available	Not Applicable	407	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2011	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	100	Left	Not Available	Not Available	NO	NO	Not Available	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5853	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-5853-R16882	d3140de0-23cc-497d-99ae-f7ad3be953b4	1	20	65	28	Not Available	9	27	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-DU-A5TY	46	FEMALE	1033	Astrocytoma	Central nervous system	Dead	G3	1	526.0			WITH TUMOR		46	Not Available	Not Available	NO	TCGA-DU-A5TY	0167CF11-74BE-4701-AB9A-4E057D4BB545	14	-16945	Not Applicable	0	371	Not Available	Not Available	TCGA-DU-A5TY-D43151;TCGA-DU-A5TY-D43152;TCGA-DU-A5TY-D71311;TCGA-DU-A5TY-D71314;TCGA-DU-A5TY-D71315;TCGA-DU-A5TY-D71316;TCGA-DU-A5TY-D71318	D513EE25-1F99-4AB0-B5E6-1DC3F9A89627;AEE678D7-9A1F-42D2-AC2A-2A69B93B504A;ACB8A855-B072-4C9B-8DAC-71E04B4E3D8F;16FD7E66-71DE-46C1-8137-8438D870707D;A53ACC9C-1221-4CF3-AAAC-458E728EEEF8;20EC2652-DBC9-4B60-91D0-72DF2238C13E;77E2D94A-C04E-4377-A483-E5F22FF9E830	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;24;24;24;24;24	64;Not Available;812;812;855;855;914	17;79;553;553;814;814;872	Temozolomide;Temozolomide;Mibefradil;Temozolomide;Lomustine;Procarbazine;bevacizumab	Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	5;5;3;3;3;3;3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;YES;NO;NO;NO;NO;NO	Chemotherapy;Not Available;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;YES;YES;NO;NO;NO	2013;2013;2015;2015;2015;2015;2015	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	YES	YES	TCGA-DU-A5TY-F71302	3B48BFEF-E87E-44E1-9603-C3FEBB34D10A	24	536	955	1033	Not Available	526	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Discrepancy	YES	Dead	2015	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	Not Evaluated	Left	NO	IHC	YES	YES	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5TY	Not Evaluated	WITH TUMOR	YES	YES	YES	Discrepancy	WHITE	YES	Primary Tumor Field;Local Recurrence	TCGA-DU-A5TY-R43150;TCGA-DU-A5TY-R71319	568FCC5F-8E0C-4CE1-9293-3494A1AD7009;28143B3E-5A8D-44F1-A95B-E1FF52A82830	Not Available;Not Available	14;24	34;989	17;980	Stable Disease;Radiographic Progressive Disease	5;3	30;8	6000;56	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Gy	2013;2015	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-TM-A84O	61	FEMALE	1011	Oligodendroglioma	Central nervous system	Dead	G3	1				WITH TUMOR		61	NO	Not Available	NO	TCGA-TM-A84O	8839F236-BC04-416F-84D4-50F67FB338DC	17	-22327	1011	0	Not Available	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84O-F65303	FA6E84D3-ED73-4CD3-A559-C203150B434E	22	Not Available	Not Available	1011	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response	YES	Dead	2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84O	Preoperative	WITH TUMOR	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A84O-R56524	013FE693-91A4-4333-8054-7F656683AE24	Not Available	16	73	30	Complete Response	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Not Otherwise Specified	Central nervous system	NO	Dead	2014	2011
TCGA-RY-A83Z	54	FEMALE	301	Astrocytoma	Central nervous system	Alive	G3	0	301			WITH TUMOR		54	Not Available	Not Available	NO	TCGA-RY-A83Z	145C3685-F6DE-4669-8EC4-6C3431A90532	15	-19903	Not Applicable	0	301	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-RY-A83Z-F69683	7FFE6D88-3A4E-4CC6-85C0-81A47066F754	15	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2015	Not Available	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	NO	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A83Z	Not Evaluated	WITH TUMOR	YES	Not Available	Not Available	Stable Disease	WHITE	YES																			YES	NO	Cerebral Cortex	YES	NO	RY	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-HT-8564	47	MALE	478	Astrocytoma	Central nervous system	Alive	G3	1	120.0			WITH TUMOR		47	NO	Not Available	NO	TCGA-HT-8564	f625e522-226b-450f-af94-dd2f5adb605e	17	-17499	Not Applicable	0	478	Not Available	Not Available	TCGA-HT-8564-D46310;TCGA-HT-8564-D48471;TCGA-HT-8564-D48472	A467D99D-A6A9-47BA-9227-A7A5A32D15EF;D4B869E8-9EF1-4643-A4AA-808180CF2CC5;931B1FAA-BED3-4C58-99D3-EE734B75C3C3	Not Available;Not Available;Not Available	5;13;13	135;Not Available;Not Available	13;184;184	Temodar;Avastin;CeeNU	Clinical Progressive Disease;Complete Response;Not Available	8;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;Not Available;Not Available	Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Unknown	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	YES	NO	Not Available	Not Available	TCGA-HT-8564-F48467	E21930D3-7A78-4345-8CBE-0D4C8D4330C9	13	Not Available	Not Available	Not Applicable	478	120	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Alive	2013	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	80	Left	Not Available	Not Available	Unknown	YES	NO	7	NO	G3	YES	YES	120	YES	120	Not Available	Not Available	YES	No	8564	Post-Adjuvant Therapy	WITH TUMOR	YES	Unknown	Unknown	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-HT-8564-R46309	06B2F41D-0BFC-40F1-ADF3-FB40E1C7F443	Not Available	5	128	35	Radiographic Progressive Disease	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-8186	42	FEMALE	487	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		42	NO	Not Available	NO	TCGA-FG-8186	dcd45077-f068-490b-bdcc-4d4a62285116	31	-15431	Not Applicable	0	121	Not Available	13																								Not Available	NO	HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-8186-F42521	334FE4DD-8288-4A57-8DEA-11089B240612	23	Not Available	Not Available	Not Applicable	487	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	4	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	YES	Alive	2013	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	70	Right	Not Available	Not Available	NO	NO	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8186	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-8186-R32567	C97E8B71-D5DB-4343-8674-174A5A7E9B08	Not Available	1	105	60	Stable Disease	6	31	5450	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-DU-8168	55	FEMALE	431	Oligodendroglioma	Central nervous system	Alive	G3	0	431			WITH TUMOR		55	Not Available	Not Available	Not Available	TCGA-DU-8168	fc8828ae-484d-4fc8-a168-f8bc58ad65b9	15	-20136	Not Applicable	0	108	Not Available	14	TCGA-DU-8168-D33151;TCGA-DU-8168-D33152	A4810C43-5747-4139-B975-76501A8399A3;FC39F971-D16D-40D7-84D1-EF3519EF014F	Not Available;Not Available	21;21	71;Not Available	25;106	Temozolomide;Temozolomide	Stable Disease;Not Applicable	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	1	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-8168-F44360	7D1E6E45-9A92-4D08-A722-6097060DBBD6	19	Not Available	Not Available	Not Applicable	431	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2013	Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	70	Right	Not Available	Not Available	NO	NO	Not Available	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8168	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-8168-R33149	96CEF708-0CF8-4D90-94CA-32D3F4AEB66F	Not Available	21	71	25	Stable Disease	6	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2012
TCGA-DB-5278	17	MALE	2772	Oligodendroglioma	Central nervous system	Alive	G2	1	507.0			WITH TUMOR		17	NO	Not Available	NO	TCGA-DB-5278	010aac75-3bfe-4bf2-b866-af0f2d92f125	22	-6480	Not Applicable	0	1526	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO;Not Available	YES;Not Available	YES;Not Available	NO;Not Available	TCGA-DB-5278-F14232;TCGA-DB-5278-F67393	5a466d77-8d24-4dfe-a5ea-7e01088a5c4b;1F698A07-82BB-4D75-9329-2A0A9F3EE1B4	22;7	507;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1526;2772	507;Not Available	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	Not Available;NO	7;11	Not Available;Not Available	YES;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	NO;NO	Stable Disease;Stable Disease	NO;NO	Alive;Alive	2011;2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	Not Available	YES	NO	7	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5278	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DB-5278-R14238	f15293c5-c966-4bfe-a15f-40d926e6aa86	1	22	903	866	Not Available	7	28	5040	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2007
TCGA-S9-A6U6	28	MALE	1069	Astrocytoma	Central nervous system	Alive	G3	0	1069			TUMOR FREE		28	NO	Not Available	NO	TCGA-S9-A6U6	8ED09A8A-3284-4A1B-B369-E25D2FAB0F61	4	-10253	Not Applicable	0	300	Not Available	-3																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6U6-F67224;TCGA-S9-A6U6-F72342	128E5C5A-A168-4BB1-B88E-EA04AC0F0A70;696B1232-17D7-451C-B9F5-CB0EB01B56B4	3;27	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	489;1069	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Unknown	Not Available;Not Available	NO;NO	11;5	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Unknown	NO;NO	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Alive	2014;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	100	Left	YES	IHC	YES	NO	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6U6	Preoperative	TUMOR FREE	NO	NO	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6U6-R54271	6AE9AA8B-596B-429D-B0DF-ECA833190BF2	Not Available	18	110	60	Complete Response	12	33	59,4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-7018	57	FEMALE	933	Oligodendroglioma	Central nervous system	Dead	G3	1	338.0			WITH TUMOR		57	Not Available	Not Available	Not Available	TCGA-DU-7018	f18dab99-26b0-4727-89a9-7f16bd382356	23	-21019	933	0	Not Available	Not Available	12	TCGA-DU-7018-D17072;TCGA-DU-7018-D17071	0ff38e24-e65f-4420-b997-6be8f0cbe1f4;de8a8468-26f5-46ad-8a52-b62f67e846ea	Not Available;Not Available	23;23	697;605	635;56	Temozolomide;Temozolomide	Not Available;Not Available	9;9	2;17	100;150	mg/m2;mg/m2	PROGRESSION;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	150;330	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	YES	NO	YES	NO	TCGA-DU-7018-F17070	18c378df-0866-422a-bffd-67bdd9e939e5	23	844	Not Available	933	Not Available	338	343	Not Available	Not Available	Progressive Disease	90	Not Available	9	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	YES	YES	Not Available	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7018	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	Not Available	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2006
TCGA-IK-7675	43	MALE	578	Oligodendroglioma	Central nervous system	Dead	G2	1	123.0			WITH TUMOR		43	Not Available	Not Available	NO	TCGA-IK-7675	a5f851c5-6130-4ea1-9f86-be59331a92f7	24	-15900	578	0	Not Available	Not Available	48	TCGA-IK-7675-D33079;TCGA-IK-7675-D33083	5622E3C6-D9EF-4F6A-98FC-980910049058;1A8C1EB1-B052-4A32-AFA6-74AA05DDAF36	Not Available;Not Available	20;20	510;552	Not Available;531	Bevacizumab;Irinotecan	Unknown;Unknown	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Targeted Molecular therapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	YES	Not Available	Not Available	Not Available	TCGA-IK-7675-F33064	7861079D-6A1A-40A4-801B-8064AA218090	19	Not Available	Not Available	578	Not Available	123	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2012	Not Available	Not Available	MALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	Not Available	NO	Not Available	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7675	Other	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-IK-7675-R21159	ef3cf798-a791-4210-95d2-254f33e4f272	1	2	88	46	Not Available	2	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	YES	NO	IK	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2012	2009
TCGA-HT-7680	32	FEMALE	23	Astrocytoma	Central nervous system	Alive	G2	0	23			TUMOR FREE		32	NO	Not Available	NO	TCGA-HT-7680	62e27075-7ddc-4f15-ac21-0a8244abb12d	7	-11970	Not Applicable	0	23	Not Available	Not Available																								Not Available	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	NO	NO	Not Available	Not Available	TCGA-HT-7680-F28949	6dbf58fb-bcc0-4b60-9447-efeeb1edbf97	2	Not Available	Not Available	Not Applicable	23	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.9	9400/3	C71.9	YES	NO	Not Available	Not Available	Midline	Not Available	Not Available	NO	NO	NO	2	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7680	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Posterior Fossa, Cerebellum	Central nervous system	NO	Alive	2012	2010
TCGA-P5-A5EX	41	FEMALE	243	Oligodendroglioma	Central nervous system	Alive	G3	0	243			WITH TUMOR		41	Unknown	Not Available	NO	TCGA-P5-A5EX	1F13065A-40F7-455D-B8EB-F9A128722EAC	12	-15091	Not Applicable	0	50	Not Available	Not Available	TCGA-P5-A5EX-D56611	8F3188FD-9D3F-4F2E-BDF9-0EC79E09DDA3	Not Available	8	243	16	Temozolomide	Partial Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	NO	2014	Unknown	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5EX-F69042	85CB3742-9457-45B1-831C-3BD285AEDBE7	24	Not Available	Not Available	Not Applicable	243	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	12	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Partial Remission/Response	YES	Alive	2014	Unknown	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	80	Right	Not Available	Not Available	NO	NO	NO	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5EX	Unknown	WITH TUMOR	YES	NO	NO	Unknown	WHITE	YES	Primary Tumor Field	TCGA-P5-A5EX-R56610	4459E17A-0D09-4CF6-98F5-07D765DE892C	Not Available	8	31	16	Partial Response	5	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	YES	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-TM-A84S	36	MALE	454	Oligodendroglioma	Central nervous system	Alive	G3	0	454			TUMOR FREE		36	NO	Not Available	NO	TCGA-TM-A84S	CD50AEA8-A5DB-48D3-AD28-CBE9F9E75AE3	17	-13424	Not Applicable	0	139	Not Available	0																								1	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84S-F65304	1A084D7C-F83C-4D02-95AE-B049B9968F6D	22	Not Available	Not Available	Not Applicable	454	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	80	Left	YES	IHC	YES	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84S	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2013
TCGA-DB-5281	61	MALE	2381	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		61	NO	Not Available	NO	TCGA-DB-5281	15a6ad18-a81c-4f5b-80ae-ef56ccf722f9	24	-22342	Not Applicable	0	1614	Not Available	Not Available	TCGA-DB-5281-D14439;TCGA-DB-5281-D14437	e7a75c37-6dc9-4fce-8b89-f4421fbc89c1;dbd42c32-58ee-4ce6-a5fa-26fabdb20c19	Not Available;Not Available	Not Available;22	276;95	95;25	Temodar;Temodar	Not Available;Not Available	7;7	6;6	200;75	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	12000;6300	mg;mg	Not Available;Not Available	2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-5281-F42828	F80FF393-16E9-4239-87B2-06B6F50A4F0E	1	Not Available	Not Available	Not Applicable	2381	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	5	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2013	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	7	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5281	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DB-5281-R14244	dc0c4be2-9541-4746-8957-c94db68d808e	1	22	69	25	Not Available	7	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Deep Gray (e.g.basal ganglia, thalamus)	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2006
TCGA-HT-7875	56	MALE	10	Oligodendroglioma	Central nervous system	Alive	G2	0	10			TUMOR FREE		56	NO	Not Available	NO	TCGA-HT-7875	40ae8507-c08a-45d5-9bbb-65d236c82319	7	-20613	Not Applicable	0	10	Not Available	0																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7875-F28953	cb96a53d-ffed-4904-8bf2-8a744902dcda	2	Not Available	Not Available	Not Applicable	10	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	YES	Alive	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	80	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7875	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-S9-A6TW	40	MALE	1250	Oligodendroglioma	Central nervous system	Alive	G3	1	861.0			WITH TUMOR		40	NO	Not Available	NO	TCGA-S9-A6TW	C45E02E5-7E3C-4F36-8B8D-F54617E8A436	31	-14679	Not Applicable	0	860	Not Available	-8	TCGA-S9-A6TW-D54121	CE62E6FD-96CE-4050-999D-5D133BB1CA4D	Not Available	17	304	25	Temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	31 - 90 Days	NO;Not Available	YES;Not Available	YES;Not Available	Not Available;Not Available	TCGA-S9-A6TW-F63103;TCGA-S9-A6TW-F69523	A569F2B3-7F15-4579-B8DC-59536DBD1FB2;FEC5BB13-A2E8-46F8-B571-27DEAD8E9C6B	31;13	1018;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1151;1250	861;Not Available	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	YES;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Partial Remission/Response;Partial Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	YES	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	90	Left	YES	IHC	YES	NO	NO	10	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6TW	Preoperative	WITH TUMOR	YES	NO	YES	Partial Remission/Response	WHITE	NO	Local Recurrence	TCGA-S9-A6TW-R63105	6BD39A50-8DAE-4E77-BBDC-6572A6BEFF4C	Not Available	31	1104	1057	Complete Response	7	33	49,4	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	NO	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-E1-A7YY	27	FEMALE	4445	Oligodendroglioma	Central nervous system	Dead	G2	1	958.0			WITH TUMOR		27	NO	Not Available	YES	TCGA-E1-A7YY	722C172F-46E6-47A1-82E5-3207278DF89B	11	-9867	4445	0	Not Available	Not Available	428	TCGA-E1-A7YY-D61626;TCGA-E1-A7YY-D61629;TCGA-E1-A7YY-D61631;TCGA-E1-A7YY-D61633;TCGA-E1-A7YY-D61635;TCGA-E1-A7YY-D61638	4A36C2BC-E737-4A26-912B-61212551557A;F865A9A1-5405-4ED7-8982-32BE7D405518;B46C8F8D-1DE0-4243-90D2-896143B8DB38;9F5DC724-EF96-4637-8F7A-54D2380DEE17;9CDFAC52-BFDF-45CC-9806-B36B7A015161;918DD13E-DDC7-4DB8-8A7D-E2C12D364BFB	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15	1351;2470;2590;4152;4207;4418	982;2378;2465;3501;4152;4289	Temodar;Temodar;CCNU;Temodar;VP-16;Avastin	Stable Disease;Clinical Progressive Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Unknown	8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO;NO;NO	2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO;YES;YES;YES;YES;YES	YES;NO;NO;NO;NO;NO	NO;NO;NO;NO;NO;NO	NO;NO;NO;NO;NO;NO	TCGA-E1-A7YY-F61627;TCGA-E1-A7YY-F61628;TCGA-E1-A7YY-F61630;TCGA-E1-A7YY-F61632;TCGA-E1-A7YY-F61634;TCGA-E1-A7YY-F61637	DF5886B5-A4D8-4A5A-AF4F-8261839A8CCB;6547A344-3ACF-4D74-8098-876AFDFDBD25;0C0555D4-D87B-477D-9187-DF6CA3F14391;876426C0-2C74-4646-82B9-96DB2F459442;6464AE58-0611-4391-A819-0430E4A684D6;3504AEFD-39BA-4F92-AED7-227C3617D0A9	15;15;15;15;15;15	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4445;4445;4445;4445;4445;4445	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2121;2380;2464;3500;4143;4266	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES;YES;YES	Stable Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease	YES;YES;YES;YES;YES;YES	Dead;Dead;Dead;Dead;Dead;Dead	2014;2014;2014;2014;2014;2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	8	NO	G2	YES	NO	958	NO	Not Available	Not Available	Not Available	YES	No	A7YY	Pre-Adjuvant Therapy	WITH TUMOR	NO	YES	YES	Stable Disease	WHITE	NO	Primary Tumor Field	TCGA-E1-A7YY-R61622	360D11A2-43C8-439E-B6EC-FB186F12126A	Not Available	15	2184	2143	Stable Disease	8	Not Available	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	1998
TCGA-FG-8188	41	MALE	455	Oligoastrocytoma	Central nervous system	Alive	G2	1	384.0			WITH TUMOR		41	NO	Not Available	NO	TCGA-FG-8188	106709ec-72df-44f0-8c71-87b7c755f8f0	31	-15051	Not Applicable	0	97	Not Available	-15																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	NO	YES	NO	Not Available	TCGA-FG-8188-F43454	E831A388-07D2-48D2-B7F5-C4605C7513CC	22	Not Available	Not Available	Not Applicable	455	384	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2013	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	YES	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8188	Preoperative	WITH TUMOR	Not Available	YES	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-8188-R43455	719F96FC-3B45-4CAE-927C-97B6F05CAEFA	Not Available	22	455	418	Unknown	5	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2012
TCGA-TM-A84T	19	MALE	724	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		19	NO	Not Available	NO	TCGA-TM-A84T	F9052682-B689-4696-9AB9-3F55976B43EE	17	-6994	Not Applicable	0	365	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84T-F65306	5EA90894-4C4E-4D53-9F39-8814A10380EC	22	Not Available	Not Available	Not Applicable	724	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Left	YES	IHC	YES	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84T	Preoperative	WITH TUMOR	NO	Unknown	Unknown	Stable Disease	WHITE	NO																			YES	YES	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-DB-A75P	25	FEMALE	492	Astrocytoma	Central nervous system	Alive	G2	0	492			TUMOR FREE		25	NO	Not Available	NO	TCGA-DB-A75P	904371B0-1E2C-4CD7-A69D-29AE8C5FEC8B	3	-9413	Not Applicable	0	116	Not Available	Not Available																								Not Evaluated	NO	Unknown	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A75P-F67380	CE19F9B8-A169-4C9C-8943-7BAC3D871664	4	Not Available	Not Available	Not Applicable	492	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	NO	IHC	YES	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A75P	Not Available	TUMOR FREE	NO	YES	NO	Complete Remission/Response	Unknown	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-7013	59	MALE	269	Astrocytoma	Central nervous system	Dead	G3	1	187.0			WITH TUMOR		59	Not Available	Not Available	Not Available	TCGA-DU-7013	d61b5d20-4d6d-4fdc-afe8-4b100b686eda	26	-21824	269	0	Not Available	Not Available	11	TCGA-DU-7013-D17094	909faac9-a567-4223-b445-653d75e77445	Not Available	26	163	101	Temozolomide	Not Available	9	03	Not Available	mg/m2	ADJUVANT	Not Applicable	01	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	NO	NO	NO	NO	TCGA-DU-7013-F17092	2ecfa536-7e1a-44e2-869f-10186c321f1c	26	Not Available	Not Available	269	Not Available	187	211	Not Available	Not Available	Progressive Disease	70	Not Available	9	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	80	Left	Not Available	Not Available	NO	NO	Not Available	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7013	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7013-R17093	32a1df90-3dd6-43e0-bed2-3985174505b2	01	26	71	10	Not Available	9	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	White Matter	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	2001
TCGA-HT-7477	62	MALE	738	Astrocytoma	Central nervous system	Alive	G3	0	738			TUMOR FREE		62	NO	Not Available	NO	TCGA-HT-7477	38f4b9f3-6709-40ff-9a81-5fa2111b1ce6	24	-22948	Not Applicable	0	738	Not Available	24	TCGA-HT-7477-D49436	4844019E-25CF-4290-9A62-5187446664FF	Not Available	3	428	24	Temodar	Complete Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2015	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7477-F45880	D2B0C5EB-642D-44DA-9710-8F25EF7126C5	24	Not Available	Not Available	Not Applicable	738	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	80	Left	Not Available	Not Available	Unknown	NO	NO	7	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	7477	Post-Adjuvant Therapy	TUMOR FREE	YES	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-7477-R49437	7922FCA5-01EA-4B3B-800B-74885ABDDD4E	Not Available	1	83	24	Complete Response	4	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2015	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-P5-A735	38	FEMALE	292	Astrocytoma	Central nervous system	Alive	G2	0	292			TUMOR FREE		38	Not Available	Not Available	Not Available	TCGA-P5-A735	A3822B5E-D794-4126-B31F-C70E1CC47F22	13	-14152	Not Applicable	0	7	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A735-F69024	0BFD6EB5-B542-4461-8DEA-1C3875E82587	24	Not Available	Not Available	Not Applicable	292	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	Not Available	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A735	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown																			Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-RY-A843	30	MALE	63	Astrocytoma	Central nervous system	Alive	G3	0	63			WITH TUMOR		30	Not Available	Not Available	NO	TCGA-RY-A843	1F2F3BF6-ACDD-4A72-8C33-230DE40910EB	16	-11083	Not Applicable	0	63	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-RY-A843-F69739	7694306A-668D-469A-8334-666FBEB3F8EB	16	Not Available	Not Available	Not Applicable	63	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	YES	1	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2015	Not Available	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	NO	IHC	YES	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A843	Not Evaluated	WITH TUMOR	YES	Not Available	Not Available	Unknown	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	RY	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-DB-5280	43	MALE	1112	Oligoastrocytoma	Central nervous system	Alive	G2	0	1112			TUMOR FREE		43	NO	Not Available	NO	TCGA-DB-5280	4797c600-f024-42fe-b287-d919b24dcb79	23	-15836	Not Applicable	0	404	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-5280-F42831	8E9057ED-5296-44E9-8615-10D99718111D	1	Not Available	Not Available	Not Applicable	1112	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	Not Available	NO	NO	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5280	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2007
TCGA-E1-A7YS	71	MALE	466	Oligodendroglioma	Central nervous system	Dead	G3	1				WITH TUMOR		71	NO	Not Available	NO	TCGA-E1-A7YS	5E2539E0-2088-43DF-AD2A-F854D8BB6D30	11	-26159	466	0	Not Available	Not Available	16	TCGA-E1-A7YS-D61559;TCGA-E1-A7YS-D61560	2E2BE95F-A48A-4AA6-A723-E3789B943E9F;C5132DE8-7AA1-4C48-A553-400452DEB9CB	Not Available;Not Available	15;15	106;365	67;127	Temodar;Temodar	Stable Disease;Stable Disease	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-E1-A7YS-F61561	957D7062-3ECD-4B67-B413-E807263BA805	15	Not Available	Not Available	466	Not Available	Not Available	Not Available	Not Available	Not Available	Stable Disease	Not Available	NO	8	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Dead	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	80	Left	Not Available	Not Available	NO	YES	NO	8	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7YS	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Stable Disease	BLACK OR AFRICAN AMERICAN	YES	Unknown	TCGA-E1-A7YS-R61558	C0C156D5-4F9A-468A-96EB-DFFFF02F4316	Not Available	15	106	67	Stable Disease	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2007
TCGA-EZ-7264	47	FEMALE	1201	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		47	NO	Not Available	NO	TCGA-EZ-7264	fc3b7596-f515-446f-81db-fed0154ca2c5	10	-17432	Not Applicable	0	160	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-EZ-7264-F34555;TCGA-EZ-7264-F66594	E28C6322-8BA1-4C6E-856C-923588E4766A;EE8FB968-30C3-4F87-8D30-7ACCEB586649	22;21	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	436;1201	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	8;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Stable Disease;Stable Disease	NO;NO	Alive;Alive	2012;2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	YES	NO	11	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7264	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available																			YES	NO	White Matter	YES	NO	EZ	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2011
TCGA-E1-A7YJ	55	MALE	592	Astrocytoma	Central nervous system	Dead	G3	1	516.0			WITH TUMOR		55	Unknown	Not Available	NO	TCGA-E1-A7YJ	BC6FBB3C-870D-40B5-983B-7C88705E020D	12	-20180	592	0	Not Available	Not Available	12	TCGA-E1-A7YJ-D61250;TCGA-E1-A7YJ-D61252;TCGA-E1-A7YJ-D61253;TCGA-E1-A7YJ-D61254;TCGA-E1-A7YJ-D61258	B7766092-014A-4022-B955-64E79DCB5CF6;BC5EE672-52C4-4BF2-B34C-19B1F8E3EB2E;54D88AA0-390E-4D3F-ABF4-A143045CF5F6;E73CAFDA-7537-40C4-96BB-C655A0C45770;FC1FB192-BAC6-4038-87DE-C3EA5C46495F	Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15	84;144;504;518;541	39;96;96;96;537	Temodar;CPT-11;Avastin;Temodar;MR1-1	Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	NO	NO	NO	NO	TCGA-E1-A7YJ-F61259	4E8E539B-5CB1-438B-A49D-733DAB7F089F	15	Not Available	Not Available	592	Not Available	573	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Dead	2014	Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	Not Available	Not Available	NO	NO	Unknown	5	YES	G3	YES	NO	516	NO	Not Available	Not Available	Not Available	YES	No	A7YJ	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-E1-A7YJ-R61249	A3D1F515-CAAD-42EA-937A-B95C9350B91E	Not Available	15	84	39	Stable Disease	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	White Matter	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	2008
TCGA-DB-A4XG	34	MALE	2219	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		34	NO	Not Available	NO	TCGA-DB-A4XG	7704E4A8-C7AA-4288-B1ED-68C23ABBE924	21	-12550	Not Applicable	0	2219	Not Available	Not Available	TCGA-DB-A4XG-D40491	4D136088-CEE6-415F-B6C4-EE9883EF46A0	Not Available	21	2067	1732	Temodar	Stable Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XG-F60957	B1BED398-FE7B-4E03-B96F-F2D0D6592C16	19	Not Available	Not Available	Not Applicable	2219	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	6	Not Available	Unknown	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.1	9451/3	C71.1	YES	NO	Not Available	Not Evaluated	Right	NO	IHC	YES	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4XG	Not Available	WITH TUMOR	YES	YES	Unknown	Stable Disease	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2006
TCGA-S9-A6U5	33	MALE	992	Astrocytoma	Central nervous system	Alive	G2	0	992			TUMOR FREE		33	NO	Not Available	NO	TCGA-S9-A6U5	621424EC-67BC-4C42-B0AD-64C5654B5AD9	31	-12417	Not Applicable	0	610	Not Available	-6																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	NO	NO	Not Available	Not Available	TCGA-S9-A6U5-F62932	16B4B4CE-88A3-4F93-9EDD-7996245DDB89	29	Not Available	Not Available	Not Applicable	992	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	100	Right	YES	IHC	YES	NO	NO	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6U5	Preoperative	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-DU-6396	31	FEMALE	2286	Oligoastrocytoma	Central nervous system	Dead	G3	1	106.0			WITH TUMOR		31	Not Available	Not Available	Not Available	TCGA-DU-6396	152eaa99-05f5-4d30-bfb1-494a9a900e49	27	-11427	2286	0	Not Available	Not Available	19	TCGA-DU-6396-D14935;TCGA-DU-6396-D14933;TCGA-DU-6396-D14932;TCGA-DU-6396-D14936;TCGA-DU-6396-D14939;TCGA-DU-6396-D14930;TCGA-DU-6396-D14931;TCGA-DU-6396-D14934	1084ba3c-b0c8-4f60-ab84-83956e33cb8d;4cd94d5c-66be-4c9b-93ff-f46de4f44b15;9a014511-a6fa-415d-94b6-e1b66bd06118;406e2b57-e5a0-44cc-b65e-881ee8287f0f;fa3ee205-f1c2-449a-bb8d-c7be90bb81a2;cd5425bf-34a2-4a3d-9fe1-dcf4c872d12a;94427195-4e76-4498-8d14-caa0f65bd8f1;27e77493-3706-4477-8dde-0f13bb5c3d05	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27;27	1946;1062;636;2250;2250;59;89;2188	1823;915;240;2127;2250;28;82;1762	Isotretinoin;Irinotecan;9 Aminocamptothecin;Tamoxifen;Capecitabine;Bromo deoxyuridine;PCV;Temozolomide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7;7	4;4;18;4;1;1;1;7	Not Available;125;1611;Not Available;Not Available;Not Available;Not Available;150	mg;mg/m2;mg/m2;mg;mg/day;Not Available;Not Available;mg/m2	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	5;4;3;6;7;1;2;5	PO;IV;IV;PO;PO;IV;IV;PO;PO	NO;NO;NO;NO;NO;NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Radiosensitizer;Not Available;Not Available	Not Available;Not Available;1611;160;3500;Not Available;Not Available;225	mg;Not Available;mg/m2;mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	YES	YES	YES	NO	TCGA-DU-6396-F14916	1f867d72-0181-4137-b7fa-702450603912	27	169	Not Available	2286	Not Available	106	Not Available	0	Not Available	Progressive Disease	Not Available	Not Available	7	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	7	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6396	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Local Recurrence;Primary Tumor Field;Local Recurrence;Local Recurrence	TCGA-DU-6396-R14926;TCGA-DU-6396-R14927;TCGA-DU-6396-R14925;TCGA-DU-6396-R14928;TCGA-DU-6396-R14929	8c7be1d2-33fc-44fd-9f85-88fe52cfa913;157246a0-ede8-49ca-9759-47f82191a245;0b042829-6f75-49c5-8299-9af5359f0b21;8592a4cc-06e6-4aea-812e-eca28b8e8bfd;22dda534-0900-4f11-902d-28e547e4a812	2;3;1;4;5	27;27;27;27;27	59;1825;25;2097;2216	28;1825;25;2066;2198	Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7	Not Available;1;1;Not Available;6	5940;1800;800;5600;3000	NO;NO;NO;NO;NO	EXTERNAL BEAM;OTHER;OTHER;OTHER;OTHER	Not Applicable;Stereotactic radiosurgery;Stereo Radiosurgery;Intensity Modulated Radio Therapy;Fractionated stereotactic radio therapy	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Available;Not Available;Not Available;Not Available;Not Available	cGy;cGy;cGy;cGy;cGy	2011;2011;2011;2011;2011	NO	YES	White Matter	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1996
TCGA-DB-A64V	54	MALE	889	Oligodendroglioma	Central nervous system	Alive	G2	0	889			WITH TUMOR		54	Unknown	Not Available	NO	TCGA-DB-A64V	176D89D7-F8F1-4A72-B45A-31CBE1632A30	7	-19950	Not Applicable	0	448	Not Available	-17	TCGA-DB-A64V-D46511	DACF8EBF-D304-4805-901B-8D708EBB040A	Not Available	7	330	20	Temodar	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64V-F67368	F777C61F-6F0C-40BE-85BE-D8546781F0A3	4	Not Available	Not Available	Not Applicable	889	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2014	Unknown	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	Unknown	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64V	Preoperative	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-P5-A72W	35	MALE	317	Astrocytoma	Central nervous system	Alive	G3	0	317			TUMOR FREE		35	Not Available	Not Available	Not Available	TCGA-P5-A72W	59012B43-AB0B-42C3-AED3-94E224A3DFA7	13	-12848	Not Applicable	0	9	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A72W-F69016	A9CF3F16-71CE-459A-96F4-D5CAE4A9C4CB	24	Not Available	Not Available	Not Applicable	317	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	12	Not Available	NO	Not Available	Not Available	Not Available	Unknown	Unknown	YES	Alive	2014	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	Not Available	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A72W	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A72W-R69017	89D10F52-BBD0-496C-8FD4-DEA18D97950A	Not Available	24	Not Available	467	Not Available	12	29	58	YES	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-FG-6688	59	FEMALE	571	Astrocytoma	Central nervous system	Alive	G3	1	405.0			WITH TUMOR		59	NO	Not Available	NO	TCGA-FG-6688	dadd7428-9e4d-4652-9469-ab521b88d529	25	-21745	Not Applicable	0	221	Not Available	60	TCGA-FG-6688-D14644;TCGA-FG-6688-D32792	3882f392-f750-4236-adc1-8196e3e64b74;112A79D4-BB4F-4DDC-B489-5234CE6720FA	Not Available;Not Available	5;12	Not Available;Not Available	159;483	Temodar;Avastin	Not Available;Stable Disease	8;6	3;Not Available	345-460;Not Available	mg;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	1;Not Available	PO;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	5750;Not Available	mg;Not Available	Not Available;NO	2011;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;YES	Not Available;NO	Not Available;NO	Not Available;NO	TCGA-FG-6688-F14222;TCGA-FG-6688-F32791	142ba9f8-8153-4f6c-9d29-d39f1ce2162c;2551C7FD-64C6-4688-A4C0-136A81A6A265	25;12	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	221;571	Not Available;405	60;405	Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event	Stable Disease;Stable Disease	80;50	Not Available;Not Available	7;6	Not Available;Not Available	NO;YES	Not Available;Not Available	Pre-Adjuvant Therapy;Post-Adjuvant Therapy	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	YES;YES	Alive;Alive	2011;2012	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Left	Not Available	Not Available	NO	NO	NO	7	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6688	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-FG-6688-R14643	d07e978d-2448-4725-b88d-8570fbf340f6	1	5	124	82	Not Available	8	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	YES	Not listed in Medical Record	YES	NO	FG	Supratentorial, Parietal Lobe	Central nervous system	YES	Alive	2011	2010
TCGA-HT-A74K	58	FEMALE	467	Oligodendroglioma	Central nervous system	Alive	G3	0	467			TUMOR FREE		58	Unknown	Not Available	Unknown	TCGA-HT-A74K	A3BE4E6F-C845-4D64-8111-D63FDF8CC8F1	26	-21189	Not Applicable	0	467	Not Available	Not Available	TCGA-HT-A74K-D65341	EF15302A-0D4E-4223-A024-900520E4DC39	Not Available	27	277	35	temodar	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days																														Unknown	Not Available	FEMALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	Not Evaluated	Right	Not Available	Not Available	Unknown	NO	Unknown	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A74K	Not Available	TUMOR FREE	YES	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A74K-R65334	F3FB5023-AD5D-4B2A-B464-63F7BBB7CF3F	Not Available	27	79	35	Complete Response	10	42	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-RY-A840	47	MALE	854	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		47	Not Available	Not Available	NO	TCGA-RY-A840	738143B3-2D82-42F0-9FD4-8CBABC9C9B4F	16	-17501	Not Applicable	0	854	Not Available	22																								0	NO	Unknown	NO	NO	< 12 Years	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-RY-A840-F69714	62C23FD3-D088-4DBA-8444-DB73F572BC0D	16	Not Available	Not Available	Not Applicable	854	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	1	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2015	NO	Not Available	MALE	YES	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A840	Pre-Adjuvant Therapy	WITH TUMOR	YES	Not Available	Not Available	Stable Disease	Unknown	NO																			YES	NO	Cerebral Cortex	YES	NO	RY	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-S9-A6U8	24	MALE	2988	Astrocytoma	Central nervous system	Dead	G2	1	367.0			WITH TUMOR		24	NO	Not Available	NO	TCGA-S9-A6U8	B10A9314-FD40-459E-97EA-AFFC636DCEEA	4	-9044	Not Applicable	0	2878	Not Available	-31	TCGA-S9-A6U8-D65503;TCGA-S9-A6U8-D67329;TCGA-S9-A6U8-D67331;TCGA-S9-A6U8-D67333	DA2DA54A-C52B-49DE-8153-D1D2207C107D;A70CE6B1-C8BE-460D-9896-3B76422807D9;01F378FF-08BF-4C09-940D-608E205273E1;50DE2066-0076-475B-9024-2CB0E175992A	Not Available;Not Available;Not Available;Not Available	24;4;4;4	2988;2200;2762;2794	2832;1995;2720;2787	Bevacizumab;Temozolomide;Carmustin;Temozolomide	Unknown;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease	9;11;11;11	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	NO	Not Available	Not Available	TCGA-S9-A6U8-F65495	ABC7E671-7584-4D6A-BDE7-B180552B3D64	24	Not Available	Not Available	2988	Not Available	367	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Dead	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	11	NO	G2	NO	YES	367	NO	Not Available	Not Available	Not Available	YES	No	A6U8	Preoperative	WITH TUMOR	NO	NO	NO	Partial Remission/Response	WHITE	NO	Primary Tumor Field	TCGA-S9-A6U8-R67326	E73B5756-CD45-4CC7-9EC8-DE84DB5EFAA1	Not Available	4	Not Available	381	Partial Response	11	Not Available	59,4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	White Matter	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2005
TCGA-HT-A5RB	24	MALE	3	Astrocytoma	Central nervous system	Alive	G2	0	3			Unknown		24	Unknown	Not Available	NO	TCGA-HT-A5RB	04D56BED-98FB-45EB-8C90-95E69264DFE2	11	-8820	Not Applicable	0	3	Not Available	Not Available																								Not Available	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A5RB-F61266	B068D2BC-9208-4B9A-B376-41AC8695869D	26	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	Unknown	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Unknown	Right	Not Available	Not Available	Unknown	NO	NO	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5RB	Not Available	Unknown	Unknown	YES	NO	Unknown	WHITE	Unknown																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-FG-A4MT	27	FEMALE	1164	Oligodendroglioma	Central nervous system	Alive	G2	1	499.0			TUMOR FREE		27	NO	Not Available	NO	TCGA-FG-A4MT	E30F1994-3622-43D0-BEC2-6D7E2D9881D2	7	-10082	Not Applicable	0	744	Not Available	499																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	YES	YES	Not Available	TCGA-FG-A4MT-F56666	DB10AE49-6308-48A2-B191-C910D14CD1B1	17	647	Not Available	Not Applicable	1164	499	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	2	Not Available	YES	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.2	9450/3	C71.2	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	1	NO	G2	NO	YES	499	YES	637	Not Available	Not Available	YES	No	A4MT	Pre-Adjuvant Therapy	TUMOR FREE	NO	YES	YES	Complete Remission/Response	WHITE	NO	Local Recurrence	TCGA-FG-A4MT-R38971	7045531A-AB48-444B-9849-D8CA948F9F0B	Not Available	7	731	686	Complete Response	1	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-P5-A5ET	27	MALE	0	Oligodendroglioma	Central nervous system	Alive	G2	0	0			TUMOR FREE		27	NO	Not Available	NO	TCGA-P5-A5ET	D87742FD-FF94-4EF0-BBF4-5DD5A185A0E7	22	-10027	Not Applicable	0	0	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5ET-F69038	96CEF3FA-AAF8-4525-B223-CD3E9AC84B9E	24	Not Available	Not Available	Not Applicable	-10	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	Unknown	NO	8	Unknown	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5ET	Not Available	TUMOR FREE	Unknown	YES	Unknown	Unknown	WHITE	Unknown																			Unknown	Unknown	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Unknown	Alive	2013	2012
TCGA-DU-A5TW	33	FEMALE	760	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		33	Unknown	Not Available	Unknown	TCGA-DU-A5TW	4C167F09-D664-425F-BD84-6FF8C21B272B	18	-12107	Not Applicable	0	172	Not Available	53																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	NO	NO	Not Available	TCGA-DU-A5TW-F71321	17A68D60-5301-4640-BDFB-29F9E672E4C1	24	Not Available	Not Available	Not Applicable	760	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	3	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Alive	2015	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	YES	IHC	YES	YES	Unknown	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	NO	No	A5TW	Other	WITH TUMOR	NO	YES	YES	Progressive Disease	BLACK OR AFRICAN AMERICAN	NO																			YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-S9-A6WL	52	MALE	946	Astrocytoma	Central nervous system	Alive	G3	1	240.0			WITH TUMOR		52	NO	Not Available	NO	TCGA-S9-A6WL	D62D871B-4612-4BF4-B53C-9DD431E507A0	5	-19234	Not Applicable	0	331	Not Available	-2																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	YES	Not Available	Not Available	TCGA-S9-A6WL-F67227	714A88DA-1BF3-46E9-9462-DEF3E2AB2FF2	3	Not Available	Not Available	Not Applicable	946	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	11	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	YES	IHC	YES	NO	NO	11	NO	G3	NO	YES	240	NO	Not Available	Not Available	Not Available	YES	No	A6WL	Preoperative	WITH TUMOR	NO	YES	NO	Progressive Disease	WHITE	NO	Regional site	TCGA-S9-A6WL-R67226	31F58B83-D63E-4A27-9ABB-2A8A79F7199B	Not Available	3	Not Available	285	Unknown	11	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-5854	57	FEMALE	257	Astrocytoma	Central nervous system	Alive	G3	1	202.0			WITH TUMOR		57	Not Available	Not Available	Not Available	TCGA-DU-5854	b95afb1a-a1df-4d85-ad34-191928e28a77	22	-21106	Not Applicable	0	257	Not Available	19	TCGA-DU-5854-D14895;TCGA-DU-5854-D14896;TCGA-DU-5854-D14897	3457f389-62db-4528-b1fb-9a1470be12f7;ae61433b-1ffa-476f-9a1e-4c4301ae7c53;3f5bab65-4c76-47ee-9c6e-ba279e02acc9	Not Available;Not Available;Not Available	25;25;22	90;193;Not Available	45;134;292	Temozolomide;Temozolomide;Bevacizumab	Not Available;Not Available;Not Available	5;5;6	1;3;Not Available	75;150;10	mg/m2;mg/m2;mg/kg	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	1;1;2	PO;PO;IV	NO;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	200;400;850	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	91 - 180 Days	YES	NO	NO	NO	TCGA-DU-5854-F14893	1acc95b2-82d8-43e5-900c-b0fab68bb879	25	Not Available	Not Available	Not Applicable	257	202	202	Not Available	Not Available	Not Available	100	Not Available	5	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	6	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5854	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-5854-R14894	34d8de22-65b2-4ff9-9564-2056bac4b6dd	1	25	90	45	Not Available	5	30	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	YES	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-DU-6542	25	MALE	73	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		25	Not Available	Not Available	Not Available	TCGA-DU-6542	cd69d509-a652-4257-a8d3-767296bbb4ec	8	-9380	Not Applicable	0	73	Not Available	Not Available	TCGA-DU-6542-D18405;TCGA-DU-6542-D18403	cf893d09-aefc-4352-abba-97c4bfc43091;bd0dc956-293e-4f72-9177-31732a441d96	Not Available;Not Available	31;31	Not Available;95	97;56	Temozolomide;Temozolomide	Not Available;Not Available	5;5	6;1	200;75	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	YES;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	400;145	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Visual Changes	31 - 90 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DU-6542-F18401;TCGA-DU-6542-F46623	f49257c8-56b0-483d-874a-15dd18d27dfe;5ED0B6CB-6EB7-4813-A49D-44C0AAE482F1	8;13	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	73;73	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;YES	11;8	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	YES;YES	Stable Disease;Unknown	YES;YES	Alive;Not Available	2011;2013	Not Available	Not Available	MALE	Not Available	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	Not Available	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6542	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6542-R18402	8dce0eef-e30d-4766-8953-d8c8440cb73d	1	8	95	56	Not Available	11	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2011	2011
TCGA-DB-A4XF	41	FEMALE	1021	Astrocytoma	Central nervous system	Alive	G3	1	468.0			WITH TUMOR		41	Unknown	Not Available	NO	TCGA-DB-A4XF	40587B69-0F62-4A2A-88CB-1BD711377F19	21	-15066	Not Applicable	0	559	Not Available	Not Available	TCGA-DB-A4XF-D40479	C06C881C-FE44-474B-84FC-132007A2C22A	Not Available	21	264	34	Temodar	Stable Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XF-F60956	1A4C3DB8-2034-4460-A326-7995E281CC7D	19	Not Available	Not Available	Not Applicable	1021	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2014	Unknown	Not Available	FEMALE	Unknown	YES	Astrocytoma	NO	No	C71.1	9401/3	C71.1	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	NO	Unknown	2	NO	G3	YES	Unknown	468	NO	Not Available	NO	Not Available	YES	No	A4XF	Not Available	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DB-A4XF-R40481	55806992-D6B5-4AC3-A568-BE72DAB71E68	Not Available	21	74	34	Stable Disease	2	33	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-DU-7292	69	MALE	242	Astrocytoma	Central nervous system	Dead	G3	1	91.0			WITH TUMOR		69	Not Available	Not Available	YES	TCGA-DU-7292	145f87a3-5e86-4a87-8e49-b166a2271d02	5	-25266	242	0	Not Available	Not Available	Not Available	TCGA-DU-7292-D17520;TCGA-DU-7292-D17519	849dca85-f3f7-4138-98cf-26f78f38d3d9;d5d225da-320e-4069-b6ac-2bb4744af8ae	Not Available;Not Available	5;5	206;206	176;176	Tomaxifen;Procarbazine	Not Available;Not Available	10;10	1;1	20;100	mg/day;mg/day	PROGRESSION;PROGRESSION	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	20;100	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	< 12 Years	Not Available	Not Available	Seizures	91 - 180 Days	YES	YES	NO	NO	TCGA-DU-7292-F17515	1d9caf5d-2042-4b15-9a88-289bbebbec66	5	Not Available	Not Available	242	Not Available	91	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	10	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7292	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Local Recurrence;Primary Tumor Field	TCGA-DU-7292-R17518;TCGA-DU-7292-R17517	cbd3769b-1820-4e2f-9c78-70499ac85179;bb874f4a-2106-4b76-a851-2e946b69a322	2;1	5;5	158;84	158;23	Not Available;Not Available	10;10	1;Not Available	1200;5940	NO;NO	OTHER;EXTERNAL BEAM	Sterotactic radiosurgery;Not Applicable	PROGRESSION;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	1997
TCGA-FG-6692	63	MALE	561	Oligodendroglioma	Central nervous system	Dead	G3	1				WITH TUMOR		63	Not Available	Not Available	Not Available	TCGA-FG-6692	5f10cd91-1e03-4016-b35a-8629a1a8fcc9	9	-23374	Not Applicable	0	126	Not Available	42	TCGA-FG-6692-D32839	CCA2C4C1-27B5-4165-8E5D-3FCAFA02E0A2	Not Available	13	Not Available	149	Temodar	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	1	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-6692-F32838;TCGA-FG-6692-F41569	A9CF8A04-87B0-4216-85B8-65F8E08C1D20;3299F933-61B1-4CCC-8ECF-67E937CAFB99	13;21	Not Available;Not Available	Not Available;Not Available	Not Applicable;561	413;Not Available	Not Available;Not Available	413;Not Available	1;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	Not Available;NO	6;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Adjuvant therapy;Not Available	WITH TUMOR;Unknown	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Dead	2012;2013	Not Available	Not Available	MALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	Not Available	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6692	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-6692-R14737	499c1eda-6e90-4cd3-9911-bfd7cb82670b	1	9	116	68	Not Available	8	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2011
TCGA-E1-5305	34	MALE	2433	Astrocytoma	Central nervous system	Dead	G3	1	1604.0			WITH TUMOR		34	Not Available	Not Available	YES	TCGA-E1-5305	a0bc5147-d9b4-41fd-8df3-a241d23722e8	8	-12655	2433	0	Not Available	Not Available	89	TCGA-E1-5305-D16186;TCGA-E1-5305-D16187;TCGA-E1-5305-D16192;TCGA-E1-5305-D16188;TCGA-E1-5305-D16189;TCGA-E1-5305-D16191;TCGA-E1-5305-D16190;TCGA-E1-5305-D16193;TCGA-E1-5305-D16194;TCGA-E1-5305-D16195	cc8b2398-6351-496d-bfa5-956192b8589e;5d578bf2-fe1e-4e7f-8523-d97643d02d5f;5b398d6b-46a5-4af0-bb70-090461da40f1;9f0d6b1f-f74b-4767-9651-07f383616e6a;3c3689e6-abc3-4764-919c-996ab92275b6;fc80d459-8d13-46dd-bf95-7a1e5482fcb6;829f988e-fba1-419d-812d-1e060a1124fd;b6d30749-dc7c-4990-8996-85babd3a83e0;08d7b369-80c0-4476-bd5c-0183cf96984c;21b355a2-4ea3-473b-b4ad-f238bd434a78	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;9;9;9;9;9;9;9;10;11	2331;593;1994;593;1825;1994;1825;2093;2241;2241	2280;148;1861;148;1636;1861;1636;1994;2128;2128	CCNU;VP-16;Topotecan;Temozolomide;Hydroyurea;Temozolomide;Gleevec;CPT-11;Cytoxan;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8;8;8	1;12;6;12;6;6;6;2;4;4	110;50;200;150;500;200;500;340;730;10	mg/m2;mg/m2;mg/m2;mg/m2;mg;mg/m2;mg;mg/m2;mg;mg/kg	Discrepancy;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;4;2;3;4;3;5;6;6	PO;PO;PO;PO;PO;PO;PO;IV;PO;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	220;25200;14400;18600;84000;12000;84000;5440;81760;10192	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	YES	NO	TCGA-E1-5305-F16185	af6705c7-fde2-4237-9d64-946a169eb81b	8	1623	Not Available	2433	Not Available	1604	1631	Not Available	Not Available	Progressive Disease	90	Not Available	8	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	Discrepancy	Stable Disease	YES	Dead	2011	Not Available	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	100	Right	Not Available	Not Available	Not Available	NO	YES	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5305	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5305-R16196	8d909f75-960d-42dc-9238-3ecbebff4f00	1	11	88	27	Not Available	8	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	YES	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2000
TCGA-VM-A8CD	58	MALE	240	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		58	Unknown	Not Available	NO	TCGA-VM-A8CD	B3F0DECE-94E8-4EAF-91BC-4B3F4DAE12D2	13	-21200	240	0	Not Available	Not Available	-43																								Not Evaluated	Unknown	Unknown	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	NO	Not Available	Not Available	TCGA-VM-A8CD-F66848	E15EC510-C27B-4560-86DE-FD340727DC9F	24	Not Available	Not Available	240	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	10	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Unknown	YES	Dead	2014	Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	NO	IHC	YES	YES	Unknown	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A8CD	Pre-Adjuvant Therapy	WITH TUMOR	NO	YES	NO	Unknown	WHITE	YES	Primary Tumor Field	TCGA-VM-A8CD-R56928	C86B2261-01A0-4F4A-8193-6F9792AC7062	Not Available	26	73	27	Unknown	2	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	NO	YES	VM	Supratentorial, Temporal Lobe	Central nervous system	YES	Dead	2014	2012
TCGA-CS-5397	54	FEMALE	194	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		54	NO	Not Available	NO	TCGA-CS-5397	bdfade49-9059-4665-beea-c55117ba6564	23	-19866	194	0	Not Available	Not Available	-1	TCGA-CS-5397-D17569	884d36f1-3c32-4867-8f9f-9f0421d6362b	Not Available	23	Not Available	8	Temodar	Not Available	9	Not Available	Not Available	mg	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Sensory Changes	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-CS-5397-F17567	8b60680c-e1ed-4f73-8357-ae7dbf276aba	23	Not Available	Not Available	194	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	80	Left	Not Available	Not Available	NO	NO	NO	9	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5397	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-5397-R17568	9ddde8ea-270a-41ca-aed1-079f333a0f6e	1	23	55	13	Not Available	9	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	YES	Cerebral Cortex	NO	YES	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	2010
TCGA-DU-6397	45	MALE	1401	Oligodendroglioma	Central nervous system	Dead	G3	1	837.0			WITH TUMOR		45	Not Available	Not Available	Not Available	TCGA-DU-6397	e695b780-17f4-4e71-9120-7c6bcafaa3a7	19	-16695	1401	0	Not Available	Not Available	Not Available	TCGA-DU-6397-D14797	92151a5e-0c57-4433-a49a-a714f5aa1cd7	Not Available	26	1219	884	Temozolomide	Not Available	5	12	150	mg/m2	PROGRESSION	Not Applicable	01	PO	NO	Chemotherapy	Not Available	325	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	YES	YES	YES	NO	TCGA-DU-6397-F14794	2469c273-067e-4328-a6af-1c7f54be15d0	26	837	Not Available	1401	Not Available	837	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	Not Available	7	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6397	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Local Recurrence	TCGA-DU-6397-R14795;TCGA-DU-6397-R14796	8ac280a5-473e-47a0-95cc-4a69bd27bb70;efe0b4e1-e823-4c27-a2d7-ff605fce580c	01;02	26;26	69;853	25;853	Not Available;Not Available	5;5	28;01	5940;4500	NO;NO	EXTERNAL BEAM;OTHER	Not Applicable;Brachytherapy	ADJUVANT;PROGRESSION	Not Available;Not Available	cGy;cGy	2011;2011	NO	Not Available	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	YES	Dead	2011	1997
TCGA-E1-5303	38	MALE	2052	Astrocytoma	Central nervous system	Dead	G3	1	156.0			WITH TUMOR		38	Not Available	Not Available	NO	TCGA-E1-5303	44a5c3b4-62a7-407b-b492-7069e1a43a26	19	-14212	2052	0	Not Available	Not Available	582	TCGA-E1-5303-D7457;TCGA-E1-5303-D7459;TCGA-E1-5303-D7456	899ae1b9-557b-4dd0-a562-d761ba723890;7031c972-5b2d-490d-a80e-b578837a941f;834cdac1-d3ad-4199-a1dd-4bba5c989fd1	Not Available;Not Available;Not Available	19;19;19	215;582;190	202;218;156	Tamoxifen;Temozolomide;CCNU	Not Available;Not Available;Not Available	1;1;1	1;12;1	40;150;110	mg;mg/m2;mg/m2	PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	3;1;2	PO;PO;PO	NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1120;19375;200	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	NO	NO	TCGA-E1-5303-F7453	28ffb925-5809-470b-8160-0cb66850cbcf	19	Not Available	Not Available	2052	Not Available	156	582	Not Available	Not Available	Progressive Disease	80	Not Available	1	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	Discrepancy	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	NO	Not Available	80	Left	Not Available	Not Available	Not Available	NO	Not Available	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5303	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5303-R7455	8f0ece70-b215-4cce-b64a-f895f4ccfe12	1	19	110	73	Not Available	1	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1998
TCGA-HT-7610	25	FEMALE	1706	Oligoastrocytoma	Central nervous system	Alive	G2	1	1205.0			TUMOR FREE		25	NO	Not Available	NO	TCGA-HT-7610	4839a058-fbca-44c7-bd61-81943b4d45d5	7	-9447	Not Applicable	0	1706	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	YES	YES	Not Available	TCGA-HT-7610-F28944	2b9085e1-8d09-4e4f-bb50-9b41abc637d1	2	1205	Not Available	Not Applicable	1706	1205	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	YES	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7610	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2007
TCGA-S9-A6U1	22	FEMALE	785	Astrocytoma	Central nervous system	Alive	G3	0	785			WITH TUMOR		22	NO	Not Available	NO	TCGA-S9-A6U1	A5E10E2E-5157-487B-88DC-6C70AD5E244A	31	-8271	Not Applicable	0	344	Not Available	-13	TCGA-S9-A6U1-D54137	DAF6DEBA-5874-4702-8C90-D11C9A811963	Not Available	17	253	1	Temozolomide	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6U1-F63760;TCGA-S9-A6U1-F69560	67CE99F0-7B27-4F16-97D4-A8E6784C6E6B;F3A4A89B-CAE9-46CE-B976-C258A8BCC331	18;14	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	536;785	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	8;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	NO	IHC	YES	NO	NO	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6U1	Preoperative	WITH TUMOR	YES	NO	NO	Complete Remission/Response	WHITE	NO																			NO	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-HT-7483	14	MALE	5255	Oligoastrocytoma	Central nervous system	Alive	G2	0	5255			TUMOR FREE		14	NO	Not Available	NO	TCGA-HT-7483	183dd089-e932-4be2-b252-0e8572e7da4e	31	-5267	Not Applicable	0	4690	Not Available	Not Available	TCGA-HT-7483-D70767	672863E8-5DFB-4EF4-BA29-D2AD413781A2	Not Available	2	3287	2861	Temodar	Complete Response	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2015	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7483-F45917	D6D4A8CD-1727-421D-B42A-F02D776120B7	25	Not Available	Not Available	Not Applicable	5255	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7483	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7483-R45918	61A69B6A-059A-46FD-8CC1-6D96ECFBDEBF	Not Available	2	2918	2876	Complete Response	4	30	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2015	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	1998
TCGA-S9-A6TY	50	MALE	1076	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		50	YES	hair of animals, not further specified	NO	TCGA-S9-A6TY	DCBBACA6-A24B-4BED-95DE-314CFF71E436	31	-18564	Not Applicable	0	684	Not Available	-18	TCGA-S9-A6TY-D54129	B9AD9F54-7C56-4194-9F81-5B8774E9E3A2	Not Available	17	274	5	Temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6TY-F62929;TCGA-S9-A6TY-F69979	EC8D9DEB-D61F-4DC5-9CEB-60911357995D;7C0F957F-C722-4E99-A2AC-ECC1180A0DB6	29;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	953;1076	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Partial Remission/Response;Partial Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	100	Left	NO	IHC	YES	NO	YES	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6TY	Preoperative	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-DU-6399	54	MALE	2000	Oligodendroglioma	Central nervous system	Dead	G2	1	1629.0			WITH TUMOR		54	Not Available	Not Available	Not Available	TCGA-DU-6399	4ef429be-c345-4258-9b42-b56e215e1a2c	19	-19906	2000	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	NO	Not Available	Not Available	Not Available	Not Available	31 - 90 Days	NO	NO	YES	NO	TCGA-DU-6399-F14710	2498cad6-0235-4c94-af9c-f382ddc17c80	31	1629	Not Available	2000	Not Available	1629	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	Not Available	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6399	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6399-R14711	27b9b901-4300-4f2e-aa7c-478a20bec807	01	31	63	32	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	White Matter	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	1998
TCGA-E1-A7YW	28	MALE	1120	Oligoastrocytoma	Central nervous system	Dead	G2	1	409.0			WITH TUMOR		28	NO	Not Available	NO	TCGA-E1-A7YW	5EEF573E-6A44-4DC7-8AA7-B136863CE910	11	-10571	1120	0	Not Available	Not Available	13	TCGA-E1-A7YW-D61606;TCGA-E1-A7YW-D61608;TCGA-E1-A7YW-D61609;TCGA-E1-A7YW-D61610;TCGA-E1-A7YW-D61612	C6A6B183-A122-4AC1-B392-64D8EC4ED163;E95A013A-8E18-4D40-8DC6-F34CA45CFE04;EF7E27E9-3B2E-43DF-8540-076341AD9835;20DC6FA9-757C-4537-902C-7A29D6290FCF;60C2DD63-0669-444B-8104-3CDBD15271F6	Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15	978;1025;1025;1095;608	711;999;999;1040;418	CCNU;Avastin;CPT-11;VP-16;Temodar	Clinical Progressive Disease;Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;YES;YES;NO;NO	2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	YES;NO;NO	NO;NO;YES	NO;NO;NO	NO;NO;NO	TCGA-E1-A7YW-F61607;TCGA-E1-A7YW-F61611;TCGA-E1-A7YW-F61613	3A051725-ABC7-4A86-8712-034FEDE85000;4CFD30D7-0351-465E-BE73-B9B9C1C5551D;3494EE98-57A6-4AD5-869C-51E3A70195C8	15;15;15	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	1120;1120;1120	Not Available;Not Available;Not Available	980;1085;613	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available	NO;NO;NO	8;8;8	Not Available;Not Available;Not Available	YES;YES;YES	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES	Dead;Dead;Dead	2014;2014;2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	8	NO	G2	YES	NO	409	NO	Not Available	NO	Not Available	YES	No	A7YW	Pre-Adjuvant Therapy	WITH TUMOR	NO	YES	Unknown	Progressive Disease	WHITE	NO	Primary Tumor Field	TCGA-E1-A7YW-R61605	CFA814D9-FD27-4189-B7E7-4ACF7BCD7B87	Not Available	15	686	641	Stable Disease	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Cerebral Cortex	NO	YES	E1	Supratentorial, Parietal Lobe	Central nervous system	NO	Dead	2014	2002
TCGA-HT-7608	61	MALE	671	Oligoastrocytoma	Central nervous system	Alive	G2	0	671			TUMOR FREE		61	NO	Not Available	NO	TCGA-HT-7608	45b6d41b-3a1b-47e9-80e4-59355170aee7	27	-22302	Not Applicable	0	671	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7608-F28803	2d43bc08-7f22-44da-be6a-63ec6d06c6ab	1	Not Available	Not Available	Not Applicable	671	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	1p19q deletion	Not Available	Right	Not Available	Not Available	NO	NO	NO	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7608	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2007
TCGA-S9-A7R1	35	MALE	5166	Oligodendroglioma	Central nervous system	Dead	G2	1	3637.0			WITH TUMOR		35	NO	Not Available	NO	TCGA-S9-A7R1	78A212BC-A740-46BF-A10D-0B9809A5BB3F	5	-12828	Not Applicable	0	5000	Not Available	-122	TCGA-S9-A7R1-D52667	5BFE8996-358E-4F43-9550-08E976624A6C	Not Available	5	3835	3801	Temozolamide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	NO	Not Available	Not Available	TCGA-S9-A7R1-F67312	0FBDCD7F-54A2-4EF8-A5CE-B06309EFF200	4	Not Available	Not Available	5166	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	11	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	YES	Dead	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	90	Midline	Not Available	Not Available	NO	NO	NO	12	NO	G2	YES	YES	3637	YES	3637	NO	Not Available	YES	No	A7R1	Preoperative	WITH TUMOR	NO	NO	NO	Stable Disease	WHITE	YES	Primary Tumor Field;Local Recurrence	TCGA-S9-A7R1-R52665;TCGA-S9-A7R1-R52666	FD984EEA-C12D-41BB-ADAE-A8D0E5368880;C0935ABF-2DCB-4660-A907-D20F6ADD0648	Not Available;Not Available	5;5	Not Available;3835	-70;3801	Stable Disease;Stable Disease	12;12	30;25	54;45	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2013	YES	NO	Not listed in Medical Record	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2013	1999
TCGA-WY-A85A	20	MALE	1320	Astrocytoma	Central nervous system	Alive	G2	0	1320			TUMOR FREE		20	NO	Not Available	NO	TCGA-WY-A85A	09552B53-4393-4811-A671-A9EF6EFF4790	27	-7380	Not Applicable	0	1320	Not Available	718																								0	NO	Unknown	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days																														NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A85A	Not Available	TUMOR FREE	NO	YES	YES	Partial Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	WY	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-TQ-A7RH	39	MALE	486	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		39	NO	Not Available	NO	TCGA-TQ-A7RH	6EF2D9AB-F72E-48CF-92B8-F3159D28160C	25	-14524	Not Applicable	0	486	Not Available	Not Available																								Not Evaluated	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RH-F65502	75BCBC59-D184-4059-9905-FA4F08ED5E72	25	Not Available	Not Available	Not Applicable	486	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	YES	NO	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RH	Not Available	WITH TUMOR	YES	YES	YES	Partial Remission/Response	BLACK OR AFRICAN AMERICAN	YES																			YES	NO	White Matter	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DH-5140	38	FEMALE	607	Oligoastrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		38	NO	Not Available	NO	TCGA-DH-5140	2c03e8b9-8856-43a7-853d-5ec51a6e5330	8	-13943	607	0	Not Available	Not Available	259	TCGA-DH-5140-D6486;TCGA-DH-5140-D6489;TCGA-DH-5140-D6487;TCGA-DH-5140-D6488	ee3a53f2-38a0-413a-bede-f2536de84d7e;8e430c37-8406-47f8-a618-2744c8b542a1;2528c43a-9af2-43f6-8c9d-e3e5749fdf41;fb9a572a-d724-4ef3-9bc4-857e31e85406	Not Available;Not Available;Not Available;Not Available	17;17;17;17	98;Not Available;250;342	54;385;136;Not Available	Temozolomide;AT 101;Temozolomide;BCNU (carmustine)	Not Available;Not Available;Not Available;Not Available	12;12;12;12	1;2;1;2	75;Not Available;200;Not Available	mg/m2/day;Not Available;mg/m2/day;Not Available	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;5;2;3	PO;PO;PO;IV	NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3375;Not Available;1000;Not Available	mg/m2;Not Available;mg/kg;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DH-5140-F6484	a41295f7-4f68-4f98-a986-9a09ec569032	8	Not Available	Not Available	607	Not Available	Not Available	259	1	Not Available	Progressive Disease	90	Not Available	12	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2010	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5140	Other	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DH-5140-R6485	11d3ed4a-56ee-4a1a-91f1-b8bdacac2279	1	17	98	54	Not Available	12	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	NO	NO	Cerebral Cortex	NO	YES	DH	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2010	2007
TCGA-DU-6403	60	FEMALE	354	Oligoastrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		60	Not Available	Not Available	Not Available	TCGA-DU-6403	8daa29c0-f652-4130-a004-5183bbe30c63	21	-22031	354	0	Not Available	Not Available	207	TCGA-DU-6403-D14748;TCGA-DU-6403-D14746;TCGA-DU-6403-D14747	24ea3712-f7e6-417c-a7e2-777e6d70e4f7;988b4562-6b54-445c-a85a-778d1d4a43a1;7ac56d66-1bea-479f-bce7-8039d1d1eb5c	Not Available;Not Available;Not Available	31;31;31	196;74;10	104;43;10	BCNU (Carmustine);Hydroxyurea;Gliadel Wafer	Not Available;Not Available;Not Available	5;5;5	2;1;1	Not Available;Not Available;1	Not Available;mg;{Wafer}	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	IV;PO;INTUM	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;mg;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-6403-F14743	b96fa671-bc3b-4d6b-bc72-7a414c3f44e3	31	Not Available	Not Available	354	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	WITH TUMOR	YES	Not Available	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6403	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6403-R14745	410b9180-ad95-4315-b5ce-25aad889b660	1	31	74	43	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	1999
TCGA-FG-A4MW	63	MALE	559	Oligoastrocytoma	Central nervous system	Dead	G3	1	226.0			TUMOR FREE		63	NO	Not Available	YES	TCGA-FG-A4MW	DCE168B1-D2A9-4409-8437-AB382F6D7D31	29	-23077	Not Applicable	0	160	Not Available	141	TCGA-FG-A4MW-D39710;TCGA-FG-A4MW-D39712;TCGA-FG-A4MW-D61645	2B02C0A0-719B-48E1-A7F1-DEB9BC1C4F78;5E3E00F7-6C27-42D4-A54F-744510155C02;9B07A59C-3AF4-4CE4-AB86-37E3F96535BA	Not Available;Not Available;Not Available	30;30;2	71;105;379	32;101;231	Temodar;Temodar;Avastin	Stable Disease;Stable Disease;Clinical Progressive Disease	1;1;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	NO	Not Available	TCGA-FG-A4MW-F61644	773B1C98-4D21-44FC-96BF-6BFF866293B4	2	Not Available	Not Available	559	Not Available	226	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	7	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Dead	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.1	9382/3	C71.1	YES	NO	Not Available	80	Right	NO	IHC	YES	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4MW	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Unknown	WHITE	YES	Primary Tumor Field	TCGA-FG-A4MW-R39711	2E2B9EF1-F46E-4C91-8532-63A7C89763F6	Not Available	30	71	32	Stable Disease	1	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-CS-4944	50	MALE	1828	Astrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		50	Not Available	Not Available	Not Available	TCGA-CS-4944	64cd17eb-c778-45e9-b994-02b68182e51b	6	-18494	Not Applicable	0	323	Not Available	-2																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mental Status Changes	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-4944-F10062;TCGA-CS-4944-F71553	8a06709f-b242-476c-91e3-2778cb413a93;5A1EE9D3-37E7-4F88-B8BA-C5BD5D349C0B	16;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	323;1828	Not Available;Not Available	251;Not Available	0;Not Available	Not Available;Not Available	Not Available;Progressive Disease	100;Not Available	Not Available;NO	3;3	Not Available;Not Available	Not Available;NO	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	Not Available;WITH TUMOR	NO;Not Available	Stable Disease;Not Available	YES;Not Available	Alive;Alive	2011;2015	Not Available	Not Available	MALE	Not Available	NO	Astrocytoma	NO	No	C71.9	9400/3	C71.9	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	YES	Not Available	4	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4944	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-4944-R15819	dacd6eea-b85a-40d6-be05-90864da56296	1	1	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Available	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-HW-A5KL	42	FEMALE	878	Astrocytoma	Central nervous system	Alive	G2	0	878			WITH TUMOR		42	Not Available	Not Available	Not Available	TCGA-HW-A5KL	0639B753-4099-4CA4-ADB9-763069A614EF	12	-15513	Not Applicable	0	294	Not Available	Not Available	TCGA-HW-A5KL-D48707;TCGA-HW-A5KL-D71506	BA95AA18-80DF-426E-B58A-11395CF5B384;CB1932E9-7E48-4908-97B0-B2A1AAF8C207	Not Available;Not Available	19;31	71;648	10;102	Temozolomide;Temozolomide	Stable Disease;Stable Disease	9;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2015	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HW-A5KL-F59871;TCGA-HW-A5KL-F71508	55022EE1-B63C-4B94-AB2B-918A2EEFCD77;39007937-D8BD-4815-8394-A31A3C501AFC	22;31	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	633;878	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Stable Disease	Not Available;Not Available	NO;NO	5;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	Unknown;Unknown	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2014;2015	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5KL	Not Available	WITH TUMOR	YES	Not Available	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-HW-A5KL-R48705	11312E35-B281-439A-A534-47F9ED8FAB13	Not Available	19	71	10	Stable Disease	9	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	Not Available	White Matter	YES	NO	HW	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2013	2012
TCGA-FN-7833	25	MALE	837	Oligoastrocytoma	Central nervous system	Alive	G3	0	837			Not Available		25	Not Available	Not Available	Not Available	TCGA-FN-7833	5b9d7565-a933-449d-8ffa-ec5f82db2e77	9	-9228	Not Applicable	0	4	Not Available	Not Available	TCGA-FN-7833-D66002	7C0713E1-5F69-498C-BE16-D29E53FCFF1D	Not Available	1	134	95	Temozolomide	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Mental Status Changes	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-FN-7833-F66000	09E158D4-2E7A-4C4F-B593-E2576EF592CC	1	Not Available	Not Available	Not Applicable	837	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Midline	Not Available	Not Available	Not Available	YES	Not Available	3	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7833	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FN-7833-R66001	E021BB81-236B-453D-B1BF-B8EDA44FB3C7	Not Available	1	120	95	Complete Response	10	20	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	YES	NO	FN	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-HT-7479	44	MALE	1227	Astrocytoma	Central nervous system	Alive	G3	1	705.0			TUMOR FREE		44	NO	Not Available	NO	TCGA-HT-7479	a96fabfa-e830-476a-b2a1-899689570bd9	7	-16137	Not Applicable	0	13	Not Available	Not Available	TCGA-HT-7479-D29545;TCGA-HT-7479-D29544	44160ede-5946-4524-88e3-cd6315f0f750;36fef324-f74a-471a-9682-0843dc229a3f	Not Available;Not Available	19;19	200;74	105;33	Temodar;Temodar	Not Available;Not Available	3;3	4;1	480;175	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	9600;7350	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available;NO	Not Available;NO	Not Available;YES	Not Available;Not Available	TCGA-HT-7479-F29543;TCGA-HT-7479-F66425	86783abf-eb1b-4d30-ad18-dd06802fa521;7612BD19-3DFB-431D-BB36-188DBEFFB8CE	19;14	Not Available;705	Not Available;Not Available	Not Applicable;Not Applicable	216;1227	Not Available;705	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	3;10	Not Available;Not Available	NO;YES	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Alive	2012;2014	NO	Not Available	MALE	YES	YES	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7479	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-P5-A72X	21	MALE	403	Astrocytoma	Central nervous system	Alive	G3	0	403			TUMOR FREE		21	Not Available	Not Available	Not Available	TCGA-P5-A72X	2FB951F1-00A0-4CAF-AC93-096056E77B1F	13	-7913	Not Applicable	0	8	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A72X-F69018	D593A359-3F6D-42C9-B67B-1FA9A9A8F2EF	24	Not Available	Not Available	Not Applicable	403	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Unknown	YES	Alive	2014	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	Not Available	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A72X	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A72X-R69019	E60D6F80-BFEF-44DF-B32C-003941DE4C06	Not Available	24	192	150	Unknown	12	30	66	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-HT-A74L	22	FEMALE	336	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		22	NO	Not Available	NO	TCGA-HT-A74L	559A8F6F-DD60-43B7-AE09-16CC4206064C	26	-8240	Not Applicable	0	336	Not Available	Not Available																								Unknown	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A74L-F65345	BFEB1178-726D-45D5-AB56-3FDD3EFDDB72	22	Not Available	Not Available	Not Applicable	336	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	Unknown	Partial Remission/Response	Unknown	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	YES	IHC	YES	NO	NO	6	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A74L	Pre-Adjuvant Therapy	WITH TUMOR	Unknown	Unknown	Unknown	Partial Remission/Response	WHITE	Unknown																			YES	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-8161	63	FEMALE	722	Oligoastrocytoma	Central nervous system	Dead	G3	1	111.0			WITH TUMOR		63	Not Available	Not Available	Not Available	TCGA-DU-8161	b9a3b647-61b3-4d98-90ca-e307ab50984a	15	-23064	722	0	Not Available	Not Available	14	TCGA-DU-8161-D33115;TCGA-DU-8161-D33116;TCGA-DU-8161-D33117;TCGA-DU-8161-D33118	6F53A1F5-D096-44F4-A3D5-58A2EB152E79;0576A374-F67E-4078-8448-105A7EC56073;0FC1D028-5E10-4C7E-B6FC-88DD0BA67079;9D020EFF-C8D2-4473-8610-F7D5053A97EE	Not Available;Not Available;Not Available;Not Available	21;21;21;21	78;92;575;638	39;92;134;162	Temozolomide;Temozolomide;Irinotecan;Bevacizumab	Stable Disease;Clinical Progressive Disease;Stable Disease;Clinical Progressive Disease	6;6;6;6	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Sensory Changes	31 - 90 Days	YES	NO	YES	Not Available	TCGA-DU-8161-F51985	241C113C-474E-4AAC-87D4-0913FE9BC491	26	113	Not Available	722	Not Available	111	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2013	Not Available	Not Available	FEMALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	70	Left	Not Available	Not Available	NO	NO	Not Available	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8161	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-DU-8161-R33113;TCGA-DU-8161-R33114	7083E821-0AF5-4E11-974C-B4CF0B6E07F3;48A90F7A-C79B-49C6-9B6A-8E6065503832	Not Available;Not Available	21;21	26;78	26;39	Stable Disease;Stable Disease	6;6	1;30	1800;6000	NO;NO	Not Available;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2012;2012	NO	YES	Not listed in Medical Record	NO	YES	DU	Supratentorial, Not Otherwise Specified	Central nervous system	NO	Dead	2012	2009
TCGA-QH-A6XA	23	FEMALE	502	Oligoastrocytoma	Central nervous system	Alive	G2	0	502			Unknown		23	NO	Not Available	NO	TCGA-QH-A6XA	4289A50B-C6BE-495E-9826-53AEB67B6A22	9	-8508	Not Applicable	0	7	Not Available	7																								0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A6XA-F67837	498861CB-8AE0-4DAA-8DDA-EB9A529A8AAE	12	Not Available	Not Available	Not Applicable	502	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	100	Left	YES	Sequence Analysis	YES	NO	YES	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A6XA	Pre-Adjuvant Therapy	Unknown	Unknown	NO	NO	Unknown	WHITE	Unknown																			NO	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-7468	30	MALE	203	Oligodendroglioma	Central nervous system	Alive	G3	0	203			TUMOR FREE		30	NO	Not Available	NO	TCGA-HT-7468	e6c55ba6-4c8a-4ea4-8dde-74d01915db02	27	-11209	Not Applicable	0	146	Not Available	8	TCGA-HT-7468-D21234	639fb2be-a64c-4ee6-baa4-d2381bfbf493	Not Available	7	Not Available	35	temodar	Not Available	2	5	280	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Chemotherapy	Not Available	1400	mg	Not Available	2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7468-F21233	f6007a1f-e3eb-427a-8e5b-38048663fb8e	7	Not Available	Not Available	Not Applicable	203	Not Available	203	Not Available	Scheduled Follow-up Submission	Stable Disease	80	Not Available	2	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Stable Disease	NO	Alive	2012	YES	shellfish	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	1p and 19Q deleted	80	Right	Not Available	Not Available	NO	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7468	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-CS-4941	67	MALE	234	Astrocytoma	Central nervous system	Dead	G3	1	9.0			WITH TUMOR		67	NO	Not Available	NO	TCGA-CS-4941	fc222f23-b3b2-4ac0-bc61-e8e8fa5cc160	5	-24578	234	0	Not Available	Not Available	77	TCGA-CS-4941-D19325	5fa9ba75-3196-4fba-a773-77e500473c2f	Not Available	8	Not Available	Not Available	Temodar	Not Available	12	Not Available	Not Available	mg	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	NO	YES	YES	NO	TCGA-CS-4941-F10024	b217ab88-fe6e-4503-9f17-a4a6265b71a3	16	77	77	234	Not Available	9	82	1	Not Available	Progressive Disease	90	Not Available	3	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	YES	Dead	2011	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	Not Available	NO	4	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4941	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-CS-4941-R10026;TCGA-CS-4941-R19324	2b1b8923-2a20-4029-8e45-20b77daa392a;a59d4616-3446-4fd9-b6a5-2df4a1e025bc	3;2	16;8	122;67	108;24	Not Available;Not Available	3;12	11;30	3850;66	NO;NO	OTHER;EXTERNAL BEAM	XRT;Not Applicable	PROGRESSION;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	Not Available	Not Available	Cerebral Cortex	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Dead	2011	2005
TCGA-E1-5318	42	FEMALE	2379	Oligodendroglioma	Central nervous system	Dead	G2	1	362.0			WITH TUMOR		42	NO	Not Available	NO	TCGA-E1-5318	400b2fa3-baf7-4baa-99b4-88b9f25b5049	26	-15372	2379	0	2379	Not Available	362	TCGA-E1-5318-D7629;TCGA-E1-5318-D7623;TCGA-E1-5318-D7636;TCGA-E1-5318-D7635;TCGA-E1-5318-D7630;TCGA-E1-5318-D7638;TCGA-E1-5318-D7645;TCGA-E1-5318-D7620;TCGA-E1-5318-D7631;TCGA-E1-5318-D7622;TCGA-E1-5318-D7619;TCGA-E1-5318-D7633;TCGA-E1-5318-D7628;TCGA-E1-5318-D7641	0b29e6cd-3baa-44d6-8169-0fdb64b67e0e;d27f585c-53c0-431f-ab79-d54b772620ce;feb703c5-9c8f-4b8f-8353-1131d01355ee;40ce51f2-557a-411e-b618-642259b5929d;b198aef2-c997-4ab1-b5a8-b44b8baca604;7969fe3e-4682-4dee-bff6-7132ab8e916c;ead855f0-e402-4be5-b160-3036d37fb8ed;c339ebe1-aa49-47c8-8088-5428d4e2f3b2;4fbbc709-b41c-4ba8-ac98-21ead1ae43cf;74468cb9-fcf4-4b97-a28f-164a5d94f934;c5a29f35-97d1-47f2-87fb-afa2b3ce97e5;bf3b38cc-7ed0-4a72-a3ff-78ce8f745487;ed6e5212-874d-425d-8a55-fc01a6fe7210;f3a68eda-ff46-4f81-a053-350e269044ed	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26;26;26;26;26;26;26;26;26;26	1904;1231;2211;2127;1971;2267;2335;824;2043;1026;781;2043;1652;2267	1655;1043;2127;2023;1904;2211;2268;781;1980;824;385;1980;1590;2211	CCNU;Gliadel Wafers;CPT-11;CPT-11;CCNU;Procarbazine;CCNU;Temazolomide;Cytoxan;Temozolomide;Carboplatin;Celebrex;VP-16;Tamoxiten	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1;1;1;1;1;1;1;1	3;1;2;1;2;2;2;1;2;7;11;2;2;2	110;8;260;350;82.5;75;82.5;200;100;150;560;400;50;80	mg/m2;{Wafer};mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg;mg/m2;mg/m2;mg;mg/m2;mg	PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	7;4;11;10;8;12;13;2;9;3;1;9;9;12	PO;INTUM;IV;IV;PO;PO;PO;PO;PO;PO;IV;PO;PO;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;NSAIDs;Not Available;Not Available	540;8;3400;1710;280;6720;280;1650;5600;8400;6507;44800;3000;4480	mg;{Wafer};mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	YES	YES	YES	NO	TCGA-E1-5318-F7616	51a8dea9-1657-4ee3-9300-98ee3478d4ef	26	362	Not Available	2379	2379	362	362	Not Available	Not Available	Stable Disease	100	Not Available	1	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	100	Left	Not Available	Not Available	Not Available	NO	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5318	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5318-R7618	398860f3-e1c8-4e8a-bc60-f5e65d14afb1	5	26	1301	1258	Not Available	1	30	5400	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1997
TCGA-S9-A7IQ	45	FEMALE	1099	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		45	NO	Not Available	NO	TCGA-S9-A7IQ	CC451E2A-FA85-42D7-B7AF-9FC0166945FA	12	-16512	Not Applicable	0	434	Not Available	-14																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Sensory Changes	0 - 30 Days	NO	NO	Not Available	Not Available	TCGA-S9-A7IQ-F65750	4612FF68-D0CE-463A-B03E-A108EF77C9C8	30	Not Available	Not Available	Not Applicable	1099	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7IQ	Preoperative	WITH TUMOR	NO	NO	NO	Partial Remission/Response	WHITE	NO																			NO	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-S9-A89V	70	MALE	569	Astrocytoma	Central nervous system	Alive	G3	1	129.0			Unknown		70	NO	Not Available	NO	TCGA-S9-A89V	C4F522C9-BFF5-4899-8D27-C105DAB795A9	23	-25570	Not Applicable	0	569	Not Available	-32	TCGA-S9-A89V-D55979;TCGA-S9-A89V-D55980	5E019CFD-373C-4B12-BEF4-3C1D3B482A9B;BB815198-62A3-4438-8B48-CC0D406E897A	Not Available;Not Available	23;23	46;222	12;80	Temozolomide;Temozolomide	Clinical Progressive Disease;Clinical Progressive Disease	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	> 181 Days	Unknown	Unknown	Not Available	Not Available	TCGA-S9-A89V-F67315	9DA4BF2E-513F-4634-B0FE-F6CA8E288BEC	4	Not Available	Not Available	Not Applicable	569	221	Not Available	Not Available	Additional New Tumor Event	Unknown	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	80	Right	NO	IHC	YES	NO	NO	1	YES	G3	NO	NO	129	YES	129	Not Available	Not Available	YES	No	A89V	Preoperative	Unknown	YES	NO	NO	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-S9-A89V-R55978	75E7C9E7-A33A-4A4A-B794-34A0291348E8	Not Available	23	46	12	Radiographic Progressive Disease	1	25	45	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	YES	Cerebral Cortex	NO	YES	S9	Posterior Fossa, Cerebellum	Central nervous system	NO	Alive	2014	2012
TCGA-DU-6400	66	FEMALE	37	Oligodendroglioma	Central nervous system	Dead	G2	1				WITH TUMOR		66	Not Available	Not Available	Not Available	TCGA-DU-6400	178ab87c-0582-4b02-bf6b-3a4c59a5ee1b	22	-24122	37	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Mental Status Changes	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-6400-F14782	8b885145-23a0-4fd0-9dcf-efba57a0034c	31	Not Available	Not Available	37	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	Not Available	6	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6400	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available																			NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	1998
TCGA-E1-A7YE	32	FEMALE	886	Astrocytoma	Central nervous system	Dead	G3	1	188.0			WITH TUMOR		32	NO	Not Available	NO	TCGA-E1-A7YE	F842F756-CE78-4C99-BCF8-3BCE18A4D9EF	12	-11971	886	0	Not Available	Not Available	81	TCGA-E1-A7YE-D61167;TCGA-E1-A7YE-D61171;TCGA-E1-A7YE-D61176;TCGA-E1-A7YE-D61182;TCGA-E1-A7YE-D61183;TCGA-E1-A7YE-D61185;TCGA-E1-A7YE-D61186;TCGA-E1-A7YE-D61190;TCGA-E1-A7YE-D61221	FEC71CDC-DE35-494B-98CD-D6220CBB39BD;749626B5-D27B-4310-97E3-98021E6D8405;B567E6D2-B15B-4B4B-A61F-3D3DF2F38AE4;8A4C234D-7FE4-4E07-9CD1-2A9F114D0155;49132B44-9583-4FFA-B258-1E1AB02D5463;FC58BB6D-E623-4730-A2E4-6E20F62D0660;16DD15B7-73A8-4C14-A3DA-44798CC4F85B;D184A86B-A497-489C-B3A2-942FA29B3C16;F26BB5B1-A15D-4B38-9446-7F43647D04B8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14;14;14;14;14	185;468;237;695;703;731;731;787;845	81;378;237;482;469;704;704;715;790	CCNU;CCNU;Gliadel wafers;Temodar;Celebrex;Temodar;Benzylguanine;Karenitecin;VP-16	Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Not Available;Ancillary;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;YES;YES;NO	2014;2014;2014;2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES;YES;YES;YES;NO	NO;NO;NO;NO;NO	NO;NO;NO;NO;NO	NO;NO;NO;NO;NO	TCGA-E1-A7YE-F61181;TCGA-E1-A7YE-F61184;TCGA-E1-A7YE-F61187;TCGA-E1-A7YE-F61191;TCGA-E1-A7YE-F61220	506DB1D9-781D-4EB4-9F12-61653CC2DFEF;2BBDD640-B6A1-4138-A77B-F97E6AB61CD3;9E8FBFC3-393C-428B-9C14-B57861F80314;A4F44093-AC77-4B2C-9A41-73C8CDC928D0;CADFFFAB-D13B-4F47-83EF-347F81FD2399	14;14;14;14;14	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	886;886;886;886;886	Not Available;Not Available;Not Available;Not Available;Not Available	466;694;725;783;846	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES;YES	Stable Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease	YES;YES;YES;YES;YES	Dead;Dead;Dead;Dead;Dead	2014;2014;2014;2014;2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	5	NO	G3	YES	Unknown	188	YES	237	YES	237	YES	No	A7YE	Post-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-E1-A7YE-R61162	0E8C3FE3-EA21-4F32-AC99-07F57773235F	Not Available	14	73	14	Stable Disease	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	YES	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	2001
TCGA-FG-A710	50	FEMALE	1115	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		50	Unknown	Not Available	Unknown	TCGA-FG-A710	5B199E7E-CC23-4065-88AD-FDFE3D0683D6	27	-18415	Not Applicable	0	698	Not Available	Not Available	TCGA-FG-A710-D52090	05A41623-D7F0-4D8E-BE95-99FD6083FAAE	Not Available	27	218	18	Temodar	Stable Disease	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A710-F64423	34A04B52-5A6A-4F51-87A7-DA7DB2BBDCFD	2	Not Available	Not Available	Not Applicable	1115	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2014	Unknown	Not Available	FEMALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	11	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A710	Not Available	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	NO																			YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-HT-8563	30	FEMALE	860	Astrocytoma	Central nervous system	Alive	G3	0	860			TUMOR FREE		30	Unknown	Not Available	Unknown	TCGA-HT-8563	dd7b23a7-b41b-4670-9fc8-78895fb00cff	15	-11305	Not Applicable	0	488	Not Available	Not Available																								Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	NO	> 20 Years	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8563-F61084	15AC3DED-B53B-4458-B1E1-E62FF1BFC992	23	Not Available	Not Available	Not Applicable	860	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	Unknown	Not Available	FEMALE	YES	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	Unknown	Right	Not Available	Not Available	Unknown	NO	Unknown	7	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	8563	Not Available	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES																			NO	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2013	2011
TCGA-DH-A66F	49	MALE	523	Oligodendroglioma	Central nervous system	Alive	G2	0	523			TUMOR FREE		49	Unknown	Not Available	NO	TCGA-DH-A66F	CFCD3835-BB09-400E-B7EB-55AC139D01F8	25	-18193	Not Applicable	0	237	Not Available	18																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DH-A66F-F61144;TCGA-DH-A66F-F68872	65D52AD5-AF5E-4045-BB46-F754B49607D1;E1383473-4F48-45D2-AA42-D8B000EC282C	25;12	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	523;523	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Unknown	Not Available;Not Available	NO;YES	6;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	NO	Unknown	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A66F	Other	TUMOR FREE	NO	YES	YES	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	YES	NO	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-TQ-A7RU	51	MALE	1032	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		51	NO	Not Available	NO	TCGA-TQ-A7RU	B19DCBC2-B0D4-4759-9213-1A5B99DF7E76	30	-18990	Not Applicable	0	1032	Not Available	158																								0	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RU-F65649	12A918FB-6FB0-4529-B6F6-DE42B7F4558A	30	Not Available	Not Available	Not Applicable	1032	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	80	Left	Not Available	Not Available	NO	NO	NO	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RU	Preoperative	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-HT-7616	75	MALE	7	Oligodendroglioma	Central nervous system	Dead	G3	1				WITH TUMOR		75	NO	Not Available	NO	TCGA-HT-7616	ab24cdc3-74a1-443f-831f-b7fb3821de6a	30	-27685	7	0	Not Available	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7616-F28640	e5ca9901-4486-4be5-ad14-7964a482beaa	27	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	2	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Dead	2012	Not Available	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.9	9451/3	C71.9	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	1	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7616	Not Available	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2012	2007
TCGA-FG-8187	31	MALE	611	Oligoastrocytoma	Central nervous system	Alive	G2	0	611			TUMOR FREE		31	Not Available	Not Available	Not Available	TCGA-FG-8187	0df37550-9421-4571-9844-51b457d7cb2b	31	-11684	Not Applicable	0	215	Not Available	0																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-FG-8187-F43456	29942C78-1077-4C04-98F2-C6CCD707C9D6	22	Not Available	Not Available	Not Applicable	611	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	Not Available	Not Available	MALE	Not Available	Not Available	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	8187	Other	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Available	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-HT-8113	49	FEMALE	900	Oligodendroglioma	Central nervous system	Alive	G2	0	900			TUMOR FREE		49	NO	Not Available	YES	TCGA-HT-8113	9e621541-d603-4d2d-b86e-2834d3b9f9a5	17	-18173	Not Applicable	0	900	Not Available	Not Available	TCGA-HT-8113-D32201;TCGA-HT-8113-D32203	af5f47b4-f241-4cbe-8a7b-920f8954e465;9b6c6140-feb6-420d-914a-2878bb3a53cd	Not Available;Not Available	18;18	74;331	34;159	temodar;temodar	Partial Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8113-F32197	2b8fda2e-0355-4690-bf02-889473499ac5	17	Not Available	Not Available	Not Applicable	900	Not Available	102	Not Available	Scheduled Follow-up Submission	Not Available	90	Not Available	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8113	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-HT-8113-R32199	3907ace0-66d5-41cc-92aa-4680aa529ada	1	17	75	34	Not Available	5	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2006
TCGA-TM-A84Q	31	MALE	772	Astrocytoma	Central nervous system	Alive	G2	1	455.0			TUMOR FREE		31	NO	Not Available	YES	TCGA-TM-A84Q	FCF14E9D-4671-453D-B8E0-5008E916F56D	17	-11668	Not Applicable	0	575	Not Available	0																								1	NO	NOT HISPANIC OR LATINO	NO	NO	> 20 Years	Not Available	Not Available	Mental Status Changes	0 - 30 Days	NO	NO	Not Available	Not Available	TCGA-TM-A84Q-F65305	81BCC4FF-5990-442E-AE66-7393835A6AAC	22	Not Available	Not Available	Not Applicable	772	455	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	YES	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	80	Left	Not Available	Not Available	NO	YES	NO	2	NO	G2	NO	NO	455	YES	455	Not Available	Not Available	YES	No	A84Q	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A84Q-R56526	F9AC2F30-1490-486E-8AA3-D54F7C245D7E	Not Available	17	65	22	Complete Response	2	30	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-DU-7304	43	MALE	709	Oligoastrocytoma	Central nervous system	Dead	G3	1	309.0			WITH TUMOR		43	Not Available	Not Available	Not Available	TCGA-DU-7304	d61710c1-8ac3-44e3-b567-66288a6ab731	4	-15931	709	0	Not Available	Not Available	8	TCGA-DU-7304-D17507;TCGA-DU-7304-D17506;TCGA-DU-7304-D17505;TCGA-DU-7304-D17504	492b5f3f-0776-4b74-85cf-ffa80d16869d;7670b1e3-d6e8-4f91-9f36-9fa51f2bd638;9152384e-f80f-405e-ab67-8634ae067452;87477a13-3bb0-4f08-baab-53f814a9501e	Not Available;Not Available;Not Available;Not Available	4;4;4;4	623;539;318;69	363;363;97;20	Bevacizumab;Irinotecan;Temozolomide;Temozolomide	Not Available;Not Available;Not Available;Not Available	10;10;10;10	10;7;8;1	10;125;150;75	mg/kg;mg/m2;mg/m2;mg/m2	PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;2;1;1	IV;IV;PO;PO	NO;NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	759;241;280;150	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	YES	NO	TCGA-DU-7304-F17502	a7ba4aac-768e-432c-b26f-b092c007e0ba	4	332	Not Available	709	Not Available	309	350	Not Available	Not Available	Progressive Disease	80	Not Available	10	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	80	Left	Not Available	Not Available	NO	NO	Not Available	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7304	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7304-R17503	8444ace7-9063-44ed-9afc-fe32f9a487f1	1	4	69	20	Not Available	10	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2008
TCGA-HT-A74J	33	MALE	320	Oligoastrocytoma	Central nervous system	Alive	G2	0	320			Unknown		33	Unknown	Not Available	Unknown	TCGA-HT-A74J	1A20F675-D9BB-48B0-A49F-D52270BD8973	26	-12393	Not Applicable	0	320	Not Available	Not Available																								Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days																														Not Available	Not Available	MALE	Unknown	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	Unknown	Left	YES	IHC	YES	NO	Unknown	6	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A74J	Not Available	Unknown	NO	YES	Unknown	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-7306	67	MALE	1277	Oligoastrocytoma	Central nervous system	Alive	G2	1	1250.0			WITH TUMOR		67	Not Available	Not Available	Not Available	TCGA-DU-7306	c35f36b1-ba3d-4eea-bf5a-c95480202176	11	-24800	Not Applicable	0	1277	Not Available	-11	TCGA-DU-7306-D17493;TCGA-DU-7306-D17494;TCGA-DU-7306-D17495	d7b62d39-291a-455c-bfa1-f56e105a9589;f5e5a76a-cc3a-45ee-b051-c45252fa2d95;c8f0a2bd-3046-41db-bcb7-3774577ca4ae	Not Available;Not Available;Not Available	11;11;12	59;250;Not Available	14;97;1283	temozolomide;Temozolomide;Temozolomide	Not Available;Not Available;Not Available	10;10;10	01;06;Not Available	75;150;75	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	01;01;02	PO;PO;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	160;310;165	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	NO	NO	TCGA-DU-7306-F17490	6e1a0ca9-c080-44b1-a88a-7dfa09d517b0	11	Not Available	Not Available	Not Applicable	1277	1250	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2011	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	Not Available	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7306	Preoperative	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7306-R17492	f284eee6-d1cb-4afc-b7a8-6efc27a2bf93	01	11	72	28	Not Available	10	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2008
TCGA-HT-7677	53	MALE	494	Oligodendroglioma	Central nervous system	Alive	G3	0	494			Discrepancy		53	NO	Not Available	NO	TCGA-HT-7677	00b18ad6-ff70-41fe-8f4d-0763ac8f28b9	27	-19610	Not Applicable	0	494	Not Available	Not Available	TCGA-HT-7677-D28948;TCGA-HT-7677-D28947	1c6de7b4-f6d8-4a65-85db-4b8a8668e65a;07093cd9-38cc-401b-8d81-d005b4cfa6b3	Not Available;Not Available	2;2	Not Available;73	98;31	temodar;temodar	Not Available;Not Available	3;3	6;1	300.0;140	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	YES;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	9000;6020	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7677-F28945	baa7ce11-be55-4690-a2e2-f95b312a2797	2	Not Available	Not Available	Not Applicable	494	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	Discrepancy	YES	Stable Disease	YES	Alive	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	1	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7677	Not Available	Discrepancy	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7677-R28946	ae25ee1d-1a3b-4941-9c5d-79a4f138c146	1	2	73	31	Not Available	3	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-HT-7470	37	MALE	1220	Oligodendroglioma	Central nervous system	Dead	G3	0	1220			TUMOR FREE		37	NO	Not Available	NO	TCGA-HT-7470	fee2114e-f723-4374-91f8-f1dcc6b3eaee	7	-13611	Not Applicable	0	268	Not Available	133	TCGA-HT-7470-D29528	9d3d68dd-e843-4ebf-9e64-8f8aa2349ac7	Not Available	16	94	45	Temodar	Not Available	3	1	140	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	7000	mg	Not Available	2012	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HT-7470-F29527;TCGA-HT-7470-F66413	d13400b6-100b-45b1-8fdf-1ec11c38cb08;1B9B341E-9C63-4BA0-8D2D-DA8E55149B52	16;14	Not Available;Not Available	Not Available;Not Available	Not Applicable;1220	268;Not Available	Not Available;Not Available	126;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Progressive Disease	90;Not Available	Not Available;NO	3;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	YES;YES	Complete Remission/Response;Progressive Disease	YES;YES	Alive;Dead	2012;2014	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9451/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7470	Post-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7470-R29529	894e3d22-b58f-468e-a1dc-166d16527ac2	1	16	94	45	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	YES	White Matter	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-DB-5275	36	MALE	1458	Oligoastrocytoma	Central nervous system	Alive	G3	0	1458			TUMOR FREE		36	NO	Not Available	NO	TCGA-DB-5275	bbfb5399-8d43-4b75-bf90-23ec142697d7	30	-13371	Not Applicable	0	1458	Not Available	Not Available	TCGA-DB-5275-D14426;TCGA-DB-5275-D14430	e91c5836-1333-44d8-960e-24db52d231d9;cb6f0480-725d-4ef7-979e-e0f5799383bd	Not Available;Not Available	22;22	129;359	72;129	Temodar;Temodar	Not Available;Not Available	7;7	6;7	75;200	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6300;14000	mg;mg	Not Available;Not Available	2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DB-5275-F42827;TCGA-DB-5275-F67391	368BCE13-8513-48CC-90B3-950B84885368;47AF9BF7-ED03-417E-BDCE-CC5AC12A0E32	1;4	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1458;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown	Not Available;Not Available	YES;YES	5;11	Not Available;Not Available	Unknown;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Not Available	2013;2014	YES	lactose containing products	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	Not Available	YES	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5275	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DB-5275-R14241	d1e69f86-4491-4cbf-b37f-4fa4ff002d45	1	22	114	72	Not Available	7	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2006
TCGA-E1-A7YK	52	MALE	378	Astrocytoma	Central nervous system	Dead	G3	0	378			Unknown		52	Unknown	Not Available	NO	TCGA-E1-A7YK	BB4A30D5-4EBA-45DB-B05A-BD843044D508	12	-19236	378	0	Not Available	Not Available	6	TCGA-E1-A7YK-D61284;TCGA-E1-A7YK-D61286	04EACA74-1CCC-4875-BDC6-D7D6849194E7;21B1EFC1-D066-448B-862F-6CE7E60C5790	Not Available;Not Available	15;15	68;Not Available	27;90	Temodar;Temodar	Stable Disease;Unknown	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-E1-A7YK-F61287	D4C0543D-9C55-4B7C-875E-48141874E51D	15	Not Available	Not Available	378	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	8	Not Available	Unknown	Not Available	Not Available	Unknown	YES	Stable Disease	YES	Dead	2014	Unknown	Not Available	MALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	Unknown	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7YK	Pre-Adjuvant Therapy	Unknown	YES	YES	YES	Stable Disease	WHITE	YES	Unknown	TCGA-E1-A7YK-R61283	0EB07C68-8D89-424F-9E9D-98CE6E32EC2F	Not Available	15	68	27	Stable Disease	8	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2014	YES	NO	Cerebral Cortex	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2009
TCGA-HT-7880	30	MALE	162	Oligoastrocytoma	Central nervous system	Alive	G2	0	162			TUMOR FREE		30	NO	Not Available	NO	TCGA-HT-7880	4240c137-ee3a-474c-9426-470380cb41a2	27	-11043	Not Applicable	0	162	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7880-F29680	929d8093-71d5-4f99-9a28-59beb307023f	19	Not Available	Not Available	Not Applicable	162	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Not Available	NO	Alive	2012	YES	peanuts	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	NO	NO	3	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7880	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available																			YES	YES	White Matter	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-FG-7643	49	FEMALE	611	Oligoastrocytoma	Central nervous system	Alive	G2	1	254.0			WITH TUMOR		49	YES	Cats	NO	TCGA-FG-7643	b6f13250-31b3-46ad-b514-5a684f1094a9	6	-18206	Not Applicable	0	27	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	> 20 Years	Not Available	Seizures	91 - 180 Days	NO;NO	NO;NO	YES;YES	NO;Not Available	TCGA-FG-7643-F32953;TCGA-FG-7643-F45156	481FF79C-513F-442B-A8B9-7E32C5D51C0D;1D1C9240-EA03-4F9A-8EEA-C96C482FBF72	18;10	286;286	Not Available;Not Available	Not Applicable;Not Applicable	293;611	254;254	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Progressive Disease;Stable Disease	Not Available;Not Available	Not Available;NO	6;7	Not Available;Not Available	YES;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Stable Disease;Progressive Disease	NO;NO	Alive;Alive	2012;2013	NO	Not Available	FEMALE	YES	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	YES	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7643	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-FG-7638	31	FEMALE	686	Oligodendroglioma	Central nervous system	Alive	G3	1	407.0			TUMOR FREE		31	NO	Not Available	NO	TCGA-FG-7638	1f54d21e-752f-496d-8453-4b9b8738cbce	10	-11528	Not Applicable	0	233	Not Available	-13	TCGA-FG-7638-D20408;TCGA-FG-7638-D43362;TCGA-FG-7638-D43365	e75a0f71-b3d0-4896-ad35-9d7062cf4fd7;E71157DA-8780-4039-A459-78C0B78182C3;2C840323-3AB9-4788-9A3C-40B8FA3AAD99	Not Available;Not Available;Not Available	11;20;20	78;336;595	37;122;411	Temodar;Temodar;Temodar	Not Available;Stable Disease;Stable Disease	1;5;5	1;Not Available;Not Available	145;Not Available;Not Available	mg;Not Available;Not Available	ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	1;Not Available;Not Available	PO;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	6090;Not Available;Not Available	mg;Not Available;Not Available	Not Available;NO;NO	2011;2013;2013	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	YES	NO	NO	Not Available	TCGA-FG-7638-F43363	4BA9C02D-9340-448E-8E76-6453BB4EC917	20	Not Available	Not Available	Not Applicable	686	407	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2013	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	1	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7638	Preoperative	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-7638-R20405	f422d1d9-aa17-41e5-82b0-d7b2e65746a0	1	11	85	35	Not Available	1	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-HT-7620	40	MALE	434	Oligodendroglioma	Central nervous system	Alive	G3	1	280.0			TUMOR FREE		40	NO	Not Available	NO	TCGA-HT-7620	0d61bdbd-24b1-4885-a099-9e42ca7eedcd	31	-14659	Not Applicable	0	434	Not Available	Not Available	TCGA-HT-7620-D29128;TCGA-HT-7620-D29473;TCGA-HT-7620-D29472;TCGA-HT-7620-D29553	610c74ab-459c-4a79-a763-41468eb2c258;4db359b9-40ba-487f-9e64-03906a939784;3b4d9fc5-cb4c-4599-8b89-1b6e329774b9;76638084-d5cc-494f-b4a2-ff3ab6966527	Not Available;Not Available;Not Available;Not Available	8;19;19;22	Not Available;Not Available;199;Not Available	126;285;195;285	Temodar;Irinotecan;Temodar;Avastin	Not Available;Not Available;Not Available;Not Available	3;3;3;3	1;Not Available;1;Not Available	150;Not Available;250;Not Available	mg/m2;Not Available;mg/day;Not Available	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;4	PO;Not Available;PO;Not Available	NO;Not Available;NO;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;1250;Not Available	Not Available;Not Available;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	YES	NO	NO	Not Available	TCGA-HT-7620-F29125	8457027b-0643-4217-b0b8-49e4befa4ddf	8	Not Available	Not Available	Not Applicable	434	280	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	3	Not Available	YES	Not Available	Not Available	Not Available	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	YES	YES	Oligodendroglioma	NO	No	C71.9	9451/3	C71.9	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	1	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7620	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7620-R29127	efdcbc13-09c7-4e1f-acaa-dee1a505b967	1	8	70	40	Not Available	3	Not Available	60	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	YES	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2007
TCGA-HT-A61A	20	FEMALE	194	Oligodendroglioma	Central nervous system	Alive	G2	0	194			TUMOR FREE		20	Unknown	Not Available	Unknown	TCGA-HT-A61A	EFFB5839-24A2-4B8C-8B6D-08CB66503D16	18	-7664	Not Applicable	0	194	Not Available	Not Available	TCGA-HT-A61A-D55964	D5FD6C40-BDE5-4B92-85B8-26D505579FC4	Not Available	22	Not Available	52	Temodar	Not Applicable	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days																														Unknown	Not Available	FEMALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	80	Left	Not Available	Not Available	Unknown	NO	Unknown	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A61A	Other	TUMOR FREE	YES	YES	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A61A-R55963	5D8F40F7-94BB-4D8F-955A-5E896B93EE52	Not Available	22	104	52	Partial Response	1	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-DU-6393	66	MALE	1585	Oligodendroglioma	Central nervous system	Dead	G3	0	1585			Not Available		66	Not Available	Not Available	Not Available	TCGA-DU-6393	1937318f-a1bb-4f48-b8ec-4aadd406e52a	21	-24282	1585	0	Not Available	Not Available	Not Available	TCGA-DU-6393-D14738	9b11fdd3-35d1-4fd6-a51e-567c2ebb9f45	Not Available	27	431	97	Carmustine BCNU	Not Available	5	8	60	mg/m2	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-DU-6393-F14735	24a5127d-2573-44c6-be60-f6eabd62ee58	27	Not Available	Not Available	1585	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	Not Available	Not Available	6	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6393	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6393-R14736	96345ee6-1761-42df-a0b6-a8e1c7ee4ae8	1	27	Not Available	Not Available	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Available	Not Available	White Matter	NO	YES	DU	Supratentorial, Occipital Lobe	Central nervous system	Not Available	Dead	2011	1993
TCGA-HT-8109	64	MALE	169	Oligodendroglioma	Central nervous system	Alive	G3	0	169			TUMOR FREE		64	NO	Not Available	NO	TCGA-HT-8109	c7b2833a-9fe8-49f6-b888-2d27b0516f5c	15	-23486	Not Applicable	0	120	Not Available	Not Available																								Not Available	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8109-F45921	514C32A7-BD8D-4DE7-BA10-C98DB0C32233	25	Not Available	Not Available	Not Applicable	169	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	7	Not Available	Unknown	Not Available	Not Available	Unknown	YES	Unknown	YES	Alive	2013	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8109	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-P5-A781	34	FEMALE	134	Astrocytoma	Central nervous system	Alive	G3	0	134			TUMOR FREE		34	Not Available	Not Available	Not Available	TCGA-P5-A781	3C6DC0EB-E94B-4293-B665-F3CBA04FC8DE	13	-12757	Not Applicable	0	5	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A781-F69033	E9A6EFAD-B1E8-42EE-AF9F-CECA0957904F	24	Not Available	Not Available	Not Applicable	134	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	Not Available	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A781	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A781-R69034	D3E7FA5C-3889-4C7E-AA50-6B7D3F47BF0F	Not Available	24	134	73	Unknown	12	30 fr	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-HT-7603	29	MALE	705	Oligodendroglioma	Central nervous system	Alive	G2	0	705			Not Available		29	NO	Not Available	NO	TCGA-HT-7603	b435e88b-f105-4c65-b725-126e5a299113	6	-10883	Not Applicable	0	705	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7603-F29571	5037ddb8-5cf9-4ac1-a8fb-dc23e5201eda	7	Not Available	Not Available	Not Applicable	705	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7603	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7603-R29572	261ce1db-313e-4449-a118-471a2b98719b	1	7	76	34	Not Available	3	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2008
TCGA-HT-A617	47	MALE	491	Oligodendroglioma	Central nervous system	Alive	G2	1	395.0			Unknown		47	Unknown	Not Available	NO	TCGA-HT-A617	E0F8E70A-AC91-4D3C-806C-BA9C14ED43AB	11	-17331	Not Applicable	0	491	Not Available	486																								Unknown	NO	Unknown	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A617-F61272	23ADCEC6-9F03-452C-9517-F9850B8B7E50	26	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	6	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	Unknown	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	60	Right	Not Available	Not Available	NO	NO	NO	9	NO	G2	Unknown	Unknown	395	YES	395	Not Available	Not Available	YES	No	A617	Post-Adjuvant Therapy	Unknown	Unknown	YES	NO	Progressive Disease	AMERICAN INDIAN OR ALASKA NATIVE	Unknown																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Not Otherwise Specified	Central nervous system	NO	Alive	2013	2010
TCGA-IK-8125	62	MALE	1301	Oligoastrocytoma	Central nervous system	Alive	G3	0	1301			TUMOR FREE		62	Not Available	Not Available	NO	TCGA-IK-8125	a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f	11	-22745	Not Applicable	0	909	Not Available	42	TCGA-IK-8125-D32771;TCGA-IK-8125-D32772	1c78021d-9fd1-4a52-a555-ff3f7a350d55;cad891ef-1404-4310-9584-2fac7a4052a7	Not Available;Not Available	11;11	99;265	55;111	Temodar;Temodar	Unknown;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	0	YES	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-IK-8125-F33858;TCGA-IK-8125-F40395	5F2476DE-8BAC-424D-8E74-93A87F9D8435;6540965A-4BA0-4DBA-8A76-CBA665EF28B5	20;18	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1120;1301	Not Available;Not Available	1120;Not Available	1;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	7;2	Not Available;Not Available	NO;NO	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Alive	2012;2013	NO	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	Not Available	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	8125	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-IK-8125-R32770	83e55c73-fdfa-42e8-a380-4a667b1f8ea1	Not Available	11	99	55	Unknown	6	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	NO	Not Available	YES	NO	IK	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-DB-A4X9	33	FEMALE	1412	Oligoastrocytoma	Central nervous system	Alive	G2	1	501.0			TUMOR FREE		33	Unknown	Not Available	NO	TCGA-DB-A4X9	5E0748F1-990B-43A9-9FF1-6A667CC228A8	21	-12131	Not Applicable	0	915	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4X9-F60941	8D548802-4FBE-478B-A044-4001DCF174F7	19	Not Available	Not Available	Not Applicable	1412	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	Unknown	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.2	9382/3	C71.2	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	YES	NO	NO	2	NO	G2	NO	NO	501	YES	518	NO	Not Available	YES	No	A4X9	Not Available	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-CS-6665	51	FEMALE	1568	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		51	NO	Not Available	NO	TCGA-CS-6665	c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f	24	-18977	Not Applicable	0	378	Not Available	-1	TCGA-CS-6665-D17574	c3b5ee73-099a-47c3-abb8-c0dcca5e0033	Not Available	13	Not Available	6	Temodar	Not Available	10	Not Available	250	mg	ADJUVANT	Not Applicable	1	PO	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-6665-F17572;TCGA-CS-6665-F71561	271af954-7138-45e7-b648-fd33718d201e;05873FC2-528A-4B98-9E96-5AB567DC84FF	13;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	378;1568	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	Not Available;Not Available	Not Available;NO	10;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Stable Disease;Stable Disease	YES;Not Available	Alive;Alive	2011;2015	YES	Hazelnuts	FEMALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	6665	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-6665-R17573	8644dbf7-d4e8-4287-b54d-b6d065a314c3	1	13	69	22	Not Available	10	33	59.4	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-HT-A616	36	FEMALE	55	Astrocytoma	Central nervous system	Alive	G2	0	55			Unknown		36	NO	Not Available	NO	TCGA-HT-A616	D43581A5-3D49-4263-862B-CA99D15EC03D	5	-13222	Not Applicable	0	55	Not Available	Not Available																								Unknown	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A616-F61270	7B48D813-C3AE-4B87-8F6C-A51608B54A9C	26	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	Not Available	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Unknown	Left	Not Available	Not Available	Unknown	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A616	Not Available	Unknown	NO	Unknown	Unknown	Unknown	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-DU-A7TD	52	MALE	228	Oligoastrocytoma	Central nervous system	Dead	G3	1	188.0			WITH TUMOR		52	Unknown	Not Available	Unknown	TCGA-DU-A7TD	E349D8AA-BB82-4CE8-B14C-61216289F25B	3	-19025	228	0	Not Available	Not Available	170	TCGA-DU-A7TD-D56313;TCGA-DU-A7TD-D56314	D9622AE8-7E36-415A-A2B5-745803CEF0C4;300D4223-5E66-4FF5-9DAF-1B6E6E9A1870	Not Available;Not Available	3;3	63;151	22;77	Temozolomide;Temozolomide	Stable Disease;Clinical Progressive Disease	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Immunotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days																														Unknown	Not Available	MALE	Unknown	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	60	Right	Not Available	Not Available	NO	NO	Unknown	2	YES	G3	NO	NO	188	YES	188	Not Available	Not Available	YES	No	A7TD	Post-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-DU-A7TD-R56312	5FB33F7B-CB4D-4453-B214-4B74C040A036	Not Available	3	63	22	Stable Disease	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	Not Available	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2012
TCGA-FG-5962	54	MALE	1453	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		54	NO	Not Available	NO	TCGA-FG-5962	e09f93e1-1649-48fa-9e2e-d13ac6d50b97	21	-19818	Not Applicable	0	787	Not Available	Not Available	TCGA-FG-5962-D14111;TCGA-FG-5962-D14107	08349992-366b-42ba-8cb9-e93b7b024923;310362a0-7d4a-4042-beec-96856efdea8a	Not Available;Not Available	21;21	258;79	112;28	Temodar;Temodar	Not Available;Not Available	7;7	6;1	320-400;160	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	10800;6720	mg;mg	Not Available;Not Available	2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	Not Available	Not Available	Visual Changes	> 181 Days	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-FG-5962-F14101;TCGA-FG-5962-F32794;TCGA-FG-5962-F43040	a3f8fb99-0444-42b4-a650-05e6287c2d00;69588F28-C267-4B27-B101-8CBBFB2DCE39;AAC87B50-E045-4A2F-BD54-0035DF5825C5	21;12;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	787;1099;1453	Not Available;Not Available;Not Available	386;1099;Not Available	1;1;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease;Stable Disease	Not Available;Not Available;Not Available	Not Available;Not Available;NO	7;6;5	Not Available;Not Available;Not Available	NO;NO;NO	Not Available;Not Available;Not Available	Post-Adjuvant Therapy;Post-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Stable Disease;Stable Disease;Stable Disease	YES;YES;YES	Alive;Alive;Alive	2011;2012;2013	NO	Not Available	MALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	7	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5962	Not Available	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-5962-R15911	4018f116-3ae6-4525-89f3-f90482911137	1	6	79	28	Not Available	9	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	White Matter	NO	YES	FG	Supratentorial, Occipital Lobe	Central nervous system	YES	Alive	2011	2009
TCGA-DU-A7TC	32	MALE	1137	Astrocytoma	Central nervous system	Alive	G2	1	1114.0			TUMOR FREE		32	Unknown	Not Available	NO	TCGA-DU-A7TC	5A3EF1CB-C98E-473A-B097-20307B04BC1B	23	-11884	Not Applicable	0	715	Not Available	Discrepancy																								Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Unknown	Unknown	Not Available	Not Available	TCGA-DU-A7TC-F71626	3DFCCE21-3C7E-4AD7-A244-8063756CFE38	27	Not Available	Not Available	Not Applicable	1137	1114	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	3	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Discrepancy	NO	Alive	2015	Unknown	Not Available	MALE	NO	YES	Astrocytoma	Not Available	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	YES	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7TC	Discrepancy	TUMOR FREE	NO	NO	NO	Discrepancy	WHITE	NO																			NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-HT-A618	37	FEMALE	512	Astrocytoma	Central nervous system	Alive	G3	0	512			Unknown		37	Unknown	Not Available	Unknown	TCGA-HT-A618	A4E2E507-7DDF-43DF-B959-FE451971AF1E	11	-13595	Not Applicable	0	162	Not Available	62	TCGA-HT-A618-D48309	AB2785F9-9744-4CE6-A919-C7229D9F7AD6	Not Available	11	Not Available	110	Temodar	Not Applicable	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Unknown	Unknown	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A618-F61273	432C2426-FAE1-426A-A632-1DEE41F4A197	26	Not Available	Not Available	Not Applicable	512	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	80	Not Available	Not Available	Not Available	Unknown	YES	Unknown	9	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A618	Pre-Adjuvant Therapy	Unknown	YES	Unknown	Unknown	Unknown	WHITE	YES	Primary Tumor Field	TCGA-HT-A618-R48308	42129F8B-AE93-4E1B-B19D-D857A93D2121	Not Available	11	85	40	Partial Response	9	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Unknown	YES	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HW-7486	37	MALE	1721	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		37	Not Available	Not Available	Not Available	TCGA-HW-7486	55a67639-ed05-4143-af96-a377bc5489ee	6	-13546	Not Applicable	0	609	Not Available	Not Available	TCGA-HW-7486-D20186	5d850c60-70ae-4855-bbff-84de40f0e806	Not Available	6	216	66	Temozolomide	Not Available	1	6	Not Available	Not Available	ADJUVANT	Not Applicable	5/28 - schedule which indicates 5 days out of 28 day cycle	PO	NO	Chemotherapy	Not Available	150-200	mg/m2	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-HW-7486-F20185;TCGA-HW-7486-F35024;TCGA-HW-7486-F63120;TCGA-HW-7486-F71504	48f7ad8a-519d-4053-9a38-8e9b7d4fcfdc;DBB8C9BE-873B-43D2-8DF5-9DC46E331D0F;D7EDBF5B-0DD3-42F7-9CFD-B0492BFE51D5;F5635761-4654-43F5-B0E7-31D406CFDC05	6;13;31;31	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	609;910;1491;1721	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Stable Disease;Stable Disease;Stable Disease	Not Available;Not Available;Not Available;Not Available	Not Available;NO;NO;NO	1;9;7;3	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;TUMOR FREE	YES;YES;YES;YES	Stable Disease;Stable Disease;Stable Disease;Stable Disease	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2012;2012;2014;2015	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7486	Not Available	WITH TUMOR	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			YES	Not Available	White Matter	Not Available	Not Available	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2010
TCGA-HT-7686	29	FEMALE	1300	Astrocytoma	Central nervous system	Alive	G3	0	1300			TUMOR FREE		29	NO	Not Available	NO	TCGA-HT-7686	3d58ded1-b7cf-420c-ba59-5b424683f0df	15	-10724	Not Applicable	0	1300	Not Available	Not Available	TCGA-HT-7686-D29418;TCGA-HT-7686-D29417	66ee4c20-c346-4423-a222-2a1d1f49b1d3;866496de-3a98-4e61-95e6-7523222fd8d1	Not Available;Not Available	16;16	239;73	145;26	Temodar;Temodar	Not Available;Not Available	3;3	4;1	300;130	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6000;6110	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7686-F29415	417e0d62-a9b6-4c84-ab1e-cf8d83f8ea92	16	Not Available	Not Available	Not Applicable	1300	Not Available	231	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	90	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7686	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7686-R29416	d4c40ef7-39c9-4560-a6d8-493e80ccebd6	1	16	74	27	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	YES	Alive	2012	2008
TCGA-CS-5390	47	FEMALE		Oligodendroglioma	Central nervous system		G2	1				TUMOR FREE		47	Not Available	Not Available	NO	TCGA-CS-5390	c6cf2b8e-40ed-4c9f-8419-d868bd5afe11	16	-17460	Not Applicable	0	Discrepancy	Not Available	1848	TCGA-CS-5390-D15570	db6ba6a3-3a44-4ecb-919e-282d78f1412a	Not Available	25	Not Available	886	Temodar	Not Available	8	Not Available	300	mg	ADJUVANT	Not Applicable	1	PO	Not Available	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	0	NO	Not Available	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-5390-F10070;TCGA-CS-5390-F71691	eb4805ac-bf42-42c6-b050-783b4d8b2d7b;6F7F0C80-AF49-49AE-B5BB-76D8F2BE8B6D	13;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Available	Discrepancy;Not Available	Not Available;Not Available	1848;Not Available	0;Not Available	Not Available;Not Available	Complete Remission/Response;Stable Disease	100;Not Available	Not Available;NO	3;3	Not Available;Not Available	NO;Discrepancy	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	Not Available;WITH TUMOR	YES;Not Available	Complete Remission/Response;Discrepancy	YES;Not Available	Alive;Dead	2011;2015	Not Available	Not Available	FEMALE	NO	Not Available	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	3	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5390	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-5390-R15569	d9fdf67c-7cde-4591-990f-e9acf2dbd8f4	1	17	65	27	Not Available	8	Not Available	5600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	YES	Cerebral Cortex	NO	YES	CS	Supratentorial, Parietal Lobe	Central nervous system	Not Available	Alive	2011	2005
TCGA-HW-A5KM	35	MALE	630	Astrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		35	Not Available	Not Available	Not Available	TCGA-HW-A5KM	0DB80DFF-5586-4D9F-B253-DF82E6FD6901	12	-12845	Not Applicable	0	201	Not Available	Not Available																								Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-HW-A5KM-F59872	A21EC243-977F-4520-84CF-86A0A0798873	22	Not Available	Not Available	Not Applicable	630	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Alive	2014	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5KM	Not Available	WITH TUMOR	NO	Not Available	NO	Progressive Disease	WHITE	NO																			YES	Not Available	White Matter	YES	NO	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2013	2012
TCGA-QH-A65S	32	FEMALE	77	Oligoastrocytoma	Central nervous system	Alive	G2	0	77			Discrepancy		32	NO	Not Available	NO	TCGA-QH-A65S	92EBE72E-508D-4547-B14B-B8E02E6233CA	2	-11861	Not Applicable	0	77	Not Available	-7																								1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	Not Available	Not Available	TCGA-QH-A65S-F42106	05F17A8A-EDDA-4973-8CDA-3A93E912104E	14	Not Available	Not Available	Not Applicable	77	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	Discrepancy	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	NO	Not Available	90	Left	YES	IHC	YES	YES	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A65S	Preoperative	Discrepancy	NO	YES	YES	Not Available	WHITE	NO																			YES	NO	White Matter	NO	YES	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-E1-A7YV	26	FEMALE	987	Oligoastrocytoma	Central nervous system	Dead	G3	1	97.0			WITH TUMOR		26	NO	Not Available	NO	TCGA-E1-A7YV	23C335F6-5749-4443-8AE8-61CCCBB137CB	11	-9546	987	0	Not Available	Not Available	6	TCGA-E1-A7YV-D61580;TCGA-E1-A7YV-D61581;TCGA-E1-A7YV-D61583;TCGA-E1-A7YV-D61585;TCGA-E1-A7YV-D61586;TCGA-E1-A7YV-D61587;TCGA-E1-A7YV-D61589;TCGA-E1-A7YV-D61590;TCGA-E1-A7YV-D61592;TCGA-E1-A7YV-D61593	7AD57CF9-00E2-4559-B7AD-40FBEAA4326E;0506D544-A5D6-4023-BAD1-370DFC75744D;4926D47F-2BAD-4C57-B6E8-73C812870A88;6D3239C8-3331-4030-847F-FE7FC26AB248;53943E9C-9ABE-4A2C-9110-866DAE738672;B074897E-18F6-4840-80E1-526B6416343C;0E78805C-5BFF-477A-8883-3F6CED061FCC;DE30E03E-61B6-444E-9F9D-1141A44FEBE9;3DB2CB93-6AFA-4E43-9799-B5F624044D7B;420D4CD3-B59D-4097-8180-B35DD38C51FA	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15;15;15;15;15	82;156;507;674;674;824;887;887;948;948	38;70;195;507;507;678;846;832;888;888	Temodar;Temodar;Avastin;Avastin;Gleevec;Gleevec;Avastin;Gleevec;Avastin;CPT-11	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	2014;2014;2014;2014;2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	YES;YES;YES;YES;NO	NO;NO;NO;NO;NO	NO;NO;NO;NO;NO	NO;NO;NO;NO;NO	TCGA-E1-A7YV-F61582;TCGA-E1-A7YV-F61584;TCGA-E1-A7YV-F61588;TCGA-E1-A7YV-F61591;TCGA-E1-A7YV-F61594	643F9F6C-C7A6-451C-BEEC-701528EB2EF9;2B2BF0C6-0775-4EA6-953F-1D460F858486;D949EF3B-1F7C-4134-9C06-BB4FAB3BB937;36203C12-FB1F-4FC3-BBE2-98A33274C325;0C7350AA-C3EA-406C-9F2F-573EA87198CD	15;15;15;15;15	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	987;987;987;987;987	Not Available;Not Available;Not Available;Not Available;Not Available	164;507;832;888;948	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES;YES;YES	Dead;Dead;Dead;Dead;Dead	2014;2014;2014;2014;2014	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	YES	3 X chromosomes (super female) Osler-Weber-Rendu syndrome	90	Left	YES	IHC	YES	NO	NO	8	NO	G3	YES	NO	97	NO	Not Available	NO	Not Available	YES	No	A7YV	Pre-Adjuvant Therapy	WITH TUMOR	YES	NO	YES	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-E1-A7YV-R61579	90EC69B2-7310-4215-8320-F33FE6832F6A	Not Available	15	82	38	Radiographic Progressive Disease	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	2010
TCGA-HT-7475	67	MALE	530	Oligoastrocytoma	Central nervous system	Alive	G3	0	530			TUMOR FREE		67	NO	Not Available	NO	TCGA-HT-7475	41456932-436e-4cdb-bfe8-97d089656786	31	-24686	Not Applicable	0	446	Not Available	Not Available	TCGA-HT-7475-D28957;TCGA-HT-7475-D29490;TCGA-HT-7475-D29491	e1c1f02b-819c-432b-93a5-4ec7446c64b1;ed530a3e-5be2-4690-9291-de69ba2053d6;6b138f48-1cb5-40ea-a1ea-fc90b93424ab	Not Available;Not Available;Not Available	2;20;20	441;162;218	393;130;186	Temodar;Temodar;Temodar	Not Available;Not Available;Not Available	3;3;3	1;2;2	160;280;360	mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	7840;2800;3600	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7475-F29411	0111db17-38a0-4f64-a70d-3b64b9ef196f	16	Not Available	Not Available	Not Applicable	530	Not Available	209	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	70	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	NO	Not Available	70	Right	Not Available	Not Available	NO	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7475	Post-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7475-R21259	4f32ad00-d232-4d93-baca-cbd531ab26d7	1	7	76	28	Not Available	2	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-HT-7467	54	MALE	3	Oligodendroglioma	Central nervous system	Alive	G2	0	3			TUMOR FREE		54	NO	Not Available	NO	TCGA-HT-7467	f4a1fc14-0d32-4e77-a8a3-fd8fea82188a	31	-19944	Not Applicable	0	3	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Sensory Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7467-F28641	f8acf925-2905-47a5-94a3-647e7f05c7e5	27	Not Available	Not Available	Not Applicable	3	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Complete Remission/Response	Not Available	Alive	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7467	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			NO	YES	White Matter	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-TM-A84I	30	MALE	854	Astrocytoma	Central nervous system	Alive	G3	0	854			TUMOR FREE		30	NO	Not Available	NO	TCGA-TM-A84I	71EC4C84-4AEF-4C1F-AB07-DC264C5C0602	17	-11221	Not Applicable	0	589	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84I-F65390	DCF5D427-FC5F-469F-B9ED-BB49B442224B	22	Not Available	Not Available	Not Applicable	854	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84I	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A84I-R56497	0A4025FB-A96D-4DE6-870B-DED3B307C0DD	Not Available	17	84	41	Complete Response	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-FG-8182	35	MALE	416	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		35	NO	Not Available	NO	TCGA-FG-8182	6a0bcf0c-fa4c-4119-99d2-f722b781d20f	7	-12972	Not Applicable	0	101	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-8182-F43399	1BCD2558-21E9-4CBB-9EF5-E7C9AA44457B	20	Not Available	Not Available	Not Applicable	416	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	5	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2013	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8182	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2012
TCGA-TM-A7C5	30	MALE	1500	Oligoastrocytoma	Central nervous system	Alive	G2	0	1500			TUMOR FREE		30	NO	Not Available	YES	TCGA-TM-A7C5	84D80BCF-DA24-4B93-BFE3-3D2D53B8B07D	9	-11286	Not Applicable	0	770	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	NO	NO	< 12 Years	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A7C5-F63554	6543512D-4F4B-4543-AB50-20CFFAA555EE	12	Not Available	Not Available	Not Applicable	1500	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	8	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7C5	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A7C5-R52925	10DAE5BB-EB78-4EC2-A486-FB83784145B8	Not Available	9	79	38	Complete Response	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-S9-A6WQ	57	FEMALE	428	Oligoastrocytoma	Central nervous system	Alive	G2	1				Unknown		57	NO	Not Available	NO	TCGA-S9-A6WQ	14E6C57D-D78E-4660-A21F-4F90A4503080	5	-21133	Not Applicable	0	103	Not Available	-7																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	NO	NO	Not Available	Not Available	TCGA-S9-A6WQ-F62938	B80D0531-29A0-491C-9B3C-6947219F52D7	29	Not Available	Not Available	Not Applicable	428	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	7	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	100	Left	YES	IHC	YES	YES	YES	11	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WQ	Preoperative	Unknown	NO	NO	NO	Partial Remission/Response	WHITE	NO																			YES	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-DU-5872	43	FEMALE	532	Oligoastrocytoma	Central nervous system	Alive	G2	1	265.0			WITH TUMOR		43	Not Available	Not Available	Not Available	TCGA-DU-5872	48607130-c09a-491d-882f-7d2591d13182	26	-15986	Not Applicable	0	532	Not Available	Not Available	TCGA-DU-5872-D14773;TCGA-DU-5872-D14776;TCGA-DU-5872-D14774;TCGA-DU-5872-D14775	2e3322bc-a7d1-49c4-89f3-507124d59aac;b3d8b5ea-bd0b-4738-ab53-d7aa88304b35;1772ca68-1a45-4fb5-a6f7-b5708225d9f3;212f0ee4-683e-426b-99f3-2ae9beadf05d	Not Available;Not Available;Not Available;Not Available	20;20;20;20	73;Not Available;267;370	34;540;83;328	Temozolomide;Temozolomide;Temozolomide;Bevacizumab	Not Available;Not Available;Not Available;Not Available	6;6;6;6	1;1;6;2	75;Not Available;150;10	mg/m2;mg/m2;mg/m2;mg/kg	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;1;2	PO;PO;PO;IV	NO;YES;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	155;150;310;959	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	YES	NO	YES	NO	TCGA-DU-5872-F14771	09c6e4ae-0110-42e6-9289-2d594caefd9c	20	283	Not Available	Not Applicable	532	265	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5872	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-DU-5872-R14772	f92b3052-5815-4afe-85dd-80acec4563a4	1	20	73	34	Not Available	6	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2009
TCGA-E1-5311	31	MALE	4084	Oligodendroglioma	Central nervous system	Dead	G3	1	2602.0			WITH TUMOR		31	NO	Not Available	NO	TCGA-E1-5311	0061e9ef-df6a-414e-af64-c88f8192e2d3	25	-11332	4084	0	Not Available	Not Available	-8	TCGA-E1-5311-D7605;TCGA-E1-5311-D7611;TCGA-E1-5311-D7604;TCGA-E1-5311-D7609;TCGA-E1-5311-D7613;TCGA-E1-5311-D7606;TCGA-E1-5311-D7612;TCGA-E1-5311-D7610	30aab203-831a-45a5-a8bb-a12345ebb0fb;23ccb473-f54d-4bbd-a42f-5a08ba5eb8e3;9c1483be-c582-4e5c-8521-bff2d3373ffa;093fbbe5-b3b5-4b77-aae3-1290f4970a0a;3b12c8ac-446c-48f9-83c7-b47fd1922807;d0f8800f-d92b-4fef-9e99-4ed9b6730e9b;09853759-bc18-4985-a43b-250c56485528;ab0c2859-49f7-44b4-95c2-cd241ada23fc	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	25;25;25;25;25;25;25;25	2799;3868;20;3282;4084;2848;3996;3749	2615;3282;20;2925;3996;2825;3868;3282	Temozolomide;Celebrex;MAGI131-81c6;CCNU;VP-16;Karerltecin;Cloretazine;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1;1	6;19;1;8;3;1;3;15	200;400;40;110;50;2.2;300;100	mg/m2;mg;mCi;mg/m2;mg/m2;mg;mg/m2;mg	PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;6;1;5;8;3;7;6	PO;PO;INTUM;PO;PO;IV;IV;PO	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Other, specify in notes;Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;NSAID;Brachytherpy;Not Available;Not Available;Not Available;Not Available;Not Available	13200;425600;40;2000;6930;11;2040;84000	mg;mg;mCi;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	YES	YES	YES	NO	TCGA-E1-5311-F7600	0874a41d-64ee-423d-a9ca-36d6969cb583	25	2602	Not Available	4084	Not Available	2602	-8	Not Available	Not Available	Progressive Disease	100	Not Available	1	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	YES	Dead	2011	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9451/3	C71.9	YES	Not Available	Not Available	100	Right	Not Available	Not Available	Not Available	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5311	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5311-R7603	75d929c6-2695-4464-9fa1-76c7fc75190c	4	25	2919	2871	Not Available	1	30	6000	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	1994
TCGA-DU-A76O	30	MALE	522	Astrocytoma	Central nervous system	Alive	G2	0	522			WITH TUMOR		30	NO	Not Available	NO	TCGA-DU-A76O	C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B	18	-10960	Not Applicable	0	217	Not Available	Not Available	TCGA-DU-A76O-D50234;TCGA-DU-A76O-D50235	1C804B86-2372-4F40-80DC-03362D801B79;4F9A0EDA-E68B-4E0F-AE64-C0A5AD4F12FD	Not Available;Not Available	18;18	94;Not Available	49;115	Temozolomide;Temozolomide	Stable Disease;Not Applicable	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Unknown	Unknown	Not Available	Not Available	TCGA-DU-A76O-F71621	32357AA7-5D8E-4620-93FF-F77AC4DDC231	27	Not Available	Not Available	Not Applicable	522	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	3	Not Available	Unknown	Not Available	Not Available	Unknown	YES	Unknown	YES	Alive	2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	NO	IHC	YES	NO	NO	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Prior Malignancy	A76O	Not Evaluated	WITH TUMOR	YES	YES	NO	Not Applicable	WHITE	YES	Primary Tumor Field	TCGA-DU-A76O-R50233	6A0929BA-C4F9-4603-857E-B77D41E28835	Not Available	18	94	49	Stable Disease	10	33	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-8107	62	MALE	14	Oligodendroglioma	Central nervous system	Alive	G2	0	14			Not Available		62	NO	Not Available	NO	TCGA-HT-8107	f2d3fea5-0d20-42d3-b918-adad715be4ee	3	-22880	Not Applicable	0	14	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8107-F32633	f44397cb-1e2f-4fd5-bda9-d16644b49409	4	Not Available	Not Available	Not Applicable	14	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8107	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-FG-8181	23	MALE	862	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		23	Not Available	Not Available	Not Available	TCGA-FG-8181	1159c88c-39d0-4c03-9c66-36af5340a67a	7	-8642	Not Applicable	0	106	Not Available	-13	TCGA-FG-8181-D64420	2D62A107-8CCE-489F-92A4-C38E2B1ACA7F	Not Available	2	105	64	Temodar	Stable Disease	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-8181-F43398;TCGA-FG-8181-F64421	0678B69F-E4D4-49C4-AE92-E5A6003302C0;6C9E9000-C343-4750-AB64-17DB935BD178	20;2	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	394;862	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	5;9	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2013;2014	Not Available	Not Available	MALE	Not Available	Not Available	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	Not Available	Not Available	6	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8181	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Unknown	TCGA-FG-8181-R32722	76E8A43D-2250-4284-BBC2-9A8F22831141	Not Available	7	Not Available	64	Not Applicable	6	Not Available	Not Available	YES	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Available	Not Available	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2012
TCGA-VM-A8CH	24	FEMALE	714	Astrocytoma	Central nervous system	Alive	G2	0	714			TUMOR FREE		24	Unknown	Not Available	Unknown	TCGA-VM-A8CH	484DD45B-A16C-4650-BAC9-832FBE4D96EB	14	-9005	Not Applicable	0	333	Not Available	-38																								Not Evaluated	Unknown	Unknown	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-VM-A8CH-F69641	6886FEAA-2D0A-410A-AB6C-4E99EE4FF100	15	Not Available	Not Available	Not Applicable	714	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	1	Not Available	NO	Not Available	Not Available	Unknown	NO	Complete Remission/Response	NO	Alive	2015	Not Available	Not Available	FEMALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	Unknown	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8CH	Preoperative	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			YES	YES	Not listed in Medical Record	NO	YES	VM	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2013
TCGA-FG-7636	48	MALE	544	Astrocytoma	Central nervous system	Alive	G3	0	544			TUMOR FREE		48	NO	Not Available	NO	TCGA-FG-7636	b342e980-8383-4f1b-bf57-4098c37a536c	29	-17843	Not Applicable	0	124	Not Available	-7	TCGA-FG-7636-D19850	7b3133a0-75ec-4ece-b722-8deb8f2823d2	Not Available	29	84	33	Temodar	Not Available	12	1	150	mg	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	6300	mg	Not Available	2011	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-7636-F43425	DC5BAB9B-1C09-4D17-AB72-09C263DAAD11	21	Not Available	Not Available	Not Applicable	544	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	YES	NO	12	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7636	Preoperative	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-7636-R19849	334be0ca-2520-4235-8d59-fd281cca8581	1	29	84	33	Not Available	12	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	YES	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2011
TCGA-QH-A6X3	27	MALE	313	Oligoastrocytoma	Central nervous system	Alive	G2	0	313			Unknown		27	Not Available	Not Available	NO	TCGA-QH-A6X3	B60FCE04-9779-42C0-8161-D29D8A1D7C64	9	-10184	Not Applicable	0	18	Not Available	16																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A6X3-F67748	94F8F675-8373-4F83-B1D9-DB09536BD306	11	Not Available	Not Available	Not Applicable	313	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	Not Available	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A6X3	Other	Unknown	NO	NO	NO	Complete Remission/Response	WHITE	NO																			YES	NO	White Matter	YES	NO	QH	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-CS-5395	43	MALE	639	Oligodendroglioma	Central nervous system	Dead	G2	1	287.0			WITH TUMOR		43	Not Available	Not Available	Not Available	TCGA-CS-5395	f86fa219-34e9-4812-8edf-2b66d7219779	13	-15848	639	0	Not Available	Not Available	-1	TCGA-CS-5395-D10076;TCGA-CS-5395-D19845	f6605382-bfa1-4648-bbe1-4da6295aa7a8;135a69bd-6cdb-45f9-b1d7-f698b8fea52a	Not Available;Not Available	13;29	579;Not Available	411;259	Bevacizumab;Temodar	Not Available;Not Available	3;12	11;Not Available	980;100	mg;mg	PROGRESSION;ADJUVANT	Not Applicable;Not Applicable	Not Available;1	IV;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	10780;Not Available	mg;mg	Not Available;Not Available	2011;2011	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	YES	YES	TCGA-CS-5395-F10075	2ecd9589-b572-4c74-85ae-d2a7649caac1	13	287	287	639	Not Available	287	379	2	Not Available	Progressive Disease	80	Not Available	3	Not Available	YES	Not Available	Preoperative	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5395	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-CS-5395-R15925	3900f1f9-ef6d-47d9-868b-8d5633ac1bc0	1	7	119	60	Not Available	9	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Available	Not Available	Cerebral Cortex	NO	YES	CS	Supratentorial, Parietal Lobe	Central nervous system	Not Available	Dead	2011	2007
TCGA-DB-5276	32	MALE	2218	Oligoastrocytoma	Central nervous system	Alive	G3	0	2218			TUMOR FREE		32	Not Available	Not Available	NO	TCGA-DB-5276	9d0c1552-00a7-4f0a-a04a-a82e721ee4e3	22	-11738	Not Applicable	0	1595	Not Available	Not Available	TCGA-DB-5276-D14435;TCGA-DB-5276-D14433;TCGA-DB-5276-D15525;TCGA-DB-5276-D15527	cf5efc36-9230-4008-a50c-1f5d89ca5c64;d0517edd-ec4b-4404-a060-e8fe19782140;a0a1954b-de5b-479d-92f5-dcab0a809a1d;9509ff37-b028-4b82-8039-a62706ff87c8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;22;22	283;69;1189;1342	69;12;1011;1196	Temodar;Temodar;Gleevec;Gleevec	Not Available;Not Available;Not Available;Not Available	7;7;8;8	6;6;6;5	200;75;600;300	mg/m2;mg/m2;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;2	PO;PO;PO;PO	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	9000;6510;Not Available;Not Available	mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-5276-F42832	138C59E8-E941-4456-AC94-188D121ECC08	1	Not Available	Not Available	Not Applicable	2218	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	7	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5276	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DB-5276-R14242	e902b2f8-abc9-47e4-8823-946192c2de1b	1	22	67	12	Not Available	7	29	5800	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2007
TCGA-E1-A7YU	42	MALE	23	Oligoastrocytoma	Central nervous system	Dead	G3	0	23			WITH TUMOR		42	Unknown	Not Available	NO	TCGA-E1-A7YU	FC3948FB-DF27-4149-BBFB-04443DFECC19	11	-15345	23	0	Not Available	Not Available	Not Available	TCGA-E1-A7YU-D61577	44D3E63F-E995-4857-8B11-4B9AA355DA5F	Not Available	15	6	6	I 131 81C6	Unknown	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Immunotherapy	Not Available	Not Available	Not Available	YES	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Headaches	31 - 90 Days																														Unknown	Not Available	MALE	Unknown	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Not Available	Not Available	Not Available	NO	NO	Unknown	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A7YU	Not Evaluated	WITH TUMOR	YES	YES	Unknown	Unknown	WHITE	NO																			Not Available	YES	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	1996
TCGA-DU-5871	37	FEMALE	576	Oligoastrocytoma	Central nervous system	Alive	G2	0	576			TUMOR FREE		37	Not Available	Not Available	Not Available	TCGA-DU-5871	ddfd76dc-15d6-4efc-85ea-31674161ebf3	21	-13673	Not Applicable	0	576	Not Available	-6	TCGA-DU-5871-D14695;TCGA-DU-5871-D14696	23026c9a-3af3-475a-a74f-4a6ca91d1c66;9ea9bdb9-1ae6-4eb4-8b30-74581a481d49	Not Available;Not Available	21;21	57;222	14;71	Temozolomide;Temozolomide	Not Available;Not Available	6;6	1;6	75;200	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	160;450	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	NO	TCGA-DU-5871-F15057	73f162b3-7846-413f-bf2d-ed0c2459cea9	27	Not Available	Not Available	Not Applicable	576	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	100	Left	Not Available	Not Available	NO	NO	Not Available	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5871	Preoperative	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-5871-R14694	62103261-2602-476e-bb66-5e86968a4746	1	21	57	14	Not Available	6	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	White Matter	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2009
TCGA-E1-A7Z6	41	FEMALE	984	Astrocytoma	Central nervous system	Dead	G2	1	294.0			WITH TUMOR		41	NO	Not Available	NO	TCGA-E1-A7Z6	8B10F00F-FDE6-423D-BC36-027931359A5A	11	-14985	984	0	Not Available	Not Available	19	TCGA-E1-A7Z6-D61768;TCGA-E1-A7Z6-D61773;TCGA-E1-A7Z6-D61774	5E182D11-B082-4B6B-893A-51EA9ABE7041;E16FBDC2-F705-40B9-AAF1-4597CD3CACF3;86902F7A-58BF-43A9-A43C-9FF453EAC8B3	Not Available;Not Available;Not Available	19;19;19	705;964;966	356;907;901	Temodar;Temodar;Avastin	Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	YES;NO	YES;NO	NO;NO	NO;NO	TCGA-E1-A7Z6-F61769;TCGA-E1-A7Z6-F61776	31873296-B979-4568-B1AF-A6EF6D2DE01B;B1286E73-5C72-4144-914D-479CF8F2ADF8	19;19	Not Available;Not Available	Not Available;Not Available	984;984	Not Available;Not Available	872;971	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	8;8	Not Available;Not Available	YES;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	YES;YES	Dead;Dead	2014;2014	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	NO	8	NO	G2	YES	NO	294	NO	Not Available	NO	Not Available	YES	No	A7Z6	Pre-Adjuvant Therapy	WITH TUMOR	NO	NO	YES	Progressive Disease	WHITE	NO	Primary Tumor Field	TCGA-E1-A7Z6-R61770	0824E9EE-E409-4708-ACB9-A48080A0F8DB	Not Available	19	964	907	Radiographic Progressive Disease	8	31	5580	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	2009
TCGA-DU-6401	31	FEMALE	2660	Oligodendroglioma	Central nervous system	Dead	G2	1	1886.0			WITH TUMOR		31	Not Available	Not Available	Not Available	TCGA-DU-6401	97cb8701-7d63-4142-b404-006fbb3ecb0b	21	-11595	2660	0	Not Available	Not Available	Not Available	TCGA-DU-6401-D14755;TCGA-DU-6401-D14757;TCGA-DU-6401-D14754	15e13b5e-7bc1-4492-9706-544b77b7d03c;455a61e4-9acc-4709-9dad-491b3c3bcc80;d9b9efc4-14cf-4394-a70b-1117bea8d4d8	Not Available;Not Available;Not Available	31;31;31	2512;2542;2451	2512;2542;1903	Sorafenib (Bay 43-9006);Procarbazine;Temozolomide	Not Available;Not Available;Not Available	5;5;5	02;01;16	400;Not Available;Not Available	mg;mg/m2;mg/m2	PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	02;03;01	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	400;Not Available;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	> 181 Days	YES	NO	YES	NO	TCGA-DU-6401-F14751	b3218113-7ff8-4a85-a759-c7ce7489b35e	31	2464	Not Available	2660	Not Available	1886	2454	Not Available	Not Available	Progressive Disease	100	Not Available	5	Not Available	YES	Not Available	Preoperative	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6401	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6401-R14753	f821fcbf-99a8-4f00-a950-b9ce37a89965	01	31	228	187	Not Available	5	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	YES	Dead	2011	1998
TCGA-DH-5144	56	FEMALE	748	Oligodendroglioma	Central nervous system	Alive	G3	0	748			TUMOR FREE		56	NO	Not Available	NO	TCGA-DH-5144	083c0b78-88c2-4ec1-8a81-a0792b16e2cc	8	-20558	Not Applicable	0	244	Not Available	19																								0	NO	NOT HISPANIC OR LATINO	Not Available	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DH-5144-F6562;TCGA-DH-5144-F66726	d3c9cc2a-b2c6-4f59-af0f-f0cdf0741590;4BF3BBE8-6690-43B3-B7A4-8AB0031D6FE8	8;22	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	244;748	Not Available;Not Available	19;Not Available	0;Not Available	Not Available;Scheduled Follow-up Submission	Stable Disease;Stable Disease	100;Not Available	Not Available;NO	12;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Alive	2010;2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5144	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DH-5144-R6566	29b8de6b-1412-4646-9cc4-6bab0aa564e7	1	20	106	81	Not Available	12	20	3600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	YES	NO	Cerebral Cortex	NO	YES	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2010	2009
TCGA-WY-A858	32	FEMALE	1337	Astrocytoma	Central nervous system	Alive	G3	0	1337			TUMOR FREE		32	Unknown	Not Available	NO	TCGA-WY-A858	C8700CA3-8C0B-4B2A-9E87-79D244A0F892	10	-11855	Not Applicable	0	1337	Not Available	45																								0	Unknown	Unknown	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days																														YES	fresh pitted fruit	FEMALE	YES	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	100	Left	Unknown	Not Available	Unknown	NO	Unknown	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A858	Pre-Adjuvant Therapy	TUMOR FREE	YES	NO	NO	Complete Remission/Response	WHITE	YES																			NO	NO	Not listed in Medical Record	NO	YES	WY	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-DB-A64U	38	FEMALE	846	Oligoastrocytoma	Central nervous system	Alive	G2	0	846			TUMOR FREE		38	YES	ant stings	NO	TCGA-DB-A64U	99D396BB-5F51-4EE4-A149-244E8FCAF522	7	-14019	Not Applicable	0	846	Not Available	118																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64U-F67353	20D832BC-3520-4688-9943-77C0E0BFB20A	4	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Complete Remission/Response	NO	Not Available	2014	YES	shellfish	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64U	Preoperative	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			NO	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-FG-8191	30	MALE	992	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		30	NO	Not Available	NO	TCGA-FG-8191	029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7	7	-11252	Not Applicable	0	199	Not Available	Not Available	TCGA-FG-8191-D32716;TCGA-FG-8191-D43400	3AD13E50-1087-452C-ACA6-CF2E3EFFED20;EE6C5FFC-7ABE-44E6-BBE6-EFC24033B9A9	Not Available;Not Available	20;20	76;448	31;122	Temodar;Temodar	Stable Disease;Stable Disease	6;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2013	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-8191-F43401;TCGA-FG-8191-F66698	CF41150A-13E4-4A10-A9C7-101098FE37A4;391D5E18-E90E-40C5-8B31-10ADE0A7B74E	20;22	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	472;992	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	5;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2013;2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8191	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-8191-R32715	4D84320E-AF88-4BE0-9F49-3C363AC48A19	Not Available	7	76	31	Stable Disease	6	30	5700	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	NO	YES	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-TQ-A7RK	29	MALE	1341	Oligoastrocytoma	Central nervous system	Alive	G2	1	858.0			TUMOR FREE		29	NO	Not Available	NO	TCGA-TQ-A7RK	2F8C789E-BBD8-4753-A48B-6894C21162F8	7	-10742	Not Applicable	0	1341	Not Available	-115																								0	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	YES	YES	YES	Not Available	TCGA-TQ-A7RK-F61519	27807EBA-1E55-4B8C-8770-B870A32F8DBD	30	882	Not Available	Not Applicable	1341	858	Not Available	Not Available	Additional New Tumor Event	Complete Remission/Response	Not Available	NO	6	Not Available	YES	Not Available	Not Available	Not Available	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	Unknown	Not Available	NO	YES	NO	10	NO	G2	YES	YES	858	YES	882	Not Available	Not Available	YES	No	A7RK	Preoperative	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	NO																			NO	NO	White Matter	NO	YES	TQ	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-HT-7472	38	MALE	1	Oligodendroglioma	Central nervous system	Alive	G2	0	1			Not Available		38	NO	Not Available	NO	TCGA-HT-7472	482d4078-7576-48cf-bf7c-29014935fd47	27	-13968	Not Applicable	0	1	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7472-F28774	2aa3d0e7-1e3a-4ced-b312-87e53c38bfa8	1	Not Available	Not Available	Not Applicable	1	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7472	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-DB-5277	34	MALE	1547	Astrocytoma	Central nervous system	Dead	G3	1	1156.0			WITH TUMOR		34	Not Available	Not Available	NO	TCGA-DB-5277	d05079f2-9883-46e6-ad06-9e561f08d819	22	-12725	Not Applicable	0	1419	Not Available	Not Available	TCGA-DB-5277-D14420;TCGA-DB-5277-D14419;TCGA-DB-5277-D15524	cbc335aa-955f-443f-b8db-b8466075d2e3;b8d13d9f-90f4-43c2-b5fc-2f55941c5b20;9adc1973-ccc6-446b-a88e-66582277fa98	Not Available;Not Available;Not Available	22;22;22	361;61;1239	91;27;1117	Temodar;Temodar;Temozolamide	Not Available;Not Available;Not Available	7;7;8	9;5;Not Available	110;75;Not Available	mg/m2;mg/m2/day;mg	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	1;1;2	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	9900;5250;Not Available	mg;mg;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	YES	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	NO	Not Available	TCGA-DB-5277-F42826	765F3A87-86CD-411A-8BD8-D62C04417C2A	1	Not Available	Not Available	1547	Not Available	1156	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	YES	Dead	2013	YES	seafood	MALE	YES	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	YES	7	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5277	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-DB-5277-R14240;TCGA-DB-5277-R15523	a1357bc4-a680-4eff-b1cc-ddd88b81696f;42d6b46b-23d8-44e2-9da5-74d3bd2d50e6	1;2	22;22	71;Not Available	26;1148	Not Available;Not Available	7;8	33;Not Available	5940;5600	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;PROGRESSION	Not Available;Not Available	cGy;cGy	2011;2011	YES	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2007
TCGA-VV-A829	44	MALE	1127	Oligoastrocytoma	Central nervous system	Alive	G3	0	1127			WITH TUMOR		44	NO	Not Available	NO	TCGA-VV-A829	10887E42-444D-49FC-AEE5-DD0E9FC4EA54	31	-16163	Not Applicable	0	823	Not Available	Not Available	TCGA-VV-A829-D57959	F31E4A15-F92E-476B-9296-0AE75CCA7F75	Not Available	31	792	0	Temodar	Stable Disease	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-VV-A829-F65521	574F7E56-9B17-4C8E-92AE-D1931B459A87	2	Not Available	Not Available	Not Applicable	1127	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	NO	3	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A829	Not Available	WITH TUMOR	YES	Not Available	Not Available	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-VV-A829-R57957	1BA6BD0C-0A71-45E1-B794-A5365E84E4DD	Not Available	31	61	0	Stable Disease	3	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	NO	NO	Not listed in Medical Record	NO	YES	VV	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-DH-A7UV	49	MALE	566	Astrocytoma	Central nervous system	Alive	G3	0	566			WITH TUMOR		49	Unknown	Not Available	Unknown	TCGA-DH-A7UV	3B19B5D1-13AF-4669-A082-1BD546048185	10	-18161	Not Applicable	0	189	Not Available	19	TCGA-DH-A7UV-D60356	23F803F1-9471-463E-B2A5-74C49E3A765A	Not Available	6	463	20	Temodar	Stable Disease	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DH-A7UV-F68876	8EB6C9E8-AEF1-40BD-984B-3AE773C351DF	22	Not Available	Not Available	Not Applicable	566	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	12	Not Available	NO	Not Available	Not Available	Unknown	YES	Stable Disease	YES	Alive	2014	Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Right	NO	IHC	YES	YES	Unknown	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7UV	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Not Applicable	WHITE	YES	Primary Tumor Field	TCGA-DH-A7UV-R60355	91A4D4BB-9FCA-4AD2-9A3E-4D0470B30504	Not Available	6	67	20	Stable Disease	6	34	6120	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	Not listed in Medical Record	YES	NO	DH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-HW-8319	34	FEMALE	1209	Astrocytoma	Central nervous system	Dead	G3	1	997.0			WITH TUMOR		34	Not Available	Not Available	Not Available	TCGA-HW-8319	bc3b4816-df1d-44ed-a8c6-f32c8e011a1f	30	-12557	Not Applicable	0	262	Not Available	Not Available	TCGA-HW-8319-D34779;TCGA-HW-8319-D34780;TCGA-HW-8319-D71531;TCGA-HW-8319-D71533;TCGA-HW-8319-D71534	4FE29BAD-2AE2-4747-BFE9-468975720AA0;6A4BBC1C-240E-4B7D-8F16-6D8A134AF5B7;CB111AD6-332F-4C3D-B711-E62ADD0567B9;4B6291A6-31E5-49D0-8852-72FFAD185089;E73AFB4E-639F-42E1-B35E-06C19A05328F	Not Available;Not Available;Not Available;Not Available;Not Available	30;30;31;31;31	66;Not Available;1058;1150;1150	23;94;1028;1058;1089	Temozolomide;Temozolomide;Temozolomide;Bevacizumab;Lomustine	Stable Disease;Not Available;Partial Response;Partial Response;Unknown	8;8;3;3;3	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;YES;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available;YES	Not Available;Not Available;NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-HW-8319-F34777;TCGA-HW-8319-F48677;TCGA-HW-8319-F71526	812C654C-B01A-43C0-A41B-AFA0375F91A8;53A20085-ECCB-4CC2-8F29-B0D6FDB7FEAC;61A5091C-7B98-4198-A87C-28DD46553F6D	30;19;31	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;1209	262;660;Not Available	Not Available;Not Available;997	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Progressive Disease;Unknown	Not Available;Not Available;Not Available	NO;NO;NO	8;9;3	Not Available;Not Available;Not Available	NO;NO;YES	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES	Alive;Alive;Dead	2012;2013;2015	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	8319	Not Available	WITH TUMOR	YES	Not Available	NO	Partial Remission/Response	WHITE	YES	Regional site	TCGA-HW-8319-R34778	1D629E41-1C65-45F0-B812-033EB34481A1	Not Available	30	66	23	Stable Disease	8	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	NO	Not Available	Not Available	YES	NO	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-WY-A85C	36	MALE	1426	Astrocytoma	Central nervous system	Alive	G2	1	809.0			WITH TUMOR		36	NO	Not Available	NO	TCGA-WY-A85C	F62BE2B8-88C4-4A7E-8C80-8176FB5F6C56	26	-13506	Not Applicable	0	866	Not Available	Not Available																								1	Unknown	Not Available	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Unknown	Unknown	YES	Not Available	TCGA-WY-A85C-F65786	2962BA57-7459-4F6A-A8DA-3CEBD18670FF	22	1337	Not Available	Not Applicable	1426	1261	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	1	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2015	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	NO	NO	2	YES	G2	YES	YES	809	YES	819	Not Available	Not Available	YES	No	A85C	Not Available	WITH TUMOR	NO	YES	YES	Not Applicable	WHITE	NO																			NO	YES	Not listed in Medical Record	NO	YES	WY	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-P5-A5EW	20	FEMALE	204	Astrocytoma	Central nervous system	Alive	G2	0	204			TUMOR FREE		20	YES	cats	Unknown	TCGA-P5-A5EW	6D02E00C-56A5-4433-9930-F036E2AA39AA	22	-7612	Not Applicable	0	204	Not Available	-2																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	< 12 Years	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5EW-F69041	A19F1C6F-8887-4337-9936-67713224B969	24	Not Available	Not Available	Not Applicable	204	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	80	Right	Not Available	Not Available	NO	Unknown	NO	8	Unknown	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5EW	Preoperative	TUMOR FREE	Unknown	YES	NO	Unknown	WHITE	Unknown																			Unknown	Unknown	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Unknown	Alive	2013	2012
TCGA-DB-A75O	29	MALE	935	Astrocytoma	Central nervous system	Alive	G3	0	935			Unknown		29	NO	Not Available	NO	TCGA-DB-A75O	0C52A842-C220-486E-88DE-8A4FEC5D6A58	3	-10812	Not Applicable	0	935	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A75O-F67378	0BAEB720-45BF-4297-8225-7AB148471E75	4	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Partial Remission/Response	Unknown	Not Available	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A75O	Preoperative	Unknown	Unknown	YES	NO	Partial Remission/Response	WHITE	Unknown																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-DU-A7TA	32	MALE	2565	Oligodendroglioma	Central nervous system	Alive	G2	0	2565			TUMOR FREE		32	NO	Not Available	NO	TCGA-DU-A7TA	EF12BFB7-4147-407F-84E9-586DBB10D583	23	-11764	Not Applicable	0	2369	Not Available	17	TCGA-DU-A7TA-D54834;TCGA-DU-A7TA-D54835	DE394888-84AB-408B-9F41-E3BEE9D96E4C;34144EAA-92D6-45E8-A9A8-A1E143BB9761	Not Available;Not Available	23;23	70;413	33;77	Temozolomide;Temozolomide	Stable Disease;Stable Disease	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	12 - 20 Years	Not Available	Not Available	Visual Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-A7TA-F71628	A8405ACC-9E5A-4B72-A896-EF161B36A069	27	Not Available	Not Available	Not Applicable	2565	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2015	NO	Not Available	MALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	80	Right	Not Available	Not Available	NO	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7TA	Pre-Adjuvant Therapy	TUMOR FREE	YES	NO	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DU-A7TA-R54833	303FB194-AD83-47AD-A8AF-7B124C195D17	Not Available	23	70	33	Stable Disease	12	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Occipital Lobe	Central nervous system	YES	Alive	2013	2007
TCGA-E1-A7Z4	35	MALE	4412	Astrocytoma	Central nervous system	Dead	G2	1	846.0			WITH TUMOR		35	NO	Not Available	NO	TCGA-E1-A7Z4	975E17C2-B93C-4D45-8A85-786F365E4A93	11	-12849	4412	0	Not Available	Not Available	974	TCGA-E1-A7Z4-D61742;TCGA-E1-A7Z4-D61744;TCGA-E1-A7Z4-D61746;TCGA-E1-A7Z4-D61748;TCGA-E1-A7Z4-D61749;TCGA-E1-A7Z4-D61751;TCGA-E1-A7Z4-D61753;TCGA-E1-A7Z4-D61754;TCGA-E1-A7Z4-D61756;TCGA-E1-A7Z4-D61758;TCGA-E1-A7Z4-D61759;TCGA-E1-A7Z4-D61761;TCGA-E1-A7Z4-D61762	45034EE3-2514-4F2E-BDAC-DA0F43B0E592;DAC8BC69-6B96-4C72-8F2A-081329407FC3;C4B86A27-716A-4EB9-9857-868CEBF922A0;B907B025-FF2B-4F61-8A78-B413C29B8826;C99CD020-7894-4F1F-A627-78E331F26389;799AA848-1E30-4DC7-8CAA-B6F0AF17B2D8;9DF62BE0-F268-4DE1-8030-57475AC58C16;0282393A-FCBA-4D4A-AC74-B0D9C5C66032;A7B85916-1068-405F-B574-5D1E8807337B;0161FE00-CD4D-47E4-879C-208B19B2958B;7964078B-3059-4440-8855-5ADA2090CFE0;98E606FE-D8E2-423E-A0EF-C9F8D553ED9C;5CD187C5-7576-451C-B84D-341B29CC2732	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;19;19;19;19;19;19;19;19;19	883;952;1100;1176;1176;1249;1834;1834;3888;4124;4137;4336;4308	883;896;974;1101;1101;1182;1266;1266;3545;4081;4081;4138;4138	Gliadel;Temodar;CCNU;Thalidomide;Cyclophosphamide;Karenitecin;Temodar;Tamoxifen;Avastin;Avastin;Temodar;Avastin;Carboplatin	Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Not Available;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Immunotherapy;Immunotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;YES;YES;NO;NO;NO;NO;NO;NO;NO	2014;2014;2014;2014;2014;2014;2014;2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	YES;YES;YES;YES;YES;YES;YES;NO	NO;NO;NO;NO;NO;NO;YES;NO	NO;NO;NO;NO;NO;NO;NO;NO	Unknown;NO;NO;NO;NO;NO;NO;NO	TCGA-E1-A7Z4-F61745;TCGA-E1-A7Z4-F61747;TCGA-E1-A7Z4-F61750;TCGA-E1-A7Z4-F61752;TCGA-E1-A7Z4-F61755;TCGA-E1-A7Z4-F61757;TCGA-E1-A7Z4-F61760;TCGA-E1-A7Z4-F61765	E8590421-9023-43E7-95BF-B1ABE453A53B;F7738E55-C329-4EC0-BDBA-76CC64C0E8A0;E0E8D78B-9BC8-4429-BD02-28CB3A7AC1C5;45D130FD-979A-4A46-905B-9886A3DAD26D;81FB6004-B172-4336-89B4-96229C2FF220;FEF02454-9AA5-4331-9677-685208DAEB8D;B13971D1-089B-4932-8927-3841C5C6D801;E2E2D852-98D1-4DE3-B9C2-6C7E3C958A95	18;18;18;18;18;18;18;18	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4412;4412;4412;4412;4412;4412;4412;4412	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	973;1099;1169;1262;3485;4047;4138;4339	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES;YES;YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES;YES;YES;YES;YES;YES	Dead;Dead;Dead;Dead;Dead;Dead;Dead;Dead	2014;2014;2014;2014;2014;2014;2014;2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	NO	NO	8	NO	G2	YES	NO	846	YES	883	NO	Not Available	YES	No	A7Z4	Post-Adjuvant Therapy	WITH TUMOR	NO	YES	YES	Progressive Disease	WHITE	NO	Primary Tumor Field;Primary Tumor Field	TCGA-E1-A7Z4-R61743;TCGA-E1-A7Z4-R61764	DDFB9FB0-158C-4625-9A5B-FF945C2680C8;030FEBDD-AB25-4DF7-86D1-5BE05AE2FE4C	Not Available;Not Available	19;19	961;4152	916;4152	Radiographic Progressive Disease;Radiographic Progressive Disease	8;8	33;Not Available	5940;2000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	YES	Dead	2014	1999
TCGA-S9-A6TV	50	MALE	571	Oligoastrocytoma	Central nervous system	Alive	G3	0	571			TUMOR FREE		50	NO	Not Available	NO	TCGA-S9-A6TV	048056CD-39DD-4134-A58B-70BEBB3DD2FF	12	-18321	Not Applicable	0	571	Not Available	-14	TCGA-S9-A6TV-D54120	D2063D3F-C321-44EF-97BF-4C2A2430F264	Not Available	17	68	26	Temozolamide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-S9-A6TV-F67222	A33D1658-C2DB-47BB-BF53-04E59CD75E27	3	Not Available	Not Available	Not Applicable	571	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	11	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	YES	IHC	YES	NO	NO	12	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6TV	Preoperative	TUMOR FREE	YES	NO	YES	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6TV-R54119	66ACC269-A510-46AC-807B-BFF67F5229B6	Not Available	17	68	26	Stable Disease	12	30	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2013	2010
TCGA-HW-7495	45	FEMALE	1078	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		45	Not Available	Not Available	Not Available	TCGA-HW-7495	49967a57-7c12-46bb-8d71-cebbb17c9935	6	-16460	Not Applicable	0	13	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HW-7495-F35030;TCGA-HW-7495-F66931	C77C5E98-BFD4-4143-80F2-88510E5479B1;D0AEF044-2D9B-4D18-9BAE-026917A7332C	13;28	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	131;1078	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Progressive Disease	Not Available;Not Available	NO;NO	9;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Progressive Disease;Progressive Disease	NO;NO	Alive;Alive	2012;2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7495	Not Available	WITH TUMOR	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			YES	Not Available	White Matter	Not Available	Not Available	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-HT-7481	39	MALE	2918	Oligodendroglioma	Central nervous system	Alive	G2	1	880.0			TUMOR FREE		39	NO	Not Available	NO	TCGA-HT-7481	bff37de3-dc68-4e69-bdfc-8b524dd7774f	7	-14306	Not Applicable	0	1800	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO;NO	YES;NO	YES;YES	Not Available;Not Available	TCGA-HT-7481-F29530;TCGA-HT-7481-F66422	520b18e5-4f56-49dc-8420-77fbba2ef28b;535405F9-77D7-4D4C-AD65-9EBCE1216130	16;14	880;3071	Not Available;Not Available	Not Applicable;Not Applicable	1800;2918	880;3071	1524;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Partial Remission/Response	80;Not Available	Not Available;NO	3;10	Not Available;Not Available	YES;YES	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Stable Disease;Partial Remission/Response	NO;YES	Alive;Alive	2012;2014	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7481	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7481-R29531	adbaf187-5d34-42f5-8efc-d03a9c7b82f2	1	16	1596	1552	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2012	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2006
TCGA-E1-A7YQ	58	FEMALE	1578	Oligodendroglioma	Central nervous system	Dead	G3	1	580.0			WITH TUMOR		58	NO	Not Available	NO	TCGA-E1-A7YQ	75DBC8FB-4DB8-4764-824C-ECCF3A223884	19	-21341	1578	0	Not Available	Not Available	346	TCGA-E1-A7YQ-D61539;TCGA-E1-A7YQ-D61540;TCGA-E1-A7YQ-D61541	90634921-7D21-4FA2-A5F5-727E4AACF439;52EA3236-D091-43D8-B6B4-E9F026FFD823;7A823A25-5BF8-44D6-95B4-4EE024A299B2	Not Available;Not Available;Not Available	15;15;15	396;512;559	346;429;532	Temodar;CCNU;Temodar	Stable Disease;Stable Disease;Clinical Progressive Disease	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	NO	NO	NO	NO	TCGA-E1-A7YQ-F61543	619FD566-C9F3-4B08-AE43-260B227F61B9	15	Not Available	Not Available	1578	Not Available	1149	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Dead	2014	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	60	Right	Not Available	Not Available	NO	NO	NO	6	NO	G3	NO	NO	580	NO	Not Available	NO	Not Available	YES	No	A7YQ	Post-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Stable Disease	BLACK OR AFRICAN AMERICAN	YES	Unknown	TCGA-E1-A7YQ-R61538	4719F477-586A-4B29-B269-81F7EFB15653	Not Available	15	184	92	Stable Disease	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	NO	NO	White Matter	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	YES	Dead	2014	2000
TCGA-DB-A64P	40	MALE	916	Oligodendroglioma	Central nervous system	Alive	G3	0	916			TUMOR FREE		40	Unknown	Not Available	NO	TCGA-DB-A64P	12F02422-585D-4068-BBDE-BC279C6A89AB	7	-14936	Not Applicable	0	511	Not Available	Not Available	TCGA-DB-A64P-D46428	E56A1559-9641-454E-9F14-ED00F645D89E	Not Available	7	430	36	Temodar	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64P-F62612	16F9C7BF-68E8-4833-9FCF-60B56D6CF169	22	Not Available	Not Available	Not Applicable	916	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2014	Unknown	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	YES	NO	Unknown	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64P	Not Available	TUMOR FREE	YES	YES	YES	Complete Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-HT-7684	58	MALE	184	Oligoastrocytoma	Central nervous system	Alive	G3	0	184			TUMOR FREE		58	NO	Not Available	NO	TCGA-HT-7684	b027ab77-70eb-4877-91a3-702064d9cc8b	15	-21352	Not Applicable	0	184	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7684-F29412	01dfde1e-7373-4623-8db9-1c166eee0241	16	Not Available	Not Available	Not Applicable	184	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2012	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7684	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	YES	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-TQ-A7RR	38	MALE	787	Oligoastrocytoma	Central nervous system	Alive	G2	0	787			TUMOR FREE		38	NO	Not Available	NO	TCGA-TQ-A7RR	607B1F22-B744-43C5-91F7-FC69142BA30E	30	-14022	Not Applicable	0	787	Not Available	31																								0	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RR-F65569	5F8388ED-1130-458F-AF45-67B79FD0B180	30	Not Available	Not Available	Not Applicable	787	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Partial Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RR	Pre-Adjuvant Therapy	TUMOR FREE	YES	NO	NO	Partial Remission/Response	WHITE	YES																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-HT-7691	31	FEMALE	3	Astrocytoma	Central nervous system	Alive	G2	0	3			TUMOR FREE		31	NO	Not Available	NO	TCGA-HT-7691	6a3e577a-4e07-4468-857a-79edbe6833cd	27	-11465	Not Applicable	0	3	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7691-F29641	8faf3fd5-8d8f-4c08-bbf6-ea39d6da13f9	27	Not Available	Not Available	Not Applicable	3	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Not Available	NO	Alive	2012	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	3	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7691	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Not Otherwise Specified	Central nervous system	YES	Alive	2012	2008
TCGA-HT-A5R7	33	FEMALE	615	Astrocytoma	Central nervous system	Alive	G3	0	615			TUMOR FREE		33	Unknown	Not Available	Unknown	TCGA-HT-A5R7	7E41BABA-7EF6-4030-B595-D95CD96336B5	18	-12092	Not Applicable	0	426	Not Available	Not Available	TCGA-HT-A5R7-D51388	7FAB670A-73A4-4F32-9271-75849742F9B3	Not Available	18	Not Available	10	Temodar	Not Applicable	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Unknown	Unknown	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A5R7-F61086	97459042-6A51-4558-A406-4929D88A3877	23	Not Available	Not Available	Not Applicable	615	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	YES	NO	Unknown	11	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5R7	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A5R7-R51387	3294C637-55F2-4773-AD1D-E6055C9CB3AB	Not Available	18	64	10	Complete Response	11	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-HT-8104	51	FEMALE	372	Astrocytoma	Central nervous system	Alive	G3	0	372			TUMOR FREE		51	NO	Not Available	NO	TCGA-HT-8104	5de6fd84-ed02-4c27-9947-db57f05faf6d	14	-18748	Not Applicable	0	372	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8104-F45987	ACB94785-7717-41C8-9914-F23EFFF407B3	26	Not Available	Not Available	Not Applicable	372	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	7	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Alive	2013	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	5	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8104	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-8104-R32652	e0d47e5a-3f60-46cf-893d-d4fb2b09b77a	Not Available	5	80	33	Complete Response	6	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-DB-A64O	59	MALE	775	Oligoastrocytoma	Central nervous system	Dead	G2	1	430.0			WITH TUMOR		59	Unknown	Not Available	NO	TCGA-DB-A64O	0536F465-1650-4411-823C-C660BC7F3ADC	7	-21811	Not Applicable	0	573	Not Available	Not Available	TCGA-DB-A64O-D46423	D1E2E600-66EC-46FA-8AFB-930AD71BBE58	Not Available	7	551	461	Temodar	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64O-F62610	33D8CBBF-5F7A-40AD-A399-4E8E0F33F07B	22	Not Available	Not Available	775	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	7	Not Available	Unknown	Not Available	Not Available	Unknown	NO	Stable Disease	YES	Dead	2014	Unknown	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	NO	IHC	YES	NO	Unknown	8	YES	G2	YES	NO	430	NO	Not Available	NO	Not Available	YES	No	A64O	Not Available	WITH TUMOR	NO	YES	YES	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DB-A64O-R46425	81260D92-F4A1-4448-A77D-36867F20239C	Not Available	7	264	222	Stable Disease	8	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-S9-A7IY	39	MALE	715	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		39	NO	Not Available	NO	TCGA-S9-A7IY	94B95C07-5F70-4A1B-B40F-DC13F6A160D5	12	-14422	Not Applicable	0	383	Not Available	-6	TCGA-S9-A7IY-D54303;TCGA-S9-A7IY-D55868;TCGA-S9-A7IY-D55869	AF8DF137-6656-4FF2-92A9-67F97531CC73;1C2108F9-CDE5-4A43-8E7B-0965A28A76C0;4A8E784C-9AEA-416A-8597-E7C7FE05DA0C	Not Available;Not Available;Not Available	18;17;17	383;383;383	160;162;162	Lomustine;Procarbazine;Vincristine	Unknown;Unknown;Unknown	12;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2014;2014	2	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	NO	NO	Not Available	Not Available	TCGA-S9-A7IY-F65751	8932CE6F-4465-4EAC-ACC1-149A3A2C72F5	30	Not Available	Not Available	Not Applicable	715	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	80	Right	YES	IHC	YES	YES	NO	12	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7IY	Preoperative	WITH TUMOR	YES	NO	YES	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A7IY-R54302	137D046D-6544-4F0B-BE88-0C1EEF9C133C	Not Available	18	118	78	Stable Disease	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	White Matter	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-HT-A615	38	FEMALE	515	Oligodendroglioma	Central nervous system	Alive	G2	0	515			WITH TUMOR		38	Unknown	Not Available	NO	TCGA-HT-A615	E89F7631-FDAC-4BE9-9997-70E400EFDC04	5	-13892	Not Applicable	0	396	Not Available	271																								Unknown	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HT-A615-F61268;TCGA-HT-A615-F66402	39689D3E-FECE-4F37-9C29-BA7F4A31A4E0;0BBC8CDA-183D-4CC2-9F38-CB22547CC40D	26;14	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	515;515	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	6;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Alive	2014;2014	Unknown	Not Available	FEMALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	Unknown	NO	Unknown	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A615	Post-Adjuvant Therapy	WITH TUMOR	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A615-R46301	8463B71E-893B-4540-9FA9-8E61374D5914	Not Available	5	271	227	Partial Response	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-TM-A7C4	39	FEMALE	1470	Astrocytoma	Central nervous system	Alive	G2	0	1470			TUMOR FREE		39	NO	Not Available	NO	TCGA-TM-A7C4	F5416DC4-D161-4776-9827-E4CEAF42D19F	9	-14603	Not Applicable	0	1093	Not Available	0																								0	YES	NOT HISPANIC OR LATINO	NO	NO	> 20 Years	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A7C4-F63553	968EF754-2879-4EEC-801E-671426D58A1C	12	Not Available	Not Available	Not Applicable	1470	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	8	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	NO	Unknown	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7C4	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-DU-A7TG	40	MALE	1351	Oligodendroglioma	Central nervous system	Dead	G2	0	1351			Unknown		40	Unknown	Not Available	Unknown	TCGA-DU-A7TG	62EC50E7-636E-46C6-AFED-66BF217B59C1	3	-14671	1351	0	Not Available	Not Available	59	TCGA-DU-A7TG-D56330	861B5CB7-3DED-4E28-AED7-0360F4F277F3	Not Available	3	128	26	Temozolomide	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days																														Unknown	Not Available	MALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	70	Right	Not Available	Not Available	NO	YES	Unknown	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A7TG	Post-Adjuvant Therapy	Unknown	YES	Unknown	Unknown	Unknown	WHITE	NO																			NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	2008
TCGA-E1-5307	62	FEMALE	1762	Astrocytoma	Central nervous system	Dead	G3	1	1452.0			WITH TUMOR		62	Not Available	Not Available	NO	TCGA-E1-5307	a6ee311c-0a7b-4f47-86f1-f2164b128f9c	12	-22837	1762	0	Not Available	Not Available	95	TCGA-E1-5307-D16200;TCGA-E1-5307-D16206;TCGA-E1-5307-D16204;TCGA-E1-5307-D16203;TCGA-E1-5307-D16199;TCGA-E1-5307-D16202;TCGA-E1-5307-D16201;TCGA-E1-5307-D16207;TCGA-E1-5307-D16205	44bf42b3-c194-4c93-9a88-42447409a82f;f9c645bb-d341-4d79-9d1a-b1bb3018a1d4;8ae3fefe-fa9b-4330-a82b-b331c3757014;a05e8ef2-3ab3-4592-9849-4c7a8d2225da;f796702a-6646-41d0-8bf5-02c53810a781;9a84e651-ef5f-4428-9a41-9abe3f200b09;c8dca0fe-e3b8-4666-9e57-0bf36edf5219;66c28e64-827c-4f8c-9f50-10830898b436;d7f710d5-d665-4d0c-9092-28c16ca3cd47	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12	260;1599;560;466;215;351;285;1720;1453	229;1462;466;382;126;313;260;1599;560	Temodar;Temodar;Temodar;CCNU;CCNu;CCNU;Temodar;Temodar;Celebrex	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8;8	1;4;3;1;2;1;1;4;41	150;150;150;82.5;110;110;200;175;400	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;8;6;5;1;4;3;9;7	PO;PO;PO;PO;PO;PO;PO;PO;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Antiongiogenic	1250;4800;3750;130;300;180;1675;6000;45920	mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	YES	YES	NO	NO	TCGA-E1-5307-F16198	c558db33-9c3f-4440-853e-a2bd6ea06a6b	12	Not Available	Not Available	1762	Not Available	1452	Discrepancy	Not Available	Not Available	Progressive Disease	80	Not Available	8	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	YES	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	80	Left	Not Available	Not Available	Not Available	YES	Not Available	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5307	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5307-R16208	bf92da20-f3a8-4d87-86b0-181369e7893d	1	12	91	43	Not Available	8	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	2000
TCGA-P5-A731	59	FEMALE	274	Oligoastrocytoma	Central nervous system	Alive	G2	0	274			TUMOR FREE		59	Not Available	Not Available	Not Available	TCGA-P5-A731	335BC811-8BDC-4F66-BDD0-703B7CC7464B	13	-21715	Not Applicable	0	6	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A731-F69010	43180EA8-2B76-4335-B421-AEA6A02D260E	24	Not Available	Not Available	Not Applicable	274	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Not Available	NO	Unknown	YES	Alive	2014	Not Available	Not Available	FEMALE	Not Available	YES	Oligoastrocytoma	Not Available	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	Not Available	YES	Not Available	11	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A731	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Unknown	WHITE	Unknown	Unknown	TCGA-P5-A731-R69011	C4F65DF3-758A-4F57-871A-6A2795C515FC	Not Available	24	Not Available	274	Not Available	12	2	60	YES	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-HT-7693	51	FEMALE	533	Oligodendroglioma	Central nervous system	Alive	G2	0	533			Not Available		51	NO	Not Available	YES	TCGA-HT-7693	491ea65b-86c8-4686-99cf-f09505e20183	1	-18956	Not Applicable	0	533	Not Available	200	TCGA-HT-7693-D29613;TCGA-HT-7693-D29612	a6443c66-e7a4-4edb-87ab-02d7667a8452;41536fee-095b-4da9-afaf-2643af23e7bc	Not Available;Not Available	16;16	440;63	102;22	Temodar;Temodar	Not Available;Not Available	3;3	02;1	370;140	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	20350;5880	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7693-F29610	ec5c9624-543a-4497-9f96-2ddd8e899a06	16	Not Available	Not Available	Not Applicable	533	Not Available	472	Not Available	Scheduled Follow-up Submission	Not Available	90	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Partial Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	Not Available	NO	NO	3	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7693	Post-Adjuvant Therapy	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7693-R29611	4558f4fa-776e-4522-b2a7-cbcb8ebb312a	1	16	60	17	Not Available	3	31	5580	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	Not Available	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-HW-7491	35	MALE	2078	Oligodendroglioma	Central nervous system	Alive	G2	1	2197.0			WITH TUMOR		35	Not Available	Not Available	Not Available	TCGA-HW-7491	a85fdb41-24c1-420d-8905-ec297f018bd9	6	-12874	Not Applicable	0	854	Not Available	Not Available	TCGA-HW-7491-D35015	99E72303-B1BF-46BF-8A48-3180B3E1CB46	Not Available	13	Not Available	1011	Temozolomide	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;NO	Not Available;NO	Not Available;Not Available	Not Available;Not Available	TCGA-HW-7491-F34886;TCGA-HW-7491-F71510	3D8DE6B6-8CA8-42B6-839E-872D70DE2BF0;90E70DEF-3F70-4CD0-A7E2-39D61B6E79D8	13;31	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1222;2078	Not Available;2197	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	NO;NO	9;3	Not Available;Not Available	NO;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	NO;NO	Alive;Alive	2012;2015	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7491	Not Available	WITH TUMOR	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			NO	Not Available	White Matter	Not Available	Not Available	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2009
TCGA-F6-A8O4	44	MALE	6	Astrocytoma	Central nervous system	Alive	G2	0	6			TUMOR FREE		44	NO	Not Available	NO	TCGA-F6-A8O4	735B1100-07F6-43D4-B29C-46D0F025573F	13	-16202	Not Applicable	0	6	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-F6-A8O4-F67156	1282C066-4D84-4ACB-A244-E2021A82547B	24	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.9	9400/3	C71.9	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8O4	Not Available	TUMOR FREE	Unknown	NO	NO	Complete Remission/Response	ASIAN	Unknown																			NO	NO	Not listed in Medical Record	YES	NO	F6	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-E1-A7Z2	58	FEMALE	398	Oligodendroglioma	Central nervous system	Dead	G2	1	213.0			WITH TUMOR		58	NO	Not Available	NO	TCGA-E1-A7Z2	97FFBE14-9070-4A5A-8760-225A88834B40	11	-21341	398	0	Not Available	Not Available	39	TCGA-E1-A7Z2-D61676;TCGA-E1-A7Z2-D61679;TCGA-E1-A7Z2-D61684;TCGA-E1-A7Z2-D61685;TCGA-E1-A7Z2-D61686;TCGA-E1-A7Z2-D61687	E49A4E1A-2003-4C46-9203-C77957172ECB;3BBF97E6-A99D-4729-9DC4-0D5682FAAD0E;D7ACEF48-175D-4009-89E8-CBB102479177;577CE699-A162-4B2B-A02B-2DCD62513704;5EF5B9BF-0974-44F1-BB04-29581A402B1A;93A4F821-08F8-4977-82FE-6034DCC8A9D2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15	213;270;328;334;383;369	102;230;286;293;356;356	Temodar;Temodar;Temodar;Avastin;Temodar;Avastin	Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease	8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	YES	YES	NO	NO	TCGA-E1-A7Z2-F61680	878CFBAC-CA8A-41F6-968C-B0236CF5143B	15	Not Available	Not Available	398	Not Available	269	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2014	YES	clams	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	80	Left	NO	IHC	YES	NO	NO	8	NO	G2	YES	NO	213	YES	215	NO	Not Available	YES	No	A7Z2	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Progressive Disease	WHITE	NO	Primary Tumor Field	TCGA-E1-A7Z2-R61681	FD6CC079-89C7-4D6C-81C2-77F264E1C97A	Not Available	15	328	286	Stable Disease	8	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Cerebral Cortex	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	2012
TCGA-DB-A64R	24	FEMALE	955	Oligodendroglioma	Central nervous system	Alive	G2	0	955			TUMOR FREE		24	YES	Unknown	NO	TCGA-DB-A64R	67E9B426-72EB-4475-9689-EB75B22C4FD5	7	-8947	Not Applicable	0	489	Not Available	-6																								Not Evaluated	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64R-F62622	3BEDC66F-7D68-418F-A99D-BFC341FAA55C	4	Not Available	Not Available	Not Applicable	955	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	YES	lactose	FEMALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	Unknown	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64R	Preoperative	TUMOR FREE	NO	YES	NO	Complete Remission/Response	Not Evaluated	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-S9-A6U2	48	FEMALE	908	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		48	NO	Not Available	NO	TCGA-S9-A6U2	41FBB9F1-4A13-48AB-8649-0608C89CDD9F	31	-17800	Not Applicable	0	475	Not Available	-6																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6U2-F62930;TCGA-S9-A6U2-F69983	D7605DAC-EA70-4CDE-A78C-93C34384D691;5C5198F1-AE6F-4D1D-81A5-FF00BD8C15A2	29;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	719;908	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Partial Remission/Response;Partial Remission/Response	YES;YES	Alive;Alive	2014;2015	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	100	Right	YES	IHC	YES	NO	NO	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6U2	Preoperative	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6U2-R54138	8CA00905-E837-4875-B334-F75087B929AE	Not Available	17	66	6	Stable Disease	12	30	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-A4MY	44	FEMALE	721	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		44	NO	Not Available	NO	TCGA-FG-A4MY	FEBE2CE5-737B-43B8-BC70-4194FE3ED5FB	5	-16310	Not Applicable	0	294	Not Available	Not Available																								Not Evaluated	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A4MY-F58505	4B881BCA-EEBE-46A9-875B-AD192D8C630A	11	Not Available	Not Available	Not Applicable	721	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	4	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	YES	Alive	2014	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.3	9382/3	C71.3	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	YES	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4MY	Not Evaluated	WITH TUMOR	NO	Unknown	Unknown	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-FG-A4MY-R39891	D8BA1822-6561-40F1-AD8A-927D658F2876	Not Available	5	77	36	Stable Disease	2	30	5700	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DB-A64Q	31	FEMALE	182	Oligoastrocytoma	Central nervous system	Alive	G2	0	182			WITH TUMOR		31	Unknown	Not Available	NO	TCGA-DB-A64Q	887DEF39-E212-490D-8849-2BC932FCEFF0	7	-11637	Not Applicable	0	182	Not Available	-3	TCGA-DB-A64Q-D46483	016B428B-6EFC-4316-AE5C-9575AB2885A2	Not Available	7	Not Available	57	Temodar	Not Applicable	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	Unknown	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64Q-F62614	3C186FED-FD9C-48FA-8771-BADADB363934	22	Not Available	Not Available	Not Applicable	182	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2014	Unknown	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	NO	Unknown	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64Q	Preoperative	WITH TUMOR	YES	YES	NO	Stable Disease	Unknown	NO																			YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-HW-A5KJ	68	MALE	962	Oligodendroglioma	Central nervous system	Dead	G3	1	615.0			WITH TUMOR		68	Not Available	Not Available	Not Available	TCGA-HW-A5KJ	8996DC64-8C5E-4E07-8ED8-2EB11C03626B	12	-24966	Not Applicable	0	321	Not Available	Not Available	TCGA-HW-A5KJ-D48693;TCGA-HW-A5KJ-D65472	68E1D203-9CE5-4C38-BCF7-C5CC0965C5E2;22481586-D92B-4036-99B4-F82F5A132DDF	Not Available;Not Available	19;23	16;899	16;656	Temozolomide;Temozolomide	Clinical Progressive Disease;Stable Disease	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2014	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO;Not Available;Not Available	NO;Not Available;Not Available	YES;Not Available;Not Available	NO;Not Available;Not Available	TCGA-HW-A5KJ-F59868;TCGA-HW-A5KJ-F65243;TCGA-HW-A5KJ-F71524	6B320E5B-9823-4C50-BBA8-9940D4E0B27C;21BEB795-FDE8-4B00-A7D8-6D7B87A2C0E5;B107795E-86A5-4E8D-AECC-BFA0F2E5F8C3	22;23;31	615;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;962	619;860;Not Available	615;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease;Stable Disease	Not Available;Not Available;Not Available	NO;NO;NO	5;9;3	Not Available;Not Available;Not Available	YES;NO;NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES	Alive;Alive;Dead	2014;2014;2015	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5KJ	Not Available	WITH TUMOR	YES	Not Available	NO	Progressive Disease	WHITE	YES	Regional site	TCGA-HW-A5KJ-R48692	E7085728-DBDC-43BB-AD40-6325207A4A5F	Not Available	19	169	107	Stable Disease	9	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	Not Available	White Matter	YES	NO	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2013	2012
TCGA-S9-A89Z	40	MALE	623	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		40	NO	Not Available	NO	TCGA-S9-A89Z	CC8614C4-D535-4AD9-82F0-F4DC7AD11D0F	23	-14858	Not Applicable	0	152	Not Available	-10	TCGA-S9-A89Z-D55988	B5AC47E4-BDB2-40EC-8E75-8E0B6BBAF37A	Not Available	23	308	29	Temozolomide	Stable Disease	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	YES;NO;Not Available;Not Available	NO;NO;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-S9-A89Z-F67318;TCGA-S9-A89Z-F70013;TCGA-S9-A89Z-F71267;TCGA-S9-A89Z-F72341	BB11C41A-2B33-430E-AAF2-834C23ACFB30;374911A8-1351-47A0-A8D2-E7FB54E1FD39;CDDFE9F2-2196-451D-8644-B742B29B53D8;2B6B53EF-7DDF-41DF-A8F0-5793D00B5CD9	4;26;24;27	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	364;448;448;623	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Partial Remission/Response;Partial Remission/Response;Partial Remission/Response;Stable Disease	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	11;1;3;5	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES	Partial Remission/Response;Partial Remission/Response;Partial Remission/Response;Partial Remission/Response	YES;YES;YES;YES	Alive;Alive;Alive;Alive	2014;2015;2015;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	70	Right	YES	IHC	YES	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A89Z	Preoperative	WITH TUMOR	YES	YES	YES	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A89Z-R55987	27306A63-07D2-4906-83F6-4D74C4582C50	Not Available	23	77	29	Stable Disease	1	33	59.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	White Matter	YES	NO	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-A5TR	51	MALE	908	Oligoastrocytoma	Central nervous system	Alive	G2	1	848.0			WITH TUMOR		51	NO	Not Available	NO	TCGA-DU-A5TR	4BD8EBC1-6F6E-44A2-8544-106901A7BAE5	18	-18791	Not Applicable	0	383	Not Available	11	TCGA-DU-A5TR-D44292	62A543A1-22E3-4C0B-817B-2DF6FADDE48B	Not Available	18	Not Available	25	Temozolomide	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	YES	Not Available	TCGA-DU-A5TR-F71611	0D9DFD57-519F-4FE2-AC62-C27732C93B72	27	848	Not Available	Not Applicable	908	848	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	TUMOR FREE	YES	Discrepancy	NO	Alive	2015	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	YES	NO	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5TR	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Discrepancy	WHITE	YES	Primary Tumor Field	TCGA-DU-A5TR-R44293	EB5F5C6D-E53B-43E7-9B8C-27E70CD579F7	Not Available	18	63	25	Stable Disease	6	30	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-7298	38	FEMALE	576	Astrocytoma	Central nervous system	Dead	G3	1	200.0			WITH TUMOR		38	Not Available	Not Available	Not Available	TCGA-DU-7298	292cf158-dd47-44a1-912b-73626095a0f7	12	-14205	576	0	Not Available	Not Available	-2	TCGA-DU-7298-D17500;TCGA-DU-7298-D17499	0ce65b73-52ed-4e3c-8c63-059390085216;cd4abb43-8f0d-4aae-ab32-ff00a06e3023	Not Available;Not Available	11;12	207;101	207;41	Temozolomide;Temozolomide	Not Available;Not Available	10;10	1;1	200;75	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	350;140	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	NO	NO	YES	NO	TCGA-DU-7298-F17497	85485a0d-903c-4718-94f5-7748a959ce70	12	546	Not Available	576	Not Available	200	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	80	Left	Not Available	Not Available	NO	NO	Not Available	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7298	Preoperative	WITH TUMOR	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-DU-7298-R17498	b1b06e61-9965-4b82-bfc8-fcd35fdef5a2	1	12	101	41	Not Available	10	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Cerebral Cortex	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	YES	Dead	2011	2006
TCGA-HT-8018	40	FEMALE	1152	Oligoastrocytoma	Central nervous system	Dead	G2	0	1152			TUMOR FREE		40	NO	Not Available	NO	TCGA-HT-8018	80db28ec-ab3d-42a7-af88-b60fe8acb5b5	15	-14910	Not Applicable	0	654	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8018-F45912	7C3529CD-D5D9-4A10-9EEB-C73F233DA2A1	25	Not Available	Not Available	1152	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	7	Not Available	NO	Not Available	Not Available	Unknown	YES	Partial Remission/Response	YES	Dead	2013	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	5	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8018	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-S9-A6WD	58	MALE	2289	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		58	NO	Not Available	NO	TCGA-S9-A6WD	3E4851CA-4D69-4035-A2DD-8ED6E70F1FFB	4	-21231	Not Applicable	0	1897	Not Available	-2	TCGA-S9-A6WD-D54273	ABFA8D57-5DAF-4AB3-A26C-A1C0BD804AF3	Not Available	18	322	62	Temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO;Not Available	NO;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6WD-F62935;TCGA-S9-A6WD-F69986	CD513468-EFB5-4482-8D2F-882FF11F5B6D;2F07981F-D7E3-463A-A87F-A1C565D4CD91	29;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	2114;2289	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Partial Remission/Response;Partial Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WD	Preoperative	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2008
TCGA-HW-7490	41	MALE	1387	Astrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		41	Not Available	Not Available	Not Available	TCGA-HW-7490	c3c41fd2-f0d7-4f46-9e18-cce4626538c2	6	-15092	Not Applicable	0	165	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HW-7490-F35029;TCGA-HW-7490-F71515	367CE251-0386-40B4-814D-F8841ED31E36;33DD8C64-D014-4180-A302-7B74A4ACC84E	13;31	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	585;1387	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Progressive Disease	Not Available;Not Available	NO;NO	9;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Progressive Disease;Progressive Disease	NO;NO	Alive;Alive	2012;2015	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Left	YES	Not Available	YES	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	7490	Not Available	WITH TUMOR	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			NO	Not Available	White Matter	Not Available	Not Available	HW	Supratentorial, Occipital Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-TM-A84R	46	MALE	566	Oligodendroglioma	Central nervous system	Alive	G2	0	566			TUMOR FREE		46	NO	Not Available	NO	TCGA-TM-A84R	21BBE030-8DBB-47EB-A670-13EB57C12159	17	-16843	Not Applicable	0	287	Not Available	0																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84R-F65388	4B7BD017-308D-4AFA-A914-C7F9498DF88F	22	Not Available	Not Available	Not Applicable	566	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	80	Left	NO	Sequence Analysis	YES	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84R	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-HT-7694	60	MALE	210	Oligodendroglioma	Central nervous system	Alive	G3	0	210			Not Available		60	NO	Not Available	NO	TCGA-HT-7694	49a87025-d0a4-44b3-b6ad-563bf9651093	1	-21930	Not Applicable	0	210	Not Available	182																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7694-F29607	5863990b-5374-4937-9010-a68122866939	9	Not Available	Not Available	Not Applicable	210	Not Available	210	Not Available	Scheduled Follow-up Submission	Not Available	90	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	YES	NO	3	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7694	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7694-R29608	0032f995-f852-4ecc-bd33-e0fc70e6a4f0	1	8	66	20	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-HT-7856	35	MALE	1189	Oligodendroglioma	Central nervous system	Alive	G3	0	1189			TUMOR FREE		35	NO	Not Available	NO	TCGA-HT-7856	c2c16878-b615-496c-8fcb-d49c97e15551	15	-13145	Not Applicable	0	1189	Not Available	Not Available	TCGA-HT-7856-D29425	3d00d873-e11b-4a5a-bd53-06a8739ef4f0	Not Available	16	71	32	Temodar	Not Available	3	1	160	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	6240	mg	Not Available	2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7856-F29423	5d02bdc1-f460-4039-a270-6a7101a977b9	16	Not Available	Not Available	Not Applicable	1189	Not Available	383	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	80	Not Available	3	Not Available	NO	Not Available	Adjuvant therapy	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7856	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7856-R29424	b14ca12a-47ed-4e32-b5bc-ffc997634447	1	16	71	32	Not Available	3	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-HT-A74H	62	MALE	74	Astrocytoma	Central nervous system	Alive	G3	0	74			Unknown		62	NO	Not Available	NO	TCGA-HT-A74H	FDFF46A7-F92A-45CF-8756-6C73A406C923	18	-22850	Not Applicable	0	74	Not Available	Not Available	TCGA-HT-A74H-D51383	FC0A8270-87F3-4552-B3F8-8F8583FB636D	Not Available	18	Not Available	28	Temodar	Unknown	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Unknown	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A74H-F65103	C589DB9D-7A32-4BAC-B664-393197975B6A	18	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	YES	9	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Unknown	Left	Not Available	Not Available	NO	YES	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A74H	Not Available	Unknown	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-HT-A74H-R51382	F06C3A7D-5B98-4F3B-B2BD-32D10EBAE43F	Not Available	18	73	28	Partial Response	11	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-S9-A7R7	27	MALE	3000	Astrocytoma	Central nervous system	Alive	G2	1	144.0			WITH TUMOR		27	NO	Not Available	NO	TCGA-S9-A7R7	A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F	18	-10108	Not Applicable	0	2549	Not Available	-8	TCGA-S9-A7R7-D54335;TCGA-S9-A7R7-D54336;TCGA-S9-A7R7-D66256	C0C32C24-B274-471E-80F8-E7962685C779;86FE680F-EC70-47BB-A988-C5653F3519F8;C5D00225-BD0E-449C-B3C8-EFB43706B949	Not Available;Not Available;Not Available	18;18;7	526;1095;2847	144;716;2720	Temozolomide;Temozolamide;Carmustine	Stable Disease;Stable Disease;Clinical Progressive Disease	12;12;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2014	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	YES	Not Available	TCGA-S9-A7R7-F66258	6DEC1C68-865E-4A6A-876B-7CB0FA0244D6	7	2976	Not Available	Not Applicable	3000	2894	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	10	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	80	Left	YES	IHC	YES	NO	NO	12	NO	G2	YES	NO	144	NO	Not Available	NO	Not Available	YES	No	A7R7	Preoperative	WITH TUMOR	NO	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field;Unknown	TCGA-S9-A7R7-R54334;TCGA-S9-A7R7-R66257	90839AB5-975E-4490-B0CE-E1391D227897;5AF95883-D0F1-463A-8690-3AA1555B3BB2	Not Available;Not Available	18;7	92;2929	50;2913	Radiographic Progressive Disease;Radiographic Progressive Disease	12;10	30;Not Available	54;42	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2014	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2006
TCGA-DU-7302	48	FEMALE	1834	Oligodendroglioma	Central nervous system	Alive	G3	1	1374.0			WITH TUMOR		48	Not Available	Not Available	Not Available	TCGA-DU-7302	5a769292-c3ce-4e18-b821-2bfe0e24978c	11	-17656	Not Applicable	0	1834	Not Available	-4	TCGA-DU-7302-D17546;TCGA-DU-7302-D17545;TCGA-DU-7302-D17544	0cb7bafc-7b49-415e-9c8d-cd09c26933bc;a3fdb0ab-0826-4b2e-bc73-953b1b75392d;086ba121-af92-44a0-b136-f364d2d61ae8	Not Available;Not Available;Not Available	11;11;11	Not Available;1686;530	1691;1382;14	Bevacizumab;Temozolomide;Temozolomide	Not Available;Not Available;Not Available	10;10;10	7;10;12	10;75;200	mg/kg;mg/m2;mg/m2	PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	IV;PO;PO	YES;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1020;155;390	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	NO	NO	TCGA-DU-7302-F17543	a62c9d32-d2f7-462c-9f09-c0f130a1af3f	11	Not Available	Not Available	Not Applicable	1834	1374	1404	Not Available	Not Available	Progressive Disease	70	Not Available	10	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Alive	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	Not Available	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7302	Preoperative	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2006
TCGA-HT-8013	37	FEMALE	1933	Oligoastrocytoma	Central nervous system	Dead	G2	1	1306.0			WITH TUMOR		37	NO	Not Available	NO	TCGA-HT-8013	e669a4b7-a494-490a-b78c-e664c59d0697	3	-13753	1933	0	Not Available	Not Available	Not Available	TCGA-HT-8013-D32630;TCGA-HT-8013-D32631	b4d2d8dd-f207-479c-b56d-c7881078d4e5;4645a0aa-b790-479c-8477-eee9994bbcd1	Not Available;Not Available	4;4	1742;1693	1334;1610	Temodar;Avastin	Clinical Progressive Disease;Clinical Progressive Disease	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Targeted Molecular therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	YES	NO	TCGA-HT-8013-F32627	6ead80d0-4cf8-4010-ba95-6213237a3bc3	4	1306	Not Available	1933	Not Available	1306	1587	Not Available	Scheduled Follow-up Submission	Not Available	70	Not Available	6	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	YES	Dead	2012	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8013	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-HT-8013-R32628;TCGA-HT-8013-R32629	211a631b-c473-423b-8b72-649303a3fe21;f6a91e32-77c9-4af8-917f-3490225a1c60	Not Available;Not Available	4;4	146;1743	103;1726	Stable Disease;Stable Disease	6;6	30;13	5400;3900	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2012;2012	YES	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2012	2005
TCGA-E1-A7YD	57	MALE	435	Astrocytoma	Central nervous system	Dead	G3	1	284.0			WITH TUMOR		57	Unknown	Not Available	NO	TCGA-E1-A7YD	457EC7F6-8612-4641-AAEF-8A7F2C44C30C	12	-21020	435	0	Not Available	Not Available	Not Available	TCGA-E1-A7YD-D61159;TCGA-E1-A7YD-D61160	3901572E-7813-4FBB-8E34-1C99B7646119;DDC53550-72CF-4515-9AAB-013E69C0E58E	Not Available;Not Available	14;14	285;Not Available	111;314	CCNU;Temodar	Clinical Progressive Disease;Unknown	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days																														Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	5	NO	G3	YES	NO	284	NO	Not Available	Not Available	Not Available	YES	No	A7YD	Not Evaluated	WITH TUMOR	YES	YES	Unknown	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-E1-A7YD-R61158	90AF3A20-81FB-4C54-A239-A15C62CA4EAB	Not Available	14	81	34	Stable Disease	8	30	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	1998
TCGA-TM-A7CF	41	FEMALE	1989	Astrocytoma	Central nervous system	Alive	G2	1	924.0			WITH TUMOR		41	NO	Not Available	YES	TCGA-TM-A7CF	033C1F48-9225-4159-B23B-7042272877DA	9	-15178	Not Applicable	0	1472	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	NO	NO	< 12 Years	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-TM-A7CF-F63556;TCGA-TM-A7CF-F70345	7A5C176B-2617-483A-95F3-CEF1784F1077;1599E163-8C0F-47C1-952B-D139A24BBE04	12;5	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1688;1989	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Stable Disease	Not Available;Not Available	NO;NO	8;2	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;YES	Complete Remission/Response;Complete Remission/Response	NO;YES	Alive;Alive	2014;2015	NO	Not Available	FEMALE	YES	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	12	NO	G2	Unknown	Unknown	924	YES	924	Not Available	Not Available	YES	No	A7CF	Preoperative	WITH TUMOR	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2009
TCGA-TM-A7CA	44	MALE	1058	Astrocytoma	Central nervous system	Alive	G2	0	1058			TUMOR FREE		44	NO	Not Available	YES	TCGA-TM-A7CA	288F6C7E-D96F-4BE1-8312-77C67F75C467	9	-16415	Not Applicable	0	687	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A7CA-F63555	89B2D176-FE10-4DD6-941E-0CA6F7F09778	12	Not Available	Not Available	Not Applicable	1058	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	8	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7CA	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-DU-7301	53	MALE	788	Oligodendroglioma	Central nervous system	Dead	G2	1	366.0			WITH TUMOR		53	Not Available	Not Available	Not Available	TCGA-DU-7301	84ae73e4-3b39-4444-9bfb-3fc6057eab32	12	-19644	788	0	Not Available	Not Available	14	TCGA-DU-7301-D17535;TCGA-DU-7301-D17536;TCGA-DU-7301-D17537;TCGA-DU-7301-D17539;TCGA-DU-7301-D17538	da481593-0d3e-4440-bd59-c93ce95df640;0339bf1b-2b0f-4bff-9616-99a7c337c6d4;416f8414-2219-49f9-90fb-13a43fb6b5a2;ba652ae9-a162-43de-88df-d4fa7bade195;42dc258d-7ebc-4fb1-8523-b39d28369a1f	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	66;369;534;643;629	28;65;379;626;379	Temozolomide;Temozlomide;Irinotecan;Temozolomide;Bevacizumab	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	1;9;4;1;7	75;200;125;75;10	mg/m2;mg/m2;mg/m2;mg/m2;mg/kg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;3;2	PO;PO;IV;PO;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available	160;450;280;160;1058	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	YES	NO	NO	NO	TCGA-DU-7301-F17533	ea8ab6bb-4477-43b8-8e23-ada7f7feed8f	12	Not Available	Not Available	788	Not Available	366	366	Not Available	Not Available	Progressive Disease	60	Not Available	10	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	100	Left	Not Available	Not Available	NO	NO	Not Available	10	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7301	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7301-R17534	f88cf697-3ab8-4d57-855a-dc94237b6d7b	1	12	66	28	Not Available	10	27	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	YES	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	2006
TCGA-RY-A845	40	FEMALE	596	Oligoastrocytoma	Central nervous system	Alive	G2	0	596			TUMOR FREE		40	Not Available	Not Available	NO	TCGA-RY-A845	36615695-921C-4C8A-93D6-6C788079BEAE	16	-14617	Not Applicable	0	596	Not Available	1																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	< 12 Years	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-RY-A845-F69753	841FBC5A-C059-46D9-9B81-FECE85329AD8	16	Not Available	Not Available	Not Applicable	596	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	1	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Not Applicable	NO	Alive	2015	NO	Not Available	FEMALE	YES	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	80	Left	NO	IHC	YES	YES	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A845	Not Evaluated	TUMOR FREE	NO	Not Available	Not Available	Not Applicable	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	RY	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2015	2013
TCGA-DB-A75L	36	FEMALE	342	Astrocytoma	Central nervous system	Alive	G3	0	342			TUMOR FREE		36	NO	Not Available	NO	TCGA-DB-A75L	BA62B5EB-E169-4B41-B949-E004D66E98A1	30	-13338	Not Applicable	0	196	Not Available	Not Available	TCGA-DB-A75L-D56226	4A9963F5-D17C-456A-8750-B7246AC188A0	Not Available	30	Not Available	25	Temozolomide	Not Applicable	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A75L-F67636	46EE5FFB-0D1C-4A81-BADF-87DC0A292907	7	Not Available	Not Available	Not Applicable	342	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	YES	lactose intolerance	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A75L	Preoperative	TUMOR FREE	YES	YES	NO	Not Applicable	WHITE	YES	Primary Tumor Field	TCGA-DB-A75L-R56228	02F5FB97-3AE8-4649-B521-E3C8E3E0FB12	Not Available	30	70	25	Complete Response	1	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-A5TP	33	MALE	1012	Astrocytoma	Central nervous system	Alive	G3	1	203.0			WITH TUMOR		33	NO	Not Available	NO	TCGA-DU-A5TP	669605F6-39A1-4F8C-81DC-39430FF5F892	19	-12111	Not Applicable	0	433	Not Available	6	TCGA-DU-A5TP-D44352;TCGA-DU-A5TP-D71613	8F23D860-77E3-48FD-B210-A6DD1AF2C924;812D527E-CB77-43FC-A1BB-DD6C70B06C24	Not Available;Not Available	19;27	Not Available;493	32;123	Temozolomide;Temozolomide	Not Applicable;Stable Disease	6;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2015	Not Evaluated	YES	NOT HISPANIC OR LATINO	YES	YES	> 20 Years	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	Not Available	Not Available	TCGA-DU-A5TP-F71612	A5AED1D9-C6DB-41DD-81E4-669F4CAE66A2	27	Not Available	Not Available	Not Applicable	1012	203	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	TUMOR FREE	YES	Discrepancy	YES	Alive	2015	NO	Not Available	MALE	YES	NO	Astrocytoma	YES	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	70	Right	Not Available	Not Available	NO	NO	NO	6	NO	G3	NO	NO	203	YES	203	Not Available	Not Available	YES	No	A5TP	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Discrepancy	WHITE	YES	Primary Tumor Field	TCGA-DU-A5TP-R44351	7779016B-F5BB-4F5A-B31B-14BD268FBF9E	Not Available	19	76	32	Stable Disease	6	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-TM-A84L	31	MALE	1242	Oligoastrocytoma	Central nervous system	Dead	G2	1	987.0			WITH TUMOR		31	NO	Not Available	NO	TCGA-TM-A84L	9B161C41-4F76-4ED1-B60F-2B093BC70EDB	17	-11498	1242	0	Not Available	Not Available	0	TCGA-TM-A84L-D56507	E0E255CD-36AF-4A3B-8243-7A9B7A8F9521	Not Available	17	1185	1066	Temozolomide	Clinical Progressive Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	YES	YES	YES	Not Available	TCGA-TM-A84L-F56505	AF440F5F-AEF8-4546-9799-12C20775FF78	17	1045	Not Available	1242	Not Available	1045	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	2	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response	NO	Dead	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	NO	NO	987	YES	987	Not Available	Not Available	YES	No	A84L	Preoperative	WITH TUMOR	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO	Local Recurrence	TCGA-TM-A84L-R56506	7AD5359E-11C4-4E2D-871A-F15D9C8C5086	Not Available	17	1109	1065	Radiographic Progressive Disease	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2010
TCGA-DH-5143	30	MALE	1401	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		30	Not Available	Not Available	Not Available	TCGA-DH-5143	dcd0856d-423a-40d7-8070-4c0988d61416	8	-11291	Not Applicable	0	438	Not Available	13	TCGA-DH-5143-D6557;TCGA-DH-5143-D6555;TCGA-DH-5143-D6554	61b753cb-378d-471f-a6fa-1d534eeaa3d3;aea492a1-1963-4067-9bee-cd18fbd03c79;e0609dd7-caf7-4d71-8d16-a6c8fc349c69	Not Available;Not Available;Not Available	17;17;17	Not Available;99;64	123;95;25	Temozolomide;Temozolomide;Temozolomide	Not Available;Not Available;Not Available	12;12;12	12;1;1	200;300;75	mg/m2/day;mg/day;mg/m2/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	PO;PO;PO	YES;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;1500;3000	mg/m2;mg;mg/m2	Not Available;Not Available;Not Available	2010;2010;2010	1	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DH-5143-F6548;TCGA-DH-5143-F66710	2cee9365-d26b-4421-8107-f30b2fa880fa;E6754A9A-5C43-4B45-9D09-19EB5C1FA255	8;22	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	438;1401	Not Available;Not Available	13;Not Available	1;Not Available	Not Available;Scheduled Follow-up Submission	Stable Disease;Stable Disease	80;Not Available	Not Available;YES	12;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;Unknown	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2010;2014	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	80	Left	Not Available	Not Available	NO	YES	Not Available	12	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5143	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DH-5143-R6550	34ac3460-ba6b-4883-a5eb-cfe619431f5e	1	17	64	25	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	YES	Not Available	Cerebral Cortex	NO	YES	DH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2010	2009
TCGA-DU-7006	60	FEMALE	349	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		60	Not Available	Not Available	Not Available	TCGA-DU-7006	215e117c-4d76-463c-8f8a-fd6a28d23929	25	-21990	349	0	Not Available	Not Available	Not Available	TCGA-DU-7006-D17929;TCGA-DU-7006-D17931;TCGA-DU-7006-D17930	723ff33b-8869-4952-80a3-3713520d5eae;316e5e4e-c0f9-4edb-bee5-f09f9f0d5766;5f4d4b63-37b9-491c-ad99-60cdde292713	Not Available;Not Available;Not Available	25;25;25	Not Available;Not Available;Not Available	90;90;90	Lomustine;Vincristine;Procarbazine	Not Available;Not Available;Not Available	10;10;10	1;1;1	200;2.0;100	mg/day;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;IV;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	200;2.0;100	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-DU-7006-F17927	cc30f65b-7abb-4d47-b0f3-c4c7757417b5	25	Not Available	Not Available	349	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7006	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7006-R17928	00c23b4f-8ba7-4dde-af30-c1022285b81d	1	25	Not Available	Not Available	Not Available	10	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	YES	NO	Cerebral Cortex	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	1995
TCGA-DU-A5TT	70	MALE	743	Oligodendroglioma	Central nervous system	Alive	G3	1	584.0			WITH TUMOR		70	YES	cat	NO	TCGA-DU-A5TT	699D3BA1-94C8-409F-90C3-E7FE2F1CF825	18	-25726	Not Applicable	0	151	Not Available	Not Available	TCGA-DU-A5TT-D44301	5D04902F-3DD4-47DB-9597-CCDBA403750E	Not Available	18	Not Available	16	Temozolomide	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	> 20 Years	Not Available	Seizures	91 - 180 Days	NO	YES	NO	NO	TCGA-DU-A5TT-F71494	D1DDE5CC-8BF5-46D5-A9F1-51F4FABA08FB	26	Not Available	Not Available	Not Applicable	743	584	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Discrepancy	YES	Alive	2015	NO	Not Available	MALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	Not Evaluated	Left	NO	IHC	YES	NO	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5TT	Not Evaluated	WITH TUMOR	YES	YES	NO	Discrepancy	WHITE	YES	Primary Tumor Field;Local Recurrence	TCGA-DU-A5TT-R44299;TCGA-DU-A5TT-R71495	D0EB0C45-2D1C-4ED7-BEE0-20B1AEA2808D;DD622600-13CB-420D-B4FB-B065817B0AA8	Not Available;Not Available	18;26	57;617	16;613	Stable Disease;Radiographic Progressive Disease	6;3	30;4	60;24	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2015	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-TQ-A7RV	27	MALE	1868	Astrocytoma	Central nervous system	Alive	G2	1	530.0			WITH TUMOR		27	NO	Not Available	NO	TCGA-TQ-A7RV	5A3EDEB6-133E-4116-9F80-2485BD70754D	7	-10167	Not Applicable	0	1868	Not Available	-42																								1	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	> 181 Days	YES	YES	Not Available	Not Available	TCGA-TQ-A7RV-F61501	272B03C4-304B-4E33-8FB8-12263770C603	7	Not Available	1141	Not Applicable	1868	530	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	80	Left	Unknown	Not Available	NO	YES	NO	10	YES	G2	NO	YES	530	NO	Not Available	NO	Not Available	YES	No	A7RV	Preoperative	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	NO																			YES	YES	White Matter	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2009
TCGA-HT-7855	39	MALE	585	Astrocytoma	Central nervous system	Alive	G3	0	585			TUMOR FREE		39	NO	Not Available	NO	TCGA-HT-7855	40343ebd-0d62-401e-83a4-6cdb57662ec0	15	-14496	Not Applicable	0	118	Not Available	Not Available	TCGA-HT-7855-D29494;TCGA-HT-7855-D29493	5c82c2f1-819d-4077-ba03-c4f7981fbb6c;b4b955cc-a927-42b7-8a44-67a49a078456	Not Available;Not Available	20;20	157;67	131;25	Temodar;Temodar	Not Available;Not Available	3;3	2;1	400;160	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4000;6880	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7855-F29420	15b69158-73b3-46d0-b878-05fde8a7f1c4	16	Not Available	Not Available	Not Applicable	585	Not Available	151	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	80	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7855	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7855-R29421	bbb66954-97a9-4d56-abd1-3d54d7997672	1	16	73	20	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-HW-7489	38	MALE	1262	Oligoastrocytoma	Central nervous system	Dead	G2	1				WITH TUMOR		38	Not Available	Not Available	Not Available	TCGA-HW-7489	6957d45e-7ccb-457d-800d-c2a2037f4f01	6	-14201	Not Applicable	0	142	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HW-7489-F35026;TCGA-HW-7489-F65183	1835F398-B5D0-411D-9C1E-EBB92CE834F2;216272E2-7AFF-4905-8D53-6ECF53800403	13;19	Not Available;Not Available	Not Available;Not Available	Not Applicable;1262	253;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Not Applicable	Not Available;Not Available	NO;NO	9;9	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Progressive Disease;Progressive Disease	NO;NO	Alive;Dead	2012;2014	Not Available	Not Available	MALE	Not Available	Not Available	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	YES	Sequence Analysis	YES	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7489	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			YES	Not Available	White Matter	Not Available	Not Available	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-HT-7860	60	FEMALE	15	Astrocytoma	Central nervous system	Alive	G3	0	15			TUMOR FREE		60	NO	Not Available	NO	TCGA-HT-7860	fea46eef-6b7f-44c3-93bf-2dec16bdeb79	15	-22034	Not Applicable	0	15	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7860-F28643	1e6c9731-d20b-4753-b7d3-01ddfacc210b	27	Not Available	Not Available	Not Applicable	15	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Alive	2012	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7860	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-P5-A780	44	FEMALE	72	Astrocytoma	Central nervous system	Alive	G3	0	72			TUMOR FREE		44	Not Available	Not Available	Not Available	TCGA-P5-A780	E661E157-C6BC-4024-9905-97954759AAD6	13	-16161	Not Applicable	0	6	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A780-F69031	A132E193-F5BB-45F6-905F-8909A039B244	24	Not Available	Not Available	Not Applicable	72	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	Unknown	Complete Remission/Response	YES	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	Not Available	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A780	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A780-R69032	6A459E17-5C29-4866-AC5F-754D78309250	Not Available	24	Not Available	Not Available	Unknown	12	Unknown	40	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-FG-5964	62	MALE	1588	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		62	NO	Not Available	NO	TCGA-FG-5964	648252da-dd86-48d1-ae75-4257e3142b0b	13	-22735	Not Applicable	0	378	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	Not Available	> 20 Years	Seizures	0 - 30 Days	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-FG-5964-F10287;TCGA-FG-5964-F41576;TCGA-FG-5964-F63736	187830c2-5141-4767-8b5e-345de67ed2fa;03FDBD86-641E-4DBE-8250-E16CFD2B3654;93D99133-DD56-4FBF-A68D-2FDFC1A37683	13;21;15	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	378;1045;1588	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease;Stable Disease	Not Available;Not Available;Not Available	Not Available;NO;NO	4;3;8	Not Available;Not Available;Not Available	NO;NO;NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO	Stable Disease;Stable Disease;Stable Disease	YES;YES;YES	Alive;Alive;Alive	2011;2013;2014	YES	Processed food	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	YES	4	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5964	Not Available	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-5964-R10288	c6507bfb-908f-4971-bfbd-bb47ea283435	1	13	213	172	Not Available	4	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	White Matter	NO	YES	FG	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-HT-7601	30	FEMALE	153	Astrocytoma	Central nervous system	Alive	G3	0	153			Not Available		30	NO	Not Available	NO	TCGA-HT-7601	e7fdf164-a85d-4ff5-9676-d2215ca35403	6	-10989	Not Applicable	0	94	Not Available	Not Available	TCGA-HT-7601-D29579;TCGA-HT-7601-D29581;TCGA-HT-7601-D29580	e48a697d-7554-4e13-8a74-7217a9307ea2;8cda6fe4-25e5-442c-b5d7-33f807558541;08d78506-f3de-416d-b43a-155a4da249a0	Not Available;Not Available;Not Available	9;9;9	36;157;92	25;123;88	Temodar;Temodar;Temodar	Not Available;Not Available;Not Available	3;3;3	1;2;1	120;310;240	mg/day;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;3;2	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5040;3100;1200	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7601-F29577	6573ba1b-39b9-48fd-ab97-ec82da48696c	8	Not Available	Not Available	Not Applicable	153	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Partial Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7601	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7601-R29578	80148620-c0f8-4103-967b-5aebc3b97217	1	9	67	25	Not Available	3	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-HT-7473	28	MALE	503	Oligoastrocytoma	Central nervous system	Alive	G2	0	503			Not Available		28	NO	Not Available	NO	TCGA-HT-7473	dbfaccb0-e8c0-48e8-9aef-570267574822	31	-10306	Not Applicable	0	503	Not Available	Not Available																								Not Available	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7473-F29569	608746ac-e8a6-4b9f-ab45-bc33ab8c1d1f	19	Not Available	Not Available	Not Applicable	503	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7473	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7473-R29570	9823d62e-38b2-4299-96e5-a74dda017b68	1	19	139	93	Not Available	3	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-CS-5393	39	MALE	1222	Astrocytoma	Central nervous system	Alive	G3	0	1222			TUMOR FREE		39	Not Available	Not Available	NO	TCGA-CS-5393	e8d3d888-e5fc-4469-ad0b-2c1df6e04790	16	-14418	Not Applicable	0	857	Not Available	-3	TCGA-CS-5393-D15814	a037675e-cddc-4cdd-ab75-9221e715ca61	Not Available	18	Not Available	Not Available	Temodar	Not Available	8	5	140	mg	ADJUVANT	Not Applicable	Not Available	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	0	NO	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-CS-5393-F10073	c6689b7e-d6ff-48a7-8f6d-831b0c2ca5e4	13	Not Available	Not Available	Not Applicable	1222	Not Available	857	0	Not Available	Complete Remission/Response	100	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2011	Not Available	Not Available	MALE	Not Available	YES	Astrocytoma	YES	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	100	Left	Not Available	Not Available	NO	NO	Not Available	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5393	Preoperative	TUMOR FREE	Not Available	NO	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-5393-R15813	bd3dcb6d-3e15-4756-ab68-849f8ff4a424	Not Available	18	Not Available	Not Available	Not Available	8	30	60	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2008
TCGA-QH-A6XC	48	MALE	508	Astrocytoma	Central nervous system	Alive	G3	1	438.0			TUMOR FREE		48	Not Available	Not Available	YES	TCGA-QH-A6XC	62088274-A45B-4616-B086-B0DDD64895F0	9	-17692	Not Applicable	0	153	Not Available	153	TCGA-QH-A6XC-D52192;TCGA-QH-A6XC-D67825;TCGA-QH-A6XC-D67826;TCGA-QH-A6XC-D67827	F6A33868-3D93-44CE-9CA8-270A5FCBAE74;0B0F408C-2A81-4F43-9CA1-6DF6838B52BA;E8EBF11C-6633-4A34-AD2D-8A4C8D6E8267;F36FD59C-5D66-49E0-B8A1-7F5EED1D5496	Not Available;Not Available;Not Available;Not Available	9;12;12;12	390;Not Available;Not Available;Not Available	103;466;466;466	temozolomide;lomustine;Procarbazine;Vincristine	Clinical Progressive Disease;Not Applicable;Not Applicable;Not Applicable	12;11;11;11	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;YES;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2014;2014;2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	YES	Not Available	TCGA-QH-A6XC-F67756	E380B62D-492A-4675-BC38-C474EC318248	12	440	Not Available	Not Applicable	508	438	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Discrepancy	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	70	Right	NO	Sequence Analysis	YES	NO	Unknown	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6XC	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field;Local Recurrence	TCGA-QH-A6XC-R52190;TCGA-QH-A6XC-R67824	0894EFCF-FA07-4AD2-ACE2-D47BEC65DD79;CC0748CA-554B-4BA2-B39D-C68691F7902E	Not Available;Not Available	9;12	75;491	36;488	Complete Response;Stable Disease	12;11	27;3	54;21	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2014	YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-VV-A86M	36	FEMALE	487	Astrocytoma	Central nervous system	Alive	G3	0	487			WITH TUMOR		36	NO	Not Available	NO	TCGA-VV-A86M	284680B2-F961-402D-8740-E5F9E4FB4A98	31	-13453	Not Applicable	0	214	Not Available	Not Available	TCGA-VV-A86M-D57956	4FB2666B-CE05-4669-AF85-AE4DB466E4E0	Not Available	31	Not Available	122	Temozolomide	Not Applicable	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Sensory Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-VV-A86M-F66128	1DF7F259-4EB4-4B05-B15D-10DBAFA71DDA	2	Not Available	Not Available	Not Applicable	487	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Unknown	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Evaluated	Left	Not Available	Not Available	Unknown	YES	NO	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A86M	Not Available	WITH TUMOR	YES	Not Available	Not Available	Unknown	Not Evaluated	YES	Primary Tumor Field	TCGA-VV-A86M-R57955	5F8689F7-0636-45A8-9A68-B8173112025E	Not Available	31	122	92	Stable Disease	3	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	YES	YES	Not listed in Medical Record	NO	YES	VV	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-S9-A7IS	33	FEMALE	241	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		33	NO	Not Available	NO	TCGA-S9-A7IS	F6A81D81-7DF4-4273-8A86-E0CD3B8B1DF5	12	-12402	241	0	Not Available	Not Available	-2																								2	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Mental Status Changes	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-S9-A7IS-F51948	4D7A1F89-459C-482B-BF97-B1BB43944B4A	26	Not Available	Not Available	241	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	11	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2013	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	60	Right	Not Available	Not Available	NO	YES	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7IS	Preoperative	WITH TUMOR	NO	NO	NO	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-S9-A7IS-R54279	68747758-E82A-441C-B02B-99C2A4C60E5D	Not Available	18	29	21	Radiographic Progressive Disease	12	7	14	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Not listed in Medical Record	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2013	2004
TCGA-HT-7695	29	FEMALE	442	Oligodendroglioma	Central nervous system	Alive	G2	0	442			Not Available		29	NO	Not Available	NO	TCGA-HT-7695	5017c115-39b8-4c5c-8be6-2cb298d7c641	25	-10827	Not Applicable	0	442	Not Available	Not Available	TCGA-HT-7695-D29606	fae54b60-4659-442e-b848-217b8e971356	Not Available	16	110	78	Temodar	Not Available	3	1	150	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	4950	mg	Not Available	2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7695-F29604	e79d4ac0-3668-4fde-91e0-684c587f2d21	16	Not Available	Not Available	Not Applicable	442	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	3	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7695	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7695-R29605	60874d2b-9b1f-47c7-bb40-37091a8cde5a	1	16	125	52	Not Available	3	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2009	2009
TCGA-HT-8110	57	MALE	419	Astrocytoma	Central nervous system	Alive	G3	0	419			TUMOR FREE		57	NO	Not Available	NO	TCGA-HT-8110	ad1c5951-ca93-4102-889b-e28e2bcfea76	13	-21183	Not Applicable	0	143	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Visual Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8110-F43794	15409568-896E-4F94-AC2E-BE7C3DBC2045	26	Not Available	Not Available	Not Applicable	419	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	Unknown	Complete Remission/Response	YES	Alive	2013	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8110	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-8110-R32651	1215bad3-593f-4a27-afeb-7ab48c0960d9	Not Available	5	81	32	Complete Response	6	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-E1-5319	48	FEMALE	2907	Oligodendroglioma	Central nervous system	Dead	G2	1	923.0			WITH TUMOR		48	Not Available	Not Available	NO	TCGA-E1-5319	84569c1a-6baa-4380-ae3c-707df1be4618	17	-17612	2907	0	Not Available	Not Available	936	TCGA-E1-5319-D16174;TCGA-E1-5319-D16175;TCGA-E1-5319-D16177;TCGA-E1-5319-D16176;TCGA-E1-5319-D16179;TCGA-E1-5319-D16178;TCGA-E1-5319-D16180;TCGA-E1-5319-D16181;TCGA-E1-5319-D16182	6d31737d-4921-402e-bc85-10d762ed7932;d27d6d3e-f1bc-4afe-80ec-a894e4d73091;04a91ee2-d48f-4bdd-b621-ddab8425a59a;b869d193-25b4-4aae-beaa-6f44acda704a;d5514219-5b0e-482f-a2af-027c0ba5427b;90657aae-3bf5-4ed4-9b0b-9588f876b750;561946e1-a96c-47aa-ae5f-3f1dd8684ea5;da80b4cc-3bf5-4b0b-8f98-d2fb84c55973;1e479794-aec8-4230-b7e8-f00f75cf7bf9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;19;19;19;22;22;23;23;24	1385;1511;1993;1933;2364;2121;2433;2587;2818	952;1385;1933;1826;2322;2029;2364;2433;2587	Temodar;Celebrex;Carboplatin;Carboplatin;CCNU;Temodar;CCNU;VP-16;VP-16	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8;8	13;4;2;3;1;2;1;3;6	200;800;450;560;110;200;82.5;50;25	mg/m2;mg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;4;3;6;5;7;8;9	PO;PO;PO;PO;PO;PO;PO;PO;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Antiongigenic;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	26650;95200;50400;94920;240;4000;180;6300;6300	mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	Not Available	Not Available	Not Available	Not Available	Visual Changes	0 - 30 Days	YES	YES	YES	NO	TCGA-E1-5319-F16173	0d246892-36a7-42d9-a474-590ba523e9a8	17	923	Not Available	2907	Not Available	923	952	Not Available	Not Available	Stable Disease	100	Not Available	8	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	NO	Stable Disease	NO	Dead	2011	Not Available	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	100	Right	Not Available	Not Available	Not Available	NO	Not Available	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5319	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5319-R16183	c6470616-fb03-4678-bf8c-3a3183e301f5	5	18	2304	2243	Not Available	8	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	YES	Dead	2011	1998
TCGA-HT-7854	62	MALE	1201	Astrocytoma	Central nervous system	Alive	G2	1	1147.0			TUMOR FREE		62	NO	Not Available	NO	TCGA-HT-7854	4a7d4805-09e3-4044-9800-73239f4d66d4	7	-22738	Not Applicable	0	292	Not Available	208																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Visual Changes	31 - 90 Days	Not Available;NO	Not Available;NO	Not Available;Not Available	Not Available;YES	TCGA-HT-7854-F21254;TCGA-HT-7854-F48001	38A5E370-2CA1-4709-AEF9-8C78F3A3AACF;D6E6FF39-FFE2-4774-AFD7-EDDC9E622283	7;3	Not Available;Not Available	Not Available;1191	Not Applicable;Not Applicable	292;1201	Not Available;1147	208;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	100;Not Available	Not Available;NO	2;9	Not Available;Not Available	NO;YES	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;Unknown	NO;NO	Stable Disease;Unknown	YES;YES	Alive;Alive	2012;2013	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	YES	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7854	Post-Adjuvant Therapy	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7854-R21255	9E9ED397-8067-4585-8115-99897216474D	1	7	176	138	Not Available	2	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2012	2010
TCGA-VM-A8C9	37	FEMALE	1314	Astrocytoma	Central nervous system	Alive	G2	0	1314			Unknown		37	Unknown	Not Available	Unknown	TCGA-VM-A8C9	50975570-C0D5-4EE7-9226-40B3DB1BDE84	13	-13663	Not Applicable	0	915	Not Available	Not Available																								Not Evaluated	Unknown	Not Evaluated	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO;NO	NO;NO	Not Available;Not Available	Not Available;Not Available	TCGA-VM-A8C9-F66845;TCGA-VM-A8C9-F70437	ED6577E0-4F69-4A00-A87E-C0E6DCC270EC;CC4D8248-4B2D-4D0B-B674-4366E004D3F4	24;16	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	915;1314	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Complete Remission/Response	Not Available;Not Available	NO;NO	10;2	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	Unknown;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2015	Unknown	Not Available	FEMALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8C9	Not Evaluated	Unknown	NO	Unknown	Unknown	Complete Remission/Response	Not Evaluated	NO																			YES	NO	Not listed in Medical Record	NO	YES	VM	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-HT-7692	43	MALE	90	Oligoastrocytoma	Central nervous system	Alive	G2	0	90			Not Available		43	NO	Not Available	NO	TCGA-HT-7692	6a0b306b-f73d-45b2-93a6-b9bd625644a3	1	-15727	Not Applicable	0	90	Not Available	29																								Not Available	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7692-F29616	5cbaf3dd-0e68-4a8e-b1cf-3eacbb8d5a7c	16	Not Available	Not Available	Not Applicable	90	Not Available	29	Not Available	Scheduled Follow-up Submission	Not Available	100	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	100	Left	Not Available	Not Available	Not Available	YES	NO	3	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7692	Pre-Adjuvant Therapy	Not Available	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7692-R29617	d80f0d6d-6af2-4524-bd0b-893d96219438	1	16	90	46	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	Not Available	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-P5-A5EU	35	MALE	0	Astrocytoma	Central nervous system	Alive	G3	0	0			Unknown		35	Unknown	Not Available	Unknown	TCGA-P5-A5EU	1AA6B9FF-7C97-47D9-923F-2BD83F20E531	3	-12851	Not Applicable	0	0	Not Available	Not Available																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5EU-F69039	83071394-4CC2-47AC-B866-07BA48B22797	24	Not Available	Not Available	Not Applicable	0	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	60	Right	Not Available	Not Available	NO	Unknown	Unknown	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5EU	Not Evaluated	Unknown	NO	YES	YES	Unknown	WHITE	NO																			Unknown	YES	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2013	2012
TCGA-DU-8167	69	FEMALE	471	Oligoastrocytoma	Central nervous system	Alive	G2	0	471			WITH TUMOR		69	Not Available	Not Available	Not Available	TCGA-DU-8167	58c82c76-9198-4c95-80f8-c043d1cea5eb	15	-25262	Not Applicable	0	98	Not Available	-69																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-8167-F44357	097A71A0-C88B-4D08-AA26-560E44DF8FAF	19	Not Available	Not Available	Not Applicable	471	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	YES	Alive	2013	Not Available	Not Available	FEMALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	Not Available	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8167	Preoperative	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-8167-R33131	EAB94EE5-927C-412D-BF7F-26625A8D0444	Not Available	21	78	31	Stable Disease	6	27	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2012
TCGA-S9-A6WM	59	FEMALE	604	Astrocytoma	Central nervous system	Alive	G3	1	505.0			WITH TUMOR		59	NO	Not Available	NO	TCGA-S9-A6WM	F79420CA-B0AE-417C-95F7-D28C35760202	5	-21761	Not Applicable	0	283	Not Available	-9	TCGA-S9-A6WM-D54283;TCGA-S9-A6WM-D63844	E04F54CA-4188-438B-9469-AE68951B6396;4636DEAC-D69D-4A41-BD2A-2CEFFC48A682	Not Available;Not Available	18;20	64;Not Available	16;524	Temozolomide;Bevacizumab	Stable Disease;Not Applicable	12;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Targeted Molecular therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2014	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	YES	NO	NO	Not Available	TCGA-S9-A6WM-F63843	C0AF2FB7-C8B4-41A8-831B-C1935CFB038E	20	Not Available	Not Available	Not Applicable	604	505	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Left	NO	IHC	YES	NO	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WM	Preoperative	WITH TUMOR	YES	NO	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6WM-R54282	337D8CAA-AC35-463E-81C8-7BDFCEFAC1A6	Not Available	18	64	16	Stable Disease	12	33	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-7014	59	MALE	3571	Oligodendroglioma	Central nervous system	Dead	G2	1	3437.0			WITH TUMOR		59	Not Available	Not Available	Not Available	TCGA-DU-7014	a776cfd0-db9f-450a-943c-5a9a80a75fb7	26	-21865	3571	0	Not Available	Not Available	-13																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	NO	TCGA-DU-7014-F17101	0574bb8a-fadd-4617-9cbd-7304da5a30f5	26	Not Available	Not Available	3571	Not Available	3437	3558	Not Available	Not Available	Progressive Disease	50	Not Available	9	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	YES	NO	Not Available	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7014	Preoperative	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7014-R17103	b0713596-86b5-4631-8d3e-09ef8dfed980	1	26	85	43	Not Available	9	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	White Matter	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2001
TCGA-R8-A6ML	52	MALE	2860	Oligodendroglioma	Central nervous system	Alive	G3	0	2860			Not Available		52	Not Available	Not Available	Not Available	TCGA-R8-A6ML	5119ACEB-AD95-4904-B6C0-A0A4B42C17D0	30	-19185	Not Applicable	0	2860	Not Available	Not Available																								Not Available	Not Available	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available																														Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	Not Available	Yes, Pharmaceutical Treatment Prior to Resection	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Unknown	Not Available	Not Available	12	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A6ML	Not Available	Not Available	YES	Not Available	Not Available	Unknown	WHITE	YES																			YES	Not Available	Not Available	NO	YES	R8	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2013	2005
TCGA-DH-A7UR	59	FEMALE	1650	Oligodendroglioma	Central nervous system	Alive	G3	0	1650			TUMOR FREE		59	Unknown	Not Available	NO	TCGA-DH-A7UR	B37ABDC8-B9E3-4F1A-B16D-2E59442DB335	10	-21803	Not Applicable	0	1650	Not Available	1174	TCGA-DH-A7UR-D60282	7500051C-55B3-465A-8FFA-30EED95ABD8B	Not Available	5	1076	33	Temodar	Complete Response	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DH-A7UR-F63627;TCGA-DH-A7UR-F64479	FA43A71B-A73F-426A-87D8-37FA2F73F395;E7F2D331-E4A6-4B1E-9622-54CCBA50AE58	14;3	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1650;1650	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown	Not Available;Not Available	NO;YES	8;9	Not Available;Not Available	Unknown;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	YES;Not Available	Complete Remission/Response;Not Available	YES;Not Available	Alive;Alive	2014;2014	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	YES	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7UR	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-DH-A7UR-R60281	D1D43760-E8D0-484B-97EB-F5751D7366CC	Not Available	5	83	33	Complete Response	6	34	61.2	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Not listed in Medical Record	NO	YES	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2008
TCGA-P5-A5F6	26	MALE	39	Oligodendroglioma	Central nervous system	Alive	G2	0	39			TUMOR FREE		26	Unknown	Not Available	Unknown	TCGA-P5-A5F6	2E3B9F32-304E-454B-AC2C-FC72D2CCAA19	19	-9575	Not Applicable	0	39	Not Available	Not Available																								Not Available	Unknown	NOT HISPANIC OR LATINO	Unknown	Not Available	Not Available	Not Available	Not Available	Headaches	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5F6-F69049	C9FF36A9-1928-4CC9-B832-D4E3535B9EF8	24	Not Available	Not Available	Not Applicable	39	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	Unknown	Not Available	MALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	70	Left	Not Available	Not Available	Unknown	Unknown	Unknown	9	Unknown	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5F6	Unknown	TUMOR FREE	Unknown	Not Available	Not Available	Not Available	WHITE	Unknown																			Unknown	Unknown	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Unknown	Alive	2013	2012
TCGA-HT-A4DV	51	FEMALE	792	Oligodendroglioma	Central nervous system	Alive	G3	0	792			TUMOR FREE		51	Unknown	Not Available	Unknown	TCGA-HT-A4DV	274496D6-0A9B-45CA-876F-B91F7277963C	27	-18799	Not Applicable	0	319	Not Available	14	TCGA-HT-A4DV-D48378;TCGA-HT-A4DV-D61276	2C642F10-B652-4553-8D9C-53D492BB6A6B;D99F0E38-B007-4A0A-925D-2A5F6BDEFA73	Not Available;Not Available	12;26	88;291	42;133	Temodar;Temodar	Complete Response;Partial Response	9;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A4DV-F61274	23007965-2DBF-464E-8178-F906CF6DAF4B	26	Not Available	Not Available	Not Applicable	792	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Partial Remission/Response	YES	Alive	2014	Unknown	Not Available	FEMALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	90	Left	Not Available	Not Available	NO	NO	Unknown	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4DV	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A4DV-R48373	FE088D4E-2536-439D-BB21-00DE71F972AB	Not Available	12	88	42	Complete Response	9	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2013	2012
TCGA-P5-A5F4	35	FEMALE	231	Oligodendroglioma	Central nervous system	Alive	G3	0	231			Unknown		35	Unknown	Not Available	Unknown	TCGA-P5-A5F4	0557B788-5AED-4919-85EB-A503AD893D75	18	-12851	Not Applicable	0	23	Not Available	Not Available	TCGA-P5-A5F4-D56617;TCGA-P5-A5F4-D59337;TCGA-P5-A5F4-D59338	C4A58407-7379-4D51-A886-47543129C008;0C98C338-FA72-4C9A-BFD2-670DEAE9811F;8E938678-3A97-410C-9B50-05FB00B868A8	Not Available;Not Available;Not Available	8;30;30	231;231;231	19;19;19	Lomustine;Vincristine;Procarbazine	Partial Response;Partial Response;Partial Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5F4-F69048	859103D0-1605-427C-8F1A-A9B796029808	24	Not Available	Not Available	Not Applicable	231	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Discrepancy	YES	Partial Remission/Response	YES	Alive	2014	Unknown	Not Available	FEMALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	70	Right	Not Available	Not Available	Not Available	Unknown	Unknown	9	Unknown	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5F4	Unknown	Unknown	YES	Not Available	Not Available	Unknown	WHITE	YES	Primary Tumor Field	TCGA-P5-A5F4-R56616	AF3B1B2F-23F6-4E2C-8D47-CD77975E0FC8	Not Available	8	80	19	Partial Response	5	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Unknown	YES	Not listed in Medical Record	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2013	2012
TCGA-FG-7634	28	MALE	467	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		28	NO	Not Available	NO	TCGA-FG-7634	2d860614-b772-46e2-b1cd-43bb3ead7255	15	-10476	Not Applicable	0	467	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-7634-F32955;TCGA-FG-7634-F41580	E3D42E54-5519-4759-8312-7962366E7B78;57A86EA2-9217-487A-8EA2-094C2C3EA4A5	18;21	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	467;467	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	Not Available;YES	6;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	NO;Not Available	Stable Disease;Stable Disease	NO;Not Available	Alive;Alive	2012;2013	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7634	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2008
TCGA-KT-A7W1	45	FEMALE	438	Astrocytoma	Central nervous system	Alive	G3	1	84.0			TUMOR FREE		45	Unknown	Not Available	Unknown	TCGA-KT-A7W1	77472095-030D-4679-921D-8E8E217956C5	3	-16560	Not Applicable	0	144	Not Available	10	TCGA-KT-A7W1-D56356	84F35414-A491-477D-8C80-61A307770786	Not Available	3	61	20	Temozolomide	Clinical Progressive Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-KT-A7W1-F69146	9A7E8177-3F8B-4527-8538-A203602BD1A5	30	Not Available	Not Available	Not Applicable	438	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	12	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Progressive Disease	YES	Alive	2014	Unknown	Not Available	FEMALE	Unknown	Unknown	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	NO	IHC	YES	NO	Unknown	2	YES	G3	NO	NO	84	YES	102	NO	Not Available	YES	No	A7W1	Pre-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field;Primary Tumor Field	TCGA-KT-A7W1-R56354;TCGA-KT-A7W1-R56355	C37AAE03-D49B-4048-B5F9-57EE24FED3F2;D30E6E60-524B-4F84-8E8E-686F6D31333D	Not Available;Not Available	3;3	61;61	20;20	Radiographic Progressive Disease;Radiographic Progressive Disease	2;2	23;7	4600;1400	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	YES	NO	White Matter	YES	NO	KT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-6406	59	FEMALE	512	Oligoastrocytoma	Central nervous system	Dead	G3	0	512			Not Available		59	Not Available	Not Available	Not Available	TCGA-DU-6406	c13a429c-99ea-478c-ae95-fa499b9ea9fa	21	-21634	512	0	Not Available	Not Available	Not Available	TCGA-DU-6406-D14902;TCGA-DU-6406-D14901;TCGA-DU-6406-D14903	2edd84a0-4c13-456b-8485-48de001ab22e;0bfe64d1-8cc5-44fc-8cda-42dd1458a08f;101eea12-9909-41a3-906e-ee2fcc94ba4f	Not Available;Not Available;Not Available	1;1;1	280;66;280	97;38;158	Temozolomide;Temozolomide;Isotrectinoin (acccutane)	Not Available;Not Available;Not Available	6;6;6	7;1;5	200;75;Not Available	mg/m2;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;retinoid	Not Available;Not Available;Not Available	mg/m2;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Motor/Movement Changes	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-6406-F14899	cda322a9-4f3b-4055-bd7a-ba83d64b09b1	1	Not Available	Not Available	512	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	6	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6406	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6406-R14900	31505f4a-2a8b-407a-ba73-479eb56c0bdf	1	1	66	38	Not Available	6	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	YES	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	YES	Dead	2011	2001
TCGA-FG-5965	39	FEMALE	1120	Oligoastrocytoma	Central nervous system	Dead	G2	1	715.0			WITH TUMOR		39	NO	Not Available	NO	TCGA-FG-5965	2cfc07f3-a31c-41a2-a9e3-b708d2421a78	22	-14249	Not Applicable	0	979	Not Available	259	TCGA-FG-5965-D14155	dfd47724-148f-4d6f-8e91-8eb96911e943	Not Available	22	Not Available	790	Temodar	Not Available	7	6	300-320	mg	PROGRESSION	Not Applicable	1	PO	YES	Chemotherapy	Not Available	9500	mg	Not Available	2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES;YES	NO;NO	YES;YES	NO;NO	TCGA-FG-5965-F14153;TCGA-FG-5965-F32837	6c1ab603-cefb-44f7-bafb-48e43040b60d;39110350-93C7-456E-A8FE-73F98DB91C9C	22;13	765;1069	Not Available;Not Available	Not Applicable;1120	979;Not Available	715;1035	460;Not Available	1;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event	Stable Disease;Progressive Disease	Not Available;Not Available	Not Available;Not Available	7;6	Not Available;Not Available	YES;YES	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	NO;YES	Stable Disease;Progressive Disease	YES;NO	Alive;Dead	2011;2012	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5965	Post-Adjuvant Therapy	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-5965-R14154	41f1a2e8-c1f7-42cd-9bc6-22030912d3dd	1	22	133	89	Not Available	7	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	YES	NO	White Matter	NO	YES	FG	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2011	2008
TCGA-HT-7690	29	MALE	3	Oligoastrocytoma	Central nervous system	Alive	G3	0	3			Not Available		29	NO	Not Available	NO	TCGA-HT-7690	e78e8845-9fba-48ba-8cf3-418429ea5f56	1	-10673	Not Applicable	0	3	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7690-F29644	d0bfb7f9-e4a9-4094-9459-0e4f45e3a891	15	Not Available	Not Available	Not Applicable	3	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Not Available	NO	Alive	2012	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7690	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-TQ-A7RM	41	FEMALE	1116	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		41	NO	Not Available	NO	TCGA-TQ-A7RM	3431A71C-FABF-440C-B11C-8ACFEE04724F	17	-15154	Not Applicable	0	1116	Not Available	45																								0	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RM-F65552	5D3A3CB1-13ED-44FB-9983-628A221F4AA6	17	Not Available	Not Available	Not Applicable	1116	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	2	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2015	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	YES	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RM	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	YES																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2015	2011
TCGA-DU-A76R	51	MALE	648	Oligodendroglioma	Central nervous system	Dead	G3	1	338.0			WITH TUMOR		51	Unknown	Not Available	Unknown	TCGA-DU-A76R	823F571A-3CFD-465D-95FD-187A398CCF6F	22	-18939	648	0	Not Available	Not Available	60	TCGA-DU-A76R-D50337	2B58828D-44A4-445E-AB04-8F22AF55BEE5	Not Available	22	394	389	Temozolomide	Clinical Progressive Disease	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days																														Unknown	Not Available	MALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	50	Right	Not Available	Not Available	NO	YES	Unknown	10	YES	G3	YES	YES	338	YES	344	Not Available	Not Available	YES	No	A76R	Pre-Adjuvant Therapy	WITH TUMOR	NO	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field;Local Recurrence	TCGA-DU-A76R-R50335;TCGA-DU-A76R-R50336	BC15647F-1DB7-4600-94F9-B3016555F60D;90445D9D-E3AB-4738-9CB9-758F7E557713	Not Available;Not Available	22;22	135;394	98;389	Radiographic Progressive Disease;Radiographic Progressive Disease	10;10	Not Available;3	30;30	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2013	NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2013	2006
TCGA-S9-A6WE	34	MALE	4113	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		34	NO	Not Available	NO	TCGA-S9-A6WE	6D2C49C3-0721-4BD2-B39F-7872F2DE996D	4	-12488	Not Applicable	0	2208	Not Available	-4	TCGA-S9-A6WE-D54274	E164A769-7AB9-4E57-BC46-B974EFBE174A	Not Available	18	Not Available	8	Temozolamide	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Sensory Changes	> 181 Days	Unknown;Unknown;Unknown;Not Available	Unknown;Unknown;Unknown;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-S9-A6WE-F67225;TCGA-S9-A6WE-F69987;TCGA-S9-A6WE-F71263;TCGA-S9-A6WE-F72356	725BCE31-0E9D-4C21-BC79-1EE2A41FD808;D0AE820D-8138-41F1-8DB8-6C84416F2A65;438EEE07-92A2-48EF-BDFA-8D83BEAB7792;E6ECB56D-713D-48FD-BF58-612FF8BC7DD8	3;26;24;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2208;2208;2208;4113	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown;Unknown;Unknown	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;NO	11;1;3;6	Not Available;Not Available;Not Available;Not Available	Unknown;Unknown;Unknown;Unknown	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES	Partial Remission/Response;Partial Remission/Response;Partial Remission/Response;Partial Remission/Response	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2014;2015;2015;2015	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	11	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WE	Preoperative	WITH TUMOR	YES	YES	YES	Partial Remission/Response	WHITE	NO																			NO	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2004
TCGA-QH-A6CS	41	MALE	588	Astrocytoma	Central nervous system	Alive	G3	1	498.0			WITH TUMOR		41	NO	Not Available	NO	TCGA-QH-A6CS	6D17C327-435A-4CBA-9626-3B5B7B7375BB	2	-15092	Not Applicable	0	127	Not Available	-25	TCGA-QH-A6CS-D46344;TCGA-QH-A6CS-D67861	E9963102-9F44-402A-AB06-9BD4490D1441;44465574-74DD-4C53-B1AE-CC241D2CD651	Not Available;Not Available	7;13	423;Not Available	45;607	TEMOZOLOMIDE;fotemustine	Stable Disease;Not Applicable	8;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	NO	Not Available	TCGA-QH-A6CS-F67755	387EAFBA-366D-4314-B9FF-9E949D4F3EBF	13	Not Available	Not Available	Not Applicable	588	498	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Right	NO	IHC	YES	NO	NO	8	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6CS	Preoperative	WITH TUMOR	YES	YES	YES	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-QH-A6CS-R46343	D34B9CEA-1188-4F0B-A98F-85849EDB037B	Not Available	7	84	45	Stable Disease	8	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-P5-A5EY	21	MALE	72	Astrocytoma	Central nervous system	Alive	G2	0	72			Unknown		21	Unknown	Not Available	Unknown	TCGA-P5-A5EY	1F33AEBC-EDC1-42C5-BAA9-E4B0A06FCB26	22	-7716	Not Applicable	0	72	Not Available	Not Available																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5EY-F69043	C666A6D7-CD56-4729-9BE2-693819FEBB2A	24	Not Available	Not Available	Not Applicable	72	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	Unknown	Not Available	MALE	Unknown	Unknown	Astrocytoma	Unknown	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	Not Evaluated	Right	Not Available	Not Available	Unknown	Unknown	Unknown	8	Unknown	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5EY	Unknown	Unknown	Unknown	YES	Unknown	Unknown	WHITE	Unknown																			YES	Unknown	Not listed in Medical Record	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	Unknown	Alive	2013	2012
TCGA-DB-5279	59	MALE	1354	Oligodendroglioma	Central nervous system	Alive	G2	1	695.0			TUMOR FREE		59	NO	Not Available	NO	TCGA-DB-5279	85f77526-791e-47cd-904d-d1dbb49eaeab	22	-21908	Not Applicable	0	1354	Not Available	Not Available																								Not Available	NO	Not Available	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO;Not Available	YES;Not Available	NO;Not Available	Not Available;Not Available	TCGA-DB-5279-F42833;TCGA-DB-5279-F67396	EA9E13A8-9410-4718-B981-5230475F2A0B;F6748453-8698-495F-B546-37F0FDFE3E5D	1;4	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1354;Not Available	695;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Partial Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;YES	5;11	Not Available;Not Available	YES;Not Available	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Not Available	2013;2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	Not Available	NO	NO	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5279	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-DB-5279-R14440	0cdb8e6d-d726-4867-aa2d-6590d7dbd574	1	22	811	773	Not Available	7	28	5600	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2007
TCGA-DB-5274	37	FEMALE	2289	Oligoastrocytoma	Central nervous system	Alive	G3	0	2289			TUMOR FREE		37	Not Available	Not Available	NO	TCGA-DB-5274	0b54cda4-7568-481e-b0c6-2c5c6de0026c	30	-13680	Not Applicable	0	1726	Not Available	12	TCGA-DB-5274-D14422;TCGA-DB-5274-D14421	9f32c049-4894-4377-a066-ae609c40a0ef;c7e43fb6-4054-47f5-b360-9c8c0357383e	Not Available;Not Available	22;22	270;98	98;52	Temodar;Temodar	Not Available;Not Available	7;7	6;6	200;75	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	10800;5670	mg;mg	Not Available;Not Available	2011;2011	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-5274-F42834	081411FB-911E-4C6F-809A-10D4CB0F9472	1	Not Available	Not Available	Not Applicable	2289	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	80	Left	Not Available	Not Available	Not Available	NO	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5274	Preoperative	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DB-5274-R14239	5752da23-01db-449c-a9f0-80fab105694d	1	22	91	51	Not Available	7	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2006
TCGA-DU-A5TU	62	FEMALE	796	Astrocytoma	Central nervous system	Alive	G2	1	186.0			WITH TUMOR		62	NO	Not Available	NO	TCGA-DU-A5TU	1C095C4A-DF97-402E-902C-FC83BCF8EF88	14	-22811	Not Applicable	0	111	Not Available	47	TCGA-DU-A5TU-D71324	EA6B1A2E-5E6D-4403-8482-A641A0E2C5B2	Not Available	24	Not Available	627	Temozolomide	Stable Disease	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2015	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	12 - 20 Years	Mental Status Changes	0 - 30 Days	YES	NO	NO	Not Available	TCGA-DU-A5TU-F71322	4D44056F-725F-462D-AD37-22D9CC011C84	24	Not Available	Not Available	Not Applicable	796	186	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Alive	2015	YES	Eggs	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	50	Left	Not Available	Not Available	NO	YES	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5TU	Other	WITH TUMOR	NO	NO	YES	Unknown	WHITE	NO	Primary Tumor Field	TCGA-DU-A5TU-R71323	2155BEB8-23FF-48A5-B5D5-BF79E7244867	Not Available	24	166	131	Radiographic Progressive Disease	3	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	NO	NO	Cerebral Cortex	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-E1-A7YI	33	FEMALE	111	Astrocytoma	Central nervous system	Dead	G3	1	56.0			WITH TUMOR		33	Unknown	Not Available	NO	TCGA-E1-A7YI	5795A884-B62A-46A9-81D6-F24058424660	12	-12229	111	0	Not Available	Not Available	11																								Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	31 - 90 Days																														Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	Not Available	Not Available	NO	NO	Unknown	5	YES	G3	NO	NO	56	NO	Not Available	NO	Not Available	YES	No	A7YI	Pre-Adjuvant Therapy	WITH TUMOR	NO	YES	Unknown	Unknown	WHITE	NO																			NO	YES	Not listed in Medical Record	NO	YES	E1	Supratentorial, Occipital Lobe	Central nervous system	YES	Dead	2014	2008
TCGA-DU-A7T6	73	FEMALE	547	Oligodendroglioma	Central nervous system	Dead	G3	0	547			WITH TUMOR		73	Unknown	Not Available	Unknown	TCGA-DU-A7T6	A0672F6F-6406-4D49-96D0-6AFD571BBD00	23	-26766	547	0	Not Available	Not Available	53																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	> 181 Days																														Unknown	Not Available	FEMALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	60	Right	Not Available	Not Available	NO	NO	Unknown	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A7T6	Pre-Adjuvant Therapy	WITH TUMOR	Unknown	Unknown	Unknown	Unknown	WHITE	Unknown																			NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2013	2002
TCGA-HT-A5R9	48	FEMALE	2	Oligodendroglioma	Central nervous system	Alive	G3	0	2			Unknown		48	Unknown	Not Available	NO	TCGA-HT-A5R9	E117FCF4-2C01-4B4D-8FAF-5DE7D0E839F1	11	-17775	Not Applicable	0	2	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A5R9-F61080	DF228E29-7F1C-4322-B95A-3EF860B0AAE7	26	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	Unknown	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Unknown	Right	Not Available	Not Available	NO	NO	NO	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5R9	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	WHITE	Unknown																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-8162	61	FEMALE	444	Oligoastrocytoma	Central nervous system	Dead	G3	1	402.0			WITH TUMOR		61	Not Available	Not Available	Not Available	TCGA-DU-8162	6fab9c30-354b-4f99-9b60-6823c12b9b0a	15	-22596	Not Applicable	0	121	Not Available	21	TCGA-DU-8162-D33121;TCGA-DU-8162-D33122	FE9B8EF7-4418-4446-9780-E2ECF8FDB8A4;B2AD4B1D-3B7E-4C0E-A590-A2E7ACB3F597	Not Available;Not Available	21;21	70;Not Available	24;108	Temozolomide;Temozolomide	Stable Disease;Not Applicable	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;NO	2012;2012	1	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	NO	YES	Not Available	Not Available	TCGA-DU-8162-F44364	584694E6-9683-451A-9294-B01A7D5713AE	19	Not Available	Not Available	444	Not Available	402	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2013	Not Available	Not Available	FEMALE	Not Available	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	80	Right	Not Available	Not Available	NO	NO	Not Available	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8162	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Local Recurrence	TCGA-DU-8162-R33120;TCGA-DU-8162-R44366	3F1FE7EC-3297-4ED8-A619-2FE06234F0C4;232A9794-A745-4784-B063-77802DCEFB8D	Not Available;Not Available	21;19	70;438	24;427	Stable Disease;Unknown	6;6	33;Not Available	5940;Not Available	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Gy	2012;2013	NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-S9-A7IX	57	MALE	819	Astrocytoma	Central nervous system	Dead	G3	1	350.0			WITH TUMOR		57	NO	Not Available	NO	TCGA-S9-A7IX	A80B0FAB-6189-497F-997F-77234B69179C	12	-21095	Not Applicable	0	597	Not Available	-2	TCGA-S9-A7IX-D54298;TCGA-S9-A7IX-D54301;TCGA-S9-A7IX-D55835;TCGA-S9-A7IX-D72343	9A786DDE-D06C-4F38-98FE-C4CF7D576A4A;905CDC2A-789D-490F-9D2B-47831F8930B5;01CF6350-DFBA-43D6-B405-ACA07C137AC2;F7CA28FD-A3F2-4A7A-86CC-6AFC4C01F159	Not Available;Not Available;Not Available;Not Available	18;18;16;27	413;470;413;640	350;437;350;589	Temozolomide;Temozolomide;Bevacizumab;Lomustine	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	12;12;1;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2014;2015	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	31 - 90 Days	Unknown;Unknown;Unknown;Not Available	Unknown;Unknown;Unknown;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-S9-A7IX-F64649;TCGA-S9-A7IX-F69996;TCGA-S9-A7IX-F71264;TCGA-S9-A7IX-F72344	C10CF272-A056-4488-9215-D13C9474A036;FBD9D228-88F2-430A-A175-4A6E3BECDF45;9E7F1B53-B0DB-43AE-AE7A-67E6B159689A;B307B3A0-BF5D-4EDE-A8BE-FD2E71121E79	9;26;24;27	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;819	679;679;679;Not Available	679;679;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease;Progressive Disease;Unknown	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	9;1;3;5	Not Available;Not Available;Not Available;Not Available	YES;YES;NO;Unknown	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO;NO	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES;YES	Alive;Alive;Alive;Dead	2014;2015;2015;2015	NO	Not Available	MALE	YES	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	12	YES	G3	YES	YES	350	NO	Not Available	NO	Not Available	YES	No	A7IX	Preoperative	WITH TUMOR	NO	YES	NO	Progressive Disease	WHITE	YES	Primary Tumor Field;Primary Tumor Field	TCGA-S9-A7IX-R54296;TCGA-S9-A7IX-R54300	CB89C64F-91B2-48FE-9FD3-2A1121926819;B4652685-5BFA-4E28-9CCB-B6E95682363D	Not Available;Not Available	18;18	87;470	36;437	Stable Disease;Radiographic Progressive Disease	12;12	33;22	59.4;39.6	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2013	NO	NO	White Matter	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-8163	29	MALE	629	Oligoastrocytoma	Central nervous system	Alive	G3	1	509.0			WITH TUMOR		29	Not Available	Not Available	Not Available	TCGA-DU-8163	c81d4681-c02f-4b33-abe0-b6ad7d61194d	15	-10824	Not Applicable	0	197	Not Available	106	TCGA-DU-8163-D33105;TCGA-DU-8163-D33106;TCGA-DU-8163-D44372	0C5880BB-0FC8-4729-BBE3-71E46ED49684;6EAD861C-E1F5-40A4-AAD1-120B9DA21E15;62C7526F-002E-45DA-BD51-8D092A894B92	Not Available;Not Available;Not Available	21;21;19	81;Not Available;Not Available	35;87;525	Temozolomide;Temozolomide;Temozolomide	Stable Disease;Not Applicable;Not Applicable	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	YES	NO	Not Available	Not Available	TCGA-DU-8163-F44371	94E1D857-1475-47C6-AE93-00E52633456A	19	Not Available	Not Available	Not Applicable	629	509	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2013	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	Not Available	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8163	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-8163-R33104	F58D5706-D367-4545-892E-CE4B4421DD8E	Not Available	21	81	35	Stable Disease	6	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-DU-6392	35	FEMALE	6423	Astrocytoma	Central nervous system	Alive	G3	1	950.0			TUMOR FREE		35	Not Available	Not Available	Not Available	TCGA-DU-6392	fcd9e1c4-bddb-4856-844c-03df48fba499	21	-12836	Not Applicable	0	6423	Not Available	Not Available	TCGA-DU-6392-D14730;TCGA-DU-6392-D14731	7ad5cb6c-01dc-4d48-bb9c-8745bb0f8a5b;6eddaf70-0f2e-433f-b5cd-36b4d14a8b6b	Not Available;Not Available	27;27	78;443	17;109	Hydroxyurea;PCV	Not Available;Not Available	5;5	1;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	300;Not Available	mg;Not Available	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	YES	YES	TCGA-DU-6392-F14726	df4852ec-fb50-40b7-a8df-fb0bb7d7389f	27	950	1055	Not Applicable	6423	950	Not Available	Not Available	Not Available	Stable Disease	Not Available	Not Available	5	Not Available	YES	Not Available	Not Available	TUMOR FREE	YES	Progressive Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	Not Available	Not Available	6	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6392	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-DU-6392-R14728;TCGA-DU-6392-R14729	95a9a327-37ed-4f37-9fca-1becbaeedb2b;56d79662-3801-470a-af6e-2567717d5390	1;1	27;27	17;78	17;17	Not Available;Not Available	5;5	1;Not Available	Not Available;Not Available	NO;NO	OTHER;EXTERNAL BEAM	Stereotactic Radiosurgery;Not Applicable	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	YES	Not Available	White Matter	NO	YES	DU	Supratentorial, Parietal Lobe	Central nervous system	Not Available	Alive	2011	1993
TCGA-P5-A72Z	64	FEMALE	354	Oligodendroglioma	Central nervous system	Alive	G3	0	354			TUMOR FREE		64	Not Available	Not Available	Not Available	TCGA-P5-A72Z	141F0546-F6F2-408F-AC86-07CA4AADF3D0	13	-23482	Not Applicable	0	8	Not Available	Not Available	TCGA-P5-A72Z-D69022	8591DB4B-A198-444D-BC08-90FEB7D6C77B	Not Available	24	Not Available	270	Temozolomide	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A72Z-F69020	3150BD46-CE53-43C6-AB49-00BFFFDEFF84	24	Not Available	Not Available	Not Applicable	354	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Not Available	YES	Unknown	YES	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Oligodendroglioma	Not Available	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A72Z	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A72Z-R69021	CE59405A-F826-4865-983B-0AC92E1F23A0	Not Available	24	50	21	Unknown	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-TQ-A7RS	25	FEMALE		Oligodendroglioma	Central nervous system		G2	0				TUMOR FREE		25	NO	Not Available	NO	TCGA-TQ-A7RS	44553E34-5111-40A8-B76A-254751BE3F87	30	-9172	Not Applicable	0	-1	Not Available	-1																								0	NO	HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RS-F65577	EA77D613-48FF-4BF1-94CD-FA307913CC74	30	Not Available	Not Available	Not Applicable	-1	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	YES	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	Not Available	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	10	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RS	Preoperative	TUMOR FREE	NO	NO	NO	Complete Remission/Response	WHITE	NO																			NO	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-S9-A6UA	66	MALE	178	Astrocytoma	Central nervous system	Dead	G3	1	161.0			WITH TUMOR		66	NO	Not Available	NO	TCGA-S9-A6UA	E6B7420F-4315-46A8-AED5-5C47CCE5DED3	4	-24242	178	0	Not Available	Not Available	-6																								2	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	NO	NO	NO	Not Available	TCGA-S9-A6UA-F51947	BA3390FC-13C2-4F4A-80E3-59AC6AAD4299	26	Not Available	Not Available	178	Not Available	161	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Dead	2013	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	60	Right	Not Available	Not Available	NO	YES	NO	11	NO	G3	NO	NO	161	NO	Not Available	Not Available	Not Available	YES	No	A6UA	Preoperative	WITH TUMOR	NO	NO	NO	Progressive Disease	WHITE	NO																			NO	NO	Deep Gray (e.g.basal ganglia, thalamus)	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2013	2008
TCGA-DB-5270	38	FEMALE	3733	Oligoastrocytoma	Central nervous system	Alive	G3	0	3733			TUMOR FREE		38	YES	Bee/Wasp	NO	TCGA-DB-5270	b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4	3	-13904	Not Applicable	0	2977	Not Available	Not Available	TCGA-DB-5270-D14213	8ec0b3e1-0428-4a80-97a0-39638ce7d944	Not Available	22	917	761	BCNU	Not Available	7	3	200	mg/m2	RECURRENCE	Not Applicable	1	IV	NO	Chemotherapy	Not Available	1080	mg	Not Available	2011	Not Available	NO	NOT HISPANIC OR LATINO	Not Available	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-5270-F42829	00DEBF96-99E9-455F-AA34-9778258E5C41	1	Not Available	Not Available	Not Applicable	3733	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5270	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DB-5270-R14211	00afb91c-fc75-41cf-8d6b-8b24dfaf1e8c	1	22	806	761	Not Available	7	33	5940	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2002
TCGA-DU-A7T8	35	MALE	4229	Oligoastrocytoma	Central nervous system	Dead	G3	1	3009.0			WITH TUMOR		35	NO	Not Available	NO	TCGA-DU-A7T8	04E6E843-7F31-43DA-B111-280CE2BD1949	23	-13108	Not Applicable	0	3787	Not Available	80	TCGA-DU-A7T8-D54838;TCGA-DU-A7T8-D54839;TCGA-DU-A7T8-D54840;TCGA-DU-A7T8-D71630;TCGA-DU-A7T8-D71631;TCGA-DU-A7T8-D71632	B31AF3E2-7AC3-4677-A9D2-FF5D4D0C368B;BB8C1762-3228-4014-88BF-A3056543F75F;76C09742-BA08-49FB-85A5-CBFA20A15108;D69B0F68-C3EC-47F6-B0DC-522C299B0887;BE695CC6-4636-4C29-BDB6-A048860C0217;60D3734B-23AB-40A3-9D2E-8A85A22BC4A0	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;27;27;27	193;407;3215;3901;4194;4194	147;211;3061;3865;4001;4001	Temozolomide;Temozolomide;Temozolomide;Temozolomide;Lomustine (CCNU);bevacizumab	Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	12;12;12;3;3;3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2013;2013;2013;2015;2015;2015	Not Evaluated	YES	NOT HISPANIC OR LATINO	NO	NO	< 12 Years	Not Available	Not Available	Mental Status Changes	91 - 180 Days	YES	NO	YES	YES	TCGA-DU-A7T8-F71629	3E8CDE54-B7B1-47D6-8B6D-F534A7B09314	27	3028	3759	4229	Not Available	3009	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2015	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	YES	NO	12	YES	G3	YES	NO	3028	YES	3028	Not Available	Not Available	YES	No	A7T8	Other	WITH TUMOR	YES	Unknown	Unknown	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DU-A7T8-R54837	B6FCEC32-4838-450A-8639-4618EFF7D721	Not Available	23	193	147	Stable Disease	12	27	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	YES	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2003
TCGA-FG-6690	70	MALE	1294	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		70	NO	Not Available	NO	TCGA-FG-6690	ad202887-88b3-4e0f-a4c3-7e135d4cb258	22	-25667	Not Applicable	0	143	Not Available	-23																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-FG-6690-F15474;TCGA-FG-6690-F32857;TCGA-FG-6690-F41567;TCGA-FG-6690-F63742	2da98bec-a2b3-4e27-8f10-cd1d23205528;282419D8-096B-4594-9188-959D226B53A6;3E399F42-4524-4AED-895A-0BE23E9EFD88;51D994FD-83FF-4B58-A03E-F9F378DAB196	22;14;21;15	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	143;391;760;1294	Not Available;Not Available;Not Available;Not Available	-23;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease;Stable Disease;Stable Disease	90;Not Available;Not Available;Not Available	Not Available;Not Available;NO;NO	8;6;3;8	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	Preoperative;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO;NO	Stable Disease;Stable Disease;Stable Disease;Stable Disease	YES;YES;YES;YES	Alive;Alive;Alive;Alive	2011;2012;2013;2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6690	Preoperative	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-6690-R15476	c72cae0d-d191-4c25-82d4-4d1c1d7c7723	1	22	111	73	Not Available	8	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2011
TCGA-HT-A5RA	65	FEMALE	832	Astrocytoma	Central nervous system	Alive	G3	0	832			WITH TUMOR		65	NO	Not Available	NO	TCGA-HT-A5RA	5A2D3BFA-4BDD-417D-9796-E3699760114C	5	-23769	Not Applicable	0	447	Not Available	244	TCGA-HT-A5RA-D46308	2A957B8F-61B9-4634-A9CE-D22F4F67B074	Not Available	5	235	13	Temodar	Partial Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Unknown	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A5RA-F61263	5FEE73BB-44AB-4D22-A1BA-6156B2D76DA4	26	Not Available	Not Available	Not Applicable	832	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	Unknown	YES	Partial Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	70	Right	Not Available	Not Available	Unknown	NO	NO	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5RA	Post-Adjuvant Therapy	WITH TUMOR	YES	Unknown	Unknown	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A5RA-R46306	DFDCD236-77C2-4159-9B4C-73D98A5DEEEA	Not Available	5	68	22	Partial Response	8	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-HT-A61B	22	MALE	533	Astrocytoma	Central nervous system	Alive	G3	0	533			TUMOR FREE		22	Unknown	Not Available	Unknown	TCGA-HT-A61B	CF2A1B98-5693-4C04-9167-F85E69A88A4A	13	-8335	Not Applicable	0	225	Not Available	Not Available	TCGA-HT-A61B-D48470	F865162E-9AF6-4DD6-9974-B16488CE6DEF	Not Available	13	Not Available	36	Temodar	Not Applicable	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Unknown	Unknown	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A61B-F61305	0DC07C0A-686E-4E73-847A-A5B80614CC2C	26	Not Available	Not Available	Not Applicable	533	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	Unknown	Not Available	MALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	80	Left	Not Available	Not Available	Unknown	YES	Unknown	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A61B	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A61B-R48469	DD860742-2FF5-4196-ACAC-51E77F682703	Not Available	22	67	36	Complete Response	11	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-S9-A7IZ	48	FEMALE	608	Astrocytoma	Central nervous system	Alive	G3	1	467.0			WITH TUMOR		48	NO	Not Available	NO	TCGA-S9-A7IZ	01A13ABA-74A4-4895-A5AD-E5119925C202	12	-17874	Not Applicable	0	128	Not Available	-5	TCGA-S9-A7IZ-D69999;TCGA-S9-A7IZ-D70000	B9C4EB70-267B-4314-9FE4-2BFE19D7C031;DDFDB90E-229B-4832-9BC3-6F0B2284E684	Not Available;Not Available	26;26	Not Available;Not Available	603;603	Carmustine;Teniposide	Stable Disease;Stable Disease	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2015;2015	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;YES	Not Available;NO	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A7IZ-F62947;TCGA-S9-A7IZ-F69998	452E4698-B415-4DA8-A766-31E1EFFE9CB7;305847F9-F721-44D5-B465-AE1DF8FCC32F	29;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	217;608	Not Available;467	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Partial Remission/Response;Partial Remission/Response	YES;YES	Alive;Alive	2014;2015	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Left	YES	IHC	YES	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7IZ	Preoperative	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A7IZ-R54304	30A0EC7E-9C56-4739-8DF9-E543F3F09DA5	Not Available	18	85	42	Stable Disease	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-P5-A77X	55	FEMALE	105	Oligoastrocytoma	Central nervous system	Alive	G2	0	105			TUMOR FREE		55	Not Available	Not Available	Not Available	TCGA-P5-A77X	878CED76-3144-4141-896F-50E3E863DF36	13	-20128	Not Applicable	0	4	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A77X-F69029	45EA1014-D5C2-4D78-8440-B7157D0F0DDE	24	Not Available	Not Available	Not Applicable	105	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Oligoastrocytoma	Not Available	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A77X	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A77X-R69030	5E0D4234-FB97-4BE2-82DA-05582A3C072C	Not Available	24	105	63	Unknown	12	Unknown	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-DB-5273	33	MALE	2493	Astrocytoma	Central nervous system	Alive	G3	0	2493			TUMOR FREE		33	NO	Not Available	NO	TCGA-DB-5273	ae2db022-eb4f-4b65-89b6-9fd4439ddeef	3	-12152	Not Applicable	0	1809	Not Available	Not Available	TCGA-DB-5273-D14441;TCGA-DB-5273-D14250	550b69bc-23b1-44c5-be57-7ecb3c5808a7;0639f52e-b0e8-4d1f-b84f-1f89647234c7	Not Available;Not Available	Not Available;22	302;74	74;17	Temodar;Temodar	Not Available;Not Available	7;7	6;6	200;75	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	12450;6720	mg;mg	Not Available;Not Available	2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-5273-F42830	BAD1B51F-5A85-4E0F-979B-99FD7B73E07D	1	Not Available	Not Available	Not Applicable	2493	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	Not Available	Not Available	YES	Complete Remission/Response	YES	Alive	2013	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	5	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5273	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DB-5273-R14243	081e2e6c-b7b1-41ac-9ebd-6809e42764ab	1	22	69	17	Not Available	7	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2006
TCGA-RY-A83X	46	FEMALE	939	Oligodendroglioma	Central nervous system	Alive	G2	0	939			TUMOR FREE		46	Not Available	Not Available	NO	TCGA-RY-A83X	739CC9F1-71BE-4F81-A5D1-EDA673903E45	7	-16911	Not Applicable	0	938	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-RY-A83X-F69371	D1FF61B1-0207-44B7-8D81-BD3EA2A2AC5B	7	Not Available	Not Available	Not Applicable	939	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Applicable	NO	Alive	2015	Not Available	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	YES	IHC	YES	YES	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A83X	Not Evaluated	TUMOR FREE	NO	Not Available	Not Available	Not Applicable	WHITE	NO																			NO	NO	Cerebral Cortex	YES	NO	RY	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-DU-6407	35	FEMALE	2875	Oligodendroglioma	Central nervous system	Dead	G2	1	2397.0			WITH TUMOR		35	Not Available	Not Available	Not Available	TCGA-DU-6407	70939245-41e0-4845-a473-5fef719b9828	19	-13021	2875	0	Not Available	Not Available	2451	TCGA-DU-6407-D14953;TCGA-DU-6407-D14954;TCGA-DU-6407-D14955;TCGA-DU-6407-D14956	68261acf-ff6e-43d0-988b-57cd040ec0be;b946be0f-487d-4707-9e9c-c8564ed98487;51323f8f-090f-40a1-b44e-7cb7117bd90f;d0c4833a-a750-4848-84b9-24bb8743c492	Not Available;Not Available;Not Available;Not Available	20;20;20;20	2516;2774;2853;2853	2473;2531;2835;2836	Temozolomide;Temozolomide;Temozolomide;Afatinib	Not Available;Not Available;Not Available;Not Available	6;6;6;6	1;8;1;1	75;150;150;50	mg/m2;mg/m2;mg/m2;mg/day	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;3;3	PO;PO;PO;PO	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	140;280;135;50	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	Not Available	YES	YES	YES	YES	TCGA-DU-6407-F14950	122ac653-5846-4d93-aadf-3e1cd3689ac9	20	2415	2797	2875	Not Available	2397	2838	Not Available	Not Available	Progressive Disease	80	Not Available	6	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6407	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Local Recurrence;Primary Tumor Field	TCGA-DU-6407-R14952;TCGA-DU-6407-R14951	00ad2a0e-77ed-469d-aa96-65fbc903753f;0535a100-d40d-436a-875a-1ad2f2d08709	2;1	20;20	2516;72	2473;31	Not Available;Not Available	6;6	30;30	5400;5400	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	PROGRESSION;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Discrepancy	Central nervous system	NO	Dead	2011	2001
TCGA-HT-8010	64	FEMALE	50	Oligodendroglioma	Central nervous system	Alive	G2	0	50			Not Available		64	NO	Not Available	NO	TCGA-HT-8010	114902c7-77b2-42ca-926b-6895e6db5e36	2	-23680	Not Applicable	0	50	Not Available	Not Available																								Not Available	NO	HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8010-F32622	a50e614c-a87f-48d3-8084-96a63a9ea0f8	4	Not Available	Not Available	Not Applicable	50	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	5	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8010	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-S9-A6TX	46	MALE	1245	Oligodendroglioma	Central nervous system	Alive	G3	1	856.0			WITH TUMOR		46	NO	Not Available	NO	TCGA-S9-A6TX	432FE4A9-2CDC-4323-AFF0-59E2FDEDA194	31	-17025	Not Applicable	0	856	Not Available	-34	TCGA-S9-A6TX-D54122	79C328DC-965E-4B79-BE0D-C28DC492D171	Not Available	17	856	268	Temozolomide	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6TX-F62924;TCGA-S9-A6TX-F69524	91D5E826-F407-414E-B1BA-ED1C5334A4AC;6BF62AEC-FDE0-4175-A8B3-48A31F3789DF	29;13	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1049;1245	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Partial Remission/Response;Partial Remission/Response	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	NO	NO	10	NO	G3	NO	YES	856	NO	Not Available	Not Available	Not Available	YES	No	A6TX	Preoperative	WITH TUMOR	YES	NO	NO	Complete Remission/Response	WHITE	NO	Primary Tumor Field	TCGA-S9-A6TX-R54123	5BC96D31-6668-433C-B9B5-1A86A745B970	Not Available	17	Not Available	875	Not Applicable	12	30	60	YES	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-FG-5963	23	MALE	775	Astrocytoma	Central nervous system	Dead	G3	1	395.0			WITH TUMOR		23	YES	Not Available	NO	TCGA-FG-5963	68f550ca-3a33-45e4-b1c9-14f99e543263	30	-8571	Not Applicable	0	547	Not Available	0	TCGA-FG-5963-D9984;TCGA-FG-5963-D42999;TCGA-FG-5963-D43000;TCGA-FG-5963-D43015	cfce2c0b-61d3-452b-ba97-2eed34aca74b;B2B918A8-6647-4CAA-A5BA-E962B2ED4CD1;CC00B63C-9810-4ADC-A195-77E5574FD002;7A6CD594-2F09-408B-BD86-DA385019EF0D	Not Available;Not Available;Not Available;Not Available	13;7;7;8	471;690;727;700	428;517;511;699	Temodar;Temodar;Avastin;BCNU	Not Available;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	4;5;5;5	1;Not Available;Not Available;Not Available	140;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	PROGRESSION;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;Not Available;Not Available;Not Available	PO;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	5880;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	Not Available;NO;NO;NO	2011;2013;2013;2013	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	12 - 20 Years	12 - 20 Years	Not Available	Seizures	0 - 30 Days	YES;YES	YES;NO	YES;NO	NO;Not Available	TCGA-FG-5963-F9672;TCGA-FG-5963-F42259	a711d2ed-a41e-479f-94fe-a18948de3473;E8210AB9-765A-4A6D-9E68-6E0965C8DB94	30;7	395;Not Available	Not Available;Not Available	Not Applicable;775	547;Not Available	395;497	106;Not Available	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	90;Not Available	Not Available;NO	3;5	Not Available;Not Available	YES;YES	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	NO;YES	Progressive Disease;Progressive Disease	YES;YES	Alive;Dead	2011;2013	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	YES	YES	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5963	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Local Recurrence	TCGA-FG-5963-R9981;TCGA-FG-5963-R10485	0e06b514-749a-421f-aa84-10748dd034a6;89e458be-bbf0-4f1c-8b7b-620408928df3	1;2	4;19	76;471	37;437	Not Available;Not Available	4;4	30;30	6000;6000	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;PROGRESSION	Not Available;Not Available	cGy;cGy	2011;2011	YES	NO	White Matter	NO	YES	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2009
TCGA-HT-7602	21	MALE	908	Oligodendroglioma	Central nervous system	Alive	G2	0	908			TUMOR FREE		21	NO	Not Available	NO	TCGA-HT-7602	799e9106-e62e-4681-8861-137f474ee8b8	7	-7946	Not Applicable	0	908	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7602-F29573	22c14639-d790-4df7-9b57-94252d8621e9	16	Not Available	Not Available	Not Applicable	908	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	NO	Alive	2012	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7602	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-S9-A7J0	30	FEMALE	609	Oligodendroglioma	Central nervous system	Alive	G3	1	390.0			WITH TUMOR		30	NO	Not Available	NO	TCGA-S9-A7J0	6A8241A8-D9EE-414B-89FD-4C3B9F181CC7	12	-10989	Not Applicable	0	285	Not Available	-7	TCGA-S9-A7J0-D54307;TCGA-S9-A7J0-D54310;TCGA-S9-A7J0-D65753;TCGA-S9-A7J0-D65754;TCGA-S9-A7J0-D72437	DA526546-EB02-46C7-B69F-63AC4DFD56AA;C9C5DF99-F530-4B6D-9195-CC37B9204FBD;421479EA-E7D1-4071-8BBD-540D82CB1276;A5356BD0-A2E0-4228-9FC0-DA26B028EAA5;8AE0AFC4-FBE5-4DE9-B572-FE5E5E766EDA	Not Available;Not Available;Not Available;Not Available;Not Available	18;18;30;30;16	91;Not Available;443;609;609	59;126;399;490;546	Temozolomide;Temozolomide;Carmustine;Bevacizumab;Irinotecan	Stable Disease;Not Available;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	12;12;9;9;6	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;YES;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2013;2013;2014;2014;2015	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	Not Available	Not Available	TCGA-S9-A7J0-F65752	5C44FD0A-3E71-4109-82D2-8052860C24FF	30	Not Available	Not Available	Not Applicable	609	390	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	9	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2014	YES	Citrus fruits	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	100	Right	NO	IHC	YES	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7J0	Preoperative	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A7J0-R54306	83A8B29B-06E7-41EF-B07D-2FF71A477D24	Not Available	18	101	59	Stable Disease	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-7877	20	FEMALE	4	Oligodendroglioma	Central nervous system	Alive	G2	0	4			Not Available		20	NO	Not Available	NO	TCGA-HT-7877	ea7f3ed6-e44b-49a1-8b5c-ce35539e7bdf	1	-7581	Not Applicable	0	4	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7877-F29672	3ccd7a35-bec1-4c9d-90eb-27253a3deb4f	19	Not Available	Not Available	Not Applicable	4	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Not Available	NO	Alive	2012	NO	Not Available	FEMALE	YES	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	3	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7877	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-TQ-A7RJ	25	FEMALE	1229	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		25	NO	Not Available	NO	TCGA-TQ-A7RJ	DF78E63D-4387-4177-B24F-F0E2C6C7AC32	25	-9209	Not Applicable	0	1229	Not Available	Not Available																								Not Evaluated	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RJ-F65494	F6BCC566-0F0C-4000-9923-DAA50081990A	25	Not Available	Not Available	Not Applicable	1229	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	NO	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RJ	Preoperative	WITH TUMOR	YES	NO	NO	Stable Disease	WHITE	YES																			NO	YES	White Matter	NO	YES	TQ	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-DU-7299	33	MALE	1339	Astrocytoma	Central nervous system	Dead	G3	1	675.0			WITH TUMOR		33	Not Available	Not Available	Not Available	TCGA-DU-7299	81622da8-9f36-4ea3-b223-d831d8c10f87	8	-12266	1339	0	Not Available	Not Available	7	TCGA-DU-7299-D18396;TCGA-DU-7299-D18395;TCGA-DU-7299-D18393;TCGA-DU-7299-D18392;TCGA-DU-7299-D18391	162e312c-756b-489c-a377-99bb5708bd8a;6c6d5e51-9acf-4db8-9c19-b46d4f36c3c5;a82d62eb-3489-4687-a17a-a46edf04c965;b7f97f91-d3bd-48ce-a985-648ac665dee8;70d4e8a3-8e0d-4bed-9501-38f2a5cbef65	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	1157;1016;945;456;70	945;721;721;91;28	Temozolomide;Bevacizumab;Irinotecan;Temozolomide;Temozolomide	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	7;6;3;12;1	75;10;125;200;75	mg/m2;mg/kg;mg/m2;mg/m2;mg/m2	PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;2;2;1;1	PO;IV;IV;PO;PO	NO;NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	140;911;256;420;160	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	YES	YES	NO	NO	TCGA-DU-7299-F18389	c1eca6e5-7cfd-4d10-8898-6d9ebcaea438	8	Not Available	Not Available	1339	Not Available	675	428	Not Available	Not Available	Progressive Disease	90	Not Available	11	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	Not Available	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7299	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Local Recurrence	TCGA-DU-7299-R18390;TCGA-DU-7299-R18394	6c98e241-d2bb-42ba-8a87-69670d404a76;ea9afc50-881a-404e-9c83-b5feb3280825	1;2	8;8	70;948	28;948	Not Available;Not Available	11;11	30;1	6000;1800	NO;NO	EXTERNAL BEAM;OTHER	Not Applicable;Stereotactic Radiosurger	ADJUVANT;PROGRESSION	Not Available;Not Available	cGy;cGy	2011;2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Parietal Lobe	Central nervous system	NO	Dead	2011	2006
TCGA-HT-8108	26	FEMALE	76	Oligodendroglioma	Central nervous system	Alive	G2	0	76			Not Available		26	NO	Not Available	NO	TCGA-HT-8108	81fb338f-1023-49aa-ac0f-ba763a6cd68c	3	-9539	Not Applicable	0	76	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8108-F32634	6ba76ca9-870b-4de0-9363-4e242cdf9218	4	Not Available	Not Available	Not Applicable	76	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8108	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-FG-A87Q	61	FEMALE	174	Astrocytoma	Central nervous system	Alive	G3	0	174			TUMOR FREE		61	Unknown	Not Available	NO	TCGA-FG-A87Q	7E17E6FD-ED83-471F-91E3-5934885C8E87	20	-22565	Not Applicable	0	174	Not Available	174	TCGA-FG-A87Q-D57695	57FB4361-A36C-441E-A313-DC2265AD2F82	Not Available	20	Not Available	48	Temodar	Not Applicable	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A87Q-F72685	5E8A32C5-C877-4CA1-96BC-11EE08E7C35E	31	Not Available	Not Available	Not Applicable	174	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	7	Not Available	Unknown	Not Available	Not Available	Not Available	YES	Complete Remission/Response	YES	Alive	2015	YES	Dairy/lactose	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	NO	IHC	YES	NO	NO	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A87Q	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-FG-A87Q-R57694	4A9E8788-48BB-4978-9156-49968F1AE67E	Not Available	20	88	48	Complete Response	3	29	58	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	White Matter	YES	NO	FG	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-P5-A5EZ	39	MALE	70	Astrocytoma	Central nervous system	Alive	G3	0	70			TUMOR FREE		39	YES	bee	Unknown	TCGA-P5-A5EZ	82FF7A48-EA97-476E-9F4E-AACDEB6659BD	22	-14375	Not Applicable	0	70	Not Available	Not Available																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	> 20 Years	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5EZ-F69044	EB9BD751-31DB-45FB-B4EE-FDAA734975DF	24	Not Available	Not Available	Not Applicable	70	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	Unknown	Unknown	8	Unknown	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5EZ	Not Evaluated	TUMOR FREE	Unknown	Unknown	Unknown	Unknown	WHITE	Unknown																			YES	Unknown	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Unknown	Alive	2013	2012
TCGA-DU-7309	41	FEMALE	84	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		41	Not Available	Not Available	Not Available	TCGA-DU-7309	ca427acb-034e-42e2-961a-b9d5dc30b741	4	-15197	Not Applicable	0	84	Not Available	11	TCGA-DU-7309-D17511	48a26f12-7ec5-410e-827f-8728eae7a1f5	Not Available	4	84	41	Temozolomide	Not Available	10	1	75	mg/m2	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	140	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	NO	NO	NO	NO	TCGA-DU-7309-F17509	3cf8d1ae-19f1-44a9-a6f5-24f97ff367b6	4	Not Available	Not Available	Not Applicable	84	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	Not Available	10	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7309	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7309-R17510	07a1ad6c-37da-4a97-b90f-c2c07c4f9f78	1	4	84	41	Not Available	10	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	YES	Cerebral Cortex	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2011	2011
TCGA-DU-A6S6	35	FEMALE	2893	Oligoastrocytoma	Central nervous system	Alive	G2	1	2267.0			WITH TUMOR		35	NO	Not Available	NO	TCGA-DU-A6S6	3BAA0015-885C-487A-9076-236F404FEB3E	22	-12809	Not Applicable	0	2372	Not Available	184	TCGA-DU-A6S6-D50317;TCGA-DU-A6S6-D50318;TCGA-DU-A6S6-D71618	87C4496C-1A16-4364-910C-E394CEC958FA;2820AAAD-AA7B-470E-944B-24A751CB3616;92B51D0D-4FD1-40A7-84ED-BCAB8709BC97	Not Available;Not Available;Not Available	22;22;27	272;Not Available;2492	25;2283;2281	Temozolomide;Temozolomide;Temozolomide	Stable Disease;Not Applicable;Stable Disease	10;10;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2015	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	< 12 Years	Not Available	Not Available	Headaches	31 - 90 Days	YES	NO	YES	Not Available	TCGA-DU-A6S6-F71617	7BEEB7BC-8363-4B89-BEE4-871F140799D6	27	2277	Not Available	Not Applicable	2893	2277	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	TUMOR FREE	YES	Discrepancy	NO	Alive	2015	NO	Not Available	FEMALE	YES	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	10	NO	G2	YES	NO	2267	YES	2267	Not Available	Not Available	YES	No	A6S6	Other	WITH TUMOR	YES	NO	NO	Discrepancy	WHITE	NO																			NO	NO	White Matter	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2007
TCGA-DH-5141	32	MALE	968	Oligodendroglioma	Central nervous system	Alive	G3	0	968			Not Available		32	NO	Not Available	NO	TCGA-DH-5141	2cf49bac-dea1-45ff-9e1d-09f5a2ac5215	17	-11846	Not Applicable	0	968	Not Available	Not Available	TCGA-DH-5141-D6519;TCGA-DH-5141-D6516	b304c8a9-f632-4a44-8e84-83cc51ce5600;d266f15b-21b0-4d1a-9585-36f36703aead	Not Available;Not Available	17;17	Not Available;936	Not Available;890	Temozolomide;Temozolomide	Not Available;Not Available	12;12	Not Available;1	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	Not Available;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	NO	HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	Not Available	Not Available;Unknown	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	TCGA-DH-5141-F6514;TCGA-DH-5141-F66668	fbc28c13-d762-4fda-bcca-c71dad6d2b49;F949EFBC-4B3F-4E66-AD99-9A6AAB796B10	8;22	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	968;968	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;YES	12;10	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2010;2014	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5141	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DH-5141-R6515	39dc4cf6-533f-44ff-be35-4fe718dd0be3	1	17	936	890	Not Available	12	33	5990	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	NO	NO	Cerebral Cortex	NO	YES	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2010	2005
TCGA-S9-A7R4	46	MALE	914	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		46	NO	Not Available	NO	TCGA-S9-A7R4	58650D08-7685-41DE-9AE0-21665F8F449F	11	-17134	Not Applicable	0	530	Not Available	-8	TCGA-S9-A7R4-D53375	E79715B3-C0A5-477E-B0D5-63850FCF96B2	Not Available	11	161	54	Temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Unknown	Unknown	Not Available	Not Available	TCGA-S9-A7R4-F67313	D96D1118-4B6D-45E9-BA74-43A6C21D2B05	4	Not Available	Not Available	Not Applicable	914	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	11	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Left	YES	IHC	YES	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7R4	Preoperative	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A7R4-R53373	10D392F2-A18D-4450-8811-302FEAB94975	Not Available	11	161	54	Stable Disease	12	30	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-KT-A74X	26	MALE	438	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		26	YES	Cat Dander	Unknown	TCGA-KT-A74X	442DF188-B678-45BB-BD9D-7071ED8AAA5A	30	-9590	Not Applicable	0	159	Not Available	Not Available	TCGA-KT-A74X-D55168	1D267D32-E728-4D81-80CC-6F90AC480D07	Not Available	30	83	40	Temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Unknown	Unknown	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-KT-A74X-F69145	C727A596-5419-4239-87C0-F17471C31E25	30	Not Available	Not Available	Not Applicable	438	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	12	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	Unknown	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Left	YES	IHC	YES	YES	NO	12	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A74X	Unknown	WITH TUMOR	YES	Unknown	Unknown	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-KT-A74X-R55166	C7E2E66E-C235-41A7-9891-0D1FB949CBBB	Not Available	30	83	40	Stable Disease	12	30	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	Unknown	Not listed in Medical Record	YES	NO	KT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-7681	29	FEMALE	1359	Oligoastrocytoma	Central nervous system	Alive	G2	0	1359			TUMOR FREE		29	Unknown	Not Available	Unknown	TCGA-HT-7681	fbe32b94-b3ba-4a56-aeba-4cffe8de2da4	16	-10790	Not Applicable	0	1359	Not Available	Not Available																								Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7681-F45882	90270A0E-EF04-4A7A-B25A-97BE90821D62	24	Not Available	Not Available	Not Applicable	1359	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	Unknown	Not Available	FEMALE	Unknown	Unknown	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Unknown	Right	Not Available	Not Available	Unknown	Unknown	Unknown	7	Unknown	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	7681	Not Available	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	NO																			Unknown	Unknown	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	Unknown	Alive	2013	2009
TCGA-S9-A7R2	69	MALE	316	Astrocytoma	Central nervous system	Dead	G3	0	316			WITH TUMOR		69	NO	Not Available	NO	TCGA-S9-A7R2	8E44FB97-C649-4056-80AC-257CEF61D226	12	-25419	316	0	Not Available	Not Available	-2																								1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days																														NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7R2	Preoperative	WITH TUMOR	NO	YES	NO	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-S9-A7R2-R52669	1FE6B175-8555-4F65-B38C-31F1110D12E0	Not Available	5	102	59	Radiographic Progressive Disease	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2013	2008
TCGA-P5-A72U	71	FEMALE	7	Oligodendroglioma	Central nervous system	Alive	G3	0	7			TUMOR FREE		71	Not Available	Not Available	Not Available	TCGA-P5-A72U	49D5ACBB-D75C-4485-B456-6B50667FEF99	13	-26002	Not Applicable	0	5	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A72U-F69015	A660818C-7861-416E-A69A-D3A5249D7F8F	24	Not Available	Not Available	Not Applicable	7	Not Available	Not Available	Not Available	Additional New Tumor Event	Not Available	Not Available	NO	12	Not Available	NO	Not Available	Not Available	Not Available	NO	Complete Remission/Response	NO	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Oligodendroglioma	Not Available	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A72U	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Unknown	WHITE	Unknown																			Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Parietal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-QH-A6CW	43	MALE	414	Oligoastrocytoma	Central nervous system	Alive	G3	0	414			WITH TUMOR		43	NO	Not Available	YES	TCGA-QH-A6CW	FE5C5C11-EF39-4907-9A70-67F37BB62FD7	2	-15847	Not Applicable	0	-1	Not Available	-8																								1	NO	NOT HISPANIC OR LATINO	NO	NO	> 20 Years	Not Available	Not Available	Seizures	31 - 90 Days	NO	NO	NO	Not Available	TCGA-QH-A6CW-F60337	D0EE6C9D-B9BF-4D05-9D17-8E26525F3FC4	6	Not Available	Not Available	Not Applicable	414	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	MALE	YES	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	YES	IHC	YES	NO	YES	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6CW	Preoperative	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	NO																			YES	NO	White Matter	YES	NO	QH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-W9-A837	47	MALE	1553	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		47	Not Available	Not Available	NO	TCGA-W9-A837	732DF38E-D32C-4D63-AC97-AD655E2E5732	6	Not Available	Not Applicable	0	1371	Not Available	610																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-W9-A837-F66176	37A74666-7CA6-41F5-9F3C-9BAC4C363477	3	Not Available	Not Available	Not Applicable	1553	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	10	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2014	Not Available	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	3	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A837	Not Available	WITH TUMOR	NO	YES	Not Available	Stable Disease	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	W9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-HT-8015	21	MALE	3	Astrocytoma	Central nervous system	Alive	G2	0	3			TUMOR FREE		21	Not Available	Not Available	Not Available	TCGA-HT-8015	81076cfb-f9d7-4add-b696-6eab0bad7945	12	-7760	Not Applicable	0	3	Not Available	Not Available																								Unknown	Not Available	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available																														Not Available	Not Available	MALE	Not Available	Unknown	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	Unknown	Left	Not Available	Not Available	Unknown	Unknown	Not Available	9	Unknown	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	8015	Unknown	TUMOR FREE	Unknown	Unknown	Unknown	Complete Remission/Response	WHITE	Unknown																			Unknown	Unknown	Deep Gray (e.g.basal ganglia, thalamus)	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	Unknown	Alive	2013	2008
TCGA-DH-A669	70	MALE	919	Oligodendroglioma	Central nervous system	Dead	G3	1	260.0			TUMOR FREE		70	Unknown	Not Available	NO	TCGA-DH-A669	76E54EF6-1799-4FD9-BEC3-0EA960E8461E	25	-25809	919	0	Not Available	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days																														NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	YES	NO	6	YES	G3	YES	YES	260	YES	426	Not Available	Not Available	YES	No	A669	Not Evaluated	TUMOR FREE	NO	NO	YES	Stable Disease	WHITE	NO																			NO	NO	Not listed in Medical Record	NO	YES	DH	Supratentorial, Parietal Lobe	Central nervous system	NO	Dead	2013	2007
TCGA-HT-A614	47	MALE	82	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		47	Unknown	Not Available	Unknown	TCGA-HT-A614	001AD307-4AD3-4F1D-B2FC-EFC032871C7E	18	-17392	Not Applicable	0	82	Not Available	Not Available																								Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A614-F61087	95D27036-BB79-48BF-96AE-459308B69896	23	Not Available	Not Available	Not Applicable	82	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	YES	6	Not Available	Unknown	Not Available	Not Available	WITH TUMOR	Unknown	Partial Remission/Response	Unknown	Alive	2014	Unknown	Not Available	MALE	Unknown	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	Unknown	Right	Not Available	Not Available	Unknown	YES	Unknown	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A614	Not Available	WITH TUMOR	Unknown	YES	Unknown	Partial Remission/Response	WHITE	Unknown																			YES	YES	Not listed in Medical Record	NO	YES	HT	Supratentorial, Not Otherwise Specified	Central nervous system	NO	Alive	2013	2013
TCGA-DU-6394	53	MALE	682	Oligodendroglioma	Central nervous system	Dead	G3	1	353.0			WITH TUMOR		53	Not Available	Not Available	Not Available	TCGA-DU-6394	42cc9620-98fb-4164-a3b2-28d084ca5a03	21	-19541	682	0	Not Available	Not Available	Not Available	TCGA-DU-6394-D14777;TCGA-DU-6394-D14766;TCGA-DU-6394-D14778	1d863f0f-4a4c-4b5b-b142-3679d22bd91c;da2a97a2-bcd0-47dd-bd02-2f76d3e2fd75;42abc1ed-a79a-4973-843d-f35f70b1343e	Not Available;Not Available;Not Available	27;27;27	459;278;Not Available	459;94;Not Available	PCV;PCV;Hydroxyurea	Not Available;Not Available;Not Available	5;5;5	1;6;1	Not Available;Not Available;500	Not Available;Not Available;mg/day	PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;500	Not Available;Not Available;mg/day	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	NO	NO	TCGA-DU-6394-F14761	08df9e55-ea0b-4445-9aed-a4c079e1a02f	27	Not Available	Not Available	682	Not Available	353	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Midline	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6394	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Local Recurrence	TCGA-DU-6394-R14762;TCGA-DU-6394-R14763	8ed2ae9e-3abe-439f-b43a-c6ea170ca7f8;18151d61-fb54-495f-a7e9-64076e1c71fa	1;2	27;27	Not Available;404	Not Available;404	Not Available;Not Available	5;5	Not Available;1	Not Available;Not Available	NO;NO	EXTERNAL BEAM;OTHER	Not Applicable;Radiosurgery	ADJUVANT;PROGRESSION	Not Available;Not Available	cGy;cGy	2011;2011	Not Available	Not Available	White Matter	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Dead	2011	1994
TCGA-DU-7009	32	FEMALE	4695	Oligodendroglioma	Central nervous system	Dead	G2	1	2960.0			WITH TUMOR		32	Not Available	Not Available	Not Available	TCGA-DU-7009	01c4ca12-ac08-41dd-9e4f-bfb0971688a2	28	-11854	Not Applicable	0	4206	Not Available	Not Available	TCGA-DU-7009-D17081	44d75b94-99ef-4bf1-8457-05af11d6ea97	Not Available	28	3279	3095	Temozolomide	Not Available	9	6	Not Available	mg/m2	PROGRESSION	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	31 - 90 Days	YES;YES	NO;YES	YES;YES	NO;Not Available	TCGA-DU-7009-F17078;TCGA-DU-7009-F46593	2495d396-f1f7-4834-bbed-5e9f3150852a;917784DD-44CF-4D05-B374-ECFD634542A7	28;12	3091;3091	Not Available;Not Available	Not Applicable;4695	4206;Not Available	2960;2960	3274;Not Available	Not Available;Not Available	Not Available;Additional New Tumor Event	Stable Disease;Progressive Disease	100;Not Available	Not Available;NO	9;8	Not Available;Not Available	YES;YES	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	NO;YES	Progressive Disease;Progressive Disease	YES;YES	Alive;Dead	2011;2013	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7009	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7009-R17080	c8574d31-8c5c-473c-826c-d78a4271de35	1	28	81	20	Not Available	9	33	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	YES	Cerebral Cortex	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2000
TCGA-P5-A736	44	FEMALE	230	Astrocytoma	Central nervous system	Alive	G3	0	230			TUMOR FREE		44	Not Available	Not Available	Not Available	TCGA-P5-A736	AC3779F6-CC8B-428B-9531-03562A614515	13	-16300	Not Applicable	0	8	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A736-F69025	3072CE7C-431C-49FA-B6CA-B85A11744A65	24	Not Available	Not Available	Not Applicable	230	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	Not Available	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A736	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A736-R69026	28B8293B-A2C2-4EFC-A0C7-00066F2D84A5	Not Available	24	230	32	Unknown	12	30 fr	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Parietal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-S9-A6WH	73	FEMALE	1173	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		73	NO	Not Available	NO	TCGA-S9-A6WH	0BDE34DD-DAE9-4533-98EF-F5A61A11E7C4	5	-26904	Not Applicable	0	697	Not Available	-14																								1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6WH-F63114;TCGA-S9-A6WH-F69989	BE50ADA6-92F8-4664-8D4B-98ECE5FAC585;9A7F0212-3FA1-48CD-B585-4A0CB61F7407	31;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	987;1173	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Partial Remission/Response;Partial Remission/Response	YES;YES	Alive;Alive	2014;2015	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	80	Right	YES	IHC	YES	YES	NO	11	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WH	Preoperative	WITH TUMOR	NO	NO	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6WH-R54280	F2CF49B6-F83C-43EF-8589-DBC5646C5FB9	Not Available	18	81	38	Stable Disease	12	33	54,9	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-WH-A86K	65	MALE	405	Astrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		65	NO	Not Available	NO	TCGA-WH-A86K	42156C6A-416E-4832-9C95-CEE6084B0910	14	-24055	Not Applicable	0	160	Not Available	20	TCGA-WH-A86K-D55918	0EA6C53F-4009-49B6-A854-8D10B5F7F352	Not Available	20	84	39	Temodar	Stable Disease	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-WH-A86K-F67062	84B642E4-93E8-4660-9CCB-39CC9CC9275B	4	Not Available	Not Available	Not Applicable	405	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	11	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	Not Evaluated	Right	YES	IHC	YES	NO	NO	1	YES	G2	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A86K	Pre-Adjuvant Therapy	WITH TUMOR	YES	Not Available	Not Available	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-WH-A86K-R55917	EA145174-F998-4E4A-B2C5-F78CF521533B	Not Available	20	84	39	Stable Disease	1	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	NO	YES	WH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-S9-A6WG	31	MALE	2602	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		31	NO	Not Available	NO	TCGA-S9-A6WG	A1192DF3-7667-4D1E-A1A0-79F6CC827DCF	5	-11509	Not Applicable	0	2146	Not Available	-12	TCGA-S9-A6WG-D54278	E826C6BB-BE8F-47ED-AB58-889FA1450494	Not Available	18	386	382	Temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6WG-F63112;TCGA-S9-A6WG-F69988	35DDA639-59D0-42F9-988C-A2C3395A8C73;3DE16DB7-B964-4A49-ADB0-D9D1086EBD3C	31;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	2437;2602	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	YES;YES	Alive;Alive	2014;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WG	Preoperative	WITH TUMOR	YES	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-S9-A6WG-R54277	7252AC65-0BBE-4D72-8BFB-9D7EFE850290	Not Available	18	71	28	Stable Disease	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2007
TCGA-DU-5851	40	FEMALE	531	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		40	Not Available	Not Available	Not Available	TCGA-DU-5851	55c78413-d102-4113-930e-6d842862fe75	8	-14802	Not Applicable	0	531	Not Available	17	TCGA-DU-5851-D15074;TCGA-DU-5851-D15073	1bff07b5-b100-4dc9-be59-bfeabebe8eaa;b08d6a07-2ac8-4949-adf8-26d8bab2f154	Not Available;Not Available	8;8	599;66	51;22	Temozolomide;Temozolomide	Not Available;Not Available	8;8	06;01	150;75	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	01;01	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	280;140	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-5851-F15071	4f33c857-2431-4cdd-934a-07dff90c57c6	8	Not Available	Not Available	Not Applicable	531	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5851	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-5851-R15072	493d05bf-6a04-4ff9-86c5-cbfd0d3b9c98	01	8	66	22	Not Available	8	30	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	YES	Cerebral Cortex	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-S9-A7R3	28	FEMALE	3013	Astrocytoma	Central nervous system	Alive	G2	1	970.0			WITH TUMOR		28	NO	Not Available	NO	TCGA-S9-A7R3	B7395082-415B-4AB3-BF1E-59D0F4E4B488	12	-10342	Not Applicable	0	2649	Not Available	-2																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	> 181 Days	NO	NO	Not Available	Not Available	TCGA-S9-A7R3-F62951	82ABE6E7-E150-4011-9359-D9DB6C13375F	29	Not Available	Not Available	Not Applicable	3013	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	7	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	12	NO	G2	NO	NO	970	YES	970	NO	Not Available	YES	No	A7R3	Preoperative	WITH TUMOR	NO	NO	NO	Partial Remission/Response	WHITE	NO																			NO	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2006
TCGA-DB-A4XA	30	MALE	573	Oligoastrocytoma	Central nervous system	Alive	G2	0	573			WITH TUMOR		30	NO	Not Available	NO	TCGA-DB-A4XA	AE61A71E-53A1-4884-A4A6-729744D1C309	21	-11195	Not Applicable	0	313	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XA-F60947	509F3547-FF88-4F84-97F9-2DB4906E089D	19	Not Available	Not Available	Not Applicable	573	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	6	Not Available	Unknown	Not Available	Not Available	Unknown	NO	Stable Disease	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.2	9382/3	C71.2	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	YES	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4XA	Not Available	WITH TUMOR	NO	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DB-A4XA-R40505	9389F8F3-3490-424A-AD9D-362B6E5467E9	Not Available	21	128	89	Stable Disease	2	30	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-R8-A6MO	53	FEMALE	993	Oligodendroglioma	Central nervous system	Alive	G2	0	993			Unknown		53	Not Available	Not Available	Not Available	TCGA-R8-A6MO	1EBDABEA-8931-47AF-A1CF-DE1BD1DE2A5B	30	-19432	Not Applicable	0	993	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available																														Not Available	Not Available	FEMALE	Not Available	Not Available	Oligodendroglioma	Not Available	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A6MO	Not Available	Unknown	NO	Not Available	Not Available	Not Available	ASIAN	NO																			YES	Not Available	Not Available	NO	YES	R8	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2013	2009
TCGA-E1-A7YN	63	FEMALE	727	Astrocytoma	Central nervous system	Dead	G3	1	420.0			WITH TUMOR		63	NO	Not Available	NO	TCGA-E1-A7YN	BCC17E9A-6FE3-44FF-963C-D2D850A431F1	9	-23180	727	0	Not Available	Not Available	20	TCGA-E1-A7YN-D61437;TCGA-E1-A7YN-D61438;TCGA-E1-A7YN-D61442;TCGA-E1-A7YN-D61444;TCGA-E1-A7YN-D61450;TCGA-E1-A7YN-D61451	1A1B6155-B8EB-4E11-BA47-F01D0C6670DD;74ABFEC7-A861-4AD2-B928-6152BE300B73;C21303E5-B241-4D5B-875A-8A02CA330EDB;74A352D0-4BEB-482A-8997-1116C31AD09A;8ED4B60C-CE8A-4638-830F-83A98961CAFD;6BAB6C63-2436-4CC9-B2C8-01B94C4FEF9F	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15	90;369;484;484;553;632	35;124;429;429;491;506	Temodar;Temodar;Avastin;Temodar;Avastin;CCNU	Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Visual Changes	0 - 30 Days	YES;YES	NO;YES	NO;NO	NO;NO	TCGA-E1-A7YN-F61441;TCGA-E1-A7YN-F61445	DCDF39DE-1439-4319-9DBC-9FF5E51E74F5;318B70C2-3AFA-496E-9A43-8A5B00F31DAA	15;15	Not Available;Not Available	Not Available;Not Available	727;727	Not Available;Not Available	420;485	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	8;8	Not Available;Not Available	YES;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Stable Disease;Stable Disease	YES;YES	Dead;Dead	2014;2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	NO	IHC	YES	NO	NO	6	NO	G3	NO	NO	420	NO	Not Available	NO	Not Available	YES	Yes, History of Prior Malignancy	A7YN	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Stable Disease	WHITE	YES	Unknown;Unknown	TCGA-E1-A7YN-R61435;TCGA-E1-A7YN-R61449	4447146D-70CD-4CBC-A04C-B171C3B8270C;E49737E7-90BA-454F-8357-17C3C2345BA9	Not Available;Not Available	15;15	90;499	35;495	Stable Disease;Radiographic Progressive Disease	8;8	30;5	6000;2500	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	NO	YES	Not listed in Medical Record	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	YES	Dead	2014	2010
TCGA-CS-6667	39	FEMALE	1469	Astrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		39	NO	Not Available	NO	TCGA-CS-6667	ae081e4a-efa9-4b52-b15e-29085c0612d3	24	-14375	Not Applicable	0	230	Not Available	-1																								1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	91 - 180 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-6667-F17581;TCGA-CS-6667-F71563	83b966e9-54f5-4f4a-9543-ce8cbf7c3d4e;2844E39E-9AC6-4776-9255-9894744DE265	1;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	230;1469	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	Not Available;Not Available	Not Available;NO	8;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;Not Available	Stable Disease;Stable Disease	YES;Not Available	Alive;Alive	2011;2015	NO	Not Available	FEMALE	YES	NO	Astrocytoma	NO	No	C71.9	9400/3	C71.9	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	YES	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6667	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-6667-R17582	f94c2f72-3441-4592-83d8-38777b0f1875	1	24	56	20	Not Available	9	27	Discrepancy	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	YES	Cerebral Cortex	NO	YES	CS	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-E1-A7YM	63	MALE	648	Astrocytoma	Central nervous system	Dead	G3	1	88.0			WITH TUMOR		63	NO	Not Available	NO	TCGA-E1-A7YM	4250AC3C-C8B0-46CE-B9C8-7963BC386041	12	-23263	648	0	Not Available	Not Available	11	TCGA-E1-A7YM-D61418;TCGA-E1-A7YM-D61420;TCGA-E1-A7YM-D61421;TCGA-E1-A7YM-D61422;TCGA-E1-A7YM-D61423;TCGA-E1-A7YM-D61424;TCGA-E1-A7YM-D61426;TCGA-E1-A7YM-D61427	D12571FF-CF1C-4376-8885-5B7847CBE49D;C19BA868-82B4-412A-8743-11B35002A24A;D5FB8A4A-6DF7-4FF6-8385-7687062849D3;63EF275B-6B0B-4476-B394-82070A5BCCB8;B35CE46A-7BDC-4879-A729-1EAE5D2F1392;53B68102-4413-48E8-9C09-F96B6B18859E;CB216B91-BE59-4485-99E3-A36277377673;229207F3-DA7E-413B-A97B-B2FB4D0A291E	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15;15;15	75;137;137;174;164;497;593;593	27;90;90;137;137;174;501;501	Temodar;Avastin;CPT-11;Avastin;VP-16;Avastin;Avastin;Carboplatin	Clinical Progressive Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease;Clinical Progressive Disease;Stable Disease;Stable Disease	8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	2014;2014;2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	YES	NO	NO	NO	TCGA-E1-A7YM-F61425	29BD014B-CD03-43CE-BFD1-13D9283FD4DC	15	Not Available	Not Available	648	Not Available	497	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Left	YES	IHC	YES	YES	NO	5	NO	G3	YES	NO	88	NO	Not Available	NO	Not Available	YES	No	A7YM	Pre-Adjuvant Therapy	WITH TUMOR	YES	NO	YES	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-E1-A7YM-R61417	14F232AE-B60B-4BDA-A806-B4D47D5113B4	Not Available	15	75	27	Radiographic Progressive Disease	8	Not Available	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2010
TCGA-E1-A7YL	46	MALE	492	Astrocytoma	Central nervous system	Dead	G3	1	91.0			WITH TUMOR		46	NO	Not Available	NO	TCGA-E1-A7YL	96D9249E-501C-49E0-9559-01DA978A9CA6	12	-16982	492	0	Not Available	Not Available	14	TCGA-E1-A7YL-D61291;TCGA-E1-A7YL-D61294;TCGA-E1-A7YL-D61295;TCGA-E1-A7YL-D61296;TCGA-E1-A7YL-D61298;TCGA-E1-A7YL-D61299	4317867D-7C62-469A-95AA-747361F74413;C0F27550-D2A5-4841-9DB5-5F2E51B66CB1;381F4079-84C8-43DF-9231-EB5855F3D737;3FCCA485-3EB4-434A-8384-FEB790C031C9;51D62C27-BDAA-41CB-8E94-6D04F00C02D2;6D0E7573-4BF2-4CFF-A210-88ADE42D77F3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15	78;289;263;249;336;325	36;103;103;103;298;298	Temodar;Avastin;Carboplatin;CPT-11;Avastin;VP-16	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	YES;NO	NO;NO	NO;NO	NO;NO	TCGA-E1-A7YL-F61297;TCGA-E1-A7YL-F61302	F735D699-ED76-4205-8144-14C9F12CC1E1;4D3F9102-D698-4946-BB09-D5EEAE3F350C	15;15	Not Available;Not Available	Not Available;Not Available	492;492	Not Available;Not Available	289;329	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	8;8	Not Available;Not Available	YES;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	YES;YES	Dead;Dead	2014;2014	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	NO	IHC	YES	NO	NO	5	NO	G3	YES	NO	91	NO	Not Available	NO	Not Available	YES	No	A7YL	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-E1-A7YL-R61290	21D4C661-F1AC-483A-BD90-43E6487C45D4	Not Available	15	78	36	Radiographic Progressive Disease	8	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	YES	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	YES	Dead	2014	2009
TCGA-HT-7480	33	MALE	2287	Oligodendroglioma	Central nervous system	Alive	G2	1	1943.0			WITH TUMOR		33	NO	Not Available	NO	TCGA-HT-7480	325138ab-2947-4131-b40e-971f024723cc	7	-12291	Not Applicable	0	2231	Not Available	Not Available	TCGA-HT-7480-D28792;TCGA-HT-7480-D28791;TCGA-HT-7480-D28790	e27b6c8a-0651-4081-a876-55751c96ad05;8567ce65-3a07-414f-9c6a-576ab9f63920;fa3e56bc-52f7-485f-80a5-4d516410bc5e	Not Available;Not Available;Not Available	1;1;1	Not Available;476;75	2189;103;26	Avastin;Temodar;Temodar	Not Available;Not Available;Not Available	3;3;3	12;12;1	970;310;155	mg;mg;mg/day	RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	IV;PO;PO	YES;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	3880;18600;7750	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	YES	NO	YES	Not Available	TCGA-HT-7480-F28787	5344f449-1933-42d6-965a-bc89183476ac	1	1943	Not Available	Not Applicable	2287	1943	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	3	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2012	NO	Not Available	MALE	YES	NO	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7480	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7480-R28788	91db7a38-5b94-418e-9764-bbc0970515fb	1	1	75	29	Not Available	3	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2005
TCGA-CS-6670	43	MALE	1426	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		43	NO	Not Available	NO	TCGA-CS-6670	60b30a95-3e4c-413a-9de6-16a5bca163c4	5	-16066	Not Applicable	0	201	Not Available	Not Available	TCGA-CS-6670-D19946;TCGA-CS-6670-D19945;TCGA-CS-6670-D19944	99349bbe-c046-49b0-a59f-b228a4426aae;ac52a959-5315-4264-9d65-a69cafb15e1a;25b4ae45-fb44-43d8-8cf3-95b10f64f46c	Not Available;Not Available;Not Available	5;5;5	201;-30;-227	68;-49;-325	Temodar;Vinblastine;Avastin	Not Available;Not Available;Not Available	1;1;1	Not Available;2;5	160;2;1000	mg;mg;mg	ADJUVANT;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Not Applicable;Neo-Adjuvant;Neo-Adjuvant	4;3;2	PO;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;4;5000	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-6670-F19941;TCGA-CS-6670-F71568	fe45d94e-c21a-489d-8f79-00788ffe5374;C1362E4E-22D7-4D8E-A0AA-3468D90992FC	5;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	201;1426	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;NO	1;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Discrepancy;Discrepancy	Discrepancy;Not Available	Alive;Alive	2012;2015	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	Yes	C71.9	9451/3	C71.9	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	6670	Not Available	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-6670-R19942	5c72a096-4f97-4be6-b0c8-942971a00dab	5	5	117	75	Not Available	1	30	Discrepancy	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	Cerebral Cortex	Not Available	Not Available	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-HT-A619	51	FEMALE	651	Oligodendroglioma	Central nervous system	Alive	G3	0	651			TUMOR FREE		51	Unknown	Not Available	Unknown	TCGA-HT-A619	C13BAC88-C85B-4EE3-A51C-FD503CD7E726	22	-18857	Not Applicable	0	434	Not Available	Not Available	TCGA-HT-A619-D58741	4547018B-20B4-4A95-979B-A37634FD7041	Not Available	22	443	19	Temodar	Complete Response	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HT-A619-F65111;TCGA-HT-A619-F66412	1894921C-DB1C-4358-82CC-1BAA88E2D242;618DA79F-9384-4DA9-86C4-137ED0EF6FCC	18;14	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	587;651	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	9;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2014	Unknown	Not Available	FEMALE	Unknown	NO	Oligodendroglioma	YES	Yes, Radiation Prior to Resection	C71.0	9451/3	C71.0	YES	Unknown	Not Available	Unknown	Left	Not Available	Not Available	Unknown	NO	Unknown	4	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Prior Malignancy	A619	Preoperative	TUMOR FREE	YES	Unknown	Unknown	Complete Remission/Response	ASIAN	NO																			NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-TQ-A8XE	42	FEMALE	954	Oligodendroglioma	Central nervous system	Dead	G2	1	455.0			WITH TUMOR		42	NO	Not Available	NO	TCGA-TQ-A8XE	135A149A-D153-465E-AA58-06D47BB18E00	7	-15629	954	0	Not Available	Not Available	0																								1	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	YES	YES	NO	Not Available	TCGA-TQ-A8XE-F61509	F3754645-96AC-473E-9A67-2C4D330C979C	30	Not Available	Not Available	954	Not Available	455	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Dead	2014	Not Available	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	70	Left	Unknown	Not Available	Unknown	NO	NO	10	YES	G2	YES	YES	455	NO	Not Available	Not Available	Not Available	YES	No	A8XE	Preoperative	WITH TUMOR	NO	NO	NO	Partial Remission/Response	WHITE	NO																			NO	YES	White Matter	NO	NO	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2010
TCGA-P5-A737	47	MALE	372	Oligoastrocytoma	Central nervous system	Alive	G2	0	372			TUMOR FREE		47	Not Available	Not Available	Not Available	TCGA-P5-A737	1B77D1E8-0A02-41DE-A408-DCF33A43407A	13	-17390	Not Applicable	0	14	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A737-F69027	42B97363-B0BB-4444-8433-09A362EA85E1	24	Not Available	Not Available	Not Applicable	372	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Unknown	NO	Not Applicable	NO	Alive	2014	Not Available	Not Available	MALE	Not Available	Not Available	Oligoastrocytoma	Not Available	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A737	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown																			Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2014	2012
TCGA-DU-A7TB	56	MALE	1567	Oligodendroglioma	Central nervous system	Alive	G2	1	74.0			TUMOR FREE		56	Unknown	Not Available	Unknown	TCGA-DU-A7TB	D3D8987D-0A54-45F8-B9C9-17EC89FA864E	23	-20704	Not Applicable	0	1287	Not Available	1111	TCGA-DU-A7TB-D56004;TCGA-DU-A7TB-D56005;TCGA-DU-A7TB-D56006	2310184D-B65B-4230-891C-E385DB08D9E4;ACA8EACC-BD7E-464E-9A01-A4C2BF5C9041;A8CF72D5-C8C6-4786-9DE9-9CCD9F0E687F	Not Available;Not Available;Not Available	23;23;23	57;127;518	20;88;153	Temozolomide;Temozolomide;Temozolomide	Clinical Progressive Disease;Stable Disease;Stable Disease	1;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	NO	Not Available	TCGA-DU-A7TB-F71627	8C26065D-9F1C-40CC-9F9E-56B8D098E5A0	27	Not Available	Not Available	Not Applicable	1567	74	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	YES	Not Available	Not Available	TUMOR FREE	YES	Progressive Disease	NO	Alive	2015	Unknown	Not Available	MALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	Unknown	1	NO	G2	YES	YES	74	NO	Not Available	NO	Not Available	YES	No	A7TB	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Progressive Disease	ASIAN	Discrepancy	Primary Tumor Field	TCGA-DU-A7TB-R56007	02607A1F-021F-453C-BF40-E11ADAD741D0	Not Available	23	124	88	Stable Disease	1	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-HT-A4DS	55	FEMALE	7	Astrocytoma	Central nervous system	Alive	G3	0	7			TUMOR FREE		55	Unknown	Not Available	Unknown	TCGA-HT-A4DS	6D020185-BDDE-4C43-9E38-71C6ED0C13D1	28	-20296	Not Applicable	0	7	Not Available	Not Available																								Unknown	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A4DS-F61277	C66CB3E0-E464-481A-97B0-E841FA6F9560	26	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	6	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	Unknown	Right	Not Available	Not Available	NO	NO	Unknown	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A4DS	Not Available	TUMOR FREE	Unknown	YES	YES	Unknown	WHITE	Unknown																			YES	YES	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-7300	53	FEMALE	1886	Oligodendroglioma	Central nervous system	Dead	G3	1	317.0			WITH TUMOR		53	Not Available	Not Available	Not Available	TCGA-DU-7300	a144e4e4-2877-4340-a2bf-524adbde8bc8	9	-19610	1886	0	Not Available	Not Available	15	TCGA-DU-7300-D17528;TCGA-DU-7300-D17529;TCGA-DU-7300-D17531;TCGA-DU-7300-D17530;TCGA-DU-7300-D17527	5431dd7a-6389-4069-92a3-6a0d5c8df2d2;c0738f83-af43-470c-b1f3-55d91ecb6c80;9fd1c5c0-311e-414e-af6d-45d54346b05f;d2d350cd-bef1-4114-ac7b-7ec3ab44b2f1;444b1400-212c-4f30-b57b-2d0b8e7b0db3	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	368;764;Not Available;Not Available;307	337;Not Available;1086;1086;3	Temozolomide;Temozolomide;Bevacizumab;Irintotecan;Temozolomide	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	1;Not Available;Not Available;Not Available;10	75;Not Available;Not Available;Not Available;200	mg/m2;mg/m2;mg/kg;mg/m2;mg/m2	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;2;3;3;1	PO;PO;IV;IV;PO	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;280	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	NO	NO	TCGA-DU-7300-F17524	2f951115-86cf-435b-960a-65b8de6be64e	9	Not Available	Not Available	1886	Not Available	317	317	Not Available	Not Available	Progressive Disease	100	Not Available	10	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	7300	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7300-R17526	c24bb301-eaf5-45b0-b85d-bef9cdd9bab8	1	5	363	337	Not Available	10	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2006
TCGA-DU-7008	41	FEMALE	4752	Oligodendroglioma	Central nervous system	Alive	G2	1	330.0			TUMOR FREE		41	Not Available	Not Available	Not Available	TCGA-DU-7008	427c40f6-d1bd-49f2-b303-a975793b937e	28	-15289	Not Applicable	0	4752	Not Available	Not Available	TCGA-DU-7008-D17224;TCGA-DU-7008-D17225;TCGA-DU-7008-D17223	34aab7aa-a5d6-4189-941a-00b031ba04c7;ca121445-5755-440b-976f-e7d670875074;0e7bb365-16bc-4962-a159-7fa3b7e6b776	Not Available;Not Available;Not Available	28;28;28	239;239;239	86;86;86	Lomustin;Vincristine;Procarbazine	Not Available;Not Available;Not Available	9;9;9	4;4;4	110;104;60	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;IV;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	YES	YES	NO	TCGA-DU-7008-F17219	3ec2ca78-3d7f-4361-b9c6-00d61be65fa5	28	330	Not Available	Not Applicable	4752	330	Not Available	Not Available	Not Available	Stable Disease	Not Available	Not Available	9	Not Available	YES	Not Available	Not Available	TUMOR FREE	YES	Progressive Disease	NO	Alive	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	Not Available	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7008	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7008-R17221	26b0a62a-54a3-4576-8168-e04fddd4c9cd	1	28	420	359	Not Available	9	Not Available	5940	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	1998
TCGA-DH-A66D	43	FEMALE	846	Astrocytoma	Central nervous system	Alive	G3	1				TUMOR FREE		43	Unknown	Not Available	NO	TCGA-DH-A66D	F005FA99-7E4E-4308-B11C-83B25683B1FD	25	-15866	Not Applicable	0	479	Not Available	404	TCGA-DH-A66D-D46564	DEF7727B-93B0-4931-BF66-027EB013CC90	Not Available	9	73	31	Temozolomide	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DH-A66D-F60638	AF4868B2-0F73-4623-80D2-F8CEB32F271E	13	Not Available	Not Available	Not Applicable	846	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	YES	lactose, cheese, gluten	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	YES	IHC	YES	YES	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A66D	Post-Adjuvant Therapy	TUMOR FREE	YES	NO	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DH-A66D-R46563	BEB15D25-F47E-4EA6-9742-CA422C32A14F	Not Available	9	73	31	Stable Disease	8	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Not listed in Medical Record	NO	YES	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-QH-A65X	28	FEMALE	482	Oligoastrocytoma	Central nervous system	Alive	G3	0	482			TUMOR FREE		28	NO	Not Available	NO	TCGA-QH-A65X	451BAD4F-6D72-4526-9978-38E090FC479F	9	-10440	Not Applicable	0	237	Not Available	237	TCGA-QH-A65X-D52174;TCGA-QH-A65X-D52175;TCGA-QH-A65X-D52178;TCGA-QH-A65X-D52179	9E786304-7510-4EEB-ADD4-8C590CD16794;BF362E39-FE1C-434A-9BD5-55034EA1D3AD;10F66F83-C03E-485A-8660-EBB562767B40;B81F99CB-649A-436E-B7B9-76FA0AA133B6	Not Available;Not Available;Not Available;Not Available	9;9;9;9	143;365;365;365	139;237;237;244	temozolomide;lomustine;vincristine;Procarbazine	Stable Disease;Stable Disease;Stable Disease;Stable Disease	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A65X-F67754	1F25CD1E-428B-42DF-945A-5A915D44049E	11	Not Available	Not Available	Not Applicable	482	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Right	NO	Sequence Analysis	YES	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A65X	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-QH-A65X-R52170	928B11E6-B6C1-4D54-88DB-8E5B274EDB8E	Not Available	9	103	63	Stable Disease	12	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HW-8320	36	MALE	1217	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		36	Not Available	Not Available	Not Available	TCGA-HW-8320	e3ed0c19-6acc-4be1-aae2-73fe73cc9f24	30	-13503	Not Applicable	0	272	Not Available	Not Available	TCGA-HW-8320-D34767;TCGA-HW-8320-D34771	BEE59C80-7266-4C1A-A9C0-6C3017ED95BA;6CF845A9-2AC6-43D1-ABB0-C4B622F023BD	Not Available;Not Available	30;30	108;Not Available	67;149	Temozolomide;Temozolomide	Stable Disease;Not Available	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-HW-8320-F34759;TCGA-HW-8320-F48679;TCGA-HW-8320-F71522	D8785593-0534-4B18-B285-E538D4F973B1;9584C9D2-E6B6-4DF4-8F6E-0356B155863A;96C444FF-7B7E-4C52-B276-F38E9E7A636B	30;19;31	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	272;657;1217	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease;Stable Disease	Not Available;Not Available;Not Available	NO;NO;NO	8;9;3	Not Available;Not Available;Not Available	NO;NO;NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;Unknown	YES;YES;YES	Stable Disease;Stable Disease;Stable Disease	YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Sequence Analysis	YES	Not Available	Not Available	8	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	8320	Not Available	WITH TUMOR	YES	Not Available	YES	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-HW-8320-R34764	2CBF0102-3D8E-415B-8786-E01847D72C5F	Not Available	30	109	68	Stable Disease	8	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	Not Available	Not Available	YES	NO	HW	Supratentorial, Parietal Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-S9-A7QZ	41	MALE	826	Oligodendroglioma	Central nervous system	Alive	G2	1	774.0			WITH TUMOR		41	NO	Not Available	NO	TCGA-S9-A7QZ	79627774-078D-4056-84B3-F1F370F643E0	5	-15300	Not Applicable	0	396	Not Available	-3																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available;NO	Not Available;NO	Not Available;YES	Not Available;Not Available	TCGA-S9-A7QZ-F67231;TCGA-S9-A7QZ-F70012	7CA980BE-F325-45E3-A264-AF6FB29C1EC9;539375DA-594D-4EFC-9245-D8E25CF5C960	3;26	Not Available;826	Not Available;Not Available	Not Applicable;Not Applicable	396;826	Not Available;774	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event	Stable Disease;Partial Remission/Response	Not Available;Not Available	NO;NO	11;1	Not Available;Not Available	NO;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Partial Remission/Response;Partial Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7QZ	Preoperative	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-R8-A73M	48	FEMALE	1806	Oligodendroglioma	Central nervous system	Alive	G2	0	1806			Not Available		48	Not Available	Not Available	Not Available	TCGA-R8-A73M	DC7EC60B-5EA5-48A4-8908-55CAF9214272	30	-17610	Not Applicable	0	1806	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Not Available	Not Available																														Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	Not Available	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Prior Malignancy	A73M	Not Available	Not Available	YES	Not Available	Not Available	Unknown	WHITE	NO																			Not Available	Not Available	Not Available	NO	YES	R8	Supratentorial, Parietal Lobe	Central nervous system	YES	Alive	2013	2008
TCGA-QH-A6CU	52	FEMALE	451	Oligodendroglioma	Central nervous system	Alive	G3	0	451			TUMOR FREE		52	NO	Not Available	NO	TCGA-QH-A6CU	76CB16F9-37BE-450E-B60A-5F0D0F1EC2BC	2	-19149	Not Applicable	0	-1	Not Available	-13	TCGA-QH-A6CU-D60340	E0569F74-EC61-4BA1-9A60-F39D2FD52391	Not Available	6	Not Available	399	Temozolomide	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	> 20 Years	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	Not Available	TCGA-QH-A6CU-F60341	01C0BF10-31DF-4233-ADB1-04756C3B7DFF	6	Not Available	Not Available	Not Applicable	451	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2014	NO	Not Available	FEMALE	YES	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	YES	YES	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6CU	Preoperative	TUMOR FREE	NO	YES	YES	Not Applicable	WHITE	NO	Primary Tumor Field	TCGA-QH-A6CU-R60338	FBFD2D0E-F6CB-49BB-9B10-A62A867B3581	Not Available	6	120	73	Stable Disease	6	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-8105	54	MALE	190	Oligodendroglioma	Central nervous system	Alive	G3	0	190			Not Available		54	NO	Not Available	NO	TCGA-HT-8105	d766c3af-f0b3-4791-a754-d6546d370f8f	2	-20041	Not Applicable	0	180	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8105-F32624	457ae466-97a5-4fa0-9c9c-6cd550cd4d84	4	Not Available	Not Available	Not Applicable	190	Not Available	190	Not Available	Scheduled Follow-up Submission	Stable Disease	70	Not Available	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	YES	Alive	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	5	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8105	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-8105-R32625	e32184b7-9711-421c-997e-a2c93d507be1	Not Available	4	89	43	Stable Disease	6	27	4860	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-VM-A8CE	25	MALE	1191	Oligodendroglioma	Central nervous system	Alive	G2	1	815.0			WITH TUMOR		25	Unknown	Not Available	NO	TCGA-VM-A8CE	66C52A31-6503-40B5-A55E-FA476EAF0567	14	-9363	Not Applicable	0	815	Not Available	15	TCGA-VM-A8CE-D56930;TCGA-VM-A8CE-D66855;TCGA-VM-A8CE-D66856;TCGA-VM-A8CE-D66854	AA881940-C510-48F7-B6A4-15DEB63B47FD;9B5668CC-DC75-4156-A200-F5D027115874;8D5F8F37-1A60-4079-8E31-EE3323D7B2C6;E095025B-7F6F-428B-9E8F-DF83D17C946F	Not Available;Not Available;Not Available;Not Available	26;24;24;19	349;986;Not Available;Not Available	37;925;898;918	temodar;Vincristine;Procarbazine;Lomustine	Stable Disease;Stable Disease;Not Applicable;Not Applicable	2;10;10;11	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Evaluated	Unknown	Unknown	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO;NO	NO;NO	Not Available;Not Available	Not Available;Not Available	TCGA-VM-A8CE-F66852;TCGA-VM-A8CE-F69636	5E70801E-BB60-4932-BA0F-F99A7D00699A;26C67B96-9A8A-45A1-87B9-2021D7E38227	24;15	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1093;1191	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown	Not Available;Not Available	NO;NO	10;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	Unknown;Unknown	YES;YES	Unknown;Unknown	NO;NO	Alive;Alive	2014;2015	Not Available	Not Available	MALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	Unknown	1	NO	G2	NO	YES	815	NO	Not Available	NO	Not Available	YES	No	A8CE	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Unknown	WHITE	NO	Local Recurrence	TCGA-VM-A8CE-R56929	58E67F9E-C1D8-439B-A8E9-B77B4F8189B7	Not Available	26	891	848	Unknown	2	30	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	NO	YES	VM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2011
TCGA-S9-A6TU	38	MALE	2650	Astrocytoma	Central nervous system	Alive	G2	1	1475.0			WITH TUMOR		38	NO	Not Available	NO	TCGA-S9-A6TU	688FC346-A14D-4859-8727-057CD0A0B880	30	-14108	Not Applicable	0	2101	Not Available	-2																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Sensory Changes	31 - 90 Days	NO	NO	NO	Not Available	TCGA-S9-A6TU-F63758	0BB2FB53-2C6E-452B-85E8-2C506EEF2C1F	18	Not Available	Not Available	Not Applicable	2650	2650	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	NO	NO	10	NO	G2	NO	NO	1475	YES	1504	Not Available	Not Available	YES	No	A6TU	Preoperative	WITH TUMOR	NO	NO	NO	Partial Remission/Response	WHITE	NO																			YES	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2007
TCGA-HT-7688	59	MALE	964	Oligodendroglioma	Central nervous system	Alive	G3	0	964			TUMOR FREE		59	NO	Not Available	NO	TCGA-HT-7688	7740824e-905f-47a0-b235-54561ef58ba3	15	-21844	Not Applicable	0	964	Not Available	Not Available	TCGA-HT-7688-D29501;TCGA-HT-7688-D29499;TCGA-HT-7688-D29500	01e3c417-2bac-43f6-8ece-15f0183282c2;45a8a109-14b4-4843-b1e3-645e23dd4a11;3f4b71ea-7a01-44c5-a14a-99fdccb4484e	Not Available;Not Available;Not Available	20;20;20	475;59;105	132;28;101	Temodar;Temodar;Temodar	Not Available;Not Available;Not Available	3;3;3	11;1;1	400;150;300	mg/day;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;1;2	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	22000;6300;1500	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7688-F29413	f6df6624-9873-4c36-a266-7828e85bf759	16	Not Available	Not Available	Not Applicable	964	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	YES	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7688	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7688-R29414	06a1bca9-78a6-4220-95a7-7a755d863e9a	1	16	65	35	Not Available	3	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2009
TCGA-HT-8011	55	MALE	494	Astrocytoma	Central nervous system	Alive	G3	1	278.0			Not Available		55	NO	Not Available	NO	TCGA-HT-8011	58de25d5-8a32-4412-866b-acac2e321bfa	2	-20175	Not Applicable	0	469	Not Available	Not Available	TCGA-HT-8011-D33342;TCGA-HT-8011-D33343	3218f23a-a617-4724-80a9-5973642659fa;53ff0b18-267b-4a80-bfa6-ec2a9fea7d27	Not Available;Not Available	28;28	69;242	14;115	Temodar;temodar	Stable Disease;Clinical Progressive Disease	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	YES	NO	TCGA-HT-8011-F32623	78774b1f-2940-4bc7-af52-293e1f0d6a33	4	278	Not Available	Not Applicable	494	278	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8011	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-8011-R33341	e9c37c4a-83df-4426-a6c7-713da3eee3f3	Not Available	28	69	14	Stable Disease	6	32	6185	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-TM-A84H	44	FEMALE	926	Oligoastrocytoma	Central nervous system	Alive	G3	0	926			TUMOR FREE		44	NO	Not Available	NO	TCGA-TM-A84H	EDBF86E5-3F55-4DDF-A97F-3E9DC607E53D	17	-16277	Not Applicable	0	738	Not Available	0																								0	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84H-F65389	5A82732F-308E-48C3-84C0-5B4C557E3A04	22	Not Available	Not Available	Not Applicable	926	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	Not Available	Not Available	NO	YES	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84H	Preoperative	TUMOR FREE	NO	Unknown	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-TM-A84H-R56495	3D0EC36C-77E6-4F9E-9A83-2B22405D836F	Not Available	17	90	45	Complete Response	2	33	59.40	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-DU-6405	51	FEMALE	605	Astrocytoma	Central nervous system	Dead	G3	1	486.0			WITH TUMOR		51	Not Available	Not Available	Not Available	TCGA-DU-6405	9239a22e-80b1-49a2-b0d5-cbab7e415254	21	-18686	605	0	Not Available	Not Available	515	TCGA-DU-6405-D14687;TCGA-DU-6405-D14686;TCGA-DU-6405-D14688;TCGA-DU-6405-D14690	27ec47b6-4503-4cfb-938a-0d32d623545e;b07896a6-e8ed-435f-9d49-ba2acf9186f9;ef4f3748-8fcf-402a-ac1c-21d617d6ca73;d5d78110-5704-4e12-81e1-1d959f123460	Not Available;Not Available;Not Available;Not Available	21;21;21;21	499;77;561;561	165;34;530;561	Temozolomide;Temozolomide;PS-341 Bortrezomib;Cilengitide	Not Available;Not Available;Not Available;Not Available	6;6;6;6	11;01;01;01	150;75;1.25;600	mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	01;01;02;03	PO;PO;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	300;140;203;1086	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	NO	NO	Not Available	TCGA-DU-6405-F14683	652f7d7b-3e61-49f6-8c06-d9375279ac83	20	Not Available	Not Available	605	Not Available	486	571	Not Available	Not Available	Progressive Disease	60	Not Available	6	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	Not Available	Not Available	6	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6405	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6405-R14684	34e4174a-6889-4de5-b565-56ff66fc2b90	01	21	77	34	Not Available	6	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	Not Available	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Dead	2011	2000
TCGA-CS-6186	58	MALE	538	Oligoastrocytoma	Central nervous system	Dead	G3	1	188.0			WITH TUMOR		58	NO	Not Available	NO	TCGA-CS-6186	9ee6e821-3af2-42d7-9d14-f0ca455f338c	18	-21321	538	0	Not Available	Not Available	-1	TCGA-CS-6186-D18645;TCGA-CS-6186-D18648	0799781a-105d-437e-afb2-6381b42c5e39;dd8b100d-1cdd-436e-af4e-d2b268c97f3c	Not Available;Not Available	18;18	188;512	146;444	Temodar;Avastin	Not Available;Not Available	11;11	Not Available;8	100;840	mg;mg	ADJUVANT;RECURRENCE	Not Applicable;Not Applicable	1;2	PO;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;6720	mg;mg	Not Available;Not Available	2011;2011	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	YES	NO	TCGA-CS-6186-F18628	c5e1f0e5-935a-4953-9be3-5d333bcefd96	18	213	Not Available	538	Not Available	188	212	1	Scheduled Follow-up Submission	Progressive Disease	80	Not Available	11	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6186	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-CS-6186-R18641;TCGA-CS-6186-R20336	a5bba276-a594-4020-8eb1-6efe3fe4afbd;e19a4169-bc2b-48a3-a5b3-a58521238c8d	1;1	18;9	266;64	251;22	Not Available;Not Available	11;1	10;30	35;60	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	PROGRESSION;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2012	YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2009
TCGA-FG-A87N	37	FEMALE	567	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		37	Not Available	Not Available	NO	TCGA-FG-A87N	872A12B4-8CBD-49D2-AC98-D846587F5794	18	-13606	Not Applicable	0	226	Not Available	Not Available	TCGA-FG-A87N-D56687	609B9DC5-249A-4272-B573-15F9B08F416E	Not Available	18	Not Available	160	Temodar	Not Applicable	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-A87N-F65757;TCGA-FG-A87N-F70255	BFD62F6C-E95F-479D-957F-76C96B592D54;3698B490-581C-4BD4-A4F6-FA13F28009AA	30;2	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	413;567	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	9;2	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2014;2015	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	YES	Unknown	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Prior Malignancy	A87N	Not Evaluated	WITH TUMOR	YES	Unknown	Unknown	Stable Disease	ASIAN	YES	Regional site	TCGA-FG-A87N-R56684	74F29F70-58CB-4166-91C6-81DA5EC817D3	Not Available	18	87	42	Stable Disease	2	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	Unknown	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2013
TCGA-HT-7471	37	FEMALE	4	Oligodendroglioma	Central nervous system	Alive	G3	0	4			TUMOR FREE		37	NO	Not Available	NO	TCGA-HT-7471	48314732-5d1c-43e6-9878-5b58dfaeb06a	29	-13564	Not Applicable	0	4	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7471-F50543	A96684B4-01E4-4FB2-8C27-B3851C9FC83E	24	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2013	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.9	9451/3	C71.9	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7471	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-FG-A70Z	53	FEMALE	328	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		53	Unknown	Not Available	NO	TCGA-FG-A70Z	98E82E98-341A-4BCA-92C0-23C65C1BF94F	2	-19717	Not Applicable	0	328	Not Available	Not Available	TCGA-FG-A70Z-D52303	BCD4BD78-2CB1-4359-A5B8-C7E9C6ADC425	Not Available	2	328	298	Temodar	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	Unknown	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A70Z-F64424	B990E668-C29F-47DD-BB18-20831DD22249	2	Not Available	Not Available	Not Applicable	328	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	YES	9	Not Available	Unknown	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	Unknown	Not Available	FEMALE	Unknown	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A70Z	Not Available	WITH TUMOR	YES	NO	YES	Unknown	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-FG-A70Z-R52082	FA89AD73-C0DA-4437-8CC1-04A935FA7155	Not Available	27	70	28	Stable Disease	11	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	YES	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2013	2011
TCGA-HW-8321	31	MALE	1294	Astrocytoma	Central nervous system	Alive	G3	0	1294			WITH TUMOR		31	Not Available	Not Available	Not Available	TCGA-HW-8321	36cf458b-3c8e-48e7-92ab-aea1c698e417	30	-11474	Not Applicable	0	17	Not Available	Not Available	TCGA-HW-8321-D48687	39FAF97B-D0A2-4D6B-8637-1C8118F20379	Not Available	19	321	47	Temozolomide	Stable Disease	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HW-8321-F48683;TCGA-HW-8321-F71520	6445FCA8-F9C3-475F-9B2E-4D2B425FB6D8;8078843B-84D0-42AD-8E17-EA0F91748355	19;31	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	596;1294	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	9;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	Unknown;Unknown	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2013;2015	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	8321	Not Available	WITH TUMOR	NO	Not Available	YES	Not Available	WHITE	NO	Primary Tumor Field;Primary Tumor Field	TCGA-HW-8321-R48685;TCGA-HW-8321-R58598	ED13CD65-4307-4813-BDA1-AA9326FB7F9E;0A1365F7-D5E3-4F40-B3BD-B4BA3BF61FF7	Not Available;Not Available	19;15	62;66	28;63	Stable Disease;Unknown	9;4	25;5	5000;1000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2014	NO	Not Available	Not Available	YES	NO	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-P5-A5F1	30	MALE	179	Astrocytoma	Central nervous system	Alive	G2	0	179			TUMOR FREE		30	Unknown	Not Available	Unknown	TCGA-P5-A5F1	0611F5BC-89B5-44BD-B301-751FAAADB561	13	-11070	Not Applicable	0	179	Not Available	Not Available																								Not Available	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5F1-F69046	D66D7D73-A4EE-49B4-8428-0445AA6999FE	24	Not Available	Not Available	Not Applicable	179	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	Unknown	Not Available	MALE	Unknown	Unknown	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Unknown	Left	Not Available	Not Available	NO	Unknown	Unknown	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5F1	Not Available	TUMOR FREE	Unknown	Unknown	Unknown	Not Available	WHITE	Unknown																			Unknown	Unknown	Not listed in Medical Record	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	Unknown	Alive	2013	2012
TCGA-P5-A5EV	39	MALE	7	Astrocytoma	Central nervous system	Alive	G2	0	7			WITH TUMOR		39	Unknown	Not Available	Unknown	TCGA-P5-A5EV	D50E944A-3CE4-4632-A878-118499E143E3	3	-14310	Not Applicable	0	7	Not Available	Not Available																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5EV-F69040	012E7A89-9F25-4ECD-A153-B621EDA34526	24	Not Available	Not Available	Not Applicable	7	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	60	Left	Not Available	Not Available	Unknown	YES	Unknown	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5EV	Unknown	WITH TUMOR	NO	YES	YES	Unknown	WHITE	Unknown																			YES	YES	Not listed in Medical Record	YES	NO	P5	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2013	2012
TCGA-TQ-A7RW	32	MALE	821	Oligodendroglioma	Central nervous system	Dead	G2	1	511.0			WITH TUMOR		32	NO	Not Available	NO	TCGA-TQ-A7RW	F878BF8D-70EB-4B74-BF74-BDF63CB9BFAE	26	-11804	821	0	Not Available	Not Available	529																								0	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	YES	YES	YES	Not Available	TCGA-TQ-A7RW-F65651	864BB89E-7976-44A9-99ED-710106FC9E68	26	Discrepancy	Not Available	821	Not Available	511	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	9	NO	G2	YES	YES	511	YES	511	NO	Not Available	YES	No	A7RW	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Progressive Disease	WHITE	YES																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2010
TCGA-HT-8114	36	MALE	1040	Oligoastrocytoma	Central nervous system	Alive	G3	0	1040			TUMOR FREE		36	NO	Not Available	NO	TCGA-HT-8114	0906ddde-02fa-417d-927b-1c400b189cac	17	-13198	Not Applicable	0	118	Not Available	Not Available	TCGA-HT-8114-D32195	de018a73-b77a-4b82-8378-096ec5e811c3	Not Available	18	90	39	Temodar	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HT-8114-F32196;TCGA-HT-8114-F66394	3500d078-bcd9-49d3-80f3-e45ea0b4f8c1;564A8AF9-E231-44BA-BF60-C33A65C09542	17;14	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	118;1040	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	5;10	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	YES;YES	Alive;Alive	2011;2014	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	5	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8114	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-8114-R32194	b8a4a61a-bbd3-4b71-a7cf-b928d3a51564	1	17	90	39	Not Available	5	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-HT-7478	36	MALE	194	Astrocytoma	Central nervous system	Alive	G2	0	194			TUMOR FREE		36	NO	Not Available	NO	TCGA-HT-7478	4c3e709a-fd52-431c-8be5-3d9b1f80ecd2	6	-13216	Not Applicable	0	194	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7478-F29409	f8d38ab2-1114-43d2-8692-afb44a702a69	16	Not Available	Not Available	Not Applicable	194	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	2	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7478	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7478-R29410	c3723572-c9f6-4760-9695-116336006001	1	16	74	34	Not Available	3	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	YES	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-DH-A7UT	30	MALE	531	Astrocytoma	Central nervous system	Dead	G3	1	404.0			WITH TUMOR		30	Unknown	Not Available	NO	TCGA-DH-A7UT	B2B57E93-2722-4546-9A0B-20155B86EDEF	10	-11014	Not Applicable	0	200	Not Available	Not Available	TCGA-DH-A7UT-D60292	AF34A876-4053-4F16-AFEF-058D051E29BA	Not Available	6	97	55	Temodar	Stable Disease	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Unknown;Unknown	Unknown;Unknown	NO;Unknown	Not Available;Not Available	TCGA-DH-A7UT-F68874;TCGA-DH-A7UT-F70996	62398C69-AEBF-4522-9E8C-20B1AAB0EB7E;EEA9E46D-CCD4-4288-9DF1-7B3E6EF40F09	22;12	Not Available;Not Available	Not Available;Not Available	Not Applicable;531	407;Not Available	404;407	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Unknown	Not Available;Not Available	NO;NO	12;3	Not Available;Not Available	YES;YES	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Dead	2014;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	YES	IHC	YES	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7UT	Not Available	WITH TUMOR	YES	YES	YES	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DH-A7UT-R60290	E31E12FD-5738-43CC-8390-78A03ABEAFF6	Not Available	5	97	55	Stable Disease	6	33	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Not listed in Medical Record	YES	NO	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-HT-7604	50	MALE	3725	Astrocytoma	Central nervous system	Alive	G2	0	3725			TUMOR FREE		50	NO	Not Available	NO	TCGA-HT-7604	019c5de9-74fd-48b7-95a3-227532e16c5a	1	-18443	Not Applicable	0	3283	Not Available	Not Available	TCGA-HT-7604-D48645	D1A61351-ABC0-43CF-9D78-2C86D8B5E85B	Not Available	18	2509	Not Available	Temodar	Partial Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7604-F48641	2CE4063A-047F-4426-AE29-A345392E3CC9	18	Not Available	Not Available	Not Applicable	3725	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	Unknown	YES	Partial Remission/Response	YES	Alive	2013	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	3	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7604	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Not Available	TCGA-HT-7604-R48642	1F9DEF02-CC00-4609-B319-A753994B925B	Not Available	18	2183	Not Available	Partial Response	9	Not Available	Not Available	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	2013	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2003
TCGA-DU-5855	49	FEMALE	207	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		49	Not Available	Not Available	Not Available	TCGA-DU-5855	e326c1dd-2ef8-431b-a657-440aa3f35ff3	13	-18234	Not Applicable	0	207	Not Available	19	TCGA-DU-5855-D14805;TCGA-DU-5855-D14806	0917cb19-d74a-4fb8-8750-5709eec75033;8fda500e-bf37-490b-816b-b3bac86f6197	Not Available;Not Available	25;25	70;Not Available	41;118	Temozolomide;Temozolomide	Not Available;Not Available	5;5	1;4	75;200	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	140;270	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-5855-F14801	c73e9b0c-c10a-42c1-b6c6-4037fb64e030	25	Not Available	Not Available	Not Applicable	207	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	YES	Not Available	7	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5855	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-5855-R14803	480f2b7a-814d-4ae5-a32c-d04caa9ab9f4	1	25	89	41	Not Available	5	30	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-DH-A66B	52	MALE	1279	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		52	Unknown	Not Available	NO	TCGA-DH-A66B	CB1E9916-C03F-405A-A797-15823DF09C8E	25	-19156	Not Applicable	0	901	Not Available	901	TCGA-DH-A66B-D46562	9A60312E-9D6E-4C6A-A773-1DD195DBA56E	Not Available	9	432	25	Temozolomide	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DH-A66B-F60629	BE9F9613-9ED6-4A86-81B7-F7E20B3AF9A6	13	Not Available	Not Available	Not Applicable	1279	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	YES	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Prior Malignancy	A66B	Post-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DH-A66B-R46561	80DD0911-773A-4063-A9F9-FF2826886E93	Not Available	9	67	24	Stable Disease	8	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Not listed in Medical Record	NO	YES	DH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-DU-5847	34	FEMALE	548	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		34	NO	Not Available	NO	TCGA-DU-5847	92a7c445-2217-400a-bdcd-df41502416b6	21	-12606	Not Applicable	0	548	Not Available	Not Available	TCGA-DU-5847-D14830;TCGA-DU-5847-D14827;TCGA-DU-5847-D14829	55c779f0-e61a-473c-8a89-935f50562c9a;3af6c9cd-f9b6-4671-a6fd-6ebfc1699b25;a3b7d452-71cd-4e89-a6ef-48dd6d15b804	Not Available;Not Available;Not Available	21;21;21	265;265;89	84;84;27	Bevacizumab;Temozolomide;Temozolomide	Not Available;Not Available;Not Available	6;6;6	06;06;01	Not Available;Not Available;Not Available	mg;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	01;01;01	IV;PO;PO	NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	YES	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-5847-F14822	38b02ba4-bd07-481f-b559-58f7b4da7786	25	Not Available	Not Available	Not Applicable	548	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2011	NO	Not Available	FEMALE	Not Available	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5847	Not Available	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-5847-R14823	da1371f1-7ce0-417e-914c-6fda8a4fce52	01	21	71	28	Not Available	6	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	White Matter	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2009
TCGA-DB-A4XC	26	MALE	1421	Oligoastrocytoma	Central nervous system	Alive	G2	0	1421			TUMOR FREE		26	Unknown	Not Available	NO	TCGA-DB-A4XC	33615113-791B-4286-A23A-AD3D1F8D4B09	21	-9705	Not Applicable	0	840	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XC-F60948	F029B0DA-91E3-4DB9-AA52-FDCED115505E	19	Not Available	Not Available	Not Applicable	1421	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Partial Remission/Response	YES	Alive	2014	Unknown	Not Available	MALE	Unknown	NO	Oligoastrocytoma	NO	No	C71.2	9382/3	C71.2	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Synchronous/Bilateral Malignancy	A4XC	Not Available	TUMOR FREE	NO	Unknown	Unknown	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-DB-A4XC-R40468	D9564B2D-4BD8-4092-84CD-ECDDE6ABB9D8	Not Available	21	191	142	Stable Disease	2	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-DU-8165	60	FEMALE	582	Oligodendroglioma	Central nervous system	Alive	G3	0	582			WITH TUMOR		60	Not Available	Not Available	Not Available	TCGA-DU-8165	11dffe71-b516-41e8-9987-e0ff5d2356d1	15	-21964	Not Applicable	0	185	Not Available	11	TCGA-DU-8165-D33110;TCGA-DU-8165-D33111	145B8B1F-FD1F-4CF3-9540-94D864B5D265;4859BCE3-A8C5-4D00-BA7C-C4F62A10220E	Not Available;Not Available	21;21	71;Not Available	30;101	Temozolomide;temozolomide	Stable Disease;Not Applicable	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-8165-F46668	D999C2B8-38BE-4D30-B3DE-39AFF2C5BE64	13	Not Available	Not Available	Not Applicable	582	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	8	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2013	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	Not Available	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8165	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-8165-R33109	AB9A94B0-31D0-43B1-B74E-0C22833787E0	Not Available	21	71	30	Stable Disease	6	30	6000	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-QH-A6CX	66	MALE	372	Astrocytoma	Central nervous system	Dead	G2	1	273.0			TUMOR FREE		66	NO	Not Available	NO	TCGA-QH-A6CX	CF29547A-305B-4E6E-8342-36AAC0850065	2	-24252	Not Applicable	0	-1	Not Available	-7																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	Not Available	TCGA-QH-A6CX-F60335	C455304E-F1C8-444F-A22F-82B3E161B057	6	Not Available	Not Available	372	Not Available	273	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	90	Left	NO	IHC	YES	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6CX	Preoperative	TUMOR FREE	NO	YES	YES	Complete Remission/Response	WHITE	NO	Unknown	TCGA-QH-A6CX-R60336	EA5C87ED-5F5A-4766-BA30-23072CA09DC3	Not Available	6	242	242	Radiographic Progressive Disease	6	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	YES	NO	White Matter	YES	NO	QH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-S9-A7QX	36	FEMALE	564	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		36	NO	Not Available	NO	TCGA-S9-A7QX	427F4D23-2B76-4A2A-A498-0C3473F57169	5	-13332	Not Applicable	0	123	Not Available	-3	TCGA-S9-A7QX-D52660	B1D7F4E1-8C4A-4A4E-8A0B-0A59C9CFDF41	Not Available	5	Not Available	113	Temozolomide	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A7QX-F66225;TCGA-S9-A7QX-F70010	DB4AAFC8-EA6D-4A3E-85DC-3189E934DE73;1155528D-1A06-4524-B3D6-03B730B52201	6;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	399;564	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	10;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Partial Remission/Response;Partial Remission/Response	YES;YES	Alive;Alive	2014;2015	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Right	YES	IHC	YES	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7QX	Preoperative	WITH TUMOR	YES	YES	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A7QX-R52659	91CD210C-6C08-4178-8152-FB500C5AE14F	Not Available	5	84	40	Stable Disease	12	33	59.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	YES	Cerebral Cortex	YES	NO	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-7874	41	FEMALE	1130	Oligodendroglioma	Central nervous system	Alive	G3	0	1130			TUMOR FREE		41	NO	Not Available	NO	TCGA-HT-7874	775c04e6-a02d-44a4-86f7-496056edd249	15	-15045	Not Applicable	0	1130	Not Available	Not Available	TCGA-HT-7874-D28709;TCGA-HT-7874-D28817;TCGA-HT-7874-D28820	162b36dc-0c84-4e5c-a93b-2f28f7bb9682;47e68bc1-347b-402b-9c84-d26927dd3b66;547b1cf3-8792-494e-b3cf-f5cc70be2a51	Not Available;Not Available;Not Available	28;1;1	87;140;549	42;136;171	Temodar;Temodar;Temodar	Not Available;Not Available;Not Available	2;3;3	1;1;11	100;240;315	mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	4200;1200;17325	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7874-F29422	e4694c1f-7591-4db8-aade-67d4600bc5d0	16	Not Available	Not Available	Not Applicable	1130	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7874	Not Available	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7874-R28708	062f27e1-d889-4572-a93b-0a26b184d364	Not Available	28	87	42	Not Available	2	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-DH-A66G	49	FEMALE	523	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		49	Unknown	Not Available	NO	TCGA-DH-A66G	DA40E6D3-A2A9-4517-AAA2-AEF6C3892EBF	25	-18199	Not Applicable	0	117	Not Available	19	TCGA-DH-A66G-D64430	E9553E2D-EAF0-48AD-979F-23ECA9666C61	Not Available	2	211	41	Temodar	Partial Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DH-A66G-F61145	4E9F8444-C625-409F-96F4-FF30E0706D2F	25	Not Available	Not Available	Not Applicable	523	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	80	Left	YES	IHC	YES	NO	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A66G	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	YES	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DH-A66G-R64428	90B175A7-CD25-4CAF-93C5-530092FEA417	Not Available	2	211	166	Partial Response	9	34	59.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Not listed in Medical Record	YES	NO	DH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-8111	32	MALE	7	Oligoastrocytoma	Central nervous system	Alive	G3	0	7			Not Available		32	NO	Not Available	NO	TCGA-HT-8111	975c76cd-f88a-4d88-93a4-fbf2cb9e2e3b	17	-11810	Not Applicable	0	7	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	Not Available	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HT-8111-F32206;TCGA-HT-8111-F66396	2b56ed8e-ae5b-40bf-8a4a-78c42163fa48;FFCC98C8-E7F7-4031-A2FB-951886847383	17;14	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	7;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;YES	5;10	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Not Available	Not Available;Not Available	NO;Not Available	Alive;Not Available	2012;2014	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8111	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2011
TCGA-DU-A6S3	60	MALE	656	Oligodendroglioma	Central nervous system	Alive	G2	0	656			TUMOR FREE		60	Unknown	Not Available	Unknown	TCGA-DU-A6S3	1E713E76-064D-46DC-A53C-20A17EB68341	20	-22038	Not Applicable	0	82	Not Available	Not Available																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	91 - 180 Days	NO	NO	Not Available	Not Available	TCGA-DU-A6S3-F71619	FEF71773-3DC0-470F-BD4F-397E3C6F704C	27	Not Available	Not Available	Not Applicable	656	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2015	Unknown	Not Available	MALE	Unknown	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	NO	Unknown	11	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6S3	Not Evaluated	TUMOR FREE	NO	NO	NO	Stable Disease	WHITE	NO																			NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-DU-7290	45	FEMALE	315	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		45	Not Available	Not Available	Not Available	TCGA-DU-7290	e00a9855-c15e-46ef-988f-25ca64ec4717	11	-16667	315	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-7290-F17541	ed99b09c-1744-4119-9c6c-d70386514d38	11	Not Available	Not Available	315	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2011	Not Available	Not Available	FEMALE	Not Available	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	Not Available	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7290	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			NO	YES	Cerebral Cortex	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	YES	Dead	2011	1995
TCGA-HT-7469	30	MALE	351	Oligodendroglioma	Central nervous system	Dead	G3	1	92.0			WITH TUMOR		30	NO	Not Available	NO	TCGA-HT-7469	b9e2f4d1-866c-4c62-a9c8-8de7eb364a6e	29	-11097	Not Applicable	0	238	Not Available	Not Available	TCGA-HT-7469-D28784;TCGA-HT-7469-D28785	96B1E5CA-DD30-4FE4-B287-100C3F6650C7;9FC120A9-D05E-4824-9EA4-6EA5F6DBCA2D	Not Available;Not Available	1;1	84;179	42;112	Temodar;Temodar	Not Available;Not Available	3;3	1;3	140;400	mg/day;mg/day	ADJUVANT;PROGRESSION	Not Applicable;Not Applicable	1;2	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5880;6000	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	YES	NO	YES	NO	TCGA-HT-7469-F28780	A446AF91-E15F-4D1C-9A89-064D0E252BD4	6	92	Not Available	351	Not Available	92	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	Not Available	4	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2012	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	Not Available	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7469	Not Available	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7469-R28783	E1D910B5-FF70-4DC2-BF35-65B4D4C71695	1	1	84	42	Not Available	3	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Available	Cerebral Cortex	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2012	2011
TCGA-QH-A6X5	58	FEMALE	497	Oligoastrocytoma	Central nervous system	Alive	G2	0	497			Unknown		58	NO	Not Available	NO	TCGA-QH-A6X5	ED833BE3-0E9B-4C9B-B6D5-1098F08265A0	9	-21239	Not Applicable	0	119	Not Available	119																								1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A6X5-F67745	32789522-AAAB-4CF4-A943-F0D84F619E1E	11	Not Available	Not Available	Not Applicable	497	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	11	Not Available	Unknown	Not Available	Not Available	Unknown	NO	Unknown	NO	Alive	2014	Not Available	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	YES	Sequence Analysis	YES	NO	NO	12	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6X5	Other	Unknown	NO	NO	NO	Unknown	WHITE	NO																			YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-DU-6404	24	FEMALE	4068	Oligodendroglioma	Central nervous system	Dead	G3	1	1154.0			WITH TUMOR		24	NO	Not Available	NO	TCGA-DU-6404	c0d47e0f-4918-4e06-9db6-201671b1259c	21	-9021	4068	0	Not Available	Not Available	126	TCGA-DU-6404-D14798;TCGA-DU-6404-D14789;TCGA-DU-6404-D14786;TCGA-DU-6404-D14790;TCGA-DU-6404-D14791;TCGA-DU-6404-D14787;TCGA-DU-6404-D14784;TCGA-DU-6404-D14785;TCGA-DU-6404-D14799;TCGA-DU-6404-D14788;TCGA-DU-6404-D14804	2128710b-2bfd-4200-a650-deb72ee4278c;b3ee688e-79eb-4dd1-a3ee-e73f99ebf877;c45c5914-3f1a-44ef-8d3d-20ef29f2e583;83dc3af5-58c5-423c-b1d7-7d9cdaf28df4;8f2f4cd2-4301-4be8-bdf3-ae8741ec4bc5;8290859f-c748-4d89-8312-4d66fb7a347b;16a48912-089b-46f1-a756-6ee83dfce1a8;4b18ce80-40f5-4f5e-99c8-9949a8689e9f;18e4081d-6f45-4245-899d-7df6394f7000;7e05a613-6102-4584-a478-8610ff8936d5;4784091c-7545-4001-bb2f-b2d9920e698b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	31;31;31;31;31;31;31;31;31;31;21	3884;3060;1967;3185;3185;2714;506;1632;3581;2714;4066	3227;2731;1762;3154;3154;2360;171;1602;3227;2360;4066	Carboplatin;Bevacizumab;Irinotecan;Temozolomide;Bevacizumab;Irinotecan;Temozolomide;Temozolomide;Bevacizumab;Bevacizumab;Bevacizumab	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;6	10;26;6;2;2;12;12;12;14;12;1	5;10;325;100;10;125;200;200;15;10;10	AUC;mg/kg;mg/m2;mg/m2;mg/kg;mg/m2;mg/m2;mg/m2;mg/kg;mg/kg;mg/kg	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	8;5;3;6;6;4;1;2;8;4;10	IV;IV;IV;PO;IV;IV;PO;PO;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Targeted Molecular therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	870;745;600;140;745;231;385;370;1172;134;635	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	12 - 20 Years	Seizures	31 - 90 Days	YES	YES	YES	NO	TCGA-DU-6404-F14781	d834c45b-b07e-4d4e-9f2e-7edc6defca95	31	1194	Not Available	4068	Not Available	1154	1398	Not Available	Not Available	Progressive Disease	100	Not Available	5	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	YES	beef	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	6	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6404	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field;Local Recurrence;Local Recurrence	TCGA-DU-6404-R14783;TCGA-DU-6404-R14793;TCGA-DU-6404-R14802	64af2b41-56bc-4089-8b6f-3dbe74a9273a;1a641820-2360-4cea-8752-d87697c36cf1;1740eb4d-a819-4829-a5b2-aed20df1e48e	1;7;9	21;31;31	76;3219;Discrepancy	28;3206;3746	Not Available;Not Available;Not Available	5;5;5	30;6;6	6000;3600;3600	NO;NO;NO	EXTERNAL BEAM;OTHER;OTHER	Not Applicable;Fractionated Stereotactic Radiotherapy;Fractionated Stereotactic Radiotherapy	ADJUVANT;PROGRESSION;PROGRESSION	Not Available;Not Available;Not Available	cGy;cGy;cGy	2011;2011;2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2000
TCGA-CS-6188	48	MALE	814	Astrocytoma	Central nervous system	Dead	G3	1	647.0			WITH TUMOR		48	NO	Not Available	NO	TCGA-CS-6188	3f70c3e3-0131-466f-92aa-0a63ab3d4258	23	-17729	Not Applicable	0	725	Not Available	-1	TCGA-CS-6188-D17678	0d299bff-323c-4529-b028-86571ff11176	Not Available	23	716	71	Temodar	Not Available	9	Not Available	400	mg	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO;Not Available	NO;Not Available	NO;Not Available	NO;Not Available	TCGA-CS-6188-F17677;TCGA-CS-6188-F71551	54a760d3-6ebb-4c37-9cfd-c88c2c6b6d33;C4DB2EE9-0C57-4658-BFA3-40D738808E03	23;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;814	725;Not Available	647;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Applicable	Not Available;Not Available	Not Available;NO	9;3	Not Available;Not Available	YES;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	YES;Not Available	Progressive Disease;Not Available	YES;Not Available	Alive;Dead	2011;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6188	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-6188-R17679	6531e8b8-1017-42e5-b6dc-e45cc304fbff	1	23	71	29	Not Available	9	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2009
TCGA-HT-7485	42	MALE	122	Astrocytoma	Central nervous system	Alive	G2	0	122			TUMOR FREE		42	NO	Not Available	NO	TCGA-HT-7485	8d06226e-500b-4172-ae96-c674913909e6	6	-15589	Not Applicable	0	122	Not Available	24																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7485-F28639	83c1c7af-2e20-42e9-83c9-c4d41ccf0e9e	2	Not Available	Not Available	Not Applicable	122	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2012	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.9	9400/3	C71.9	YES	NO	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	2	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7485	Post-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	YES	White Matter	NO	YES	HT	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2012	2006
TCGA-QH-A870	38	FEMALE	395	Oligoastrocytoma	Central nervous system	Alive	G3	1	335.0			TUMOR FREE		38	NO	Not Available	NO	TCGA-QH-A870	345D975C-E666-4614-81EB-5CCBB5BD2CF7	12	-14082	Not Applicable	0	2	Not Available	2	TCGA-QH-A870-D68241	17ABE603-39E5-415F-B81D-B29E52C111BC	Not Available	14	Not Available	396	temozolomide	Not Applicable	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	YES	NO	NO	Not Available	TCGA-QH-A870-F67994	06EDC827-0874-466D-A0FA-9A8E0361EBD5	14	Not Available	Not Available	Not Applicable	395	335	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	11	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response	NO	Alive	2014	Not Available	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	80	Right	YES	IHC	YES	NO	NO	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A870	Other	TUMOR FREE	NO	YES	YES	Complete Remission/Response	WHITE	NO																			NO	NO	White Matter	YES	NO	QH	Supratentorial, Occipital Lobe	Central nervous system	YES	Alive	2014	2013
TCGA-HT-A61C	66	MALE	537	Oligodendroglioma	Central nervous system	Dead	G3	1	476.0			TUMOR FREE		66	NO	Not Available	NO	TCGA-HT-A61C	77396AE6-3838-47BF-AAAE-F9A0F401EC7F	12	-24276	Not Applicable	0	103	Not Available	19	TCGA-HT-A61C-D48457	6B1BF855-0160-41D2-B553-3B5D84D7E0B1	Not Available	22	Not Available	27	Temodar	Complete Response	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Unknown	NO	NOT HISPANIC OR LATINO	YES	Unknown	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Unknown	Unknown	YES	Not Available	TCGA-HT-A61C-F61306	2E264C8E-9312-48F4-A62B-9F307834DE3E	15	501	Not Available	537	Not Available	476	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	7	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	YES	Dead	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	100	Left	Not Available	Not Available	Unknown	NO	NO	9	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A61C	Post-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-HT-A61C-R48421	5283D094-50A3-4497-8531-F1D755091894	Not Available	22	69	27	Complete Response	11	33	5857	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-P5-A5F2	36	FEMALE	242	Astrocytoma	Central nervous system	Alive	G2	0	242			WITH TUMOR		36	Unknown	Not Available	Unknown	TCGA-P5-A5F2	C85FA637-941A-4A9A-8029-F5B44F3DA430	13	-13396	Not Applicable	0	232	Not Available	Not Available	TCGA-P5-A5F2-D56615;TCGA-P5-A5F2-D59335;TCGA-P5-A5F2-D59336	FEAA8647-2C75-47E9-A256-1C12969E38D6;DA5506EB-D01F-4051-92F8-13CB90678F5C;4EC478D5-914A-4950-A014-60C5EEA852D3	Not Available;Not Available;Not Available	8;30;30	242;242;242	30;30;30	Mustophoran;Avastin;Themozolomide	Partial Response;Partial Response;Partial Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A5F2-F69047	F3A30DD0-7B51-45E5-AF2C-D07DDE25AAFB	24	Not Available	Not Available	Not Applicable	242	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Not Available	YES	Partial Remission/Response	NO	Alive	2014	Unknown	Not Available	FEMALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	80	Right	Not Available	Not Available	Not Available	NO	Unknown	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5F2	Not Available	WITH TUMOR	YES	Unknown	Unknown	Unknown	WHITE	NO																			YES	NO	Not listed in Medical Record	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-CS-5396	53	FEMALE	1631	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		53	Not Available	Not Available	NO	TCGA-CS-5396	b6c2c9bd-625b-4a98-830c-49c344f6cb5f	17	-19399	Not Applicable	0	303	Not Available	20	TCGA-CS-5396-D15818	7b80fb67-5c9f-4889-bab8-a973e53717f1	Not Available	1	Not Available	39	Temodar	Not Available	9	Not Available	360	mg	ADJUVANT	Not Applicable	1	PO	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Headaches	Not Available	Not Available;Not Available	NO;Not Available	NO;Not Available	NO;Not Available	TCGA-CS-5396-F10208;TCGA-CS-5396-F71560	711a9aa2-29f9-4edf-bcc2-b6fef47b0687;B006275C-7816-4EF9-9D75-D0DEE05D6055	13;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	303;1631	Not Available;Not Available	Not Available;Not Available	1;Not Available	Not Available;Not Available	Not Available;Stable Disease	90;Not Available	Not Available;NO	3;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Preoperative;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Discrepancy	YES;Not Available	Alive;Alive	2011;2015	Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	NO	No	C71.9	9451/3	C71.9	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	NO	Not Available	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5396	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-CS-5396-R15817	a380de2f-964f-434a-8c77-c126a897961c	1	1	86	39	Not Available	9	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	Not Available	Cerebral Cortex	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2011	2010
TCGA-DU-6395	31	MALE	1491	Oligoastrocytoma	Central nervous system	Dead	G2	1	1197.0			WITH TUMOR		31	Not Available	Not Available	Not Available	TCGA-DU-6395	6355cade-7b3a-43a8-9f1f-8e7bc45755a8	15	-11584	1491	0	Not Available	Not Available	Not Available	TCGA-DU-6395-D14947;TCGA-DU-6395-D14944;TCGA-DU-6395-D14946	a3b4d4ea-fc08-47a3-80d6-c96e3f4a6cd1;564bb929-f3d9-49eb-b544-286ac7cf8686;a6ce591e-8346-45ee-abee-715500c534e3	Not Available;Not Available;Not Available	26;26;26	Not Available;1266;1386	1425;870;1266	Tamoxifen;PCV;PCV	Not Available;Not Available;Not Available	1;5;5	Not Available;1;4	10;Not Available;Not Available	mg;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	3;1;2	PO;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	20;Not Available;Not Available	mg;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	YES	NO	YES	NO	TCGA-DU-6395-F14942	eee6dc78-da81-4907-9e6f-964cb40270b5	26	1197	Not Available	1491	Not Available	1197	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	Not Available	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6395	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6395-R14943	94751896-70bc-45c5-b5a2-05f51e1532b8	1	26	Not Available	Not Available	Not Available	5	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1994
TCGA-TM-A84J	63	MALE	735	Oligodendroglioma	Central nervous system	Alive	G3	1	454.0			TUMOR FREE		63	NO	Not Available	NO	TCGA-TM-A84J	B3720405-CE3F-49C7-A5D9-BBFFD06F6AEF	17	-23091	Not Applicable	0	532	Not Available	0	TCGA-TM-A84J-D56500;TCGA-TM-A84J-D56501	CD42B16D-E498-41D9-8798-158E92B765DD;083ACA4E-16F2-4700-9A59-61D762064443	Not Available;Not Available	17;17	Not Available;Not Available	61;476	Temozolomide;Procarbazine	Not Applicable;Not Applicable	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2014;2014	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Visual Changes	0 - 30 Days	YES	NO	Not Available	Not Available	TCGA-TM-A84J-F65391	94BCB671-EA3B-4207-BC7D-04DF2C874AFB	30	Not Available	Not Available	Not Applicable	735	454	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Unknown	Not Available	80	Left	Not Available	Not Available	NO	YES	NO	2	YES	G3	YES	NO	454	YES	454	Not Available	Not Available	YES	No	A84J	Preoperative	TUMOR FREE	YES	Unknown	Unknown	Not Applicable	WHITE	YES	Primary Tumor Field	TCGA-TM-A84J-R56499	C7C6203F-FB85-471A-B589-B685BDF6D30E	Not Available	17	103	61	Complete Response	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	NO	Not listed in Medical Record	NO	YES	TM	Supratentorial, Occipital Lobe	Central nervous system	YES	Alive	2014	2012
TCGA-HT-7687	74	MALE	3	Oligodendroglioma	Central nervous system	Alive	G3	0	3			TUMOR FREE		74	Not Available	Not Available	Not Available	TCGA-HT-7687	3f36cd97-eb22-47de-b447-5c96378e4a2b	15	-27186	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Visual Changes	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7687-F28642	331d5336-e632-48fa-afa7-637ce629b7c1	27	Not Available	Not Available	Not Applicable	3	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Stable Disease	Not Available	Alive	2012	Not Available	Not Available	MALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	Not Available	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7687	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	YES	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2010
TCGA-S9-A6U9	36	MALE	2918	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		36	NO	Not Available	NO	TCGA-S9-A6U9	38ECA720-AD68-43A7-8A1C-F79F838D5D03	4	-13460	Not Applicable	0	2546	Not Available	Not Available																								Unknown	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	NO	NO	Not Available	Not Available	TCGA-S9-A6U9-F62934	CC0E7418-63FE-435E-B3B1-60F28589AF2E	29	Not Available	Not Available	Not Applicable	2918	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	7	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Unknown	Right	Not Available	Not Available	NO	YES	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6U9	Unknown	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A6U9-R54272	BCFD4F13-3F7E-4E58-802D-762425DC711E	Not Available	18	276	229	Stable Disease	12	33	59,4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2006
TCGA-S9-A6WO	29	MALE	566	Astrocytoma	Central nervous system	Alive	G2	1	187.0			WITH TUMOR		29	NO	Not Available	NO	TCGA-S9-A6WO	A2202233-4A83-4163-9532-B6EDB9941453	5	-10933	Not Applicable	0	231	Not Available	-4																								0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	NO	NO	Not Available	Not Available	TCGA-S9-A6WO-F65749	C0325AEC-ABC6-414B-AAEB-80E8FABE51E9	30	Not Available	Not Available	Not Applicable	566	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	NO	NO	11	NO	G2	NO	YES	187	Not Available	Not Available	Not Available	Not Available	YES	No	A6WO	Preoperative	WITH TUMOR	NO	YES	NO	Progressive Disease	WHITE	NO	Primary Tumor Field	TCGA-S9-A6WO-R54290	68A50FCB-B349-404A-9E8B-9BDA1C80AD22	Not Available	18	231	199	Unknown	12	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-CS-6668	57	FEMALE	1519	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		57	NO	Not Available	NO	TCGA-CS-6668	a5d3f3fb-6541-419d-b47e-720d438f1bff	24	-20836	Not Applicable	0	244	Not Available	-1	TCGA-CS-6668-D17586	ae31a013-3c31-42fe-9b59-da0d0280a6fc	Not Available	24	Not Available	27	Temodar	Not Available	9	Not Available	Not Available	mg	ADJUVANT	Not Applicable	1	PO	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-6668-F17585;TCGA-CS-6668-F71564	0784086b-0ae3-44bb-9026-2b201eefc939;ED411370-989E-4FBB-8752-316230C7BB72	24;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	244;1519	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	Not Available;Not Available	Not Available;NO	9;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Stable Disease;Stable Disease	NO;Not Available	Alive;Alive	2011;2015	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6668	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2011
TCGA-HW-A5KK	64	MALE	388	Astrocytoma	Central nervous system	Dead	G3	0	388			WITH TUMOR		64	Not Available	Not Available	Not Available	TCGA-HW-A5KK	8A94FF28-A74D-4FE2-B9C0-06C01F0A3FB6	12	-23484	Not Applicable	0	240	Not Available	Not Available	TCGA-HW-A5KK-D48696;TCGA-HW-A5KK-D48698	DC0EA9A7-61C9-406F-B1FD-0D3E2267F459;33F84057-D56D-46FB-A1CB-09F56755FEBE	Not Available;Not Available	19;19	176;Not Available	23;207	Temozolomide;Bevacizumab	Clinical Progressive Disease;Not Applicable	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-HW-A5KK-F59869	B087AD19-40D2-4DA8-96BE-935B3B9845F3	22	Not Available	Not Available	388	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	5	Not Available	NO	Not Available	Not Available	Unknown	YES	Progressive Disease	YES	Dead	2014	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5KK	Not Available	WITH TUMOR	YES	Not Available	YES	Progressive Disease	WHITE	YES	Regional site	TCGA-HW-A5KK-R48694	7AE2414C-FEAC-4B2A-A922-282F56314270	Not Available	19	84	23	Radiographic Progressive Disease	9	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	Not Available	White Matter	YES	NO	HW	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2013	2012
TCGA-WY-A859	34	FEMALE	1213	Astrocytoma	Central nervous system	Alive	G2	0	1213			WITH TUMOR		34	NO	Not Available	NO	TCGA-WY-A859	DE6F01BF-2DE9-4D07-A956-E6A4C0ACB371	20	-12631	Not Applicable	0	1213	Not Available	293																								0	Unknown	Unknown	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days																														NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	Unknown	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A859	Pre-Adjuvant Therapy	WITH TUMOR	NO	YES	Unknown	Stable Disease	WHITE	YES																			YES	NO	Not listed in Medical Record	NO	YES	WY	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-DH-A7UU	43	MALE	417	Astrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		43	Unknown	Not Available	NO	TCGA-DH-A7UU	977118C8-B446-4696-AA6E-9F1A1055E241	10	-16037	Not Applicable	0	105	Not Available	18	TCGA-DH-A7UU-D60354	6B976447-B1E6-4CC4-A0A5-D25E373C2671	Not Available	6	88	41	Temodar	Stable Disease	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Sensory Changes	91 - 180 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DH-A7UU-F63633;TCGA-DH-A7UU-F66738	7A614BCC-BF48-4CB1-9643-B99F5B81CC5C;320E802C-369C-48B8-8390-CE8B2C3428BD	14;22	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	105;417	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Stable Disease	Not Available;Not Available	NO;NO	8;10	Not Available;Not Available	Unknown;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2014;2014	NO	Not Available	MALE	YES	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	YES	YES	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7UU	Pre-Adjuvant Therapy	WITH TUMOR	YES	NO	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DH-A7UU-R60353	E875558A-66EC-40BC-9809-017176B63245	Not Available	6	88	41	Stable Disease	6	34	6120	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	YES	Not listed in Medical Record	YES	NO	DH	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2013
TCGA-S9-A7QW	54	FEMALE	458	Astrocytoma	Central nervous system	Alive	G3	1	382.0			WITH TUMOR		54	NO	Not Available	NO	TCGA-S9-A7QW	765588AA-075F-477F-9C18-099D018D3A1B	5	-19869	Not Applicable	0	109	Not Available	-4	TCGA-S9-A7QW-D66224	8B394C53-188F-4E7E-A814-51B27B3B1898	Not Available	6	592	382	Temozolomide	Stable Disease	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2014	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	NO	Not Available	Not Available	TCGA-S9-A7QW-F66223	8226519D-C3E5-4F45-BB25-B894AF661FE6	6	Not Available	Not Available	Not Applicable	458	382	Not Available	Not Available	Additional New Tumor Event	Stable Disease	Not Available	NO	10	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	100	Left	YES	IHC	YES	NO	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7QW	Preoperative	WITH TUMOR	NO	NO	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-S9-A7QW-R52657	F3C1221D-2944-4F10-AE94-467E6F798E60	Not Available	5	81	36	Stable Disease	12	33	59.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Cerebral Cortex	YES	NO	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-QH-A65V	43	FEMALE	384	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		43	NO	Not Available	NO	TCGA-QH-A65V	AD72E61E-51E3-4992-AC77-65E895935736	2	-15850	Not Applicable	0	147	Not Available	-9	TCGA-QH-A65V-D47245;TCGA-QH-A65V-D47246;TCGA-QH-A65V-D47248	C19462BC-CC29-49EA-804E-A35C6FF34868;772815A6-D22C-478E-B754-DC60B27CFA26;DC68F1EC-A84E-42E8-8F2E-BD8F195F5255	Not Available;Not Available;Not Available	29;29;29	327;307;307	147;147;147	PROCARBAZINE;LOMUSTINE;VINCRISTINE	Stable Disease;Stable Disease;Stable Disease	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	Not Available	TCGA-QH-A65V-F59561	3023153A-E583-4554-B403-477E60A9CEC4	15	Not Available	Not Available	Not Applicable	384	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	5	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A65V	Preoperative	WITH TUMOR	YES	YES	YES	Stable Disease	WHITE	NO																			YES	NO	White Matter	YES	NO	QH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-WY-A85E	48	FEMALE	633	Oligoastrocytoma	Central nervous system	Alive	G2	1	532.0			WITH TUMOR		48	NO	Not Available	NO	TCGA-WY-A85E	2272DFF7-A509-496F-B500-467C1BCE2F79	27	-17878	Not Applicable	0	626	Not Available	311																								1	NO	Not Available	Unknown	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	YES	YES	YES	Not Available	TCGA-WY-A85E-F65805	2B1154F4-669D-456D-BC7D-48436E2A8734	22	536	Not Available	Not Applicable	633	532	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	1	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Alive	2015	YES	seafood, nuts	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	YES	YES	532	Not Available	536	Not Available	Not Available	YES	No	A85E	Not Available	WITH TUMOR	NO	YES	NO	Not Applicable	WHITE	NO																			YES	NO	Not Available	NO	YES	WY	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2014	2011
TCGA-DU-7012	74	FEMALE	199	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		74	Not Available	Not Available	Not Available	TCGA-DU-7012	c50c984f-316a-4f24-968d-618691c54c3d	28	-27039	199	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	NO	NO	Not Available	Not Available	TCGA-DU-7012-F17089	e0d24c46-aa23-478e-9903-43b8a2699003	28	Not Available	Not Available	199	Not Available	Not Available	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	Not Available	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7012	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-DU-7012-R17090	6568631d-562d-41fd-bded-e9c4a16ca9d6	1	28	53	53	Not Available	9	1	200	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	2001
TCGA-CS-6669	26	FEMALE	1494	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		26	NO	Not Available	NO	TCGA-CS-6669	dc5bdd21-b23f-400e-bbe2-4c98a517fc9e	24	-9809	Not Applicable	0	225	Not Available	0	TCGA-CS-6669-D17590	3f8e0599-a4ec-47cd-8894-5db97c17437c	Not Available	24	Not Available	30	Temodar	Not Available	9	Not Available	Not Available	mg	ADJUVANT	Not Applicable	1	PO	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	Not Available	YES	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-6669-F17589;TCGA-CS-6669-F71567	9b9c3ee4-c1fe-4d40-9138-c4460fa8f867;815C0801-FF73-48CA-B168-F547F8B2D8C8	24;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	225;1494	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	Not Available;Not Available	Not Available;NO	9;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Stable Disease;Stable Disease	NO;Not Available	Alive;Alive	2011;2015	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6669	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2011
TCGA-TQ-A7RI	37	FEMALE	62	Oligodendroglioma	Central nervous system	Alive	G2	0	62			Unknown		37	NO	Not Available	NO	TCGA-TQ-A7RI	7989B7FB-B9D9-4D3F-9352-CD0C1F28D828	25	-13799	Not Applicable	0	62	Not Available	Not Available																								Unknown	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RI-F65497	8AC5DBD0-C2F5-4D12-8D00-1299B2D3877A	25	Not Available	Not Available	Not Applicable	62	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	YES	9	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	NO	Unknown	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Unknown	Left	Not Available	Not Available	NO	NO	NO	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RI	Preoperative	Unknown	NO	YES	YES	Unknown	WHITE	NO																			YES	NO	White Matter	NO	YES	TQ	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-HT-8012	30	FEMALE	286	Oligodendroglioma	Central nervous system	Alive	G2	1	133.0			Not Available		30	NO	Not Available	NO	TCGA-HT-8012	9351b1ae-89e6-4091-934f-d50da06cd01d	3	-11295	Not Applicable	0	286	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	YES	NO	TCGA-HT-8012-F32626	fcdd61d8-65f9-4e94-afee-8d6a1fa757d2	4	133	Not Available	Not Applicable	286	133	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	6	Not Available	YES	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2012	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	5	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8012	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-F6-A8O3	34	MALE	7	Oligodendroglioma	Central nervous system	Alive	G2	0	7			TUMOR FREE		34	NO	Not Available	NO	TCGA-F6-A8O3	784ECAA5-7FB8-402A-8240-396AAD96BE83	12	-12578	Not Applicable	0	7	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-F6-A8O3-F67155	3B48D414-1DE9-49F6-8FB6-41883992302D	24	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Not Available	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A8O3	Not Available	TUMOR FREE	Unknown	NO	NO	Complete Remission/Response	ASIAN	Unknown																			NO	NO	Not listed in Medical Record	YES	NO	F6	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-TQ-A7RO	29	MALE	949	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		29	NO	Not Available	NO	TCGA-TQ-A7RO	D698946E-57DD-4FF2-B5FA-7A1D15C828BE	17	-10890	Not Applicable	0	949	Not Available	123																								0	NO	HISPANIC OR LATINO	YES	NO	Not Available	Not Available	12 - 20 Years	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RO-F65562	CDCF07AB-5645-49B0-8D75-746D885074F4	17	Not Available	Not Available	Not Applicable	949	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	2	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Partial Remission/Response	NO	Alive	2015	YES	Seafood	MALE	NO	NO	Oligoastrocytoma	YES	No	C71.0	9382/3	C71.0	YES	NO	Not Available	100	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RO	Other	WITH TUMOR	NO	YES	YES	Partial Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2015	2011
TCGA-S9-A7J1	43	MALE	249	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		43	NO	Not Available	NO	TCGA-S9-A7J1	33BEDFB7-33FB-479D-B997-50C3284C0AC9	12	-15926	Not Applicable	0	249	Not Available	-17																								3	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-S9-A7J1-F65755;TCGA-S9-A7J1-F70006;TCGA-S9-A7J1-F71265	DDAA34D4-1BDD-4D3C-A4F4-1D0A8AAF1BB1;96E5E63A-9910-4B02-A5BA-F4C2E5A6334C;F3A0E147-5762-4ED3-A1DB-CBDFFCD24CEF	30;26;24	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	249;249;249	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown;Unknown	Not Available;Not Available;Not Available	NO;NO;YES	9;1;3	Not Available;Not Available;Not Available	Unknown;Unknown;Unknown	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO	Partial Remission/Response;Partial Remission/Response;Partial Remission/Response	NO;NO;NO	Alive;Alive;Alive	2014;2015;2015	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	60	Right	YES	IHC	YES	NO	NO	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7J1	Preoperative	WITH TUMOR	NO	YES	NO	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-TM-A84B	40	MALE	758	Astrocytoma	Central nervous system	Dead	G3	1				WITH TUMOR		40	NO	Not Available	NO	TCGA-TM-A84B	EE6BF12F-8A73-49E2-B566-368B2B42165B	16	-14933	Not Applicable	0	365	Not Available	0	TCGA-TM-A84B-D56640	9FE9D101-9718-4241-B3BC-6459C9570FF0	Not Available	16	338	188	Temozolomide	Clinical Progressive Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TM-A84B-F65302	4D87D51A-CC16-4DA8-AD00-C539B51E8352	22	Not Available	Not Available	758	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Left	NO	IHC	YES	NO	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A84B	Preoperative	WITH TUMOR	YES	Unknown	Unknown	Progressive Disease	WHITE	NO																			YES	YES	Not listed in Medical Record	NO	YES	TM	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2014	2012
TCGA-DB-A64X	56	FEMALE	563	Astrocytoma	Central nervous system	Alive	G3	0	563			TUMOR FREE		56	Unknown	Not Available	NO	TCGA-DB-A64X	9922DE10-9280-44C0-B86F-6D1CA7E55BF2	7	-20625	Not Applicable	0	332	Not Available	-19	TCGA-DB-A64X-D46516	640A29D8-5081-47AA-93FE-06A3B488486E	Not Available	7	265	53	Temodar	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64X-F67369	155F87B9-244C-41AB-BF60-543BE4C1B697	7	Not Available	Not Available	Not Applicable	563	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2014	Unknown	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	Unknown	8	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64X	Preoperative	TUMOR FREE	YES	NO	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-DB-A64X-R46515	D710B0D9-1D61-4061-8FB0-7B1B4FA40F83	Not Available	7	83	53	Stable Disease	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	NO	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-A713	74	FEMALE	622	Oligoastrocytoma	Central nervous system	Alive	G2	0	622			TUMOR FREE		74	NO	Not Available	NO	TCGA-FG-A713	FA878A23-CD20-44EF-B438-33033B5FB1FE	4	-27232	Not Applicable	0	159	Not Available	13																								Not Evaluated	YES	NOT HISPANIC OR LATINO	NO	NO	> 20 Years	Not Available	> 20 Years	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A713-F70642	3E8AE03D-5E91-4545-9FA9-9C3B41E32E74	27	Not Available	Not Available	Not Applicable	622	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	2	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2015	YES	Melon	FEMALE	YES	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	60	Right	Not Available	Not Available	NO	YES	YES	12	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Yes, History of Prior Malignancy	A713	Pre-Adjuvant Therapy	TUMOR FREE	NO	NO	NO	Complete Remission/Response	WHITE	YES																			NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-E1-A7YH	47	FEMALE	2835	Astrocytoma	Central nervous system	Dead	G3	1	689.0			WITH TUMOR		47	Unknown	Not Available	NO	TCGA-E1-A7YH	9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7	12	-17465	2835	0	Not Available	Not Available	17	TCGA-E1-A7YH-D61224;TCGA-E1-A7YH-D61225;TCGA-E1-A7YH-D61226;TCGA-E1-A7YH-D61228;TCGA-E1-A7YH-D61231;TCGA-E1-A7YH-D61234;TCGA-E1-A7YH-D61235;TCGA-E1-A7YH-D61236;TCGA-E1-A7YH-D61238	C3FB6DAF-CC6E-4337-A4D9-428A04D885F1;5ABFE853-898E-4AE7-B004-84BA9C9F538A;497713B5-E927-49B8-BCDF-987ED2BD152D;AED54027-D9B2-47BF-A61C-FE8F7F7A96CD;0E15F21A-0740-4CEA-8117-F322CA019484;4C28D915-D694-4549-BDCD-78BB263BA535;9D2F071F-A519-4608-8897-8CB965C09A4C;7CAE29FD-FD85-47BA-B60F-BBE33F7D49FF;9CEF76EB-E81C-4496-A154-0999F535C7E9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14;14;14;14;14	87;216;537;752;835;1223;1223;1328;1627	45;117;222;706;775;867;867;1224;1345	Temodar;CCNU;Temodar;Temodar;Temodar;Erlotinib;Avastin;Avastin;VP-16	Stable Disease;Stable Disease;Unknown;Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Not Available;Not Available;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES;YES;NO;NO	2014;2014;2014;2014;2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	YES;YES;YES;NO	NO;NO;NO;NO	NO;NO;NO;NO	NO;NO;NO;NO	TCGA-E1-A7YH-F61229;TCGA-E1-A7YH-F61233;TCGA-E1-A7YH-F61237;TCGA-E1-A7YH-F61239	58B46977-C71C-4636-8A6D-6C2CDF578F85;DDBAF497-C9B3-496E-9B1A-943D6589F588;E924E65F-EADC-4F15-B4D0-F3980FA6DDF6;3A536445-56BA-4449-8C43-0A86AA7239D0	14;14;14;14	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2835;2835;2835;2835	Not Available;Not Available;Not Available;Not Available	752;840;2789;1629	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	8;8;8;8	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES	Stable Disease;Stable Disease;Stable Disease;Stable Disease	YES;YES;YES;YES	Dead;Dead;Dead;Dead	2014;2014;2014;2014	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	80	Right	Not Available	Not Available	NO	NO	Unknown	5	NO	G3	YES	NO	689	NO	Not Available	NO	Not Available	YES	No	A7YH	Pre-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	YES	Unknown	TCGA-E1-A7YH-R61223	EA0D0243-27C5-4974-9909-D9CAB3558D7F	Not Available	14	87	45	Stable Disease	8	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	White Matter	NO	YES	E1	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2014	2005
TCGA-DB-A64S	20	MALE	835	Oligoastrocytoma	Central nervous system	Alive	G2	0	835			TUMOR FREE		20	NO	Not Available	NO	TCGA-DB-A64S	66990A9D-8C40-4C56-B931-5C3826C3BC27	7	-7389	Not Applicable	0	469	Not Available	-29																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A64S-F67351	6DA0AB24-DCF6-47AC-BBE0-951428A76D50	4	Not Available	Not Available	Not Applicable	835	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	Unknown	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	100	Not Available	Not Available	Not Available	NO	NO	Unknown	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A64S	Preoperative	TUMOR FREE	NO	NO	NO	Complete Remission/Response	WHITE	NO																			NO	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-DU-6408	23	FEMALE	3470	Oligodendroglioma	Central nervous system	Dead	G3	1	2097.0			Not Available		23	Not Available	Not Available	Not Available	TCGA-DU-6408	14375753-a69f-41e0-b910-2bb8e84cc43a	21	-8752	3470	0	Not Available	Not Available	Not Available	TCGA-DU-6408-D14914;TCGA-DU-6408-D14910;TCGA-DU-6408-D14913;TCGA-DU-6408-D14911	4e0b69f2-a12d-42b1-8d9e-118a8d889a24;37c7aca8-52b5-4421-9922-52ea6ab89b0a;bf35364e-fbff-4d21-b3fc-dff1ce09cb5d;8ac55ee4-7db3-4a31-817c-de2a0893a41c	Not Available;Not Available;Not Available;Not Available	20;20;20;20	Not Available;1226;Not Available;Not Available	2608;1175;2608;2608	Capecitabine;Temozolomide;Celebrex;Temozolomide	Not Available;Not Available;Not Available;Not Available	6;6;6;6	Not Available;02;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg;mg/m2	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	02;01;02;02	PO;PO;PO;PO	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	YES	Not Available	YES	YES	TCGA-DU-6408-F14907	40b6e555-e1db-4690-ac67-c773db93adb3	20	2552	2552	3470	Not Available	2097	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	6	Not Available	YES	Not Available	Not Available	Not Available	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	YES	Not Available	6	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6408	Post-Adjuvant Therapy	Not Available	Not Available	YES	YES	Not Available	WHITE	Not Available	Local Recurrence	TCGA-DU-6408-R14909	df257ce3-15a5-495b-90e5-d7ef4ddec23b	01	20	Not Available	Not Available	Not Available	6	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1998
TCGA-QH-A6X4	47	MALE	442	Oligoastrocytoma	Central nervous system	Alive	G3	0	442			TUMOR FREE		47	NO	Not Available	NO	TCGA-QH-A6X4	976D067B-9D7F-4920-A04D-E831EDC6C2C2	9	-17258	Not Applicable	0	192	Not Available	192	TCGA-QH-A6X4-D52186	66530FFA-1EDB-4819-9F1D-22E7BD5BAC7E	Not Available	9	342	196	temozolomide	Clinical Progressive Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Sensory Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A6X4-F67744	72B8568B-9EB3-4A59-B6F0-212EAEBCDB3B	11	Not Available	Not Available	Not Applicable	442	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	Not Available	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	90	Left	YES	Sequence Analysis	YES	NO	NO	12	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6X4	Pre-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-QH-A6X4-R52185	A71931FF-E114-4EF9-97C8-B15BA7F3E156	Not Available	9	138	101	Complete Response	12	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	YES	Cerebral Cortex	YES	NO	QH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-DU-7019	39	MALE	800	Oligoastrocytoma	Central nervous system	Alive	Discrepancy	0	800			TUMOR FREE		39	Not Available	Not Available	Not Available	TCGA-DU-7019	1b43ff0c-cf13-4620-b5c7-7abd9129612f	26	-14279	Not Applicable	0	800	Not Available	21	TCGA-DU-7019-D17099;TCGA-DU-7019-D17098	407c4659-4e06-40bf-ba0f-7f715113b34f;768a76e4-31d4-43bc-85d9-e205b2e3b937	Not Available;Not Available	26;26	436;71	101;28	Temozolomide;Temozolomide	Not Available;Not Available	9;9	12;01	150;75	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	01;01	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	320;160	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-7019-F17096	bb5b9965-1de2-4ffe-b7ac-b9331e08d0c6	26	Not Available	Not Available	Not Applicable	800	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2011	Not Available	Not Available	MALE	Not Available	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	100	Right	Not Available	Not Available	NO	NO	Not Available	9	NO	Discrepancy	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7019	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7019-R17097	86a85cd1-84ad-45df-af9f-c080d128a56e	01	26	71	28	Not Available	9	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Cerebral Cortex	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2011	2009
TCGA-DU-A76K	87	MALE	347	Oligodendroglioma	Central nervous system	Dead	G2	1	203.0			WITH TUMOR		87	Unknown	Not Available	Unknown	TCGA-DU-A76K	30BF5895-0671-4FB1-A96D-857847FCF7B0	22	-31776	347	0	Not Available	Not Available	Not Available	TCGA-DU-A76K-D50343	67766C84-4517-44DE-BCA9-0A2EEA468543	Not Available	22	269	236	Temozolomide	Clinical Progressive Disease	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	> 181 Days																														Unknown	Not Available	MALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	NO	Unknown	10	NO	G2	YES	NO	203	YES	203	Not Available	Not Available	YES	No	A76K	Not Evaluated	WITH TUMOR	NO	Unknown	Unknown	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-DU-A76K-R50342	E318B914-F5F7-4D73-A7AC-D207A2C8CA9D	Not Available	22	82	34	Stable Disease	10	33	59.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	NO	Not listed in Medical Record	NO	YES	DU	Supratentorial, Parietal Lobe	Central nervous system	NO	Dead	2013	1999
TCGA-R8-A6MK	40	MALE	2702	Oligodendroglioma	Central nervous system	Alive	G2	0	2702			Not Available		40	Not Available	Not Available	Not Available	TCGA-R8-A6MK	65836B59-B469-4B89-ADF5-E65735E494F5	30	-14716	Not Applicable	0	2702	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Not Available	Not Available																														Not Available	Not Available	MALE	Not Available	Unknown	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	Unknown	Not Available	12	Unknown	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A6MK	Not Available	Not Available	YES	Not Available	Not Available	Unknown	WHITE	NO																			YES	Unknown	Not Available	NO	YES	R8	Supratentorial, Frontal Lobe	Central nervous system	Unknown	Alive	2013	2005
TCGA-HT-7879	31	MALE	112	Oligoastrocytoma	Central nervous system	Alive	G3	0	112			TUMOR FREE		31	NO	Not Available	NO	TCGA-HT-7879	c916b9a4-008e-4d79-a50c-f15c3549fcf6	1	-11622	Not Applicable	0	98	Not Available	Not Available	TCGA-HT-7879-D29675;TCGA-HT-7879-D29676	3a2e7d41-80ef-4a00-91c0-ed73bca1c3ff;c67036e4-e84e-453f-88e4-393a46c1ab59	Not Available;Not Available	19;19	78;Not Available	28;112	Temodar;Temodar	Not Available;Not Available	3;3	1;2	140;250	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	PO;PO	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	7000;Not Available	mg;Not Available	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7879-F29673	e2c73c00-8b17-4843-8269-721c0642001e	19	Not Available	Not Available	Not Applicable	112	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	Not Available	NO	NO	3	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7879	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7879-R29674	92476855-3269-42f5-91d8-3834b9d3ce2f	1	19	77	28	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	YES	NO	Not Available	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-S9-A6WP	42	MALE	567	Oligoastrocytoma	Central nervous system	Alive	G3	1				WITH TUMOR		42	NO	Not Available	NO	TCGA-S9-A6WP	081B6532-0ED4-445A-BECB-CB2290F4854D	5	-15658	Not Applicable	0	187	Not Available	-3	TCGA-S9-A6WP-D54293	95562946-2EC2-4DDA-87DE-5B8D4C2C3840	Not Available	18	Not Available	19	Temozolomide	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-S9-A6WP-F62937;TCGA-S9-A6WP-F69994	C673F00E-5339-41E2-83F4-D9CA71FD9715;F724C120-F46F-41A3-B207-79CCD61E2975	29;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	461;567	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	7;1	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Partial Remission/Response;Partial Remission/Response	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	100	Right	YES	IHC	YES	NO	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WP	Preoperative	WITH TUMOR	YES	NO	NO	Partial Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HT-8019	34	FEMALE	1004	Oligodendroglioma	Central nervous system	Alive	G3	0	1004			TUMOR FREE		34	NO	Not Available	NO	TCGA-HT-8019	9d93834a-3bf0-41fd-8c74-5ac49a6e78cd	15	-12669	Not Applicable	0	1004	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-8019-F46178	485491F5-BB92-4012-90C4-D172946DE695	18	Not Available	Not Available	Not Applicable	1004	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	5	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	8019	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-QH-A6CY	38	MALE	408	Oligoastrocytoma	Central nervous system	Alive	G3	1				Unknown		38	NO	Not Available	NO	TCGA-QH-A6CY	E1758D75-B2A0-4386-BD72-6B2421D4DA6B	2	-14140	Not Applicable	0	67	Not Available	-26	TCGA-QH-A6CY-D60334	670A7D1B-F8D3-4443-A785-8AE6F79B769F	Not Available	6	Not Available	267	Temozolomide	Stable Disease	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A6CY-F60215	2C2B9A3A-F971-4EA8-8EBC-64D524428000	6	Not Available	Not Available	Not Applicable	408	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Unknown	Not Available	90	Right	YES	IHC	YES	NO	NO	8	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6CY	Preoperative	Unknown	NO	YES	YES	Unknown	WHITE	YES	Primary Tumor Field	TCGA-QH-A6CY-R46347	F75EE16A-BC12-4E7E-933E-E86E41D76443	Not Available	9	67	30	Stable Disease	12	28	56	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-VW-A7QS	35	FEMALE	706	Oligodendroglioma	Central nervous system	Alive	G3	0	706			WITH TUMOR		35	NO	Not Available	NO	TCGA-VW-A7QS	2C982CFB-4112-4E27-8293-25AA9E01FAAE	12	-12820	Not Applicable	0	706	Not Available	Not Available	TCGA-VW-A7QS-D60049	DBE5F77E-696B-49A2-B02B-31A1ACD8F5F0	Not Available	29	595	14	Temodar	Partial Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	31 - 90 Days																														NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	YES	NO	12	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7QS	Not Evaluated	WITH TUMOR	YES	YES	YES	Stable Disease	ASIAN	NO																			NO	NO	Not listed in Medical Record	NO	YES	VW	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-HT-7605	38	MALE	139	Oligodendroglioma	Central nervous system	Alive	G2	0	139			Not Available		38	NO	Not Available	NO	TCGA-HT-7605	6b225409-09c0-4a51-8f42-8fefe3855c4d	30	-13892	Not Applicable	0	139	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	< 12 Years	Not Available	Not Available	Motor/Movement Changes	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7605-F29603	37998990-790a-4fff-b085-411ac31a6810	15	Not Available	Not Available	Not Applicable	139	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NO	Alive	2012	NO	Not Available	MALE	YES	NO	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	YES	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7605	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-S9-A6WN	38	FEMALE	805	Astrocytoma	Central nervous system	Alive	G3	1	303.0			WITH TUMOR		38	NO	Not Available	NO	TCGA-S9-A6WN	A418FE65-DFDD-4C84-B27C-B4567B50F457	5	-13961	Not Applicable	0	275	Not Available	-14	TCGA-S9-A6WN-D54288;TCGA-S9-A6WN-D63848;TCGA-S9-A6WN-D72372;TCGA-S9-A6WN-D72373;TCGA-S9-A6WN-D72375	0189105C-BCD7-4A93-8747-EB4C23CA296B;0D76F957-E4A4-48D7-91B5-14980A6F3A20;337FAAFA-E3B9-46CE-B37C-AB322DA11444;370B1B75-B283-4BF7-AD4C-7853B4A9F2E9;FFB8E833-2183-4A3F-ABB5-93C24C7B929B	Not Available;Not Available;Not Available;Not Available;Not Available	18;20;9;9;9	91;805;321;805;Not Available	42;425;317;679;846	Temozolomide;Bevacizumab;Temozolomide;Lomustin;Pembrolizumab	Stable Disease;Clinical Progressive Disease;Unknown;Clinical Progressive Disease;Not Applicable	12;8;6;6;6	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;NO	2013;2014;2015;2015;2015	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES;NO;YES	NO;NO;NO	NO;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-S9-A6WN-F63847;TCGA-S9-A6WN-F69990;TCGA-S9-A6WN-F72374	36B26A45-7E31-4622-A43D-C0D3404EF19B;C92AC1B3-8FFC-42EF-9F50-90B93BC53A9E;CCB6E31F-0B10-4B2B-B301-5488CE7FDA7A	20;26;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	484;659;805	303;679;805	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Stable Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available	NO;NO;NO	8;1;6	Not Available;Not Available;Not Available	YES;YES;YES	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES	Alive;Alive;Alive	2014;2015;2015	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Left	NO	IHC	YES	NO	NO	11	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6WN	Preoperative	WITH TUMOR	YES	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-S9-A6WN-R54284	5707470C-6EFE-4C88-B6E2-CE64322219B2	Not Available	18	160	117	Stable Disease	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	YES	Cerebral Cortex	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-CS-6290	31	MALE	1137	Astrocytoma	Central nervous system	Dead	G3	1				Not Available		31	NO	Not Available	NO	TCGA-CS-6290	42fe260f-520b-4fac-8c09-d2b31aed59fb	7	-11666	Not Applicable	0	546	Not Available	-1	TCGA-CS-6290-D17566	4b47d8fe-0c26-4476-9676-c2bcc77004ec	Not Available	13	504	Not Available	Temodar	Not Available	10	12	400	mg	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	1	NO	Not Available	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-6290-F17564;TCGA-CS-6290-F71693	0786bd8d-9f0e-4497-9725-2f8c6999ce66;0F35EB61-F7BB-4020-A48F-292437017227	13;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;1137	546;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Applicable	Not Available;Not Available	Not Available;NO	10;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	YES;Not Available	Stable Disease;Not Available	YES;Not Available	Alive;Dead	2011;2015	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6290	Preoperative	Not Available	Not Available	NO	NO	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-CS-6290-R17565	d4ef271e-6462-4de8-ba00-eb5baae0362a	1	13	115	Not Available	Not Available	10	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2009
TCGA-DB-A4XE	27	FEMALE	1139	Oligoastrocytoma	Central nervous system	Alive	G3	0	1139			TUMOR FREE		27	NO	Not Available	NO	TCGA-DB-A4XE	1701F4AD-58C5-40D8-90C4-99E3ACAC0104	21	-10150	Not Applicable	0	573	Not Available	294																								0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A4XE-F60953	93A634BB-70DF-4FFF-A0D9-53E2FF401281	19	Not Available	Not Available	Not Applicable	1139	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.2	9382/3	C71.2	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	Unknown	2	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4XE	Preoperative	TUMOR FREE	NO	YES	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-DB-A4XE-R40475	A242C032-ED33-4697-8E97-3ECB22E7BBE5	Not Available	21	73	23	Stable Disease	2	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2011
TCGA-TQ-A7RQ	38	FEMALE	795	Oligodendroglioma	Central nervous system	Alive	G2	0	795			TUMOR FREE		38	NO	Not Available	NO	TCGA-TQ-A7RQ	E2B1D161-D8CC-4EBA-87AC-9449C6CD2977	17	-14187	Not Applicable	0	795	Not Available	53																								0	NO	HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RQ-F65566	B55DC7A5-0261-448E-BAC7-C088D6398FB8	30	Not Available	Not Available	Not Applicable	795	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RQ	Pre-Adjuvant Therapy	TUMOR FREE	YES	YES	YES	Complete Remission/Response	WHITE	NO																			YES	NO	Cerebral Cortex	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-HT-7606	30	FEMALE	526	Astrocytoma	Central nervous system	Alive	G2	0	526			Not Available		30	NO	Not Available	Not Available	TCGA-HT-7606	ffcec8e5-9fd3-4b42-a7cb-74761f713cf4	31	-11233	Not Applicable	0	526	Not Available	Not Available	TCGA-HT-7606-D29686;TCGA-HT-7606-D29691;TCGA-HT-7606-D29688	a6fc3d48-fb07-4f09-af63-e2bf104238af;9df05834-b1d3-412b-9b69-0a61dc70e7dc;2936878a-df7a-4dee-8fc2-5e319bfdd03d	Not Available;Not Available;Not Available	19;27;27	64;470;102	21;163;98	temodar;temodar;temodar	Not Available;Not Available;Not Available	3;3;3	1;10;1	130;330;260	mg/day;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;3;2	PO;PO;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5720;19800;1300	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7606-F29692	abf3564f-8e72-4574-9fea-72c10581af01	27	Not Available	Not Available	Not Applicable	526	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.9	9400/3	C71.9	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	NO	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7606	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7606-R30717	c6e2e388-5a2c-4288-931b-884e397bcade	1	16	64	21	Not Available	4	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2008
TCGA-HT-7882	66	MALE	113	Oligodendroglioma	Central nervous system	Dead	G3	1				TUMOR FREE		66	NO	Not Available	NO	TCGA-HT-7882	912d6455-0a50-4fde-b785-f6c09b00b7e4	7	-24450	Not Applicable	0	52	Not Available	Not Available																								Not Available	NO	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7882-F28952	af823bb6-e3bb-4b79-bde0-aa8fe642fb18	2	Not Available	Not Available	113	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Dead	2012	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	YES	NO	2	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7882	Not Available	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2010
TCGA-DU-A6S8	74	FEMALE	678	Oligodendroglioma	Central nervous system	Alive	G3	1	641.0			WITH TUMOR		74	NO	Not Available	NO	TCGA-DU-A6S8	9CD3B3C6-2268-4E43-964B-B7A4DAF6FC6F	18	-27084	Not Applicable	0	182	Not Available	14	TCGA-DU-A6S8-D50231	05FB684B-BCF9-4C5F-9CF7-486F9A4EEA1A	Not Available	18	Not Available	57	Temozolomide	Not Applicable	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	> 181 Days	NO	NO	Not Available	Not Available	TCGA-DU-A6S8-F71614	131A2AEA-4162-4D87-AA54-F00CBB2CFE07	27	Not Available	Not Available	Not Applicable	678	641	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	3	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Alive	2015	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	YES	NO	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6S8	Pre-Adjuvant Therapy	WITH TUMOR	YES	NO	NO	Not Applicable	WHITE	NO																			NO	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-CS-4942	44	FEMALE	1335	Astrocytoma	Central nervous system	Dead	G3	1	1184.0			WITH TUMOR		44	NO	Not Available	NO	TCGA-CS-4942	230f5fa7-aa36-41ea-b40b-08f520767bd5	15	-16297	1335	0	Not Available	Not Available	-21	TCGA-CS-4942-D17619	c4d4f444-f628-43f4-8983-ff68f99b4bb0	Not Available	19	1260	1241	Avastin	Not Available	10	6	800	mg	PROGRESSION	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	4800	mg	Not Available	2011	1	NO	Not Available	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	YES	YES	YES	NO	TCGA-CS-4942-F10210	9efeae87-9e38-4c3d-b927-73c57986d68c	14	1189	1189	1335	Not Available	1184	1226	2	Not Available	Progressive Disease	70	Not Available	3	Not Available	YES	Not Available	Preoperative	WITH TUMOR	NO	Progressive Disease	YES	Dead	2011	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	NO	Not Available	90	Right	Not Available	Not Available	NO	YES	NO	3	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4942	Preoperative	WITH TUMOR	Not Available	NO	NO	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field;Local Recurrence	TCGA-CS-4942-R17620;TCGA-CS-4942-R17887	6df5cffd-413e-459e-84a1-31b55e9540a1;7cde2a29-e1f0-411e-8417-a7e388d5b27d	Not Available;2	19;27	187;1205	146;1205	Not Available;Not Available	10;10	Not Available;10	50.4;30	NO;NO	EXTERNAL BEAM;RADIOISOTOPE	Not Applicable;Not Applicable	ADJUVANT;RECURRENCE	Not Available;Not Available	cGy;cGy	2011;2011	YES	YES	White Matter	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2006
TCGA-FG-A4MU	58	MALE	326	Oligoastrocytoma	Central nervous system	Alive	G3	0	326			WITH TUMOR		58	NO	Not Available	NO	TCGA-FG-A4MU	7662940A-22DE-44D8-B59A-2F2B090EA6D5	18	-21450	Not Applicable	0	18	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A4MU-F63739	262ECA62-AC01-45A8-A6A6-B817CC807285	15	Not Available	Not Available	Not Applicable	326	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	8	Not Available	Unknown	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Alive	2014	NO	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	NO	IHC	YES	YES	NO	4	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A4MU	Not Evaluated	WITH TUMOR	Unknown	NO	YES	Unknown	WHITE	Unknown																			NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2013	2012
TCGA-HT-7902	30	FEMALE	956	Oligoastrocytoma	Central nervous system	Alive	G2	0	956			TUMOR FREE		30	NO	Not Available	YES	TCGA-HT-7902	02194c0c-e2c1-4ea7-994a-07b61b2575e2	7	-11118	Not Applicable	0	955	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	Not Available	Visual Changes	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7902-F28951	d028b4d0-1ca7-4f1d-818e-72dbef6901b8	2	Not Available	Not Available	Not Applicable	956	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Stable Disease	NO	Alive	2012	NO	Not Available	FEMALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7902	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available																			NO	NO	Cerebral Cortex	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2009
TCGA-HT-A5RC	70	FEMALE	162	Astrocytoma	Central nervous system	Dead	G3	0	162			WITH TUMOR		70	Not Available	Not Available	Unknown	TCGA-HT-A5RC	8655FA51-D784-4F8D-9BC8-F1DA7303D22F	29	-25772	162	0	Not Available	Not Available	Not Available	TCGA-HT-A5RC-D55966	7A0FFB90-CF53-43F0-828E-76B39D3E3FF2	Not Available	22	98	34	Temodar	Clinical Progressive Disease	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Unknown	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days																														Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	40	Left	Not Available	Not Available	Unknown	YES	Unknown	7	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A5RC	Post-Adjuvant Therapy	WITH TUMOR	YES	Unknown	Unknown	Progressive Disease	WHITE	YES	Primary Tumor Field	TCGA-HT-A5RC-R55965	2778410A-43B0-4303-8FD4-62B3E4E5A3A4	Not Available	22	98	34	Radiographic Progressive Disease	1	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2013	2012
TCGA-WY-A85B	24	MALE	1393	Astrocytoma	Central nervous system	Alive	G2	0	1393			TUMOR FREE		24	NO	Not Available	NO	TCGA-WY-A85B	CB041720-0EFA-4EB6-A9A5-B6E138BB1A99	20	-8817	Not Applicable	0	1003	Not Available	Not Available																								0	Unknown	Unknown	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-WY-A85B-F65769	5D885388-BDF0-454E-B0E9-8F6AF4809367	22	Not Available	Not Available	Not Applicable	1393	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	1	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2015	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	Unknown	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A85B	Not Available	TUMOR FREE	NO	YES	Unknown	Complete Remission/Response	WHITE	NO																			YES	YES	Not listed in Medical Record	NO	YES	WY	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2010
TCGA-DU-6410	56	MALE	242	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		56	Not Available	Not Available	Not Available	TCGA-DU-6410	467a7e6a-8cba-4ef1-8afd-6c8eaccbc3df	26	-20567	Not Applicable	0	242	Not Available	35	TCGA-DU-6410-D15161	86f1b69a-ced9-4edf-9c4e-7b34d0dfbb85	Not Available	20	Not Available	56	Temozolomide	Not Available	6	07	200	mg/m2	ADJUVANT	Not Applicable	01	PO	YES	Chemotherapy	Not Available	400	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-6410-F15160	edd4f60b-9a8c-4888-920f-3bcb76910ea0	20	Not Available	Not Available	Not Applicable	242	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2011	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	50	Midline	Not Available	Not Available	NO	YES	Not Available	7	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6410	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Available	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2011	2010
TCGA-FG-A711	33	FEMALE	1481	Oligodendroglioma	Central nervous system	Dead	G2	1	347.0			WITH TUMOR		33	NO	Not Available	NO	TCGA-FG-A711	1F5B6B07-45F5-4DA4-932A-DF9665F6C538	2	-12248	Not Applicable	0	1329	Not Available	871	TCGA-FG-A711-D52361;TCGA-FG-A711-D52581;TCGA-FG-A711-D52595;TCGA-FG-A711-D52597;TCGA-FG-A711-D52600;TCGA-FG-A711-D52602;TCGA-FG-A711-D65440;TCGA-FG-A711-D65441	7EB7A18F-9270-4C94-BC38-F4AD094E0753;0EF92496-C0FB-4C0D-8737-B98B06D1C2FC;2F01441C-80E1-40F1-B28A-BDDDBEF4AC52;1285B580-A770-4193-9D6E-721FB74D941B;6DE43068-EE49-4097-B2FD-A873B0930DA2;09E1B306-CDD8-4C0E-9B48-B96E9F1CE4BE;431B95E5-8501-4D87-9B24-78277A0E9D09;1595ABFC-0102-42B3-B1DD-FE7EA5AC5FAE	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;4;4;4;4;4;23;23	673;774;Not Available;1195;1277;1277;1329;1329	350;733;1097;1155;1223;1223;1284;1284	Temodar;Temodar;Avastin;CCNU;Hydroxyurea;Imatinib;Carboplatin 5 AUC;Etoposide	Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	12;12;12;12;12;12;9;9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;YES;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013;2014;2014	Not Available	YES	NOT HISPANIC OR LATINO	NO	NO	< 12 Years	Not Available	Not Available	Seizures	0 - 30 Days	YES;NO;YES;YES;YES;YES	YES;YES;NO;NO;NO;NO	NO;NO;NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	TCGA-FG-A711-F52580;TCGA-FG-A711-F52584;TCGA-FG-A711-F52590;TCGA-FG-A711-F52596;TCGA-FG-A711-F52599;TCGA-FG-A711-F65436	65F9ACB2-922B-4F17-8D92-41AC4F2638DD;F5FF9023-9AED-4A96-B07A-2213E7F02391;DB9790F4-678A-44FB-8C13-F80DC3C35639;D0A5A970-4556-4EB9-80E2-A8D1CF767ACD;2897362E-2AF6-4E60-9000-F70DEB4AA28E;F3E1F0E6-5629-44E0-B482-993E9174A344	4;4;4;4;4;23	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;1481	1329;1329;1329;1329;1329;Not Available	712;969;1097;1139;1195;1277	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	12;12;12;12;12;9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO;NO;NO;NO	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	NO;NO;NO;NO;NO;NO	Alive;Alive;Alive;Alive;Alive;Dead	2013;2013;2013;2013;2013;2014	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Left	Not Available	Not Available	NO	YES	NO	12	NO	G2	YES	NO	347	NO	Not Available	Not Available	Not Available	YES	No	A711	Post-Adjuvant Therapy	WITH TUMOR	NO	YES	YES	Progressive Disease	WHITE	NO	Primary Tumor Field;Primary Tumor Field	TCGA-FG-A711-R52583;TCGA-FG-A711-R52587	364761BD-CD03-4DA3-B5B0-B5D3164E116A;01135809-9589-4308-AFE9-9842D54134F7	Not Available;Not Available	4;4	774;992	733;992	Radiographic Progressive Disease;Radiographic Progressive Disease	12;12	30;1	6000;Not Available	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2013;2013	YES	YES	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2010
TCGA-E1-A7Z3	31	FEMALE	2235	Astrocytoma	Central nervous system	Dead	G2	1	1569.0			WITH TUMOR		31	Unknown	Not Available	NO	TCGA-E1-A7Z3	3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3	11	-11330	2235	0	Not Available	Not Available	Not Available	TCGA-E1-A7Z3-D61695;TCGA-E1-A7Z3-D61698;TCGA-E1-A7Z3-D61699;TCGA-E1-A7Z3-D61700;TCGA-E1-A7Z3-D61702	AF4DC37C-985A-4BF2-A364-273564BB866F;DDFEF29C-B6DB-49E6-AC99-A2F93816731A;3A267015-FFC3-4370-860D-AAB135DB3C2B;7C353942-BAB3-43B8-8530-CFCA1CB6318D;35FBE083-45A7-43C7-BDC0-0CF019A52F5A	Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18	1709;1921;1921;1921;2072	1709;1911;1911;1911;1995	I131-81C6;CCNU;Procarbazine;Vincristine;CPT-11	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES	2014;2014;2014;2014;2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO;YES;Unknown	YES;NO;NO	NO;NO;NO	NO;NO;NO	TCGA-E1-A7Z3-F61696;TCGA-E1-A7Z3-F61701;TCGA-E1-A7Z3-F61703	C0A6C1C2-247A-4C11-B7C3-E029EDB6AA1B;8FF5D128-F31B-4C74-8CAF-C746F71968BC;6AE510DA-136A-4246-91B5-29C641A8380B	18;18;18	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2235;2235;2235	Not Available;Not Available;Not Available	1810;1921;2072	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available	NO;NO;NO	8;8;8	Not Available;Not Available;Not Available	YES;YES;YES	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES	Dead;Dead;Dead	2014;2014;2014	Unknown	Not Available	FEMALE	Unknown	NO	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	Not Available	Not Available	NO	NO	Unknown	8	NO	G2	YES	NO	1569	YES	1656	NO	Not Available	YES	No	A7Z3	Not Evaluated	WITH TUMOR	NO	YES	Unknown	Progressive Disease	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-E1-A7Z3-R61697	70B41891-B39D-480C-8FC8-E1CA96F92F01	Not Available	18	1866	1821	Stable Disease	8	Not Available	5600	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Cerebral Cortex	NO	YES	E1	Supratentorial, Parietal Lobe	Central nervous system	NO	Dead	2014	1992
TCGA-DB-A75K	55	FEMALE	368	Oligoastrocytoma	Central nervous system	Alive	G3	0	368			TUMOR FREE		55	NO	Not Available	NO	TCGA-DB-A75K	5F853A88-811D-4EB4-914E-D90862C5D2A2	30	-20241	Not Applicable	0	225	Not Available	Not Available	TCGA-DB-A75K-D56207	9F88DDF4-2335-4239-AD47-2B1C42645364	Not Available	30	64	28	Temozolomide	Complete Response	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DB-A75K-F67635	1FCCE610-271F-4A8F-A2AF-4ECBBD159903	7	Not Available	Not Available	Not Applicable	368	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2014	NO	Not Available	FEMALE	NO	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	YES	IHC	YES	NO	NO	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A75K	Not Available	TUMOR FREE	YES	YES	Unknown	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-DB-A75K-R56208	449A6E23-D9F3-4610-8943-AE0782BB5B73	Not Available	30	73	28	Complete Response	1	33	5949	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	YES	NO	Cerebral Cortex	YES	NO	DB	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-CS-4938	31	FEMALE	3574	Astrocytoma	Central nervous system	Alive	G2	1				Not Available		31	YES	Dog, Cat	NO	TCGA-CS-4938	334f715e-08dc-4a29-b8e4-b010b829c478	15	-11509	Not Applicable	0	143	Not Available	-1																								1	NO	NOT HISPANIC OR LATINO	YES	YES	Not Available	12 - 20 Years	Not Available	Seizures	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-CS-4938-F21553;TCGA-CS-4938-F71559	2ad8c8a7-ddb6-4ff1-8979-5416917b0504;2BB62B6E-5B25-4708-A1F6-4382BB3B4FA5	15;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	143;3574	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Not Available	Not Available;Stable Disease	Not Available;Not Available	Not Available;NO	2;3	Not Available;Not Available	NO;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;Not Available	Stable Disease;Not Available	NO;Not Available	Alive;Alive	2012;2015	NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.9	9400/3	C71.9	YES	Not Available	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	2	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4938	Preoperative	Not Available	Not Available	NO	NO	Not Available	WHITE	Not Available																			YES	NO	Cerebral Cortex	NO	YES	CS	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2005
TCGA-DH-A7US	50	MALE	706	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		50	Unknown	Not Available	NO	TCGA-DH-A7US	82FD02AB-D628-469F-8853-4C603CF04964	29	-18429	Not Applicable	0	311	Not Available	Not Available																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-DH-A7US-F68873;TCGA-DH-A7US-F70994	BED71572-299C-43F7-96B3-6CDE3F59B6EF;A3C5928A-3FF0-4774-A9DD-D41CA2A5A7BB	22;12	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	399;706	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	12;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Stable Disease;Stable Disease	NO;NO	Alive;Alive	2014;2015	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	YES	IHC	YES	NO	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7US	Not Available	WITH TUMOR	NO	YES	NO	Stable Disease	WHITE	NO																			YES	NO	Not listed in Medical Record	YES	NO	DH	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2014	2013
TCGA-DU-A7TJ	55	MALE	17	Astrocytoma	Central nervous system	Alive	G3	0	17			WITH TUMOR		55	Unknown	Not Available	Unknown	TCGA-DU-A7TJ	BA910760-EBB5-41BA-81A1-C5355E3D3087	5	-20394	Not Applicable	0	17	Not Available	Not Available																								Not Evaluated	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-A7TJ-F71624	5F13BC9F-57F1-442E-82D1-89B3E5326D7F	27	Not Available	Not Available	Not Applicable	17	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	3	Not Available	Unknown	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Alive	2015	Unknown	Not Available	MALE	Unknown	YES	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	Not Evaluated	Right	YES	IHC	YES	Unknown	Unknown	2	Unknown	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A7TJ	Not Evaluated	WITH TUMOR	Unknown	YES	YES	Unknown	BLACK OR AFRICAN AMERICAN	Unknown																			YES	Unknown	Not listed in Medical Record	YES	NO	DU	Supratentorial, Temporal Lobe	Central nervous system	Unknown	Alive	2014	2013
TCGA-P5-A733	52	FEMALE	414	Astrocytoma	Central nervous system	Alive	G2	0	414			TUMOR FREE		52	Not Available	Not Available	Not Available	TCGA-P5-A733	D81B9957-8C82-4006-B111-449FA9FB95ED	13	-19142	Not Applicable	0	7	Not Available	Not Available	TCGA-P5-A733-D69014	6CFB08AB-DEA8-40DD-BF6F-4B0DE746A072	Not Available	24	414	97	Temozolomide	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-P5-A733-F69012	BCE7FE93-0CC5-4B03-B45C-2D01B5E229FC	24	Not Available	Not Available	Not Applicable	414	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	12	Not Available	Unknown	Not Available	Not Available	Not Available	YES	Unknown	YES	Alive	2014	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	Not Available	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A733	Not Available	TUMOR FREE	Unknown	Not Available	Not Available	Complete Remission/Response	WHITE	Unknown	Unknown	TCGA-P5-A733-R69013	16EBA9F7-CB5F-4AC3-AD03-9D7419444345	Not Available	24	41	21	Unknown	12	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Available	Not Available	Not Available	YES	NO	P5	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2014	2013
TCGA-RY-A83Y	45	MALE	166	Oligodendroglioma	Central nervous system	Alive	G2	0	166			TUMOR FREE		45	Not Available	Not Available	NO	TCGA-RY-A83Y	172701CF-709B-4E8F-B2FA-E2690A9E272D	15	-16470	Not Applicable	0	166	Not Available	2																								Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-RY-A83Y-F69684	B7EDDC6A-64ED-415B-BA25-42AC2A57104D	15	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2015	Not Available	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	80	Left	YES	IHC	YES	YES	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A83Y	Other	TUMOR FREE	Unknown	Not Available	Not Available	Unknown	WHITE	NO																			YES	NO	Cerebral Cortex	YES	NO	RY	Supratentorial, Parietal Lobe	Central nervous system	NO	Alive	2015	2012
TCGA-DU-5874	62	FEMALE	461	Oligodendroglioma	Central nervous system	Alive	G2	0	461			TUMOR FREE		62	Not Available	Not Available	Not Available	TCGA-DU-5874	1cc53ade-73c0-492b-a7dc-328269fd0e66	25	-22847	Not Applicable	0	461	Not Available	380	TCGA-DU-5874-D14707	93cbb4cb-db7b-465a-a69d-69dbdf14397f	Not Available	17	160	7	Temozolomide	Not Available	6	6	150	mg/m2	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	300	mg/m2	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-5874-F14706	96553367-425c-44a7-83cd-c19184fd208f	17	Not Available	Not Available	Not Applicable	461	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	100	Left	Not Available	Not Available	NO	NO	Not Available	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5874	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2011	2010
TCGA-HW-7487	39	MALE	1382	Oligodendroglioma	Central nervous system	Alive	G2	1	840.0			WITH TUMOR		39	Not Available	Not Available	Not Available	TCGA-HW-7487	42251e02-b687-4bf1-a1b6-e3dd978542e4	6	-14535	Not Applicable	0	409	Not Available	Not Available	TCGA-HW-7487-D20202;TCGA-HW-7487-D63125;TCGA-HW-7487-D72474;TCGA-HW-7487-D72475;TCGA-HW-7487-D72549;TCGA-HW-7487-D72550;TCGA-HW-7487-D72551	6d1d19fa-d658-4a97-9952-de04f72f0901;ADA2D780-8EDD-4328-9BD3-D4323E1B6739;824F45F9-53CE-48F8-A4D6-FAD259E3FAFD;D01410E1-56B4-427D-A561-FBA14BA9B356;65601EF1-0D8A-43A0-9CB4-1AB501AC127A;D635FD4C-B6F3-40B4-8CBC-609ECE0940DA;7D4EF79D-D7F3-4AC2-9A12-B4F0FC76E561	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;31;17;17;17;17;17	409;1249;1295;1236;1417;Not Available;Not Available	27;948;960;960;1386;1570;1570	Temozolomide;Lomustine;Vincristine (sulfate);Procarbazine;Temozolomide;Carboplatin;Bevacizumab	Not Available;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable;Not Applicable	1;7;7;7;7;7;7	12;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	OTHER, SPECIFY IN NOTES;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Post-operative;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	5/28 - schedule which represents 5 days out of 28 day cycle;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PO;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	150-200;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;NO;NO;NO;NO;NO;NO	2012;2014;2015;2015;2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available;YES;YES	Not Available;Not Available;YES;NO	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-HW-7487-F20201;TCGA-HW-7487-F35025;TCGA-HW-7487-F63122;TCGA-HW-7487-F63127	fed2e776-d255-4c8e-9e91-4ee791cb1db0;484967C5-7342-4CFD-98DD-641422377DC2;56D5D5E3-5EEA-461C-BE0B-B08D8DB4C335;AE0192F7-FC2F-4C56-BA5B-DC0F6810D570	6;13;31;31	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	409;605;1382;1382	Not Available;Not Available;840;1356	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission;Additional New Tumor Event	Not Available;Stable Disease;Progressive Disease;Unknown	Not Available;Not Available;Not Available;Not Available	Not Available;NO;NO;NO	1;9;7;7	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;YES	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease;Progressive Disease	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2012;2012;2014;2014	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	NO	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7487	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HW-7487-R63124	E5769314-5E17-4BF3-9E7E-91F1DFC82399	Not Available	31	930	871	Radiographic Progressive Disease	7	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	Not Available	White Matter	Not Available	Not Available	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2010
TCGA-HW-8322	39	MALE	758	Oligodendroglioma	Central nervous system	Alive	G2	1				WITH TUMOR		39	Not Available	Not Available	Not Available	TCGA-HW-8322	6105c037-90f1-42d9-ac38-6e2252999a64	30	-14548	Not Applicable	0	188	Not Available	Not Available	TCGA-HW-8322-D48690	D240733C-C662-4017-A526-2EA7F9A16968	Not Available	19	Not Available	433	Temozolomide	Not Applicable	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HW-8322-F48689;TCGA-HW-8322-F71499	5A17EA03-519A-4417-8EBC-C35A6436CD66;2C14EA0E-5F06-4849-AEF9-357E34BD32FA	19;31	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	542;758	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	9;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	YES;YES	Stable Disease;Stable Disease	NO;NO	Alive;Alive	2013;2015	Not Available	Not Available	MALE	Not Available	Not Available	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	Not Available	Left	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	8322	Not Available	WITH TUMOR	NO	Not Available	NO	Stable Disease	WHITE	NO																			YES	Not Available	Not Available	YES	NO	HW	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Alive	2012	2012
TCGA-FG-A70Y	20	FEMALE	868	Oligodendroglioma	Central nervous system	Alive	G2	1	490.0			WITH TUMOR		20	Unknown	Not Available	NO	TCGA-FG-A70Y	C6CEB220-282E-4EEF-8D36-4CE0A625CF7E	17	-7421	Not Applicable	0	868	Not Available	Not Available	TCGA-FG-A70Y-D57573	C7CBCD44-0546-4E1D-A33A-79E3D22C8167	Not Available	17	554	515	Temodar	Stable Disease	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	YES;Not Available	YES;Not Available	NO;Not Available	Not Available;Not Available	TCGA-FG-A70Y-F57571;TCGA-FG-A70Y-F65608	8F1ADBAD-5912-4EB7-91B5-0E9C49AAE28A;004DFC49-ED1E-4D87-95F0-63B7ECE233E6	20;25	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	868;868	490;Not Available	Not Available;Not Available	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	NO;YES	3;9	Not Available;Not Available	YES;Unknown	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2014;2014	Unknown	Not Available	FEMALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Evaluated	Left	Not Available	Not Available	NO	NO	Unknown	3	YES	G2	YES	YES	490	NO	Not Available	Not Available	Not Available	YES	No	A70Y	Not Evaluated	WITH TUMOR	NO	NO	NO	Complete Remission/Response	WHITE	NO	Primary Tumor Field	TCGA-FG-A70Y-R57572	7F849699-3B2F-4461-8230-6D315464D688	Not Available	17	554	515	Stable Disease	3	29	5510	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2014	2011
TCGA-E1-A7YO	45	MALE	2282	Oligodendroglioma	Central nervous system	Dead	G3	1	1977.0			WITH TUMOR		45	NO	Not Available	NO	TCGA-E1-A7YO	992452EE-8D9F-406B-9708-7BCB60062743	19	-16770	2282	0	Not Available	Not Available	1408	TCGA-E1-A7YO-D61453	9D9F9B77-FDFB-420E-B458-FD367D8B7231	Not Available	15	23	23	I131-81C6	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Immunotherapy	Not Available	Not Available	Not Available	YES	2014	Not Evaluated	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	NO	TCGA-E1-A7YO-F61455	69737E95-FCF5-44D8-8CF7-D931A480A4BB	15	Not Available	Not Available	2282	Not Available	2192	Not Available	Not Available	Additional New Tumor Event	Progressive Disease	Not Available	NO	8	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	6	NO	G3	YES	NO	1977	Not Available	Not Available	Not Available	Not Available	YES	No	A7YO	Post-Adjuvant Therapy	WITH TUMOR	YES	YES	Unknown	Stable Disease	WHITE	NO																			YES	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2014	1995
TCGA-E1-5302	41	MALE	1525	Astrocytoma	Central nervous system	Dead	G3	1	1242.0			WITH TUMOR		41	Not Available	Not Available	NO	TCGA-E1-5302	837b51d0-e6b7-431b-a5f3-7615bdf12b67	16	-15230	1525	0	Not Available	Not Available	1254	TCGA-E1-5302-D7574;TCGA-E1-5302-D7584;TCGA-E1-5302-D7583;TCGA-E1-5302-D7575;TCGA-E1-5302-D7580;TCGA-E1-5302-D7582;TCGA-E1-5302-D7576;TCGA-E1-5302-D7581;TCGA-E1-5302-D7577;TCGA-E1-5302-D7579;TCGA-E1-5302-D7585;TCGA-E1-5302-D7586;TCGA-E1-5302-D7578	2dcf157b-be37-47b2-bf3c-7b00b52229a6;c5b80291-66ea-4e01-815c-852f2e3ca534;cbc81bae-7c74-4d4e-909e-78de7bec5416;2d204677-5bb2-41ec-bf6e-f4fa7598a8df;61f57525-7536-466e-baa5-6479ad79ba99;d51c21de-9ee1-4f03-9204-7c5eaf5f1647;45fdba35-ce60-4fd5-a286-d019d4420eca;f8ac81dc-e450-4733-8d88-27b575fb5e04;9a3dd9aa-87ee-4227-af43-6166975ee44b;89e69533-028b-448e-a26c-763557be3b07;675eb0bf-0fe1-4378-8402-07804245657e;ffda16d4-ddf9-4f0a-aa66-7096203b6965;cd15de85-acfa-4ddb-b91d-ce601ea1fec3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16;16;16;16;16;16;16;16;16	154;1434;1303;154;433;1303;154;643;294;294;1434;1493;294	48;1322;1255;48;294;1255;48;433;202;202;1322;1434;202	Procarbazine;CPT-11;Tamoxifen;Vincristine;Tamoxifen;CCNU;CCNU;Temozolomide;Procarbazine;CCNU;Celebrex;Temozolomide;Vincristine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1;1;1;1;1;1;1	2;3;1;2;5;1;2;6;2;2;3;2;2	75;340;100;1.4;100;110;130;200;75;130;400;200;1.4	mg/m2;mg/m2;mg;mg/m2;mg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg;mg/m2;mg/m2	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;7;6;1;4;6;1;5;3;3;7;8;3	PO;IV;PO;IV;PO;PO;PO;PO;PO;PO;PO;PO;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;NSAID;Not Available;Not Available	7840;5670;8400;8;14000;200;480;11100;7840;480;100800;3700;8	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	YES	YES	NO	NO	TCGA-E1-5302-F7572	49d1e588-b21e-4282-8b9b-9145b04e0084	13	Not Available	Not Available	1525	Not Available	1242	1254	Not Available	Not Available	Progressive Disease	100	Not Available	1	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Astrocytoma	NO	No	C71.9	9401/3	C71.9	YES	Not Available	Not Available	100	Left	Not Available	Not Available	NO	NO	Not Available	1	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5302	Post-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E1-5302-R7573	2e8b59d8-5b5e-4982-8c4c-7fedb64ec914	2	16	195	154	Not Available	1	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Not listed in Medical Record	NO	YES	E1	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	1998
TCGA-HT-7873	29	MALE	718	Oligoastrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		29	NO	Not Available	NO	TCGA-HT-7873	c371e2b4-209f-40f3-a30c-51df8270b5de	12	-10805	Not Applicable	0	298	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available;NO	Not Available;NO	Not Available;Not Available	Not Available;Not Available	TCGA-HT-7873-F35010;TCGA-HT-7873-F48004	7B5DA072-E9BC-4FBF-868B-68C84B21905C;7A1048C0-8594-48A5-AD64-0FBE19EEC940	12;3	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	298;718	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	NO;NO	9;9	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Stable Disease;Stable Disease	YES;YES	Alive;Alive	2012;2013	Not Available	Not Available	MALE	NO	YES	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	YES	NO	9	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7873	Not Available	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7873-R35011	77A044C3-FBD4-4E99-8D90-6920D2F777CA	Not Available	12	122	80	Stable Disease	9	30	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-DU-5870	34	FEMALE	5546	Oligodendroglioma	Central nervous system	Alive	G2	1	4347.0			WITH TUMOR		34	Not Available	Not Available	Not Available	TCGA-DU-5870	eb42625e-fbbb-4bee-bbe9-315b3ca2138a	27	-12764	Not Applicable	0	5546	Not Available	4445	TCGA-DU-5870-D14733;TCGA-DU-5870-D14723	ea48cccb-3567-41ba-868f-0f3ffa507732;d81e218d-faf8-4926-9cbb-bc8f97033156	Not Available;Not Available	27;27	4901;4543	4536;4500	Temozolomide;Temozolomide	Not Available;Not Available	7;7	12;1	150;75	mg/m2;mg/m2	PROGRESSION;PROGRESSION	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	230;Not Available	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	Not Available	Not Available	Not Available	Not Available	Headaches	> 181 Days	YES	YES	YES	NO	TCGA-DU-5870-F14719	480c2306-a5b6-4617-a0c2-a398f0b758d2	27	4437	Not Available	Not Applicable	5546	4347	4671	Not Available	Not Available	Stable Disease	70	Not Available	7	Not Available	YES	Not Available	Post-Adjuvant Therapy	WITH TUMOR	NO	Progressive Disease	YES	Alive	2011	Not Available	Not Available	FEMALE	Not Available	YES	Oligodendroglioma	NO	No	C71.9	9450/3	C71.9	YES	Not Available	Not Available	70	Right	Not Available	Not Available	NO	YES	Not Available	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5870	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Local Recurrence;Primary Tumor Field	TCGA-DU-5870-R14722;TCGA-DU-5870-R14720	6cde4af2-08d3-4f77-85ed-68a93544c332;51dd90f7-9a1a-496f-a705-6cfd1eb309a4	2;1	27;27	4543;62	4500;31	Not Available;Not Available	7;7	Not Available;Not Available	5040;Not Available	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	PROGRESSION;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	NO	YES	Not listed in Medical Record	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	1995
TCGA-HT-7858	28	MALE	1540	Astrocytoma	Central nervous system	Alive	G2	0	1540			TUMOR FREE		28	NO	Not Available	NO	TCGA-HT-7858	b6951c37-377e-49b9-862c-968082e8682f	2	-10422	Not Applicable	0	1540	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7858-F29426	01d9aa5e-a5f0-4f07-b38e-fa1d6d242cfe	16	Not Available	Not Available	Not Applicable	1540	Not Available	673	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	90	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2012	NO	Not Available	MALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	Not Available	Right	Not Available	Not Available	NO	NO	NO	3	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7858	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7858-R29427	11ca6be9-f6f0-443d-af7a-8737d5416752	1	16	69	20	Not Available	3	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	NO	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2007
TCGA-DU-5852	61	FEMALE	205	Oligoastrocytoma	Central nervous system	Dead	G3	1	24.0			WITH TUMOR		61	Not Available	Not Available	Not Available	TCGA-DU-5852	9ed5af0e-c87f-46ff-81e7-9d3041b4034e	26	-22348	205	0	Not Available	Not Available	11	TCGA-DU-5852-D17046	37497c94-f7b5-4748-9413-bd374ef59b97	Not Available	26	52	26	Temozolomide	Not Available	9	1	Not Available	mg/m2	PROGRESSION	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	> 181 Days	YES	YES	NO	NO	TCGA-DU-5852-F17044	124ca139-52e7-4dfd-bcb4-95b84dd78c73	26	Not Available	Not Available	205	Not Available	24	26	Not Available	Not Available	Progressive Disease	50	Not Available	9	Not Available	YES	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	NO	Progressive Disease	NO	Dead	2011	Not Available	Not Available	FEMALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.9	9382/3	C71.9	YES	Not Available	Not Available	80	Left	Not Available	Not Available	NO	NO	Not Available	9	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5852	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-5852-R17045	1ae2bac9-893e-4a0a-b254-4cb750b4f945	1	26	97	26	Not Available	9	26	5140	NO	OTHER	Intensity modulated radiotherapy	PROGRESSION	Not Available	cGy	2011	YES	NO	White Matter	NO	YES	DU	Supratentorial, Temporal Lobe	Central nervous system	NO	Dead	2011	2010
TCGA-FG-7641	31	MALE	627	Oligodendroglioma	Central nervous system	Alive	G2	0	627			TUMOR FREE		31	NO	Not Available	NO	TCGA-FG-7641	0f0d9a7f-dd85-48aa-b5b2-deff5bb6bdeb	5	-11357	Not Applicable	0	283	Not Available	Not Available																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-FG-7641-F32993;TCGA-FG-7641-F43341	9F7E7DAF-DC0D-4794-9511-19AD6B873E1C;406DB64F-89A9-450A-8BA3-CEB89A2DF64E	18;17	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	313;627	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	Not Available;NO	6;5	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2012;2013	NO	Not Available	MALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	Not Available	Left	Not Available	Not Available	NO	NO	NO	6	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7641	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	WHITE	Not Available																			NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2012	2011
TCGA-QH-A65Z	54	MALE	427	Oligodendroglioma	Central nervous system	Alive	G2	0	427			TUMOR FREE		54	NO	Not Available	NO	TCGA-QH-A65Z	C2F9DFF7-751B-4704-8E6E-F4F800297030	2	-19921	Not Applicable	0	125	Not Available	-10	TCGA-QH-A65Z-D47242;TCGA-QH-A65Z-D47233;TCGA-QH-A65Z-D47227	417D497C-BAB9-4E2D-8ADC-CAB6A66993E8;BEB98A3B-70E9-4079-AB18-C75B959D1697;035258F9-5274-43D9-ADF6-ECE0403B8F97	Not Available;Not Available;Not Available	29;29;29	215;295;315	36;36;36	VINCRISTINE;LOMUSTINE;procarbazine	Stable Disease;Stable Disease;Stable Disease	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	1	NO	NOT HISPANIC OR LATINO	YES	NO	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	Not Available	Not Available	TCGA-QH-A65Z-F59568	99C52DD6-0D3E-4C46-A3E1-4DC2F0E54DE7	10	Not Available	Not Available	Not Applicable	427	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	6	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	NO	Not Available	90	Right	YES	IHC	YES	NO	NO	8	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A65Z	Preoperative	TUMOR FREE	YES	YES	YES	Unknown	WHITE	NO	Primary Tumor Field	TCGA-QH-A65Z-R59569	61ECE88C-1F63-48D1-BDAB-2B4799671D48	Not Available	11	375	337	Stable Disease	6	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	YES	YES	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-HW-7493	40	FEMALE	2107	Astrocytoma	Central nervous system	Alive	G2	1				WITH TUMOR		40	Not Available	Not Available	Not Available	TCGA-HW-7493	debe24c5-e4df-4e80-82f6-8f40395aa9e6	6	-14767	Not Applicable	0	285	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-HW-7493-F35016;TCGA-HW-7493-F71516	EFA1541F-1FFB-4C8F-A466-BEEE014AD078;3E1B09AB-B76A-4AF0-B24B-3F3B4B113EC0	13;31	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1092;2107	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Applicable;Stable Disease	Not Available;Not Available	NO;NO	9;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	NO;NO	Stable Disease;Stable Disease	NO;YES	Alive;Alive	2012;2015	Not Available	Not Available	FEMALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	Not Available	Not Available	1	Not Available	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7493	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-HW-7493-R71517	B1DADA56-0E9C-4FD8-9E5A-2D9E0A90ABC8	Not Available	31	1662	1632	Stable Disease	3	Not Available	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	YES	Not Available	White Matter	Not Available	Not Available	HW	Supratentorial, Temporal Lobe	Central nervous system	Not Available	Alive	2012	2009
TCGA-TQ-A7RF	27	FEMALE	650	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		27	NO	Not Available	NO	TCGA-TQ-A7RF	F5268956-789D-4B22-8F19-A3AC9353D33D	25	-9919	Not Applicable	0	650	Not Available	Not Available																								Unknown	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	> 181 Days	Not Available	Not Available	Not Available	Not Available	TCGA-TQ-A7RF-F61331	AD08CBCD-1218-42A0-8B1C-A0B67D521BFD	19	Not Available	Not Available	Not Applicable	650	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	NO	2	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2015	NO	Not Available	FEMALE	NO	YES	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	Not Available	Not Available	Unknown	Right	Not Available	Not Available	NO	YES	NO	9	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A7RF	Preoperative	WITH TUMOR	YES	YES	YES	Partial Remission/Response	WHITE	YES																			YES	YES	White Matter	NO	YES	TQ	Supratentorial, Temporal Lobe	Central nervous system	YES	Alive	2014	2012
TCGA-HT-7689	58	FEMALE	455	Oligodendroglioma	Central nervous system	Alive	G2	0	455			TUMOR FREE		58	NO	Not Available	NO	TCGA-HT-7689	d58b535a-6c95-43bb-ad88-0600e6447537	1	-21331	Not Applicable	0	125	Not Available	8	TCGA-HT-7689-D29658;TCGA-HT-7689-D29661	fd8e3b77-837a-4fdb-a3eb-02ef6930f2f8;8ea0838b-141f-4bbe-87c7-1d89688e3ce7	Not Available;Not Available	15;15	94;334	53;126	Temodar;Temodar	Not Available;Not Available	3;3	1;5	140;260	mg;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	PO;PO	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5880;6500	mg;mg	Not Available;Not Available	2012;2012	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7689-F29648	e51861b5-7796-429e-83f5-55591edfe09f	27	Not Available	Not Available	Not Applicable	455	Not Available	455	Not Available	Scheduled Follow-up Submission	Not Available	70	Not Available	3	Not Available	NO	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	NO	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Not Available	Not Available	60	Left	Not Available	Not Available	Not Available	YES	NO	3	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7689	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-HT-7689-R29662	8cfd51a1-deb2-44e5-84a5-92385d6d30ba	1	15	92	53	Not Available	3	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2009	NO	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2012	2009
TCGA-HT-7607	61	FEMALE	96	Astrocytoma	Central nervous system	Dead	G2	1				WITH TUMOR		61	NO	Not Available	NO	TCGA-HT-7607	24ebd152-f8d7-44eb-af7f-8ee7f2e458e4	27	-22585	96	0	Not Available	Not Available	8																								Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7607-F35003	31E26DF5-C3E7-42FF-B16F-7CD61A7F386F	12	Not Available	Not Available	96	Not Available	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Not Available	NO	Not Available	Not Available	WITH TUMOR	NO	Progressive Disease	NO	Dead	2012	NO	Not Available	FEMALE	YES	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	1p19q codeleted	70	Left	Not Available	Not Available	NO	YES	NO	1	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7607	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	NO	Not Available	WHITE	Not Available																			YES	NO	White Matter	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2012	2008
TCGA-DU-7011	25	MALE	3200	Oligoastrocytoma	Central nervous system	Dead	G2	1				WITH TUMOR		25	Not Available	Not Available	Not Available	TCGA-DU-7011	cb598780-9e42-4167-b487-eec90ad4f36f	28	-9322	3200	0	Not Available	Not Available	149																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	91 - 180 Days	Not Available	Not Available	Not Available	Not Available	TCGA-DU-7011-F17074	405c1282-118b-4f36-8e0b-1c876bb05263	28	Not Available	Not Available	3200	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	Stable Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	NO	Oligoastrocytoma	NO	No	C71.0	9382/3	C71.0	YES	Not Available	Not Available	80	Right	Not Available	Not Available	NO	NO	Not Available	9	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7011	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	YES	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-7011-R17076	9cf62294-d6cb-4e35-b98b-f246de6249f5	1	28	233	187	Not Available	9	31	5580	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	NO	Cerebral Cortex	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2011	2000
TCGA-FG-6691	23	FEMALE	1257	Astrocytoma	Central nervous system	Alive	G2	1	913.0			TUMOR FREE		23	NO	Not Available	NO	TCGA-FG-6691	e4d9b696-3311-44e7-9191-fde56c080a00	8	-8403	Not Applicable	0	103	Not Available	-9	TCGA-FG-6691-D63746	3B2BB044-E4EE-47E4-96F2-8D84AB7943C3	Not Available	15	Not Available	1135	Temodar	Not Applicable	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available;Not Available;Not Available;YES	Not Available;Not Available;Not Available;YES	Not Available;Not Available;Not Available;YES	Not Available;Not Available;Not Available;Not Available	TCGA-FG-6691-F14674;TCGA-FG-6691-F32858;TCGA-FG-6691-F41568;TCGA-FG-6691-F63744	6be6d043-d678-4396-b912-b64cbd2f3870;51A532EE-7CB4-4A3E-90EE-5001BF7C6E85;006941F5-55E9-4B42-BB1B-A9AED40CC7BD;6547A7FC-CD36-46B1-9A5B-3504969EE398	8;14;21;15	Not Available;Not Available;Not Available;984	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	103;382;729;1257	Not Available;Not Available;Not Available;913	103;235;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Stable Disease	90;80;Not Available;Not Available	Not Available;Not Available;NO;NO	8;6;3;8	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Not Available;Not Available;Not Available;Not Available	Adjuvant therapy;Adjuvant therapy;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE;WITH TUMOR	NO;NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2011;2012;2013;2014	NO	Not Available	FEMALE	NO	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	100	Right	Not Available	Not Available	NO	NO	NO	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6691	Preoperative	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Not Available	Local Recurrence	TCGA-FG-6691-R63745	166D0E63-CA7C-4B7A-81C1-D7E28F654CE4	Not Available	15	1058	1020	Stable Disease	8	25	45	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	NO	White Matter	YES	NO	FG	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2011	2011
TCGA-HT-7676	26	MALE	5	Oligodendroglioma	Central nervous system	Alive	G2	0	5			TUMOR FREE		26	Unknown	Not Available	Unknown	TCGA-HT-7676	9ee268a7-fa71-4f3f-919f-cf4ee1de2658	16	-9667	Not Applicable	0	5	Not Available	Not Available																								Unknown	Unknown	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Headaches	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-7676-F51023	1F76DF32-DF78-4FC4-AF9E-A95739C9A4C6	5	Not Available	Not Available	Not Applicable	5	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	11	Not Available	Unknown	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Alive	2013	Unknown	Not Available	MALE	Unknown	YES	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	Unknown	Left	Not Available	Not Available	Unknown	NO	Unknown	7	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	7676	Not Available	TUMOR FREE	Unknown	Unknown	Unknown	Not Available	WHITE	Unknown																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2009
TCGA-HT-A5R5	33	FEMALE	4	Oligodendroglioma	Central nervous system	Alive	G2	0	4			TUMOR FREE		33	Unknown	Not Available	Unknown	TCGA-HT-A5R5	618F2AA7-D1B6-430D-A157-D3D956EDEFBE	26	-12403	Not Applicable	0	4	Not Available	Not Available																								Unknown	Unknown	HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Seizures	31 - 90 Days	Not Available	Not Available	Not Available	Not Available	TCGA-HT-A5R5-F61085	2FAA740F-0E6E-4FF6-87E2-57DB5C9FB215	23	Not Available	Not Available	Not Applicable	4	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	6	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2014	Unknown	Not Available	FEMALE	Unknown	Unknown	Oligodendroglioma	NO	No	C71.0	9450/3	C71.0	YES	Unknown	Not Available	Unknown	Left	Not Available	Not Available	Unknown	NO	Unknown	7	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	No	A5R5	Not Available	TUMOR FREE	Unknown	Unknown	Unknown	Complete Remission/Response	WHITE	Unknown																			YES	NO	Not listed in Medical Record	NO	YES	HT	Supratentorial, Temporal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-A4MX	47	MALE	569	Astrocytoma	Central nervous system	Alive	G2	0	569			TUMOR FREE		47	NO	Not Available	NO	TCGA-FG-A4MX	AD80A042-C4B4-445C-9678-1C2614422684	31	-17381	Not Applicable	0	113	Not Available	-23																								0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Motor/Movement Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-FG-A4MX-F57707	049E1DFF-D191-4967-9548-3E3B78F87196	21	Not Available	Not Available	Not Applicable	569	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	YES	Alive	2014	NO	Not Available	MALE	NO	NO	Astrocytoma	NO	No	C71.1	9400/3	C71.1	YES	NO	Not Available	100	Right	NO	IHC	YES	NO	NO	1	YES	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A4MX	Preoperative	TUMOR FREE	NO	NO	NO	Complete Remission/Response	WHITE	YES	Primary Tumor Field	TCGA-FG-A4MX-R39717	60498AEB-C00E-48B5-A219-4992C24366A2	Not Available	30	76	30	Complete Response	1	33	5940	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2012
TCGA-FG-6689	30	MALE	454	Astrocytoma	Central nervous system	Alive	G2	1	119.0			WITH TUMOR		30	YES	cats	NO	TCGA-FG-6689	8d07b1e8-5d1d-4a43-b616-d29dd58ce5fe	8	-11312	Not Applicable	0	190	Not Available	-10	TCGA-FG-6689-D32856	7EDCB89C-DE05-43F5-BFB5-03D43EB7FA16	Not Available	14	424	267	Temodar	Stable Disease	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	NO	NOT HISPANIC OR LATINO	YES	NO	< 12 Years	> 20 Years	Not Available	Headaches	31 - 90 Days	NO;YES;Unknown	NO;NO;Unknown	NO;NO;NO	Not Available;NO;Not Available	TCGA-FG-6689-F14671;TCGA-FG-6689-F32855;TCGA-FG-6689-F43039	84016ac2-b58a-4b81-8150-d6ddf3aeb1e8;ACDB5A78-4A6F-4382-BFBA-BDFC64006D08;BF44E681-26E7-48E7-A3DE-351897A9F644	8;14;20	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	190;454;Not Available	119;218;218	190;Not Available;Not Available	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event;Scheduled Follow-up Submission	Progressive Disease;Stable Disease;Unknown	90;Not Available;Not Available	Not Available;Not Available;YES	8;6;5	Not Available;Not Available;Not Available	YES;YES;YES	Not Available;Not Available;Not Available	Post-Adjuvant Therapy;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO	Progressive Disease;Progressive Disease;Progressive Disease	YES;YES;YES	Alive;Alive;Not Available	2011;2012;2013	NO	Not Available	MALE	YES	YES	Astrocytoma	NO	No	C71.0	9400/3	C71.0	YES	NO	Not Available	70	Right	Not Available	Not Available	NO	YES	YES	8	NO	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6689	Preoperative	WITH TUMOR	Not Available	NO	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-FG-6689-R14672	741f9809-4511-43c4-a677-ced9ae76243b	1	8	188	139	Not Available	8	30	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	NO	NO	Not listed in Medical Record	YES	NO	FG	Supratentorial, Frontal Lobe	Central nervous system	YES	Alive	2011	2011
TCGA-DU-6402	52	MALE	214	Astrocytoma	Central nervous system	Dead	G3	1	103.0			WITH TUMOR		52	Not Available	Not Available	Not Available	TCGA-DU-6402	152f028e-ee29-40e0-8e75-5cafffacbd45	21	-19207	214	0	Not Available	Not Available	Not Available	TCGA-DU-6402-D14716	3ae81b40-a276-4005-9c64-97ceaaedc041	Not Available	31	122	117	Temozolomide	Not Available	5	01	100	mg/m2	PROGRESSION	Not Applicable	01	PO	NO	Chemotherapy	Not Available	200	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Seizures	0 - 30 Days	NO	NO	NO	Not Available	TCGA-DU-6402-F14714	f77465a6-5d0d-48bf-9e84-1be6187e80c6	31	Not Available	Not Available	214	Not Available	103	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	5	Not Available	YES	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	YES	Dead	2011	Not Available	Not Available	MALE	Not Available	Not Available	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Not Available	Not Available	Not Available	Right	Not Available	Not Available	NO	Not Available	Not Available	6	Not Available	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6402	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DU-6402-R14715	43afee50-a55e-4126-a962-4c8acba72142	01	31	88	26	Not Available	5	30	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	YES	Not Available	Not listed in Medical Record	NO	YES	DU	Supratentorial, Frontal Lobe	Central nervous system	Not Available	Dead	2011	1998
TCGA-DU-A6S7	27	FEMALE	638	Astrocytoma	Central nervous system	Alive	G3	0	638			WITH TUMOR		27	NO	Not Available	NO	TCGA-DU-A6S7	A56C2083-33D5-4C98-B85F-3B68A3D80ADD	22	-10170	Not Applicable	0	220	Not Available	-14	TCGA-DU-A6S7-D50314;TCGA-DU-A6S7-D50315;TCGA-DU-A6S7-D71616	94B12D32-E713-4FE1-A354-7969289F8195;B5521E8F-701E-4DC4-B35D-A0B7C318DDD2;861014FE-D585-429C-8C4B-933CFB115738	Not Available;Not Available;Not Available	22;22;27	57;Not Available;464	23;129;129	Temozolomide;Temozolomide;Temozolomide	Stable Disease;Not Applicable;Stable Disease	10;10;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2015	Not Evaluated	NO	NOT HISPANIC OR LATINO	NO	NO	12 - 20 Years	Not Available	Not Available	Seizures	> 181 Days	NO	NO	Not Available	Not Available	TCGA-DU-A6S7-F71615	A24E0A8D-118E-4A0F-AC39-43AB0851392F	27	Not Available	Not Available	Not Applicable	638	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	NO	Not Available	Not Available	TUMOR FREE	YES	Stable Disease	YES	Alive	2015	NO	Not Available	FEMALE	YES	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	NO	Not Available	90	Left	YES	IHC	YES	NO	NO	10	NO	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6S7	Preoperative	WITH TUMOR	YES	YES	NO	Not Applicable	WHITE	YES	Primary Tumor Field	TCGA-DU-A6S7-R50313	22B08DA5-75AE-4F6F-A038-D85C25286B91	Not Available	22	67	23	Stable Disease	10	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	Not listed in Medical Record	YES	NO	DU	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-QH-A6X8	56	FEMALE	509	Oligodendroglioma	Central nervous system	Alive	G3	1				WITH TUMOR		56	NO	Not Available	NO	TCGA-QH-A6X8	D209CFFC-FE21-4AE7-B610-E5668EA84A3B	9	-20771	Not Applicable	0	144	Not Available	144	TCGA-QH-A6X8-D52189	024FC6C6-A023-4C1A-B135-9288BDD54730	Not Available	9	292	49	temozolomide	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NO	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	Not Available	Mental Status Changes	0 - 30 Days	Not Available	Not Available	Not Available	Not Available	TCGA-QH-A6X8-F67753	A7E4AF59-6E8F-4C35-A001-B2F9304893EB	11	Not Available	Not Available	Not Applicable	509	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	11	Not Available	NO	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	YES	Alive	2014	Not Available	Not Available	FEMALE	NO	NO	Oligodendroglioma	NO	No	C71.0	9451/3	C71.0	YES	NO	Not Available	100	Left	YES	IHC	YES	YES	NO	12	YES	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	No	A6X8	Post-Adjuvant Therapy	WITH TUMOR	YES	YES	NO	Stable Disease	WHITE	YES	Primary Tumor Field	TCGA-QH-A6X8-R52188	C816FB69-CF94-43B6-9F7A-C1390854B0CB	Not Available	9	90	49	Stable Disease	12	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	YES	NO	White Matter	YES	NO	QH	Supratentorial, Frontal Lobe	Central nervous system	NO	Alive	2013	2013
TCGA-S9-A7R8	44	FEMALE	961	Astrocytoma	Central nervous system	Dead	G3	1	698.0			WITH TUMOR		44	NO	Not Available	NO	TCGA-S9-A7R8	7883E417-A793-4614-9528-6C2E9E44379F	11	-16275	961	0	Not Available	Not Available	-1	TCGA-S9-A7R8-D53396;TCGA-S9-A7R8-D53398	0036ABAB-DE64-4562-AEED-BD2BD67FA6CE;953AA7F0-A050-4742-826F-20A6C094BC2C	Not Available;Not Available	11;11	786;925	771;803	Temozolamide;Nimustine	Clinical Progressive Disease;Clinical Progressive Disease	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	1	NO	NOT HISPANIC OR LATINO	Unknown	Unknown	Not Available	Not Available	Not Available	Seizures	31 - 90 Days																														NO	Not Available	FEMALE	NO	NO	Astrocytoma	NO	No	C71.0	9401/3	C71.0	YES	Unknown	Not Available	90	Right	Not Available	Not Available	NO	NO	NO	12	NO	G3	YES	YES	698	YES	698	YES	698	YES	No	A7R8	Preoperative	WITH TUMOR	NO	YES	YES	Progressive Disease	WHITE	YES	Primary Tumor Field;Local Recurrence	TCGA-S9-A7R8-R53389;TCGA-S9-A7R8-R53392	EAF8A862-C571-4E5E-B679-17DC37F94DA1;63F68FDB-F7F4-4977-9F76-58FAD41F2D2E	Not Available;Not Available	11;11	Not Available;786	54;771	Stable Disease;Radiographic Progressive Disease	12;12	30;11	60;22	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2013	YES	NO	Not listed in Medical Record	NO	YES	S9	Supratentorial, Frontal Lobe	Central nervous system	NO	Dead	2013	2004
